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Abstract: New Approaches to Stereocontrolled Glycosylation 
Govind Pratap Singh, University of Canterbury 2015 
 
The conceptually simple process of linking carbohydrate units by glycosylation has proven to be one 
of the most difficult synthetic processes to control from a stereochemical perspective. In particular it 
is the stereocontrolled synthesis of 1,2-cis glycosyl linkages (e.g. α-glucosides, β-mannosides) which 
poses the most difficult challenge. The research presented in this thesis describes new ways in which 
stereocontrol in glycosylation reactions can be achieved.  
New methods of neighbouring group participation have been explored, utilising novel protecting 
groups at the 2-postion of a series of glycosyl donors.  
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In particular the use of glucosyl donors 3, bearing a 2-O-(2-(2,4,6- trimethoxyphenyl)thio)ethyl 
protecting group at the 2-hydroxyl, have shown exceptional α-selectivity especially when a 
completely armed donor was used.  
Work within this thesis also describes the use of chiral Brønsted acid catalysts in stereoselective 
glycosylation reactions. However the yields and stereoselectivity obtained were not very 
encouraging. 
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s                                  Singlet  
SN2                             Nucleophilic substitution, bimolecular  
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Chapter 1: Introduction  
1.1 Significance of carbohydrates and glycobiology  
Amongst the four key classes of biological macromolecules viz proteins, DNA, lipids and 
carbohydrates,
[1]
 carbohydrates show an unrivalled degree of structural diversity.
[2]
 Unlike 
proteins and DNA, which form linear chains, carbohydrates can form branched polymers and 
oligomers. The ‘Glycocode’[3] – a term used to define the huge structural diversity observed in 
the carbohydrates, was devised due to the combination of various factors listed below.  
(a) Variations in ring size (e.g. furanosyl, pyranosyl); 
(b) The inherent difference in the configuration at different chiral centres of monosaccharides 
(e.g. gluco, manno, galacto); 
(c) The number of possible sites for a glycosidic linkage to occur, which leads to vast 
numbers of non-linear structures that polysaccharides and oligosaccharides can adopt. 
(d) The anomeric configuration of glycosidic linkages, due to the formation of α- and β- 
glycosides;  
(e) Modification of carbohydrates (e.g. phosphorylation, sulfation, and acetylation). 
This structural diversity is responsible for the wide range of functions that carbohydrates play 
within Nature, and the vital roles they play in various biological events. Carbohydrates are 
mainly present in the cells in the form of oligosaccharides attached to lipids or proteins (known 
as glycolipids or glycoproteins, respectively) which are collectively known as glycoconjugates. 
Glycoproteins are of particular interest; up to half of human proteins are O- or N-glycosylated 
(through either serine/threonine, or asparagine amino acid residues). The carbohydrate moieties 
of these glycoproteins are vital in many biological processes, such as cell growth, cell-cell 
adhesion and signalling,
[4]
 fertilization,
[5]
 immune defence,
[6]
 neuronal development
[7]
 and 
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inflammation.
[8]
 Furthermore, protein glycosylation, either as a co- or post-translational 
modification, may be necessary for correct protein folding, and can also affect the protein’s 
overall stability and conformation,
[9]
 its susceptibility to proteases
[10]
 and its circulatory 
lifetime.
[11]
  
The importance of carbohydrates in a plethora of biological processes continues to fuel 
enormous interest in the field of Glycobiology. However the lack of pure and structurally well-
defined carbohydrates and glycoconjugates proves to be a major obstacle to further advances in 
this area.
[12]
 Glycoconjugates are often found in low concentrations and in microheterogeneous 
forms naturally, making them very difficult to isolate and purify. For example glycoproteins, are 
commonly found as mixtures in which the same protein structure is attached to a variety of 
different oligosaccharides, which are termed glycoforms. Frequently these materials differ in 
biological activity, but their similar structures and physical properties means that isolation of a 
single protein glycoform is almost impossible.
[13]
  
The total synthesis of oligosaccharides by chemical and/or enzymatic means is therefore of 
prime importance in Glycobiology. Enzymatic synthesis utilizes glycosyl transferases and 
glycosidases for the synthesis of oligosaccharides.
[14]
 Though they are efficient catalysts for the 
synthesis of various oligosaccharides, the availability of enzymes that are capable of performing 
desired transformations remains a limiting factor in many cases. In terms of stereo- and 
regiospecificity, enzymes are extremely efficient, and their organization into assembly lines in 
biological systems allows the production of highly complex carbohydrates. However, their 
precise selectivity for only a specific acceptor, the high costs of the required donors, and the lack 
of availability, resulting from limited stability and solubility, are still significant hinderances for 
the widespread exploitation of glycosyl transferases in synthetic glycochemistry.
[15]
 Therefore 
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chemical synthesis currently remains the principal synthetic tool available to the scientific 
community.
[16]
  
1.2 Chemical synthesis of oligosaccharides  
In the past, most of the research aimed at improving the efficiency and stereoselectivity of the 
synthesis of oligosaccharides has focused on the development of new leaving groups, new 
promoters (activators), and through the optimization of general reaction conditions. However, as 
these gradual enhancements have not yet been able to completely control the outcome of all 
glycosylation reactions, studies have additionally been directed towards gaining a better 
understanding of the mechanisms and energies controlling this fundamental reaction.
[17]
 There 
are many factors that can have a profound effect on the reactivity of a glycosyl donor and 
acceptor and influence the selectivity of glycosidic bond formation. 
The fundamental reaction performed between two monosaccharide units is the glycosylation 
reaction. Nature flawlessly and repeatedly executes this reaction to yield complex poly- and 
oligosaccharides.
[18]
 However, the chemical installation of the glycosidic linkage remains 
cumbersome, even with the aid of modern technologies. Due to significant research in the field 
over many years the formation of most glycosidic bonds can be achieved.
[17]
 Unfortunately, it is 
the inability to effectively predict and control the stereoselectivity of the reaction that has proven 
to be the synthetic hurdle. Indeed attempted improvement of this reaction has therefore remained 
an underlying theme throughout the history of carbohydrate chemistry. With recent advances in 
the rapidly expanding field of Glycobiology,
[19]
 the demand for reliable and stereocontrolled 
glycosylation methodologies has now increased, thus elevating the priority of the improvement 
of synthetic capabilities. 
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Oligosaccharide assembly hinges upon the linking of pre-formed building blocks by 
glycosylation. In a typical glycosylation reaction, the coupling of two carbohydrates is achieved 
by treating a glycosyl donor 1.1, which bears a suitable anomeric leaving group, with a promoter 
to generally form an intermediate oxocarbenium ion 1.2. Glycosyl acceptor 1.3, strategically 
protected to have only a single free hydroxyl group, then serves as the nucleophile producing the 
glycoside product 1.4 (Scheme 1.1).
[20]
 A variety of anomeric leaving groups and corresponding 
activation protocols are available to the synthetic chemist. 
O
PGO
PGO
PGO X
O
PGO
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OOPG PG
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PGO OPG
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O
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1.1
1.2
1.3
1.4
X = Leaving group
PG = Protecting group
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 1.3 Historical background and mechanistic insights 
The first chemical glycosylation was reported by Arthur Michael some 130 years ago.
[21]
 This 
reaction proceeded by the nucleophilic displacement of an anomeric leaving group (chloride), 
from the donor 1.5 using potassium aryloxide 1.6 to get the desired glycoside 1.7 (Scheme 1.2). 
It is remarkable that even without much structural or other evidence, Michael’s vision of how the 
anomeric substitution would proceed was fundamentally accurate. 
O
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Scheme 1.2 
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A decade later, Emil Fischer took a different approach to the glycosylation reaction.
[22]
 Fischer 
perceived the unprotected monosaccharide unit as a hemiacetal, and the reaction was carried out 
under harsh acidic conditions in an excess of the desired glycosyl acceptor. Although 
conceptually the simplest way to obtain a glycoside, the Fischer method commonly leads to 
equilibrium of inter-converting species, all of which are formed in addition to the desired 
product. For example, D-Glucose 1.8 upon Fischer glycosylation with methanol 1.9 actually 
results in the formation of α-methyl glucopyranosides (thermodynamically favored) 1.10 and 
methyl glucofuranosides 1.11 (Scheme 1.3).  
D-Glucose
MeOH
H+
O
HO
HO
HO
OH
+
O
OH
OMeHO HO
OH
(1.8)
(1.9)
(1.10) (1.11)
OMe
 
Scheme 1.3 
In 1901, Koenigs and Knorr
[23]
 (and independently Fischer and Armstrong)
[24]
 took the chemical 
glycosylation approach a step further by reacting glycosyl halides with alcohol acceptors in the 
presence of Ag2CO3 or Ag2O. For example, α-glucosyl bromide 1.12 was reacted with methanol 
1.13 to give β-methyl glucoside 1.14 in presence of Ag2CO3 (Scheme 1.4). 
O
O
AcO
AcO
OAc
Ac
Br
+ MeOH
Ag2CO3
DCM
O
O
AcO
AcO
OAc
Ac
OMe
1.12
(1.13)
1.14
 
Scheme 1.4 
Mechanistic analysis of the glycosylation reaction has led to very interesting insights. In the 
Koenigs and Knorr glycosylation reaction, the Ag2CO3/Ag2O were used as mild bases with the 
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primary intention to scavenge the hydrogen halide by-product. It was only much later, that it was 
realized that the silver salts played an active role by assisting the leaving group departure.
[25]
 
Based on the observation that Koenigs-Knorr glycosylation was very selective, leading to 
complete inversion of the anomeric configuration, it was concluded that the glycosylation 
reactions were a result of “Walden inversion”,[26] otherwise known as concerted nucleophilic 
substitution.
[27]
   
To provide insight into the glycosylation reaction, the energy required for nucleophilic 
substitution to occur was calculated for various 1,2-disubstituted cyclohexanes both in the 
absence or presence of participation. These studies led to the conclusion that the unassisted 
departure of a leaving group to yield a free ionic species would require much more energy than a 
concerted nucleophilic displacement that occured via intramolecular participation.
[28]
 
Consequently, the glycosylation reaction is thought to proceed through a total of four distinct 
steps:
[29]
  
(a) Formation of the donor–promoter complex 1.16, which can be reversible or irreversible 
depending on the system involved;  
(b) Ionization of the glycosyl donor, a typically irreversible act, and the slowest step (RDS) 
of the reaction, leading to formation of an oxocarbenium ion 1.17;  
(c) Nucleophilic attack by the glycosyl acceptor, forming protonated glycosides 1.19, 1.20;  
(d) Proton transfer to give neutral glycoside 1.21, 1.22. 
Product selectivities can arise from the stabilization provided by the anomeric effect, which is 
thought to be responsible for product formation under conditions of thermodynamic control. For 
example, cases have been reported reporting non-kinetically controlled glycosylations, in which 
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the initially formed β-glycoside is then anomerized into its thermodynamically more stable α-
counterpart.
[30]
 A schematic representation of the mechanism is shown in the Scheme 1.5.
[17]
 
O
LG
glycosyl donor
1.15
(a) Activation
: P
Promoter
O
LG
P
donor-promoter
complex
1.16
(b) Dissociation
(RDS)
O
:
glycosyl cation
O
oxocarbenium ion
1.17
PGO
O
O
H
a
b
glycosyl acceptor
a b
O
O
O
H
O O
O
H
1.18
1.19
1.20
Protonated
glycosides
(c) Nucleophilic
attack
(d) Proton transfer
O
O
O
OR
OR
OR
OR
OR
OR
OR
O O
O
1.22
OR
1.21
1,2-cis glycoside
main product
(anomeric effect)
1,2-trans glycoside
 
Scheme 1.5 
 
 
 
1.22 
1.16 
1.21 
1.19, 1.20 
1.17 
1.15 
Energy Profile vs Reaction Co-ordinate  
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1.4 Glycosyl donors 
A glycosyl donor is a carbohydrate mono- or oligosaccharide that will react with a suitable 
glycosyl acceptor to form a new glycosidic bond. By convention, the donor is the member of this 
pair that contains the resulting anomeric carbon of the new glycosidic bond. The resulting 
reaction is referred to as a glycosylation, or chemical glycosylation. A leaving group is required 
at the anomeric position of the glycosyl donor.
[31]
 A selection of some commonly used glycosyl 
donors is shown below in figure 1.1.  
O
PGO
PGO
PGO
OPG
O
PGO
PGO
PGO
O
Br
PG
O
PGO
PGO
PGO
OPG F
O
PGO
PGO
PGO
OPG SR
O
PGO
PGO
PGO
OPG O CCl3
NH
O
PGO
PGO
PGO
OPG O
P
O
OR
OR
O
PGO
PGO
PGO
OPG O
1.23 1.24
1.25 1.26
1.27 1.28
1.29
Cl
 
 
Figure 1.1 
 
Glycosyl bromides 1.23, typically formed as the thermodynamically more stable α-anomer, were 
first used, in what became known as the Koenigs-Knorr coupling, by activation with silver 
carbonate.
[23]
 Alternative silver sources, for example silver trifluoromethanesulfonate (AgOTf), 
can work equally well as promoters, and the efficiency of the procedure can be further improved 
by using more active catalysts such as mercury or cadmium salts.
[32]
 Glycosyl chlorides 1.24 can 
be activated under the same Koenigs-Knorr conditions, however their lower reactivity as 
compared to glycosyl bromides means that they are rarely used. Glycosyl fluorides 1.25 on the 
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other hand are very useful glycosyl donors.
[33]
 They can be formed as either the α- or β-anomer, 
and are completely stable compounds, meaning that they must be activated using strong Lewis 
acids, such as boron trifluoride diethyl etherate (BF3.OEt2). Thioglycoside donors 1.26
[34]
 are 
very commonly used, and can be activated using soft Lewis acids such as N-iodosuccinimide 
(NIS), or methylating agents such as MeOTf or dimethyl(methylthio)sulfonium triflate 
(DMTST). Trichloroacetimidate donors 1.27, developed by Schmidt as a modification of the 
original Sinay imidate donor, are very widely used, and are activated by catalytic amounts of 
hard Lewis acids, including trimethylsilyl triflate (TMSOTf) and BF3.OEt2.
[35]
 Anomeric 
phosphate leaving groups 1.28 are less commonly used; these highly reactive donors are 
generally activated with TMSOTf.
[36]
 Pent-4-enyl glycosides 1.29,
[37]
 introduced by Fraser-Reid 
and co-workers, are activated remotely from the anomeric centre by reaction of the alkene with 
NIS. The iodonium ion formed is subsequently attacked intramolecularly by the anomeric 
oxygen promoting the formation of an oxocarbenium ion.  
1.5 Challenges involved in controlling the regio- and stereoselectivity 
of glycosylation reactions 
The wide array of orthogonal protecting groups that have been developed allows access to 
building blocks with a single unprotected hydroxyl group,
[38]
 and so issues of regioselectivity in 
glycosylation reaction are easily circumvented. There are many complexities to consider when 
depicting the mechanism of the glycosylation reaction, and often a clear delineation between SN1 
and SN2 nucleophilic substitution reactions is obscured.
[29]
 Nevertheless, nowadays it is generally 
presumed that the reaction conditions favor that of a unimolecular SN1 mechanism, and hence 
controlling the stereochemistry of the new anomeric linkage requires attention.  
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The synthesis of complex oligosaccharides by chemical synthesis is generally a very 
complicated, multi-step process, often culminating in very low yields. Each monosaccharide 
component of the target oligosaccharide needs a variety of protecting groups, and thus every 
synthetic route involves multiple strategies to provide orthogonality between the different 
hydroxyl groups of each sugar unit. Efforts have been made to improve the speed and efficiency 
of oligosaccharide synthesis by using either one-pot multi-step glycosylation processes,
[39]
 or 
polymer-supported syntheses,
[40] 
 and programmable one-pot strategies.
[39a]
 These approaches are 
often compromised by the same problem that plagues any glycosylation reaction: the product 
glycoside is generally formed as an anomeric mixture.
[41]
 Enzyme-based strategies can be 
important alternatives but, as explained earlier, glycosyl transferase enzymes have a very narrow 
range of selectivity.
[39a] 
The issue of control of anomeric stereochemistry during glycosylation 
remains as the principal challenge to be addressed during any oligosaccharide synthesis. In 
particular, it is the stereocontrolled synthesis of 1,2-cis glycosyl linkages (e.g. α-glucosides, β-
mannosides) which poses the most difficult problem.
[42]
 Oligosaccharides found on the surface of 
pathogens and malignant cells frequently possess 1,2-cis- linked glycosides as a key structural 
elements.
[43]
 The possibility of using these structures in carbohydrate-based vaccine candidates 
has promoted numerous investigations into the construction of these linkages,
[44]
 and although 
many methods have been developed towards solving this problem, no generally applicable 
methodology yet exists. 
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1.6 Stereoselective glycosylation strategies  
1.6.1 The synthesis of 1,2-trans glycosides by neighboring group participation  
In contrast to the difficult synthesis of 1,2-cis glycosides, the synthesis of 1,2-trans glycosides 
(e.g. β-glucosides, α-mannosides) can usually be achieved with high levels of stereocontrol by 
taking advantage of classical neighboring group participation (NGP) of 2-O-acyl protected 
glycosyl donors.
[45]
 A schematic representation of the synthesis of a 1,2-trans glucoside 1.34 and 
a 1,2-trans mannoside 1.38 are shown below (Scheme 1.5). 
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Scheme 1.5  
Activation of the glycosyl donor 1.31 results in the formation of an oxocarbenium ion 1.32. 
Subsequent neighbouring group participation by the acyl group at the 2-position gives the more 
stable dioxolenium ion 1.33. SN2-like attack by the alcohol of a glycosyl acceptor can now only 
occur on one face, hence the glycosidic bond formed must be trans to the bond at the 2-position, 
producing the β-glycoside 1.34 in the case of glucosides. The same process occurs with the 
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manno- glycosyl donor 1.35, though this time, it is the β-face of dioxolenium ion 1.37 which is 
shielded from attack, hence the α-glycoside 1.38 is formed.  
It is also possible to form 1,2-trans glycosides from glucosamine donors by employing an amide 
protecting group at the 2-position. However, N-acetylglucosamine derivatives often react with 
low efficiency in glycosylations, as the acetamide can react with both the glycosyl acceptor and 
the activator.
[46]
 Therefore, an N-phthalimido group is often chosen as the protecting group for 
glucosamine donors. Carbamate protecting groups are also capable of performing neighbouring 
group participation, and hence N-Troc protected glucosamine donors also give 1,2-trans 
glycosides.
[47]
 
More recently, participation of the o-nitrobenzyl (oNBn) group was demonstrated, which 
allowed the stereocontrolled synthesis of glucosides with a 1,2-trans linkage.
[48]
 This new ether-
type of arming protecting group can broadly extend the concept of the use of participating groups 
in glycosylation reactions. Easy protection and deprotection of the oNBn group further 
confirmed its usefulness in synthesis. The proposed mechanism for the stereoselective synthesis 
of the β- glucoside 1.41 from the donor 1.39 containing o-nitrobenzyl group at position 2 is 
shown below (Scheme 1.6).  
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Scheme 1.6 
 
1.6.2 Stereoselective synthesis of glycosides by manipulating the reaction 
conditions 
1.6.2.1 Temperature 
Kinetically controlled glycosylations performed at lower temperatures generally favor β-D-
glycoside formation,
[19],[49]
 although converse observations have also been reported.
[50]
 Since the 
α-glycoside is thermodynamically favored due to the anomeric effect, it is predominantly formed 
at high temperatures. 
1.6.2.2 Solvent  
The simplest method used which favours the synthesis of 1,2-cis α-glycosides is to employ non-
participating protecting groups at the 2-position of the glycosyl donor, such as benzyl ethers, and 
to tune the reaction conditions towards favoring the desired stereochemical outcome. The most 
β face attack 
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common way of doing this is to take advantage of the solvent system.
[51]
 As a rule of thumb, 
ether solvents can be expected to enhance α-selectivity, whilst nitrile solvents enhance β-
selectivity.  
For example, the synthesis of 1,2-cis α-glucosides can be achieved by the use of diethyl ether as 
the reaction solvent. Diethyl ether selectively coordinates equatorially to the oxocarbenium ion 
formed upon activation giving the intermediate 1.42, and hence reaction with a glycosyl 
acceptor, in an SN2 fashion, gives the α-anomeric product 1.43 (Scheme 1.7).
[52]
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Scheme 1.7 
Selectivity is generally observed to increase with a decrease in temperature, and the methodology 
can be used with a wide range of glycosyl donors
[53] 
and also in solid supported syntheses.
[49]
 
Tetrahydrofuran and 1,4-dioxane are other examples of ethereal solvents which can direct α-
selectivity in glycosylation,
[20]
 whilst the non-ethereal solvent nitromethane also produces α-
glycosides.
[54]
  
Alternatively, the formation of β-glucosides can be achieved by using a non-participating group 
at the 2-position of the glycosyl donor and carrying out the reaction using acetonitrile as the 
solvent.
[55]
 In this case, β-selectivity is observed due to the stereoselective kinetic formation of a 
reactive α-nitrillium intermediate 1.44, which undergoes an SN2 type reaction with the glycosyl 
acceptor to give the β-anomeric product 1.45 (Scheme 1.8). 
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Scheme 1.8 
As with the use of diethyl ether as the reaction solvent, selectivity is observed to increase with a 
decrease in reaction temperature. However, in the case of mannose derived donors, enhanced 
formation of the β-mannoside is not observed as, in this case, the steric effect of the axially 
orientated hydroxyl at the 2-position outweighs the directing effect of the acetonitrile. 
A different direction in studying the reaction solvent effect by using dimethylformamide (DMF) 
as a co-solvent, was taken by Mong and co-workers.
[56]
 This study employed two conceptually 
different protocols for glycosylation. First, applying protocol A, a mixture of glycosyl donor, 
acceptor, and DMF was activated with NIS and TMSOTf. When the concentration of DMF was 
varied in these reactions, it was found that in the presence of 1.5 equiv. of DMF, moderate 
stereoselectivity was achieved. However, an increase in the amount of DMF to 3 and 6 equiv. 
was translated into a significant increase in α-stereoselectivity. 
In an alternative protocol (protocol-B), the glycosyl donor was reacted with NIS and TMSOTf in 
the presence of DMF, followed by the addition of the glycosyl acceptor, and very high α-
selectivity was observed. 
One specific example of each glycosylation reaction carried out employing protocol A and 
protocol B, and their outcomes are shown in Scheme 1.9. 
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The proposed rationalization behind the observed stereoselectivity is that DMF traps the glycosyl 
oxocarbenium ion 1.52 resulting in an equilibrating mixture of α/β-glycosyl O-imidates 
1.53/1.54 (Scheme 1.10). The more reactive β-imidate then reacts faster with the glycosyl 
acceptor producing the desired α-glycoside 1.55 with high selectivity. 
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Scheme 1.10 
Protocol-A 
DMF 
(equiv.) 
Yield 
(%) 
α:β 
1.5 82 6:1 
3.0 87 15:1 
6.0 87 19:1 
 
Protocol-B 
Yield (%) α:β 
60 36:1 
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Whilst the use of solvent effects is a useful tool for modulating the stereoselectivity of 
glycosylation reactions, the results are not always reliable and complete anomeric selectivity is 
very difficult to achieve. Another problem associated with this approach is that of the solubility 
of the glycosyl donor and/or the glycosyl acceptor in the chosen solvent. If an additional solvent 
is required to ensure reactant solubility then the action of the directing solvent may be 
diminished, and hence the selectivity of the glycosylation reaction may decrease.  
1.6.2.3 Promoters, additives, and chelators 
Several decades ago, the glycosylation of acceptors of low nucleophilicity was sluggish and 
inefficient.
[23],[25]
 However with the development of more reactive donors and activation 
conditions, the efficiency of glycosylation, including the rates of reaction and product yields, has 
improved tremendously. However, this efficiency has not led to improvements in 
stereoselectivity; rather it hads been noted that faster reactions often result in decreased 
stereoselectivity and vice versa, thus making it necessary to find a delicate balance between 
donor reactivity and stereoselectivity.
[32]
 It has become clear over time that milder activating 
conditions are beneficial for 1,2-cis glycosylations.  
The method of in situ anomerization was first reported by Lemieux and co-workers in 1975,
[57]
 
and at the time provided a major breakthrough for the synthesis of 1,2-cis α-glycosides. It was 
observed that treatment of a glycosyl halide, commonly a glycosyl bromide, with a catalytic 
source of the same halide in the presence of a glycosyl acceptor gave predominantly the α-
glycoside. This stereochemical outcome was explained using the Curtin-Hammett principle.
[58] 
For example, if the α-bromide 1.23 is treated with a catalytic amount of tetra-n-butylammonium 
bromide (TBAB), equilibrium between the α-bromide 1.23 and the β-bromide 1.56 is established 
(Scheme 1.11). 
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Although the equilibrium strongly favors the more stable α-bromide 1.23, the activation energy 
for nucleophilic attack by a glycosyl acceptor is much lower for the β-bromide 1.56. Therefore 
the1,2-cis α-glycoside 1.58 is the major product of the reaction because 1.56 reacts preferentially 
with the acceptor in an SN2 type reaction.. If the difference in the energy barriers for the two 
substitutions is sufficient, then pure α-selectivity can be obtained. It is important that the rate of 
equilibration is much higher than that of the glycosylation reaction, and hence the reaction works 
best with highly reactive glycosyl donors and poorly reactive glycosyl acceptors. Indeed, a 
highly reactive glycosyl donor is also required for treatment with such mild catalytic activators, 
and hence the reaction is limited to the use of glycosyl halides and triflates. It is also vital that a 
low polarity solvent is used, as in the presence of a polar solvent oxocarbenium ion formation 
becomes more favorable and so more SN1-like reactions may occur, reducing anomeric 
selectivity.  
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Working on the same principle, Demchenko et al. have shown that a bromine-mediated 
glycosylation of the thioglycoside 1.59 lead exclusively to the α- products 1.63 (Scheme 
1.12).
[59]
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Scheme 1.12 
The reason for the -stereoselectivity lies in the fact that the β-bromide 1.60 is the reactive 
intermediate which in addition withto reaction with the acceptor in an SN2 fashion to give the -
product, can also undergo rapid anomerization to its α-linked counterpart. However, once 
formed, the α-bromide 1.62 is totally unreactive under the reaction conditions, so the yield of 
glycosylation can be low with secondary alcohols. The α-bromide can be reactivated in the 
presence of a mercury (II) additive. This pathway was found to be very beneficial for the 
glycosylation of secondary alcohols, but can compromise the α-selectivity of glycosylation with 
primary alcohols. 
Whilst many of the current methodologies for glycosylation require the use of stoichiometric 
amounts of promoters, the use of transition metal catalysts helps achieve greener glycosylation 
conditions, and offers new opportunities for stereocontrol.
[60]
 Nguyen et al. investigated a series 
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of nickel catalysts as an efficient means for the glycosylation of the N-p-methoxybenzylidene-
protected 2-amino-2-deoxy TCAI donor (1.64).
[61]
 The nature of the ligand on nickel was found 
to be the deciding factor in controlling the stereoselectivity of glycosylation. Thus, it was 
observed that electron-withdrawing substituents helped decrease the reaction time, which was 
translated into increased α-selectivity in the product 1.65 (Scheme 1.13). 
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Scheme 1.13 
Another promising new field is the use of chiral thioureas as organocatalysts for 
glycosylation.
[62]
 As of now, this approach is limited to the synthesis of 2-deoxy α-glycosides[63] 
and β-selective glycosylation with 2-oxygenated sugars.[64] 
Bennett and co-workers recently investigated the activation of thioglycosides with Ph2SO in the 
presence of tetrabutylammonium iodide (TBAI). It was observed that this reaction proceeded via 
the intermediacy of a glycosyl iodide.
[65]
 The underpinning idea of using TBAI is that the 
conversion of α-glycosyl triflates into β-glycosyl iodides would favor the formation of α-
glycosides. Thus, when the S-phenyl donor 1.66 was preactivated using Ph2SO/Tf2O, followed 
by the addition of TBAI and then the glycosyl acceptors 1.67 or 1.68, the respective 
disaccharides 1.69 or 1.70 were obtained with excellent or even complete α-stereoselectivity 
(Scheme 1.14). 
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Scheme 1.14 
1.6.3 The synthesis of 1,2-cis β-glycosides by inversion of configuration at 
position-2   
The 1,2-cis β-mannoside linkage is found in the core pentasaccharide of all N-linked 
glycoproteins,
[66]
 as well as many other biologically relevant oligosaccharides, and therefore the 
importance of the β-mannoside linkage has fuelled great interest in developing methodologies for 
its synthesis. Whilst solvent effects and in situ anomerization protocols are useful tools for the 
synthesis of 1,2-cis α-glycosides, neither method can be used for the preparation of 1,2-cis β-
glycosides; indeed the formation of β-mannosides presents an even greater challenge than the 
synthesis of α-glucosides. The axially orientated 2-hydroxyl group shields the β-face from attack 
by the glycosyl acceptor, meaning that even under SN1-type conditions formation of the α-
product is strongly favored. Furthermore the β-glycoside is thermodynamically unfavorable due 
to not only a lack of the anomeric effect but also due to electronic repulsions by the 2-
position.
[67]
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Due to the difficulties in achieving desired stereocontrol, an indirect approach to the synthesis of 
β-mannosides is often employed involving the synthesis of a β-glucoside followed by inversion 
of stereochemistry at the 2-position. This methodology was discovered by Glisin
[68]
 where direct 
displacement of the C-2 Sulfonate of gluco and mannopyranosides were done, to form manno 
and glucopyranosides respectively. The same methodology was employed was employed by 
Fürstner and co-workers (Scheme 1.9).
[69]
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Scheme 1.15  
Glycosylation of the trichloroacetimidate donor 1.71 selectively gave the β-glucoside 1.72 by 
neighboring group participation of the acetate group at the 2-position. This was then removed 
using catalytic methoxide to give the alcohol 1.73 which was then converted to the triflate 1.74 
using triflic anhydride. Reaction with tetrabutylammonium acetate under ultrasound gave 
inversion at the 2-position, and hence the β-mannoside product 1.75. Although the yields of the 
inversion step were shown to be consistently high (upwards of 80%), clearly the requirement for 
three additional synthetic steps as compared to a direct glycosylation method is not ideal.   
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1.6.4 The synthesis of 1,2-cis β-glycosides by Crich’s methodology  
An interesting route towards synthesis of β-mannosides was pioneered by Crich and co-workers, 
by applying ‘inverse addition methodology’.[70] This approach involves the pre-activation of a 
glycosyl sulfoxide with triflic anhydride, followed by treatment with the glycosyl acceptor. The 
order of addition of reagents is very important to the stereochemical outcome of the reaction 
(Scheme 1.10).  
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Scheme 1.16  
If the reaction was carried out under glycosylation conditions (i), where a mixture of glycosyl 
donor 1.76 and the acceptor were treated with the promoter, then the α-mannoside 1.78 was 
observed to be the major product formed. However, it was discovered that pre-activation of the 
glycosyl sulfoxide 1.76 with triflic anhydride and the hindered base 2,6-di-tert-butyl-4-
methylpyridine (DTBMP) followed by addition of the glycosyl acceptor (conditions (ii)) gave 
predominantly the β-mannoside 1.80. It was postulated that this was due to attack of the glycosyl 
acceptor on the α-triflate intermediate 1.79 in an SN2 manner, which was postulated to be more 
stable than the glycosyl cation 1.77 and therefore favored at equilibrium. Low temperature NMR 
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studies subsequently proved that formation of 1.79 did indeed occur under these reactions 
conditions. In general the β-selectivity was shown to be high with primary alcohol acceptors, 
giving β:α ratios of greater than 25:1 in some cases. However, when more sterically demanding 
secondary alcohol acceptors were used the selectivity was observed to diminish. Subsequently, 
Crich and co-workers developed alternative activation conditions that allowed reaction of 
thioglycoside donors to give β-mannosides via the formation of the same α-triflate 
intermediates,
[71]
 and in these cases high β-mannoside formation was observed for bulkier 
acceptors, although the reaction is still not applicable in all situations.  
The protecting groups employed on the glycosyl donor were also found to be very important. 
Clearly it was vital that the protecting group used at the 2-position was non-participating. The 
presence of a bulky group, for example TBDMS disfavoured SN2 attack by the acceptor, and thus 
reduced stereoselectivity. Most important, however, was the presence of the 4,6-O-benzylidene 
acetal in the glycosyl donor. It has been proposed that formation of the oxocarbenium ion is 
disfavored when this protecting group is used due to the high torsional strain and unfavorable 
electronic effects inflicted on the intermediate,
[72]
 and hence the presence of a 4,6-O-benzylidene 
greatly favors the formation of the α-triflate 1.79. With more conformationally flexible glycosyl 
donors increased β-mannoside formation was observed.  
Although this inverse addition methodology can be employed very successfuly in the synthesis 
of the challenging β-mannoside linkage, there are several drawbacks. The requirement for a 4,6-
O-benzylidene acetal is very restrictive in terms of protecting group strategies available, and may 
require the use of undesirable protecting group manipulations and hence additional synthetic 
steps. The choice of donor is also somewhat limited due to the need for pre-activation and hence 
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the method is not considered as a general solution to the problem of forming β-mannosides. 
Furthermore, it does not work on GlcNAc OH-4 as acceptor. 
1.6.5 The synthesis of 1,2-cis glycosides by Intramolecular Aglycon Delivery 
(IAD)  
Hindsgaul, in 1991, developed Intramolecular Aglycon Delivery (IAD) as a method for forming 
β-mannosides.[73] The principle behind this technique involves temporarily linking the glycosyl 
acceptor to the 2-position of a glycosyl donor 1.81 via a bridging atom or group (labelled Y), 
producing a tethered glycoside 1.82 (Scheme 1.17). 
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Scheme 1.17  
Activation of the glycosyl donor then results in an intramolecular glycosylation, which as the 
aglycon is tethered to the cis face of the donor must result in formation of the 1,2-cis glycoside 
1.83. The group that remains at the 2-position after glycosylation can be cleaved either during or 
after or the glycosylation reaction to leave the 2-OH position of the product unprotected.  
For the synthesis of β-mannosides, 1.87, Hindsgaul and co-workers employed a 2-O-methylvinyl 
ether protected glycosyl donor 1.85, derived from a Tebbe reaction of the 2-O-acetate protected 
donor 1.84, to achieve tethering of the glycosyl acceptor as shown below (Scheme 1.18).
[74]
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Activation of the anomeric leaving group of the tethered mixed ketal intermediate 1.86 allowed 
formation of the disaccharide 1.87 with complete stereocontrol for the β-anomer. A major 
drawback encountered in this methodology was that both the tethering and glycosylation steps 
proceeded in poor yield. It was also observed that the mixed ketal intermediates were very 
unstable, and showed a propensity for side reactions, leading to the conclusion that IAD via this 
tethering system was not suited to the synthesis of complex oligosaccharides.  
The use of a silaketal tethering group for IAD, for the synthesis of β-mannosides, was developed 
by Stork and co-workers.
[75]
 The tethering and glycosylation steps proceeded in higher yield as 
compared to Hindsgaul’s method and complete β-selectivity was again observed. However, even 
this methodology didn’t prove to be high yielding and stereoselective for sterically hindered 
glycosyl acceptors.  
In light of these promising early discoveries, many other investigations into IAD began. It was 
hoped that this type of methodology could be used as an universal solution for the synthesis of 
1,2-cis glycosides, regardless of whether they were gluco or manno in nature. Work by Bols, 
following the approach of Stork, had already shown that silicon-tethered IAD could be used for 
the synthesis of α-glucosides.[76] Following the work of Hindsgaul, Fairbanks’ group discovered 
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that the tethering step could be improved by the use of NIS as opposed to a catalytic acid, and 
when used in conjunction with a thioglycoside donor, a one-pot procedure was developed for 
both gluco and manno donors.  Thus, a method for the synthesis of cis α-glucosides was 
achieved (Scheme 1.19).
[77]
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Scheme 1.19  
Treatment of the donor 1.88 with NIS led to formation of the tethered intermediate 1.89 as the 
enol ether was more reactive than the thioglycoside towards the electrophile. Subsequently the 
glycosyl donor was activated and the acceptor delivered intramolecularly to give the α-glycoside 
with complete stereocontrol. Yields were good for primary alcohol acceptors, and the one-pot 
procedure was actually even more efficient for mannose donors. Unfortunately, as with 
Hindsgaul’s earlier work, reaction with sterically hindered secondary alcohol carbohydrate 
acceptors proved problematic. It was thought that attachment of the alcohol at the tertiary centre 
was perhaps having a limiting effect in the tethering step, and hence an alternative tethering 
group, an allyl group, was developed and subsequently optimized (Scheme 1.20).
[78] 
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The allyl group of 1.91 was efficiently isomerized by treatment with Wilkinson’s catalyst, pre-
treated with n-butyl lithium, to give the vinyl ether 1.92.
[79]
 NIS-mediated tethering gave 1.93 
which could be glycosylated in the same fashion as before to give the 1,2-cis glycoside 1.94. 
Although, this procedure gave excellent selectivity and yields for secondary alcohol acceptors 
with mannose donor systems, it was unfortunate that these results could not be replicated with 
glucose donor systems, and generally low yields were observed. Despite the somewhat unreliable 
nature of the allyl IAD methodology for the synthesis of 1,2-cis α-glycosides, the methodology 
was eventually utilized in the synthesis of the Glc3Man N-glycan tetrasaccharide, employing an 
iterative method and optimized to produce the challenging tetrasaccharide in an efficient and 
completely stereocontrolled manner.
[80]
  
As well as the development of allyl IAD, the Fairbanks group also extended the idea to the use of 
a propargyl tethering group.
[81]
 Elsewhere, Ogawa and Ito have extensively exploited the use of a 
para-methoxybenzyl tethering group, and used this methodology to successcompletely 
synthesize the core N-glycan pentasaccharide and even to perform solid supported IAD 
processes.
[82]
 More recently, the use of naphthyl mediated IAD was also explored.
[83]
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Intramolecular aglycon delivery is clearly a powerful tool for the synthesis of 1,2-cis glycosides, 
especially β-mannosides. However, the large number of studies in the area is indicative of the 
fact that there is still no generally applicable IAD method that can be employed in 
oligosaccharide synthesis. The major drawbacks in the use of the methodology are the extra 
tethering step required, and particularly the decrease in efficiency when applied to more 
extended and hindered donors and acceptors, meaning the technique is still unsuitable for 
complex oligosaccharide synthesis.  
1.6.6 The synthesis of 1,2-cis α-glycosides via β-sulfonium Ions  
The use of neighbouring group participation for the synthesis of 1,2-cis glycosides was, up until 
recently, not considered. In the case of a manno glycosyl donor, participation from the 2-position 
could only ever give the 1,2-trans product as the axially orientated acyl substituent can only 
interact with the anomeric centre from the β-face. Participation from the 2-position of a gluco 
donor, however, could be imagined to give rise to 1,2-cis selectivity if the neighboring group 
were to coordinate to the anomeric centre in a β-configuration. In 2005, Boons and co-workers 
reported the use of novel chiral auxiliary based neighboring groups for the synthesis of both 1,2-
cis and 1,2-trans glycosides. The use of glycosyl donors bearing an (R)- or (S)-
ethoxycarbonylbenzyl moiety was reported,
[84]
 with the configuration of the chiral auxiliary 
influencing whether α- or β-glycosides were formed. Although this method gave rise to very 
good selectivity, pure anomeric stereocontrol was not achieved. Following on from this research 
the use of a (1S)-phenyl-2-(phenylsulfanyl)ethyl moiety was reported,
[85]
 which gave exclusive 
1,2-cis α-selectivity with a variety of glycosyl acceptors by formation of an intermediate  
sulfonium ion by neighboring group participation (Scheme 1.21).  
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Scheme 1.21  
Activation of the trichloroacetimidate donor 1.95 led to the formation of oxocarbenium ion 1.96. 
Neighboring group participation from the sulfur then occurred, forming a 6-membered cyclic 
intermediate. Two intermediates could be formed; a cis-decalin type of intermediate 1.97 or a 
trans-decalin type of intermediate 1.98. However, due to the presence of the chiral auxiliary, the 
formation of 1.97 is disfavored due to the steric interaction of the phenyl group with the 3-
position hydrogen atom. Therefore 1.98 is favored and subsequent SN2 displacement by the 
glycosyl acceptor produces the 1,2-cis glycoside 1.99. This elegant methodology has since been 
applied in the solid-supported synthesis of an α-glucan pentasaccharide.[86] Although the 
installation of the chiral neighboring group requires a five step manipulation from a 
commercially available chiral starting material, it was additionally shown that deprotection of the 
group led to recovery of the acetic acid (1S)-phenyl-2-(phenylsulfanyl)ethyl ester, which could 
be reused for installment of the (1S)-phenyl-2-(phenylsulfanyl)ethyl moiety.  
Interestingly, as a control reaction, the use a 2-(phenylsulfanyl)ethyl group at the 2-position of 
the glycosyl donor was investigated. Although the use of this group did not give pure α-
selectivity for the glycosylation reaction, the selectivity was still high (α:β ratio, 8:1) despite the 
       Chapter 1                                                                                                                      Introduction                                                                                                                            
31 
 
absence of any chiral auxiliary. This suggested that there was a general preference for the 
sulfonium to adopt a β-configuration, probably due to a combination of asteric and 
stereoelectronic effects. Boons
[87]
 later observed that electron withdrawing substituents on the 
donor hydroxyls, such as acetates
[88]
 which inductively disarm the ring making the anomeric 
carbon less reactive, facilitated this neighboring group participation by destabilizing the 
oxocarbenium ion intermediate 1.96, and so favoured the equilibrium towards intermediate 1.98, 
resulting in better stereoselectivity. Boons confirmed neighboring group participation by the 
substituent at position 2 by performing two dimensional NMR (HMBC) experiments at – 20 °C 
which confirmed a 3 bond correlation between H-8 and C-1 in the intermediate 1.98 (Figure 
1.2).
[85] 
O
O
SPGO
Ph
Ph+
OTf
_
1
7
8
1.98
 
Figure 1.2 
However even if spectroscopic studies showed evidence of neighboring group participation, the 
reaction could proceed without NGP if a low-energy pathway to the product exists that does not 
involve NGP.  It was suggested by the Woerpel
[89]
 that the diastereoselectivity observed in the 
Boon’s system was not necessarily due to involvement of neighboring group participation, 
implicating a Curtin-Hammett kinetic scenario: the formation of a low-energy intermediate does 
not necessitate its involvement in the product-forming pathway. It was generally presumed that 
the alcohol would directly displace the sulfonium group in an SN2-like reaction. An alternative 
explanation would be that the sulfonium ion is a “resting state” for the system, which goes on to 
react through a higher-energy oxocarbenium ion intermediate giving rise to a Curtin–Hammett 
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kinetic scenario; in this case the stereoselectivity of the reaction would be dependent on the 
conformation of the oxocarbenium ion. 
Following on from the use of a chiral auxiliary based sulfur neighboring group, Boons and co-
workers reported the use of achiral sulfonium ion intermediates that were formed 
intermolecularly to produce 1,2-cis α-glycosides via a β-configured intermediate sulfonium ion 
(Scheme 1.22).
[90]
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Scheme 1.22 
Activation of the 2-azido-2-deoxy glucose donor 1.100 in the presence of a glycosyl acceptor 
and a large excess (10 equiv.) of either phenyl-thioethyl ether or thiophene was shown to form 
the α-glycoside 1.103 with high selectivity. Interestingly, the selectivity was observed to increase 
with an increase in reaction temperature, and, at 0 °C, pure α-selectivity was observed in some 
cases. The reaction was also independent of the protecting group strategy employed, with both 
electron withdrawing esters and electron donating ethers giving equally high selectivity. NMR 
studies showed that the sulfonium ion 1.102 was indeed being formed in the reaction, and was 
exclusively in the β-configuration.  
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Although these results were only shown for one glycosyl donor, a 2-azido-2-deoxy glucose 
derivative, they potentially represented an excellent method of forming 1,2-cis α-glycosides if 
the methodology could be shown to be general for other glycosyl donors. Combined with the 
results shown for the chiral auxiliary based neighboring group participation, there is definite 
evidence that intermediate sulfonium ions are capable of achieving stereocontrol in glycosylation 
reactions.  
Turnbull
[91]
 and co-workers recently designed a new oxathiane donor scaffold where the axial 
methoxy group was replaced with an O-substituent constrained in a bicyclic ring (Scheme 1.23). 
As in the previous methods, the oxathiane ketal donor was then activated via S-arylation. 
Overall, the novel class of oxathiane glycosyl donors is easily accessible, is highly α-selective 
for glycosylation, and offers good stability towards common protecting group manipulations.  
A novel strategy was employed by Turnbull group
[92]
 to activate the glycosyl donors based on 
electrophilic aromatic substitution, which exploits the fact that trifloxysulfonium salt is more 
electrophilic at sulfur than at the anomeric carbon. Sulfoxide donors were activated with triflic 
anhydride, and allowed to react with trimethoxybenzene to give sulfonium ions. A range of 
alcohols were glycosylated in good to excellent yields, and with essentially complete α-
stereoselectivity. 
 
       Chapter 1                                                                                                                      Introduction                                                                                                                            
34 
 
O
S
Ph
O
OH
O
O
S
OMe
Ph
O
O
S Ar
OMe
Ph
ROH
O
O
OR
SAr
MeO
Ph
1.104 1.105
1.1061.107
Oxythiane glycosyl
donor
Activation as
sulfonium ion
 
Scheme 1.23 
At the time of designing the oxathiane glycosyl donors, it was assumed that stereoselectivity 
arises from an SN2-like displacement of the equatorial sulfonium ion by an acceptor alcohol. 
However, variation of the oxathiane structure in their later investigations,
[93]
 revealed that some 
of the sulfonium ions were not completely stereoselective, and probably follow an SN1-type 
mechanism. A ketal group on the oxathiane ring significantly reduced the reactivity of the 
glycosyl donors, to the point at which a methyl glycosyl sulfonium ion (1.108) was sufficiently 
stable to isolate and crystallise from an alcoholic solvent (Figure 1.3). 
O
O
S
OMe
Ph
OBn
BnO
BnO
1.108  
Figure 1.3 
In his later studies (explained in details in chapter -2, section 2.6), Turnbull
[94]
 had suggested that 
that even though NMR studies might show a stable intermediate which should result in a very 
stereoselective glycosylation reaction, caution should be applied before invoking it as an 
intermediate on the reaction pathway. NGP seen in intermediate therefore need not directly be 
reflected in diastereomeric ratio of glycosides formed. 
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The Boons’ method has proven to be a very interesting and effective approach for the formation 
of α-cis glycosides, but it relies on a chiral protecting group and thus is expensive. The Fairbanks 
group
[95] devised a simpler alternative to Boons’ methodology, which gives essentially the same 
stereoselectivity. In this methodology, the use of a 2-O-(thiophen-2-yl)methyl protecting group 
allowed for a highly stereoselective α-glucosylation with a trichloroacetimidate donor 1.109. An 
increase in stereoselectivity, presumably arising from the intramolecular formation of a transient 
intermediate thiophenium ion 1.110, correlated with increased bulk of the glycosyl acceptor 
(Scheme 1.24). 
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Scheme 1.24 
1.6.7 Remote protecting groups  
The effects of remote substituents have perhaps been considered of somewhat lesser importance 
than those of the neighbouring substituent at C-2. However, the idea of participating groups at 
remote positions has been investigated by several researchers. There have been various reports, 
ranging from the long-range 6-O-acyl or carbonate group assisted synthesis of α-glucosides,[96] 
which both favor or oppose of the idea of remote participation being useful. For glycosyl donors 
of the D-galacto series, a remote effect beneficial for the formation of α-galactosides (1.114) was 
noted when a participating moiety was present at C-4 (Scheme 1.25).
[97]
 Similar effects 
(including C-3 participation) were also reported for donors  with L-fuco,
[98]
 L-rhamno,
[99]
 D-
manno,
[100]
 and D-gluco
[101]
 stereochemistry. 
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Scheme 1.25 
Codée and co-workers investigated the use of a 2-azido-mannouronate ester donor for 
glycosylation, and observed high 1,2-cis selectivity.
[102]
 Investigations concluded that when the 
thiophenyl donor 1.115 was activated in the presence of diphenyl sulfoxide and triflic anhydride, 
the anomeric triflate was formed (Scheme 1.26). The latter exists as an interchangeable mixture 
of conformers with the 
1
C4 chair 1.116 as the predominant species. In principle, the triflate can 
lead to the β-linked product via an SN2-like displacement. Alternatively, the reaction can proceed 
via an SN1-like pathway. In this case, the oxocarbenium ion intermediate will preferentially 
adopt the 
3
H4 half-chair conformation 1.117, which closely resembles the major 
1
C4 
conformation of triflate. In this case, the C-5 carboxylate occupies a pseudo-axial position 
allowing for stabilization of the positive charge. The incoming nucleophile will then attack from 
the β-face to produce the disaccharide with complete 1,2-cis selectivity.  
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A very different stereodirecting effect was reported for remote picolinyl (Pic) and picoloyl (Pico) 
substituents by Demchenko. Picolinyl protection at C-2 formally participates at the anomeric 
center and gives 1,2-trans glycosides via a six-membered ring intermediate.
[103]
 However the 
action of the remote picolinyl and related picoloyl substituents is totally different. As they are not 
able to participate at the anomeric center directly, the nitrogen atom of the picolinyl group forms 
a hydrogen bond with the incoming glycosyl acceptor. As a result, a very high facial selectivity 
is observed, which is always syn with respect to the picolinyl substituent.
[104]
 This rather 
unexpected involvement of remote picolinyl substituents was termed ‘H-bond-mediated 
aglycone delivery’ (HAD). Based on the above hypothesis, it was also shown that under high 
dilution conditions (5 mM), 4-O-picoloyl or picolinyl glucosyl donors gave faster reactions and 
enhanced selectivity compared to those obtained under standard concentration (50 mM). Thus, 
glucosyl donors provided high levels of α-selectivity, particularly with O-picoloyl protection, 
whereas a galactosyl donor and a rhamnosyl donor gave high β-selectivity. The synthesis of 1,2-
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trans β-glycosides –[o 1.121 and1,2-cis α-glycosides 1.124 from 3-O-picoloyl/picolinyl 1.119 
and 4-O-picoloyl/picolinyl glucosyl donor 1.122 respectively are shown below (Scheme 1.27). 
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1.7 Project objectives  
The objective of this project was to develop new methods of stereocontrolled glycosylation. 
Given the recent advances in neighbouring group participation methods for the synthesis of 1,2-
cis α-glycosides developed by Boons et al., it was postulated that further improvements could be 
made towards general methodology for use in oligosaccharide synthesis.  
Although the arguments presented for the potentially widespread utility of the chiral auxiliary 
approach for the control of anomeric stereochemistry were compelling, we reasoned that perhaps 
chirality was not necessary in the 2-OH protecting group in order to achieve good α-selectivity 
for the formation of 1,2-cis α-glycosides. Indeed it was considered that the inherent preference 
shown in Boons’ research for a sulfonium ion to exist in the β-configuration[85],[90] suggested that 
simpler protecting groups could be employed at the 2-position for neighbouring group 
participation.  
The Fairbanks group has shown similar results by synthesis and utility of a series of 2-O-
(thiophen-2-yl)-methyl-protected glycosyl donors in a series of stereoselective α-glycosylation 
reactions.
[95]
 For example an α:β ratio of 8:1 was achieved with diacetone galactose as acceptor 
at -78 °C, in DCM (Scheme 1.24). It was thought that this selectivity could be improved by the 
exchange of sulfur for a better nucleophile at position-2. Following these initial studies, the use 
of softer atoms at the 2-position of an ethyl ether was contemplated in order to increase the 
propensity for 6-ring NGP, and so increase the levels of α-selectivity- that could be observed.  
Following this line of reasoning, Dan Cox, a previous Ph.D. student in the Fairbanks
[105] 
group 
reported high levels of α-selectivity by use of both iodo- and a selenophenyl groups attached to 
an ethyl ether at position-2 of a series of completely armed glycosyl donors.
[67a]
 Based on the 
observation of Boons’ that higher stereoselectivity was observed on disarmed donors compared 
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to armed donors,
[87]
  my work focused on the synthesis and investigation of a series of partially 
disarmed donors  with iodo- and a selenophenyl groups attached to an ethyl ether at position-2. 
The initial targets chosen for investigation are shown below in Figure 1.4. 
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Figure 1.4 
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Chapter 2: Synthesis and evaluation of glycosyl donors 
bearing 2-O-(2-(phenylselenyl)ethyl) and 2-O-iodoethyl 
protecting groups 
2.1 Introduction 
As noted in Chapter 1, this research project was inspired by the works of Boons
[1] 
and relies on 
neighbouring group participation (NGP) occurring via a 6-membered ring forming a trans 
decalin type structure, which the glycosyl acceptor then attacks axially to produce the α-
glycoside as a major reaction product (Scheme 2.1). 
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Nu Ph
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Scheme 2.1 
The approach developed by Boons, shown in Scheme 2.1 has proven to be an interesting 
approach for the formation of α-1,2-cis glycosides, but it relies on the use of a chiral protecting 
group and is therefore expensive. So the question arises, if an achiral protecting group is used 
instead, will it still give α-selectivity in the formation of glucosides? Postulated equilibria 
between glycosyl cation and 6-ring intermediates arising from neighbouring group participation 
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(NGP) of 2-substituted ethyl ethers, and the stereochemical consequences for the outcome of 
glycosylation is shown in scheme 2.2. 
  
Scheme 2.2 
As can been seen in Scheme 2.2, there is possibility of formation of cis- and trans- decalin 6-
membered ring intermediate, via NGP. There is also a possibility of equilibria between a 
glycosyl cation (or other acylic intermediate) and these cyclic species. It may be expected that a 
glycosyl cation should react with a glycosyl acceptor (ROH) in a predominantly non-selective 
fashion, whereas a trans-decalin cyclic intermediate should react to preferentially produce the α-
glycoside product; conversely nucleophilic attack of an acceptor directly on the cis-decalin 
intermediate should lead to the β-glycoside. 
Boons,
[1a]
 in his work has shown that even without a chiral auxiliary group at position-2, a 
stereoselectivity of α:β = 8:1 was achieved by use of an phenylthio ethyl ether protection of the 
2-position (Scheme 2.3).  
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Scheme 2.3 
The Fairbanks group has shown similar results by synthesis and utility of a series of 2-O-
(thiophen-2-yl)-methyl-protected glycosyl donors in a series of stereoselective α-glycosylation 
reactions.
[2]
 For example an α:β ratio of 8:1 was achieved with diacetone galactose as acceptor at 
-78 °C, in DCM (Scheme 2.4). 
O
OBn
BnO
BnO
O
S
O CCl3
NH
O
OBn
BnO
BnO
O
S
OR
O
OBn
BnO
BnO
O
S
ROH
 
                                                                                                                α:β = 8:1 
Scheme 2.4 
It was thought that this selectivity could be improved by the exchange of sulfur for a better 
nucleophile at position-2. Following these initial studies, the use of softer atoms at the 2-position 
of an ethyl ether was contemplated in order to increase the propensity for 6-ring NGP, and so 
increase the levels of α-selectivity- that could be observed.  
Following this line of reasoning, Dan Cox, a previous Ph.D. student in the Fairbanks
[3] 
group 
reported high levels of α-selectivity by use of both iodo- and a selenophenyl groups attached to 
an ethyl ether at position-2 of a series of completely armed glycosyl donors
[4]
 (Scheme 2.5). 
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Apart from the NGP by the position-2, the question also arises, if the substituents on the ring at 
other positions affect the outcome in stereoselectivity. The other substituents do affect the 
intermediates, and probably would affect the stereoselectivity according to Curtin-Hammett 
principle. The Curtin–Hammett principle states that, for a reaction that has a pair of reactive 
intermediates or reactants that interconvert rapidly (as is usually the case for conformational 
isomers), each going irreversibly to a different product, the product ratio will depend both on the 
difference in energy between the two conformers and the free energy of the transition state going 
to each product. As a result, the product distribution will not necessarily reflect the equilibrium 
distribution of the two intermediates. The Curtin–Hammett principle has been invoked to explain 
selectivity in a variety of stereo- and regioselective reactions.
[5]
 
In subsequent reports, Boons
[6]
 has suggested that there is an equilibrium between intermediate 
ions of types (2.2) and (2.3) (Scheme 2.1). If the substituents on the ring stabilize intermediate- 
2.3 more effectively, then a higher stereoselectivity is observed. Therefore in Boons’ case the 
completely armed donors (with electron donating groups, such as benzyl groups) at position 3, 4 
and 6 showed much lower stereoselectivity than completely disarmed donors (with electron 
withdrawing groups such as acetyl, benzoyl groups) at position 3, 4 and 6 (Scheme 2.6). 
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Based on this report, it was thought important to investigate the electronic effects of the 
protecting groups at positions 3, 4, and 6, of the donor on the stereochemical outcome of 
glycosylation.  
Dan Cox’s[3] studies were performed on completely armed glycosyl donors with 
iodo/selenophenyl ethyl group at position-2, and benzyl groups on positions 3, 4 and 6. It was 
decided to perform similar studies on a series of partially disarmed donors and completely 
disarmed donors to get an overall picture of the NGP provided by the iodoethyl and selenophenyl 
ethyl protecting groups at position 2. The synthesis of a completely disarmed donor, with acetyl 
group at positions 3, 4 and 6 was undertaken by another researcher.
[3]
 The work reported in this 
chapter focuses on the synthesis and investigation of a series of partially disarmed donors. 
Specifically, the donors for investigation contained a benzyl group at position-3, and either a 
benzylidene acetal or two acetates at position 4 and 6.   
The disarming effect of the 4,6-benzylidene acetal group on glycoside reactivity, which is due to 
a combination of torsional and electronic effects has been well established.
[7] 
The presence of a 
benzylidene ring should therefore destabilize the oxocarbenium intermediate 2.2, and should 
promote neighboring group participation by the nucleophilic group attached at the 2 position, 
favoring the formation of intermediate 2.3. Hence, it was expected that the incorporation of a 
2.13 (R = Ac), α:β = 1:0 
2.14 (R = Bn), α:β = 1:1 
 
2.10: R = Ac 
2.11: R = Bn 
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4,6-benzylidene would produce higher levels of α-selectivity. Similarly, incorporation of acetate 
groups at positions 4 and 6, was expected to produce higher levels of stereoselectivity, due to its 
–ve inductive effect leading to destabilization of oxocarbenium intermediate, favouring the ring 
formation.  
2.2 General strategy for synthesis of donors  
The following set of  partially disarmed donors were chosen as synthetic targets (Figure 2.1).    
O
BnO
O
I
O CCl3
NH
2.15
O
O
Ph
                         
O
BnO
O
SePh
O CCl3
NH
2.16
O
O
Ph
                      
OAcO
BnO
O
I
AcO
O CCl3
NH
2.17
                                                  
OAcO
BnO
O
SePh
AcO
O
2.18
CCl3
NH
 
Figure 2.1 
The general synthetic strategy envisaged for the synthesis of the donors 2.15 and 2.16 involved 
selective anomeric protection of D-glucose, followed by 4,6-benzylidene ring formation. 
Benzylidene ring formation takes place exclusively at hydroxyls 4- and 6-, because this leads to 
formation of a thermodynamic stable six membered-ring, with the phenyl ring at the acetal centre 
occupying an equatorial position. Then, it was anticipated that regioselective benzylation at 
position 3 could be achieved, followed by allylation of position-2. The allyl group could be 
converted into both to 2-iodoethyl ether and 2-(phenylseleno)ethyl ethers by a short series of 
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reactions. Finally the anomeric position could be de-protected and converted into a 
trichloroacetimidate donor as the last step.    
2.2.1 Strategy for synthesis of donors 2.15 and 2.16 
D-Glucose 2.19 was kinetically acetylated on reaction with sodium acetate and acetic anhydride 
to give glucopentaacetate 2.20 (Scheme 2.7).
[8]
   
O
OH
HO O
OAc
AcO
NaOAc, Ac2O
OAc
2.19 2.20
OH
HO AcO
HO AcO
120 °C, 2 h
(41%)
                                                 
Scheme 2.7 
Subsequently two strategies were undertaken to protect the anomeric position. In the first 
strategy, 2.20 was converted to thiophenyl glycoside by reaction with thiophenol in presence of a 
Lewis acid, to give the corresponding thioglycoside 2.21 (Scheme 2.8).
[9]
 Similarly 2.20 was 
converted to the corresponding PMP glycoside 2.22 on reaction with p-methoxyphenol in the 
presence of a Lewis acid (Scheme 2.9).
[10]
 In both the cases, exclusively β glycosides, were 
formed due to NGP provided by the acetate group at position-2. 
O
OAcAcO
AcO
OAc
PhSH, BF3.Et2O O
SPhAcO
AcO
OAc
2.20 2.21
AcO AcO
DCM, rt, 12 h
(80%)
                                                                     
Scheme 2.8 
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Scheme 2.9 
De-acetylation of both 2.21 and 2.22 by the Zemplén method,
[11]
 followed by benzylidene 
protection of positions 4 and 6, achieved by reaction with benzaldehyde dimethyl acetal in the 
presence of catalytic acid, yielded diols 2.23 and 2.24, respectively (Scheme 2.10).
[12] 
 
O
RAcO
AcO 1) NaOMe, MeOH, rt, 1.5 h
2) CSA, PhCH(OMe)2, DMF, 8 h
O
R
R = SPh, 2.21
R = OPMP, 2.22
R = SPh, 2.23 (73% over 2 steps)
R = OPMP, 2.24 (56% over 2 steps)
AcO
OAc
HO
OH
O
O
Ph
Scheme 2.10 
Regioselective benzylation of both 2.23 and 2.24, on treatment with benzyl bromide after the 
formation of tin acetals by reaction of the diols with dibutyltin oxide, regioselectively afforded 
the mono-benzylated products at position 3,
[13]
 2.25 and 2.26, respectively (Scheme 2.11).  
O
R
1) Bu2SnO, MeOH, reflux, 24 h
2) BnBr, CsF, DMF, rt, 72 h
R = SPh, 2.23
R = OPMP, 2.24
R = SPh, 2.25 (59%)
R = OPMP, 2.26 (43%)
OH
HO
O
O
Ph
O
R
OH
BnO
O
O
Ph
 
Scheme 2.11 
To confirm that the benzylation had indeed occurred selectively at position-3, 2.26 was 
acetylated by reaction with acetic anhydride and pyridine to give acetate 2.27. 
1
H-NMR clearly 
                                                             
                                                          Synthesis and evaluation of glycosyl donors bearing 2-O-(2 
Chapter 2                                          -(phenylselenyl)ethyl) and 2-O-iodoethyl protecting groups                                                                                                                                           
                                                                                                                                                                                                                                                  
57 
 
indicated a downfield shift of the H-2 signal, confirming that acetylation had occurred at 
position-2 (Scheme 2.12). 
O
OPMP
OH
2.26 2.27
Acetic anhydride, Pyridine
BnO
O
OPMP
OAc
BnO
O
O
O
OPh
Ph
rt, 20 h
 
Scheme 2.12 
Alcohols 2.25 and 2.26 were then allylated at their remaining free hydroxyl groups by reaction 
with allyl bromide in the presence of sodium hydride, to give allyl ethers 2.28 and 2.29, 
respectively (Scheme 2.13).
[14] 
O
R
R = SPh, 2.25
R = OPMP, 2.26
R = SPh, 2.28 (87%)
R = OPMP, 2.29 (72%)
BnO
OH
O
RBnO
O
O
O
O
O
Ph Ph
NaH, allyl bromide,
DMF, 0 oC, 4 h
  
Scheme 2.13 
Following the allylation reaction, various attempts to hydrolyze the SPh group of 2.28 in order to 
form 2.30 all proved unsuccessful. Generally multiple spots on t.l.c. were seen when reaction 
was carried on, possibly due to reaction on the double bond of the allyl group. Major product 
could not be isolated and characterized in any of the conditions (Scheme 2.14). 
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O
SPh
2.28
X
2.30
Reagents
BnO
O
O
BnO
O OH
O
O O
O
Ph
Ph
 
Sl. No. Reaction Conditions Outcome 
1. NBS/H2O-Acetone, rt Bromination on allyl group 
2. NIS, TFA/H2O-DCM, rt Iodination on ally group 
3. 
Chloramine-T/H2O-Acetonitrile, 
reflux 
No Reaction 
4. MeOTf, TTBP/H2O-Dioxane, reflux No Reaction 
5. Me2S2, Tf2O/H2O-DCM, rt Decomposition 
6. 
1-Benzenesulfinylpiperidine, 
Tf2O/H2O-DCM, rt 
Decomposition 
 
Scheme 2.14 
It was thought that perhaps hydrolysis of SPh was difficult due to steric hinderance, so an 
alternative strategy was attempted in which the allyl group was manipulated before the 
thioglycoside was attempted. Thus, allylated thiophenyl glycoside 2.28 was subjected to 
ozonolysis, followed by reduction with NaBH4, which led to the cleavage of double bond, and 
formation of alcohol 2.31 (Scheme 2.15).
[15]
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O
O
1) O3, DCM/MeOH, -78
oC
2) NaBH4
2.28 2.31
BnO SPh
O
O
BnO SPh
OH
O
O
Ph O
O
Ph
(69%)
                  
Scheme 2.15 
However 2.31 also proved resistant to hydrolysis, and did not give 2.32, under either sets of 
reaction conditions investigated (Scheme 2.16). 
2.31
X
2.32
ReagentsO
SPhBnO
O
OH
O
BnO
O
OH
OH
O
O O
O
Ph
Ph
 
Sl. No. Reaction Conditions Outcome 
1. NBS/H2O-Acetone, Reflux Decomposition 
2. NIS, TFA/H2O-DCM, Reflux Decomposition 
 
Scheme 2.16 
Now the attention shifted back to PMP glycoside. Ozonolysis of PMP glycoside 2.29 not only 
cleaved the allyl group, but also resulted in cleavage of PMP group at the anomeric position. 
Thus, the ozonolysis of 2.29, followed by reduction with sodium borohydride, yielded diol 2.33 
(Scheme 2.17).  
                                                             
                                                          Synthesis and evaluation of glycosyl donors bearing 2-O-(2 
Chapter 2                                          -(phenylselenyl)ethyl) and 2-O-iodoethyl protecting groups                                                                                                                                           
                                                                                                                                                                                                                                                  
60 
 
O
BnO
O
OPMP
1) O3, DCM/MeOH, -78
oC
2) NaBH4, rt
O
BnO
O
OH
OH
2.29 2.33
O
O
O
O
Ph Ph
(73%)
 
Scheme 2.17 
The Appel reaction usually results in the regioselective halogenation of primary hydroxyl groups 
in the presence of secondary hydroxyl groups.
[16]
 Accordingly reaction of 2.33, with I2/PPh3 in 
the presence of imidazole, iodide 2.34 albeit in rather low yield (Scheme 2.18). 
O
O
OH
OHBnO
2.33 2.34
O
O
I
OHBnOI2, PPh3, imidazole,
O
O
O
O
Ph Ph
THF, ref lux, 16 h
(39%)
                                         
Scheme 2.18 
The iodide of 2.34 then converted into phenyl selenyl group by reaction of 2.34 with benzene 
selenol in the presence of sodium hydride to yield hemiacetal 2.35 (Scheme 2.19).
[17]
 
O
O
I
OHBnO
2.34 2.35
O
O
SePh
OHBnOPhSeH, NaH
O
O
O
O
Ph Ph
THF, ref lux, 16 h,
(66%)
 
Scheme 2.19 
The free hydroxyl group at the anomeric centres of compounds 2.34 and 2.35 was then converted 
to a trichloroacetimidate by reaction with trichloroacetonitrile in the presence of DBU to yield 
                                                             
                                                          Synthesis and evaluation of glycosyl donors bearing 2-O-(2 
Chapter 2                                          -(phenylselenyl)ethyl) and 2-O-iodoethyl protecting groups                                                                                                                                           
                                                                                                                                                                                                                                                  
61 
 
donors 2.15 and 2.16 respectively, thus completing the synthesis of first set of donors, required 
for investigation of the stereochemical outcome of the glycosylation reactions (Scheme 2.20).
[18] 
O
O
X
OHBnO
X = I, 2.34
X = SePh, 2.35 X = I, 2.15 (96%)
X = SePh, 2.16 (92%)
O
O
X
OBnO CCl3
NHO
O
O
O
Ph Ph
Cl3CCN, DBU
DCM, 0 °C, 8 h
 
Scheme 2.20 
The successful route followed for the synthesis of the donors 2.15 (8 steps, overall yield = 1.8%) 
and 2.16 (9 steps, overall yield = 1.6%) has been summarized in the following scheme (Scheme 
2.21).  
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O
O
OPMPHO
O
O
O
OPMPBnO
O
OBnO O
I
CCl3
NH
2.16
2.15
2.19 2.20 2.22
2.24
2.26
2.29
2.33 2.34
HO
HO
HO
O
OAc
AcO
AcO
AcO
OAc O
OAc
AcO
AcO
AcO
OPMP
O
OR
OPMPBnO
O
O
BnO
OH
OH
O
O
BnO
OH
I
O
O
BnO
OH
SePh
2.35
O
OBnO O
SePh
CCl3
NH
R = H
R = OAc 2.27
O
O
Ph
O
O
Ph
O
O
Ph
O
O
Ph O
O
Ph
O
O
PhO
O
O
O
Ph
Ph
H OH
OH
(1) (2) (3)
(4) (6)
(5)
(7) (8)
(9)
(10) (11)
 
Scheme 2.21: (1) Ac2O, NaOAc, 120 °C, 2h, 41%; (2) p-Methoxyphenol, BF3.Et2O, DCM, rt, 3 
h, 81%; (3) (a) NaOMe, MeOH, 1.5 h; (b) CSA, PhCH(OMe)2, DMF, 8 h, 56% over two steps; 
(4) (a) Bu2SnO, MeOH, reflux, 24 h; (b) BnBr, CsF, DMF, 72 h, 43%; (5) Ac2O, pyridine, rt, 20 
h; (6) NaH, allyl bromide, DMF, 0 
o
C, 4 h, 72%; (7) O3, DCM/MeOH, -78 
o
C then add NaBH4, 
73%; (8) I2, PPh3, imidazole, THF, reflux, 24 h, 39%; (9) PhSeH, NaH, THF, reflux, 16 h, 66%; 
(10) Cl3CCN, DBU, DCM, 0 °C, 8 h, 96%; (11) Cl3CCN, DBU, DCM, 0 °C, 8 h, 92%.  
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2.2.2 Strategy for synthesis 2.17 and 2.18 
Now the focus shifted to the synthesis of the other two donors, diacetate 2.17, and 2.18. The 
general strategy involved similar steps to those used in the synthesis of 2.15 and 2.16 with the 
addition of hydrolysis of the benzylidene ring at appropriate step, followed by acetylation in 
order to introduce acetyl groups at position 4 and 6. 
The benzylidene ring of 2.29, was hydrolyzed by reaction with 80% aq. acetic acid to give diol 
2.36. The free hydroxyl groups at positions 4- and 6- were then acetylated by reaction with acetic 
anhydride in the presence of pyridine to yield diacetate 2.37 (Scheme 2.22).
[19]
 
2.29
O
OPMPBnO
O
AcOH/H2O
O
OPMP
HO
HO
BnO
O
Ac2O/Pyridine-DMAP
2.37
O
O
Ph
60 °C, 48 h rt, 16 h
2.36
(91% over two steps)
O
OPMP
AcO
BnO
O
AcO
Scheme 2.22 
Ozonolysis of 2.37 was followed by reduction with sodium cyanoborohydride to yield diol 2.38. 
NaBH4 led to partial reduction of acetate group, therefore a milder reducing agent NaBH3CN 
was used. Appel reaction of 2.38 then yielded iodide 2.39 (Scheme 2.23). 
O
OPMPAcOBnO
O
2.37
AcO
OAcO
BnO
O
OH
AcO
OH
2.38
1) O3, DCM, -78
oC
2) NaBH3CN, DCM, AcOH
OAcO
BnO
O
I
AcO
OH
2.39
I2, PPh3, imidazole
THF, reflux, 16 h
(20% over 3 steps)
 
Scheme 2.23 
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Finally the iodide group was replaced with phenyl-selenyl group by reaction of 2.39 with 
benzene selenol in the presence of sodium hydride to yield 2-phenylselenoethyl ether 2.40 
(Scheme 2.24). 
O
O
I
OHBnO
2.39 2.40
O
O
SePh
OHBnOPhSeH, NaH
THF, reflux, 16 h
AcO
AcO
AcO
AcO
(75%)
 
Scheme 2.24 
The free hydroxyl group at the anomeric centres of 2.39 and 2.40 was then converted to a 
trichloroacetimidate by reaction with trichloroacetonitrile in the presence of DBU to give donors 
2.17 and 2.18 respectively, thus completing the synthesis of other two donors required (Scheme 
2.25). 
OAcO
BnO
O
X
AcO
OH
X = I, 2.39
X = SePh, 2.40
Cl3CCN, DBU
DCM, 0 °C, 8 h
OAcO
BnO
O
X
AcO
O
X = I, 2.17 (89%)
X = SePh, 2.18 (74%)
CCl3
NH
 
Scheme 2.25 
The successful routes followed for the synthesis of the donors 2.17 (10 steps, overall yield = 
0.9%)  and 2.18 (11 steps, overall yield = 0.8%)  is been summarized in the following scheme 
(Scheme 2.26).  
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2.29
O
OPMPBnO
O
O
OPMP
HO
HO
BnO
O
O
OPMP
AcO
AcO
BnO
O
2.37
O
O
Ph
OAcO
BnO
O
OH
AcO
OH
OAcO
BnO
O
I
AcO
OH
2.39
OAcO
BnO
O
I
AcO
O
2.17
CCl3
NH
O
O
SePh
OHBnO
AcO
2.40
OAcO
BnO
O
SePh
AcO
O CCl3
NH
2.18
2.36
2.38
AcO
1a 1b
2a, 2b
2c
3
4
5
Scheme 2.26: (1) (a) AcOH, H2O, 60 
o
C; (b) Ac2O, pyridine, DMAP, 91%; (2) (a) O3, DCM, -78 
o
C; (b) NaBH3CN, DCM, AcOH; (c) I2, PPh3, imidazole, THF, reflux, 16 h, 20% over 3 steps; 
(3) PhSeH, NaH, THF, reflux, 16 h, 75%; (4) Cl3CCN, DBU, DCM, 0 °C, 3 h, 89%; (5) 
Cl3CCN, DBU, DCM, 0 °C, 3 h, 74%. 
2.3 Synthesis of acceptors and TTBP 
Three acceptors were synthesized for use in glycosylation reactions with the donors synthesized 
above. The first acceptor was diacetone galactose, where all the 2° hydroxyl groups are protected 
leaving only the 1° hydroxyl group free. D-Galactose 2.41 was reacted with acetone in presence 
of acid leading to the formation of 2.42 (Scheme 2.27).
[20] 
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O
OH
HO
OH OH
Acetone, H+ O
O OH
OO
2.41
2.42
OH
Ort, 24 h
(64%)
                                                                                           
Scheme 2.27 
The synthesis of acceptors containing a free 2° OH group was undertaken. Exo-dibenzylidene 
methyl mannopyranoside 2.43 was reduced with DIBAL-H to give a mixture of methyl-2-O-
benzyl-4,6-di-O-benzylidene-α-D-mannopyranoside 2.44 and methyl-3-O-benzyl-4,6-di-O-
benzylidene-α-D-mannopyranoside 2.45 which was then separated (Scheme 2.28).[21] 
O
OMe
2.43
DIBAL-H, Toluene
+O
O
Ph
H
O
O
Ph
2.44
O
OMe
HO
OBn
O
O
Ph
O
OMe
2.45
BnO
OH
O
O
Ph
-40 °C to rt, 2 h
(65%) (22%)
Scheme 2.28 
During this study, on several occassions a bulky base was required as a buffer to avoid the 
reaction mixture from becoming highly acidic. Crich
[22] 
developed a innovative method to 
synthesize TTBP 2.46, which acts as a nonnucleophilic base. I synthesized the base following the 
same methodology (Scheme 2.29).  
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O
+
O
SF3C O
O
S CF3
O
O
+ CN
N
N
2.46
rt, 5 days
(68 %)
DCM
                              
Scheme 2.29 
2.4 Glycosylation reactions 
In glycosylation reactions carried out by Dan Cox,
[3]
 the completely armed donors gave optimal 
stereoselectivity using glycosyl trichloroacetimidates as the donors, and activation with 0.1 eq. 
TMSOTf at -78 °C. This study sought to improve upon the stereoselectivity reported by him by 
using the partially disarmed donors with iodoethyl and selenophenyl ethyl groups at position 2 
for NGP. Therefore in order to draw a proper comparison this study only investigated 
glycosylation reactions using glycosyl trichloroacetimidates as donor; additionally all reactions 
carried out in DCM as solvent, at -78 °C, using 0.1 eq. of TMSOTf as the activator.    
To have a proper comparison among the donors, diacetone galactose 2.42 was used as a model 
acceptor and was glycosylated with all the four donors 2.15, 2.16, 2.17 and 2.18. Additionally 
the donor 2.15 was used for glycosylation of methanol 2.47 and methyl2-O-benzyl-4,6-di-O-
benzylidene-α-D-mannopyranoside 2.44 as it was the first donor synthesized. 
2.4.1 Glycosylation reactions of iodo donors 
To investigate the effectiveness of iodo group in NGP for stereoselective glycosylation, first 
glycosylation was undertaken with the trichloroacetamidate donor 2.15, and MeOH 2.47 (2 eq.) 
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as the acceptor. Very surprisingly the methyl glycoside 2.48 obtained was almost exclusively as 
the β-anomer (Scheme 2.30).   
O
BnO
O
I
O CCl3
NH
2.15
+
TMSOTf
DCM, -78 °C, 5 h
O
BnO
O
I
2.48
CH3OH
O
OO
O
Ph
Ph
2.47
(58%)
OCH3
Scheme 2.30 
It had been noted that, sterically hindered acceptor results in higher stereoselectivity in similar 
reactions.
[2] 
The next acceptor chosen for the glycosylation reaction, with the same donor 2.15, 
was a sugar with a free 1° hydroxyl group; diacetone galactose 2.42. The stereoselectivity (α:β = 
1:2) observed was again against our expectations (Scheme 2.31).  
O
BnO
O
I
O CCl3
NH
2.15
+
O
OO
O
O
OH
2.42
O
BnO
O
I O
O
O
O
O
O
2.49
O
O
Ph
O
O
Ph
TMSOTf
DCM, -78 °C, 7 h
(77%)
Scheme 2.31 
When glycosylation of a sugar with a free 2° hydroxyl 2.44, was carried out with 2.15, there was 
no improvement and no stereoselectivity (α:β = 1:1) was observed (Scheme 2.32). 
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O
BnO
O
I
O CCl3
NH
2.15
+ O
OMe
2.44
O
BnO
O
I
O
2.50
OBn
O
OMe
OBn
HO
O
O
Ph O
O
Ph
O
O
Ph
O
O
Ph
TMSOTf
DCM, -78 °C, 8 h
(83%)
                                                                                                                                                            
Scheme 2.32 
When the donor 2.17 took part in glycosylation reaction under the same reaction conditions, 
disaccharide 2.51 was obtained with stereoselectivity of (α:β = 1:2), raising serious doubt on 
NGP by the iodo group (Scheme 2.33). 
O
BnO
O
I
O CCl3
NH
2.17
+
O
OO
O
O
OH
2.42
O
BnO
O
I O
O
O
O
O
O
2.51
AcO
AcO
AcO
AcO
TMSOTf
DCM, -78 °C, 7 h
(81%)
     
Scheme 2.33 
2.4.2 Glycosylation reactions of selenophenyl donors 
Continuing with diacetone galactose 2.42 as a model acceptor, it was glycosylated with the donor 
2.16 under the same reaction conditions, disaccharide 2.52 was produced, but predominantly as 
the undesired beta anomer (α:β = 1:3), thus raising serious doubts about the effectiveness of the 
selenophenyl group in accomplishing 6-ring NGP (Scheme 2.34).     
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O
BnO
O
SePh
O CCl3
NH
2.16
+
O
OO
O
O
OH
2.42
O
BnO
O
PhSe O
O
O
O
O
O
2.52
O
O
O
OPh
Ph
TMSOTf
DCM, -78 °C, 7 h
(93%)
 Scheme 2.34 
When diacetone galactose 2.42 was glycosylated with donor 2.18, the product 2.53, was obtained 
with stereoselectivity of (α:β = 1:4) (Scheme 2.35).  
O
BnO
O
SePh
O CCl3
NH
2.18
+
O
OO
O
O
OH
2.42
O
BnO
O
PhSe O
O
O
O
O
O
2.53
AcO
AcO
AcO
AcO
DCM, -78 °C, 7 h
(94%)
TMSOTf
 Scheme 2.35 
Glycosylation
[a] 
reactions performed by these donors are summarized below in the table (Table 
2.1).  
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Donors 
Time 
(h) 
Acceptors used 
α:β 
ratio
[b]
 
Yield 
(%) 
Product 
2.15 5 
CH3OH 
2.47 
1:50 58 
O
BnO
O
I
2.48
O
O
Ph
OCH3
 
2.15 7 
O
O OH
O
O O
2.42  
1:2 77 
O
BnO
O
I O
OO
O
O
O
2.49
O
O
Ph
 
2.15 8 
2.44
O
OMe
OBn
HO
O
O
Ph
 
1:1 83 
O
OMe
O
BnO
O
I
O
2.50
OBnO
O
Ph
O
O
Ph
 
2.16 7 
O
O OH
O
O O
2.42  
1:3 93 
O
BnO
O
PhSe O
OO
O
O
O
2.51
O
O
Ph
 
2.17 7 
O
O OH
O
O O
2.42  
1:2 81 
O
BnO
O
I O
OO
O
O
O
2.52
AcO
AcO
 
2.18 7 
O
O OH
O
O O
2.42  
1:4 94 
O
BnO
O
PhSe O
OO
O
O
O
2.53
AcO
AcO
 
[a] Reaction conditions: acceptor (2.0 equiv.), TMSOTf (0.1 equiv.), –78 °C, DCM.  
[b] Anomeric ratios were determined by integration of appropriate peaks in the 
1
H NMR spectra. 
                                                                                                                                                                  
Table 2.1 
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2.5 Low temperature NMR investigations into neighboring group 
participation of Iodo & SePh Substitutions 
The stereoselectivity observed for the glycosylation reactions performed on the four partially 
disarmed donors investigated contrasted with the results obtained using the completely armed 
donors reported by Cox.
[3]
 These results raised serious questions as to whether NGP by these two 
groups was actually occurring. Therefore, based on the studies reported by Boons,
[6]
 we designed 
a series of experiments to investigate any intermediates produced during the activation of the 
trichloroacetimidate donors in the presence of a Lewis acid TMSOTf, at -78 °C by recording low 
temperature NMR spectra. 
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2.5.1 Low temperature NMR investigations into neighboring group 
participation of iodo substituent 
To study the neighboring group participation of the iodo group at position-2 of the donor sugar, 
trichloroacetimidate 2.15 was activated at low temperature and NMR spectra were recorded at 
that temperature. 
Firstly,
 1
H NMR spectrum of 2.15 in CD2Cl2 was recorded at -78 °C. Subsequently, an equimolar 
amount of trimethylsilyl trifluoromethanesulfonate was added to the solution at -78 °C. The 
reaction mixture was kept at -78 °C for 10 min, after which time 
1
H NMR, followed by HSQC 
(over 30 min), COSY (over 10 min) and then HMBC (over 40 min) spectra were all recorded at -
78 °C. 
1
H NMR and HMBC spectra are shown below (Figure 2.2). 
 
 O
O
I
BnO
O
O
Ph
Activated 2.15
1
23
4
5
6
7 8
+
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A – 1H-NMR of 2.15 at -78 °C; B - 1H-NMR of activated 2.15 at -78 °C by addition of 1 eq. of TMSOTf; C – 
HMBC study of activated 2.15 at -78 °C.  
Figure 2.2 
A 
B 
 
C 
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To study the neighboring group participation of iodo group at position-2 of the donor sugar, 
trichloroacetimidate 2.17 was activated at low temperature and NMR spectra ware recorded at 
that temperature. 
Firstly,
 1
H NMR spectrum of 2.17 CD2Cl2 was recorded at -78 °C. Later, an equimolar amount of 
trimethylsilyl trifluoromethanesulfonate was added to the solution at -78 °C. The reaction 
mixture was kept at -78 °C for 10 min, after which time 
1
H NMR, followed by an HSQC (over 
30 min), COSY (over 10 min) and then HMBC (over 40 min) spectra were all recorded at -78 
°C. 
1
H NMR and HMBC spectra are shown below (Figure 2.3) 
 
O
O
I
BnO
AcO
AcO
Activated 2.17
1
2
3
4
5
6
7
8
+
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A – 1H-NMR of 2.17 at -78 °C; B - 1H-NMR of activated 2.17 at -78 °C by addition of 1 eq. of TMSOTf; C – 
HMBC study of activated 2.17 at -78 °C.  
Figure 2.3 
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2.5.2 Low temperature NMR investigations into neighboring group 
participation of selenophenyl substituent 
Similarly to study the neighboring group participation of SePh group at position-2 of the donor 
sugar, trichloroacetimidate 2.16 was activated at low temperature and NMR spectra were 
recorded at that temperature.  
Firstly,
 1
H NMR spectrum of 2.16 in CD2Cl2 was recorded at -78 °C, following which equimolar 
amount of trimethylsilyl trifluoromethanesulfonate was added to the solution at -78 °C. The 
reaction mixture was kept at -78 °C for 10 min, after which time 
1
H NMR, followed by HSQC 
(over 30 min), COSY (over 10 min) and then HMBC (over 40 min) spectra were all recorded at -
78 °C. 
1
H NMR and HMBC spectra are shown below (Figure 2.4). 
 
O
O
BnO
O
O
Ph
Activated 2.16
1
23
4
5
6
Se+
7 8
Ph
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A – 1H-NMR of 2.16 at -78 °C; B - 1H-NMR of activated 2.16 at -78 °C by addition of 1 eq. of TMSOTf; C – 
HMBC study of activated 2.16 at -78 °C.  
Figure 2.4 
 
A 
B 
C 
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Similarly to study the neighboring group participation of SePh group at position-2 of the donor 
sugar, trichloroacetimidate 2.18 was activated at low temperature and NMR spectra were 
recorded at that temperature.  
Initially,
 1
H NMR spectrum of 2.18 in CD2Cl2 was recorded at -78 °C. An equimolar amount of 
trimethylsilyl trifluoromethanesulfonate was then added to the solution at -78 °C. The reaction 
mixture was kept at -78 °C for 10 min, after which time 
1
H NMR, followed by HSQC (over 30 
min), COSY (over 10 min) and then HMBC (over 40 min) spectra were all recorded at -78 °C. 
1
H NMR and HMBC spectra are shown below (Figure 2.5). 
 
O
O
BnO
AcO
AcO
Activated 2.18
1
23
4 5
6
Se+
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A – 1H-NMR of 2.18 at -78 °C; B - 1H-NMR of activated 2.18 at -78 °C by addition of 1 eq. of TMSOTf; C – 
HMBC study of activated 2.18 at -78 °C.  
Figure 2.5 
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In the partially disarmed systems, for the iodoethyl donors 2.15, and 2.17 no obvious NMR 
signal shifts in H-8 or H-1 upon activation were observed, nor were any cross correlations 
observed between C-1 and H-8a/b in the HMBC spectra, which indicates that NGP did not occur 
for these disarmed iodo-substituted donors. 
However, for the corresponding phenylseleno donors 2.16 and 2.18 evidence of NGP was 
observed. The activated donors 2.16a and 2.18a were β-configured, as confirmed by both the 
JH1,H2 (9–10 Hz) and the JH1,C1 coupling constants (168 Hz). Both materials showed cross 
correlation between C-1 and H-8eq in the HMBC spectrum, indicating that NGP occurs. The 
NMR spectroscopic data suggests that both materials are β-configured cyclised intermediates, 
but differ in that the Ph group attached to Se is either axial or equatorial.
[23]
  
The NMR studies indicated that NGP did indeed occur for all of the disarmed phenylseleno 
donors, even though these compounds were less α-selective than completely armed benzylated 
donor, which did not undergo NGP according to NMR spectroscopy. Evidence that a cyclic 
intermediate is formed upon activation of a donor does not necessarily mean that this is the 
reactive species through which glycosylation occurs. Notably, although all of the cyclic 
intermediates observed were β-configured, as indicated by NMR spectroscopic coupling 
constants, significant amounts of β-glycoside product were formed, indicating that most reaction 
must take place via intermediates not seen by NMR spectroscopy. 
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2.6 Discussion 
The NMR studies indicated that NGP has indeed occurred for both of the disarmed phenylseleno 
donors (2.16 and 2.18), even though the compounds were less α-selective than their completely 
armed benzylated counterparts (2.54, 2.55), figure 2.6, which did not undergo NGP according to 
NMR spectroscopy.
[3]
  
               
O
BnO
O
I
O CCl3
NH
2.54
BnO
BnO
                              
O
BnO
O
SePh
O CCl3
NH
2.55
BnO
BnO
 
Figure 2.6 
We further conclude that despite the evidence that a cyclic intermediate is formed upon 
activation of a donor, this does not necessarily mean that it is the reactive species through which 
glycosylation occurs. Although all of the cyclic intermediates observed were β-configured, 
addition of an alcohol resulted, however, in the formation of a mixture of anomers. This 
unexpected observation can be rationalized by the classical Curtin-Hammett principle which 
states that an equilibrium exists between the selenonium and oxocarbenium ions (Scheme 2.36). 
This equilibrium is shifted strongly in the direction of the selenonium ion as shown by the NMR 
studies. A glycosylation can, however, take place from the much more reactive oxocarbenium 
ion when the rates of interconversion (k1 and k2) are faster than that of glycosylation (k4).  
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The question therefore arises as to why the stereoselectivity of the products formed did not 
match with the configuration of the intermediates observed. A survey of the literature revealed a 
similar observation in a report by Turnbull.
[24] 
 
In this study a bicyclic thioglycoside was activated by methylation to generate a 
methylsulfonium group that acted both as an anomeric leaving group, and also provided the 
methylsulfide group in the product (Figure 2.7).  
O
S
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MeOTf O
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O
OR'
OR'
MeS
OR
 
Figure 2.7 
The studies done by Boons
[6]
 had shown that activation of a glycosyl donor protected with a 2-O-
(S)-(phenylthiomethyl)benzyl ether chiral auxiliary results in the formation of an anomeric β-
sulfonium ion, via a trans-decalin ring, which can be displaced with sugar alcohols to give 
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corresponding α-glycosides. Furthermore, Boons elaborated that formation of trans-decalin-like 
sulfonium ion is favored by the electron withdrawing groups on the donor ring, leading to higher  
stereoselectivity, by avoiding glycosylation of an oxocarbenium ion intermediate.  
Turnbull compared the methylthioxylose sulfonium ion with a trans-decalin-like sulfonium ion 
described by Boons and co-workers to be an α-directing participating group by density functional 
theory calculations, and found it to be more stable. The NMR studies, also detected a very stable 
key sulfonium intermediate, which should have acted as a participating group to direct the 
acceptor alcohol to the lower α face of the sugar, the glycosylation reaction proceeded with 
moderate stereoselectivity, apparently via an SN1-type mechanism. The whole study led to the 
conclusion that even though NMR studies might show a stable intermediate which should result 
in a very stereoselective glycosylation reaction, caution should be applied before invoking it as 
an intermediate on the reaction pathway. 
In another study, it was suggested by the Woerpel
[25]
 group that Boons’ glycosyl sulfonium ion 
does not necessarily give diastereolectivity due to involvement of neighboring group 
participation, implicating a Curtin-Hammett kinetic scenario in which the formation of a low-
energy intermediate does not necessitate its involvement in the product-forming pathway.  
2.7 Conclusions 
In an attempt to promote highly stereoselectivity α-glycosylation by 6-ring NGP, a selection of 
glycosyl donors were synthesised that possesed new 2-iodoethyl-ether and 2-
(phenylseleno)ethyl-ether protecting groups at the 2-position. Studies done earlier by the 
Fairbanks group had shown that the “completely-armed” tri-benzylated donors produced α-
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glucosides as the predominant reaction products.
[3]
 However, low temperature NMR studies did 
not provide evidence of NGP by the observable formation of cyclised reaction intermediates. 
A subsequent investigation with corresponding disarmed glycosyl donors unexpectedly revealed 
them to be less stereoselective than their completely armed counterparts.  
The fact that considerable amounts of β-glycoside product were formed from glycosylation of 
the Se-containing donors indicated that the predominant reaction pathway to product did not 
occur via the observed cyclic species. It can be reasoned from these investigations that selenium 
is a better participating group than iodine, and is therefore more likely to form the basis of a 
useful achiral participating neighbouring group designed to promote α-glycoside formation. 
However this work demonstrates that formation of a cyclised intermediate alone is not sufficient 
to ensure a high level of selectivity during glycosylation. Based on Boons’ studies discussed 
earlier, a completely disarmed donor should have given a higher stereoselectivity compared to 
the partially disarmed donors mentioned in this study. However, no such results were observed. 
Likewise, it appears that glycosylation of disarmed donors is not necessarily more stereoselective 
than that of the corresponding completely armed compounds, even if the latter do show a lower 
propensity to undergo NGP because of protecting group stabilisation of a glycosyl cation or other 
acyclic intermediate. An extremely subtle balance exists between alternative reaction pathways 
during glycosylation. Further, to develop a reliable achiral variant, fine-tuning of protecting 
group structure is required, that affects high levels of α-selectivity through 6-ring NGP. 
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Chapter 3: Development of the 2-O-(2-(2,4,6-trimethoxythio 
phenyl)ethyl) protecting group for stereocontrolled 
glycosylation 
3.1 Introduction 
As noted in Chapter 2, this research project was inspired by the works of Boons
[1] 
and relies on 
neighbouring group participation (NGP) occurring via a 6-membered ring an and intermediate a 
trans decalin type structure, which the glycosyl acceptor then attacks axially to produce the α-
glycoside as the major reaction product (Scheme 2.1). It was also mentioned that Boons
[1a]
 had 
shown that even without a chiral auxiliary group at position-2, stereoselectivity of α:β = 8:1 was 
achieved by use of an ethylthiophenyl group for protection of the 2-position of glycosyl donor 
(Scheme 2.3). This report led us to investigate the use of more nucleophilic groups, namely iodo- 
and selenophenyl,at the 2-position of an 2-O-ethyl ether in order to increase the propensity for 6-
ring NGP, in order to increase the levels of α-selectivity that could be observed. However, as 
detailed in Chapter 2, the stereoselectivity observed with these novel protecting groups was very 
disappointing, especially with the disarmed donors (Table 2.1). 
Other research in the Fairbanks group investigated the use of a benzeneseleno ethyl ether at the 
2-position in a completely disarmed donor.
[2]
 Though low temperature NMR studies had 
suggested that the selenophenyl ethyl ether did participate in NGP no stereoselectivity was 
observed. This led us to conclude that cyclic intermediate formed upon activation of the donor, 
and seen by NMR, was probably not the reactive species through which glycosylation occured. 
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However, the thiophenyl group reported by Boons,
[1a]
 had undergone both NGP via a trans-
decalin intermediate and gave α-selectivity. We therefore decided to synthesise a donor with a 
(2,4,6-trimethoxyphenyl)thio ethyl ether at position-2, with the aspiration that we may get 
effective NGP via a β-configured trans decalin cyclic intermediate, which was also an 
intermediate in Turnbull’s investigations of successful stereoselective glycosylations,[3] and 
probably would result in α-stereoselective glycosylation reactions (Scheme 3.1). 
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3.2 General strategy for the synthesis of donors  
The armed 3.1, partially disarmed 3.2, and completely disarmed donor 3.3 were chosen as 
synthetic targets (Figure 3.1). 
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OMeMeO
OMe
CCl3
NH
3.3
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OAcO
AcO
AcO
OMeMeO
OMe3.1
O
O
S
OBnO
BnO
BnO
OMeMeO
OMe
3.2
CCl3
NH
CCl3
NH
 Figure 3.1 
The strategy for the synthesis of all the donors involved the synthesis of iodo hemiacetals similar 
to 2.34 (which was a precursor for synthesis of 3.2). The iodide was later substituted by the 
trimethoxythiophenyl group by reaction of with 2,4,6-trimethoxybenzenethiol in the presence of 
base to yield trimethoxythiophenyl ethyl ether at position-2. The resulting hemiacetals were then 
converted to the corresponding trichloroacetimidates by reaction with trichloroacetonitrile in 
presence of DBU. 
3.2.1 Synthesis of completely armed donor 3.1 
The known orthoester 3.6 was synthesized using standard procedures from β-D-glucose 
pentaacetate 2.20 (Scheme 3.2).
[4]
 Treatment of 2.20 with 33% HBr in glacial acetic acid 
afforded the α-bromide 3.4[5] in 93% yield. Reaction of 3.4 with ethanol and 2,4,6-collidine in 
the presence of a catalytic amount of tetrabutylammonium bromide then gave the 3,4,6-O-acetyl 
                                                        
                                                               Development of the  2-O-(2-(2,4,6-trimethoxythiophenyl)                                   
Chapter 3                                              ethyl) protecting groups for stereocontrolled glycosylation        
                                                                                                                                                                                                                                                                                      
91 
 
protected orthoester 3.5
[4]
 in 92% yield of. Deprotection of the acetyl groups was carried out 
under Zemplén conditions,
[6]
 and the resulting product was immediately treated with sodium 
hydride and benzyl bromide to give orthoester 3.6
[4]
 in an overall yield of 81% over 3 steps from 
2.20. 
O
OAcAcO
AcO
OAc
HBr, AcOH
OAcO
AcO
AcO
2.20 3.4
AcO AcO
DCM, 0 °C
Br
rt, 2 h
(93%)
EtOH, TBAB,
2,4,6-collidine
DCM, reflux, 16 h
ORO
RO
3.5
RO
O O
OEtMe
(92%)
R = Ac
3.6 R = Bn
1) Na / MeOH, rt, 1 h
2) BnBr / DMF, rt, 16 h
(95%)
Scheme 3.2 
Treatment of orthoester 3.6 with aq. acetic acid produced a mixture of monoacetates, which were 
immediately converted to an anomeric mixture of diacetates 3.7
[7]
 (α:β = 13:1) by treatment with 
acetic anhydride and pyridine. Reaction of 3.7 with ethanethiol and boron trifluoride diethyl 
etherate then produced the thioethyl glycoside 3.8
[8]
 (α:β = 1:5) in excellent yield, from which 
the 2-O-acetate was removed by under Zemplén conditions, yielding alcohol 3.9
[9]
 (Scheme 3.5) 
with an overall yield of 66% over 3 steps from 3.6 (Scheme 3.3). 
OBnO
BnO
3.6
BnO
O O
OEtMe
1) AcOH 60% (aq.), rt, 2 h
2) Ac2O, DMAP /
Pyridine, rt, 16 h
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3.8
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RO SEt
EtSH, BF3.Et2O
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3.9 R = H
Na
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Scheme 3.3 
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The alcohol 3.9 was then treated with allyl bromide and NaH in DMF, to give the 2-O-allyl 
protected donor 3.10
[10]
 in 94% yield. Thioglycoside 3.10 was then treated with MeOTf in the 
presence of TTBP in a mixture of 1,4-dioxane and water to give the hemiacetal 3.11
[2]
 in a 80% 
yield. Subsequent ozonolysis proceeded smoothly to give the diol 3.12 (76% yield). The Appel 
reaction usually results in the regioselective halogenation of primary hydroxyl groups in the 
presence of secondary hydroxyl groups.
[11]
 Accordingly reaction of 3.12, with I2 and PPh3 in the 
presence of imidazole gave iodide 3.13 in 76% yield (Scheme 3.4). 
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O SEt
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(94%)
OBnO
BnO
BnO
O OH
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2) NaBH4, rt
O
BnO
O
OH
OH
3.12
BnO
BnO
(76%)
3.13
O
O
I
OHBnO
I2, PPh3, imidazole,
BnO
BnO
THF, ref lux, 16 h
(76%)
Scheme 3.4 
Finally the iodide group was replaced by trimethoxythiophenyl by reaction of 3.13 with 
trimethoxybenzenethiol in the presence of Hünig’s base to yield arylthio ethyl ether 3.14. 
Trichloroacetimidate formation was achieved by treatment of 3.14 with trichloroacetonitrile and 
DBU to afford donor 3.6 in 66% yield over the last two steps (Scheme 3.5). 
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3.2.2 Synthesis of partially disarmed donor 3.2 
Iodide 2.34 was synthesized as shown in Scheme 2.21 and treated with trimethoxybenzenethiol 
in the presence of Hünig’s base to yield arylthio ethyl ether 3.15. Treatment with 
trichloroacetonitrile and DBU to afforded donor 3.2 in 82% yield over two steps (Scheme 3.6). 
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3.2.3 Synthesis of completely disarmed donor 3.3 
Iodide 3.16 was synthesized by another group member as reported in the literature.
[2]
 Reaction of 
3.16 with trimethoxybenzenethiol in the presence of Hünig’s base gave arylthio ethyl ether 3.17 
(73% yield). Treatment with trichloroacetonitrile and DBU then afforded the completely 
disarmed donor 3.3 in 89% yield (Scheme 3.7). 
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R = H
3.3 R = CNHCCl3
Cl3CCN, DBU
DCM, rt, 6 h
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Scheme 3.7 
3.3 Preliminary investigations  
Two protocols for glycosylation have been reported by Boons; termed Protocol A and Protocol 
B.
[1b]
 The glycosylation reactions reported in Chapter 2, all employed ‘Protocol A’ (Section 2.4), 
wherein the donor and acceptor were first stirred at -78 °C in DCM, before the addition of a 
catalytic amount of TMSOTf, and carrying out the glycosylation at -78 °C.  
Subsequently the acceptor 2.42 was glycosylated with selenophenyl donor 2.16 using Protocol B. 
In Protocol B the donor 2.16 was first activated at -78 °C by the addition of 1 eq. of TMSOTf, 
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then warmed to 0 °C and then cooled down to -78 °C before the acceptor 2.42 and the non 
nucleophilic base TTBP 2.46 were added. Surprisingly this procedure yielded the disaccharide 
2.51 with high -stereoselectivity (α:β = 3.5:1), as compared to the stereoselectivity observed 
employing Protocol A (α:β = 1:4). However, when the acceptor 2.42 was glycosylated with iodo 
donor 2.15 using Protocol B, decomposition of the donor occured (Table 3.1). 
Sl. 
No. 
Donor Acceptor Product 
Protocol A Protocol B 
Yield α:β Yield α:β 
1. 2.16 2.42 
O
BnO
O
PhSe O
OO
O
O
O
2.51
O
O
Ph
 
93% 1:4 66% 3.5:1 
2. 2.15 2.42 
O
BnO
O
I O
OO
O
O
O
2.49
O
O
Ph
 
77% 1:2 
Deco
m-
posed 
- 
Table 3.1 
These results implied the that using Protocol B the donor (2.16) underwent NGP (Section 2.5.2) 
i.e. a selenonium ion intermediate was formed; the addition of the acceptor at a much later stage 
led to attack only on the thermodynamically stable -configured selenonium ion Thus α-
selectivity was observed in glycosylation reaction when Protocol B was employed. However as 
the iodo group did not undergo NGP (Section 2.5.1), the donor (2.14) simply decomposed at 0 
o
C 
in presence of 1 eq. of activator TMSOTf.  
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The next thing that needed to be verified was if the TTBP had any effect on the stereoselectivity 
of the reaction. The tetrabenzylglucose trichloroacetamidate donor 3.18 was chosen for 
investigation into the effect of added base. When glycosylation of acceptor 2.42 was carried out 
with donor 3.18 using Protocol B, only rearrangement of the donor to the amide isomer 3.19 was 
observed (Scheme 3.8). 
O
O
BnO
BnO
BnO
O
O O
O
O
Bn
O
O
O
BnO
BnO
BnO
N
H
3.18
O
O
BnO
BnO
BnO
Bn
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X
Section 3.8 
This unexpected isomerization of the donor, which is a known side reaction of 
trichloroacetimidates,
[12]
 indicated that in the absence of any NGP, and in absence of acceptor, 
the rearrangement was facilitated. Therefore a different approach was required to find if TTBP 
had any effect on the reaction stereoselectivity. The donor 3.18 was stirred with acceptor 2.42 
and TTBP 2.46 and then cooled to -78 °C. One equivalent of TMSOTf was then added and 
solution was allowed to warm to rt. The disaccharide 3.20 was formed with low stereoselectivity 
(α:β = 1:2.5) (Scheme 3.9), which was very similar to stereoselectivity obtained (α:β = 1:2.25) 
when protocol A (in absence of TTBP) was employed at same temperature.
[13]
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1) TTBP 2.46 (2 eq.)
2) TMSOTf (1eq.)
O
O
BnO
BnO
BnO
O
O O
O
O
Bn
O
3.18
O
BnO
BnO
BnO
BnO
O CCl3
NH
O
O O
O
O OH
+
2.42
3.20
a
b
DCM, -78 °C rt, 5 h
(64 %)
 Scheme 3.9 
Boons’[1a] use of a thiophenyl group substituted ethyl ether for protection of the 2-position was 
then investigated for a partially disarmed donor, which was similar to donor 2.16. Iodide 2.14 
was treated with thiophenol in the presence of sodium hydride to yield hemiacetal 3.21. The free 
hydroxyl group at the anomeric centre of compound 3.21 was then converted to a 
trichloroacetimidate by reaction with trichloroacetonitrile in the presence of DBU to yield donor 
3.22 (Scheme 3.10). 
O
O
I
OHBnO
2.14 3.21
O
O
SPh
OHBnO
PhSH, NaH
THF, reflux, 16 h
O
O OO
Ph Ph
(99%)
CCl3CN, DBU
DCM, rt, 6 h
3.22
O
O
SPh
OBnO CCl3
NHO
O
Ph
(93%)
Scheme 3.10 
Glycosylation of the acceptor 2.42 with donor 3.22, employing Protocol B afforded the 
disaccharide 3.23 with high stereoselectivity (α:β = 7:2) (Scheme 3.11).However, the 
stereoselectivity was completely lost when Protocol A (α:β = 1.1:1) was employed using the 
same donor and acceptor. 
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O
SPh
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O
Ph
O
O
O
O
O
3.23
a
b
i) TMSOTf (1 eq.), (-78 °C 0 °C) / DCM
ii)
O
O
O
OH
O O
,TTBP 2.46, -78 °C / DCM
(72%)
2.42
Scheme 3.11 
 It was therefore concluded that only Protocol B should be employed for all subsequent 
glycosylation reactions.  
3.4 Glycosylation reactions 
In order to systematically investigate any effect of donor protecting group regime, diacetone 
galactose 2.42 was glycosylated with all three donors. As explained previously (section 3.3), 
Protocol B was employed for all glycosylation reactions, which involves pre-activation and 
warming of the glycosyl donor before cooling and addition of the acceptors as described below. 
A mixture of donor (1 equiv.) and activated molecular sieves (3 Å) in DCM (5 mL) was stirred 
for 10 min under an atmosphere of nitrogen at rt. The mixture was then cooled to -78 °C, 
TMSOTf (1 equiv.) was added, and the reaction mixture was allowed to warm to 0 °C over a 
period of 40 min. The reaction mixture was then re-cooled to -78 °C, and diacetone galactose 
(1.1 equiv.) and TTBP (2 equiv.) were added. The reaction mixture was allowed to warm slowly 
to rt and stirred overnight at rt. Following work up, 
1
H-NMR of the crude product was obtained, 
and purification of the crude product was further achieved by column chromatography with 
silica. 
                                                        
                                                               Development of the  2-O-(2-(2,4,6-trimethoxythiophenyl)                                   
Chapter 3                                              ethyl) protecting groups for stereocontrolled glycosylation        
                                                                                                                                                                                                                                                                                      
99 
 
Using these conditions the completely armed donor 3.1 yielded exclusively the α-disaccharide 
3.24 (Scheme 3.12). 
i) TMSOTf (1 eq.), (-78 °C 0 °C) / DCM
ii)
O
O
O
OH
O O
,TTBP 2.46, -78 °C / DCM
(69%)
2.42
O
O
S
OBnO
BnO
BnO
OMeMeO
OMe
3.1
CCl3
NH
O
S
O
BnO
BnO
BnO
O
O
O
O
O
3.24
O
MeO
OMe
MeO
Scheme 3.12 
Under identical conditions the partially disarmed donor 3.2 gave disaccharide 3.25 as an 
anomeric mixture of products, which was in favour of the -anomer (α:β = 5:1) (Scheme 3.13). 
O
O
S
OBnO
O
O
Ph
OMeMeO
OMe
3.2
CCl3
NH
O
O
S
OBnO
O
O
Ph
OMeMeO
OMe
O
O
O
O
O
3.25
i) TMSOTf (1 eq.), (-78 °C 0 °C) / DCM
ii)
O
O
O
OH
O O
,TTBP 2.46, -78 °C / DCM
(61%)
2.42
Scheme 3.13 
The completely disarmed donor 3.3 yielded disaccharide 3.26 with the stereoselectivity (α:β = 
3.5:1) (Scheme 3.14). 
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i) TMSOTf (1 eq), (-78 °C 0 °C) / DCM
ii)
O
O
O
OH
O O
,TTBP 2.46, -78 °C / DCM
(63%)
2.42
O
O
S
OAcO
AcO
AcO
OMeMeO
OMe
3.3
CCl3
NH
O
O
S
OAcO
AcO
AcO
OMeMeO
OMe
O
O
O
O
O
3.26
Scheme 3.14 
The completely armed donor 3.1 was then used to glycosylate five other acceptors, and 
pleasingly all the reactions resulted in completely α-selectivity.The glycosylation reactions 
performed on donors 3.6, 3.7 and 3.8 are summarized Table 3.2. 
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Donor Acceptor  
α:β 
ratio
[a]
 
Yield 
(%) 
Product 
3.1 
O
O OH
O
O O
2.42  
1:0 69 
O
S
O
BnO
BnO
BnO
O
O
O
O
O
3.24
O
MeO
OMe
MeO
 
3.2 
O
O OH
O
O O
2.42  
5:1 61 
O
O
S
OBnO
O
O
Ph
OMeMeO
OMe
O
O
O
O
O
3.25  
3.3 
O
O OH
O
O O
2.42  
3.5:1 63 
O
O
S
OAcO
AcO
AcO
O
O
O
O
O
3.26
OMe
OMe
MeO
 
3.1 
2.44
O
OMe
OBn
HO
O
O
Ph
 
1:0 63 
O
O
BnO
BnO
BnO
3.27
O
O
MeO
OBn
O
O
Ph
S
MeO OMe
OMe
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3.1 
2.45
O
OMe
OH
BnO
O
O
Ph
 
1:0 65 
O
BnO
BnO
BnO
3.28
O
O
O
OMe
BnO
O
O
Ph
ArS
a
b
 
3.1 
3.29
O
OMe
BnO
HO
BnO
BnO
 
1:0 68 
O
S
O
BnO
BnO
BnO
3.30
O
MeO
OMe
MeO
O
OMe
BnO
BnO
BnO
 
3.1 
3.31
O
OMe
BnO
BnO
HO
BnO
 
1:0 61 
O
S
O
BnO
BnO
BnO
3.32
O
MeO
OMe
MeO
O
OMe
BnO
BnO
OBn
 
3.1 
3.33
O
OMe
BzO
HO
BzO
BzO
 
1:0 76 
O
S
O
BnO
BnO
BnO
3.34
O
MeO
OMe
MeO
O
OMe
BzO
BzO
OBz
 
[a] Anomeric ratios were determined by integration of appropriate peaks in the 
1
H NMR spectra of 
the crude products before column chromatography. 
                                                                                                                                                                  
Table 3.2 
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3.5 Low temperature NMR investigations into neighboring group 
participation of thioaryl Substituent 
3.5.1 Low temperature NMR investigations into neighbouring group 
participation during glycosylation of donor 3.1 
The complete stereoselectivity shown by donor 3.1 implied that NGP was occurring during the 
glycosylation reactions. Therefore, based on studies reported by Boons,
[14]
 we undertook a series 
of experiments to investigate the structure of intermediates produced during activation of 3.1 by 
TMSOTf, at -78 °C by recording low temperature NMR spectra. 
Firstly, the
 1
H NMR spectrum of 3.1 was recorded in CD2Cl2 at -78 °C. Then an equimolar 
amount of TMSOTf was added to the solution at -78 °C. The mixture was warmed to 0 °C over 
40 min and then again cooled to -78 °C, after which time 
1
H NMR, HSQC, COSY and HMBC 
(over 40 min) spectra were recorded at -78 °C. The 
1
H NMR and HMBC spectra are shown in 
Figure 3.2. 
O
O
BnO
BnO
BnO
3.1a
1
23
4
5
6
7 8
S Ar
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A – 1H-NMR of 3.1 at -78 °C; B - 1H-NMR of activated 3.1 at -78 °C by addition of 1 eq. of TMSOTf; C – 
HMBC study of activated 3.1 at -78 °C.  
Figure 3.2 
A 
B 
C 
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Upon activation, the anomeric proton of 3.1 (δ 6.50 ppm, J1,2 3.2 Hz) shifted upfield (δ 5.56, J1,2 
10 Hz) and its large vicinal coupling constant implied an equatorial orientation of the anomeric 
substituent in the intermediate (i.e. that is was -configured). The H-8 and H-8’ protons which 
had very similar chemical shifts in the spectrum of 3.1 (δ 2.75 ppm, m) were split into two 
distinct peaks at δ 3.64 and δ 4.69 ppm. The HMBC spectrum, which shows three bond 
heteronuclear couplings, showed a correlation between C-1 and one of the H8 protons (δ 3.64 
ppm), which is marked as a circle on the HMBC spectrum, implying the formation of a cyclic 
intermediate. However correlation of the other H-8 proton (H-8’) with C-1 was not observed. 
The 
1
H NMR did provide evidence for the formation of a -configured trans-decalin 
intermediate. The H-8 and H-8’ peaks, which were very similar in the acyclic starting material, 
would be expected to have different chemical shifts in a cyclic intermediate such as 3.6a, due to 
their different environments (axial and equatorial). Therefore the splitting of the single H8/H8’ 
multiplet in the starting materials into two distinct separated peaks for H8 and H8’ in the 
intermediate implies that a cyclic intermediate is formed, and, together with the size of the H-
1/H-2 coupling constant (J1,2 10 Hz) provides strong evidence that the cyclic intermediate is a 
configured trans-decalin. No oxocarbenium ion, anomeric triflate, or α-sulfonium ion was 
detected in the NMR spectra.  
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3.5.2 Low temperature NMR investigations into neighbouring group 
participation during glycosylation of donor 3.2 
The high stereoselectivity shown by donor 3.2 and 3.3 indicated role of NGP during the 
glycosylation reactions. The stereoselectivity observed for the partially disarmed / completely 
disarmed donors were lower than their armed counterpart, and the observation counteracted with 
the observations reported in literature.
[14]
 Therefore, based on studies reported by Boons,
[14]
 I 
undertook a series of experiments to investigate the structure of intermediates produced during 
activation of 3.2 by TMSOTf, at -78 °C by recording low temperature NMR spectra. 
Firstly, the
 1
H NMR spectrum of 3.2 was recorded in CD2Cl2 at -78 °C. Then an equimolar 
amount TMSOTf was added to the solution at -78 °C. The mixture was then warmed to 0 °C for 
40 min and then cooled back to -78 °C, after which time 
1
H NMR, HSQC, COSY and HMBC 
(over 40 min) spectra were recorded at -78 °C. The 
1
H NMR and HMBC spectra are shown in 
Figure 3.3. 
O
O
BnO
3.2a
1
2
3
4 5
78
SAr
O
O
Ph
OTf
6
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A – 1H-NMR of 3.2 at -78 °C; B - 1H-NMR of activated 3.2 at -78 °C by addition of 1 eq. of TMSOTf; C – 
HMBC study of activated 3.2 at -78 °C.  
Figure 3.3 
A 
B 
C 
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Upon activation, the anomeric proton of 3.2 (δ 6.51 ppm, d, J1,2 3.2 Hz and δ 5.80 ppm, d, J1,2 
8.0 Hz: α and β protons respectively) shifted and gave a single peak (δ 6.50, d, J1,2 5.2 Hz, JH1,C1 
165.5 Hz). The H-8 and H-8’ protons which had very similar chemical shifts in the spectrum of 
3.2 (δ 2.85 ppm, m) were split into two distinct peaks at δ 3.73 and δ 4.63 ppm. The HMBC 
spectrum, which shows three bond heteronuclear couplings, did not show any correlation 
between C-1 (86.1 ppm) and H8/H8’ protons, thus ruling out NGP between SAr and H-1. The 
HMBC spectrum also did not show any correlation of H-1 with C-7 or with aromatic C of the 
SAr substituent. Any kind of NGP with either ‘O’ at position-2 forming 1,2 epoxide 
intermediate, or through the aromatic ring at position-2 was ruled out.  
Ruling out all the possible NGPs from position-2, and high δ value of anomeric proton it led us 
to a conclusion that either α or β triflate is formed as the intermediate. Since the H-1/H-2 
coupling constant (J1,2 5.2 Hz) was not conclusive, a closer look to similar triflates reported in 
literature was needed to reveal the configuration. Crich
[15]
 had characterized tetraacetyl glucosyl-
α-triflate and tetraacetyl glucosyl-β-triflate. The α-triflate anomeric proton is seen at δ 6.21 
(JH1,C1 184.5 Hz) and β-triflate anomeric proton is seen at δ 5.60. Boons’
[1c]
 reported formation of 
2-azidotriacetyldeoxygluco-α-triflate, which showed anomeric peak at (δ 6.50, d, J1,2 3.5 Hz). 
Furthermore Crich
[16]
, while investigating the chemistry of 4,6-O-benzylidene-D-glycopyranosyl 
triflates, trapped the intermediate triflate at -78 °C. Activation of either anomer of S-phenyl 2,3-
di-O-benzyl-4,6-O-benzylidene-1-thio-D-glucopyranoside 3.35 with triflic anhydride in 
dichloromethane at -78 °C in the presence of 2,6-di-tert-butyl-4-methylpyridine affords a highly 
active glycosylating species which, on addition of alcohols, provides α-glucosides 3.36 with high 
selectivity (Scheme 3.15). 
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O
O
O
Ph
BnO
BnO
OR
3.35 3.36  
Scheme 3.15 
 To probe the nature of the reactive intermediate in the above glucosylation reactions, a CD2Cl2 
solution of sulfoxide 3.35 and DTBMP was cooled to -78 °C and its 
1
H NMR spectrum recorded 
before addition of cold (-78 °C) Tf2O. The 
1
H NMR spectrum, recorded within minutes of 
adding the anhydride, showed complete consumption of the sulfoxide and formation of one very 
major new glucoside. This species was most easily characterized at -78 °C by its very distinct 
anomeric proton resonance: a doublet at δ 6.3 with J1,2 3.5 Hz, as α-glucosyl triflate 3.37. It was 
then established by them that in 4,6 benzylidene-2,3-dibenzylglucosyl triflate, there exist a 
dynamic system in which the α-triflate 3.37 is in equilibrium with its less stable but more 
reactive β-anomer 3.38 and that the rate and equilibrium constants are such as to provide 
preferentially the α-glucoside 3.36 (Scheme 3.16).     
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Scheme 3.16 
                                                        
                                                               Development of the  2-O-(2-(2,4,6-trimethoxythiophenyl)                                   
Chapter 3                                              ethyl) protecting groups for stereocontrolled glycosylation        
                                                                                                                                                                                                                                                                                      
110 
 
Based on these observations it was concluded that intermediate 3.2a isolated in our studies at -78 
°C was α-triflate. 
3.6 Discussion 
In a complete armed donor 3.1, we concluded that a cyclic intermediate was formed upon 
activation. The cyclic intermediate observed was β-configured, and thus addition of an alcohol 
resulted in formation of exclusive α-glycosides.  
Whereas in partially disarmed donor 3.2 and completely disarmed donor 3.3, NGP does not exist, 
as observed in the low temperature NMR studies of 3.2. Based on the mechanism proposed by 
Crich
[16]
 explained earier in section 3.5, we concluded that the completely disarmed and partially 
disarmed donors (3.2 and 3.3), on activation with TMSOTf, forms triflate at -78 °C. There exists 
a dynamic equilibrium between a more stable α- triflate and more reactive β- triflate. The α- 
triflate being stable is trapped in the low temperature NMR experiment and thus shows up in 
spectra, but the β- triflate being more reactive, reacts faster in a SN2 mechanism leading to high 
stereoselectivity (α:β = 5:1) in both cases (Figure 3.4).  
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Figure 3.4 
3.7 Deprotection Reactions 
The utility of a protecting group which controls the stereochemistry of a glycosylation is limited 
by the ease with which it may be removed at the end of any synthesis. Therefore the deprotection 
of a model compound, β-methyl glucoside 3.40 was investigated under a variety of conditions. 
Use of a soft Lewis acid: First a soft Lewis acid was added to the glycoside solution, which was 
expected to form adduct with sulfur atom. After stirring the solution for different intervals of 
time, later a powerful non-nucleophilic base was added to facilitate elimination reaction to form 
a vinyl ether, which can then be removed hydrolytically (Scheme 3.17). 
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Scheme 3.17 
Sl. No. Reaction Conditions Outcome 
1. (i) NBS (ii) potassium tert. butoxide 
/ DCM, rt→reflux 
No Reaction 
2. (i) NIS (ii) potassium tert. butoxide, 
rt→reflux 
No Reaction 
 
Use of a hard Lewis acid: In the second approach, hard Lewis acid was added to the glycoside 
solution,   which was expected to form an adduct with the oxygen atom. It was expected that ‘S’ 
would anchimerically assist elimination of the ethyl ether, to result to direct deprotection of 
sugar (Scheme 3.18). 
O
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Scheme 3.18 
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Sl. No. Reaction Conditions Outcome 
1. TMSI / DCM, rt Decomposed to yield mixture of products 
2. TMSOTf / DCM, rt→reflux No Reaction 
3. TFA / DCM, rt No Reaction 
4. 
(1) TFA (2) potassium tert. butoxide 
/ DCM, rt→reflux 
Decomposed to yield mixture of products 
 
5. 
BF3. Et2O / DCM, rt→reflux No Reaction 
 
Oxidation to sulfoxide followed by pyrolytic elimination: A third approach that was 
investigated involved selective oxidation of the sulfur to a sulfoxide, which could be followed by 
elimination on heating, to give a vinyl ether, which could then be removed hydrolytically 
(Scheme 3.19). 
O
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O
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S
Ar
[O]
O
H
H
X+
Scheme 3.19 
However, reaction of the glycoside 3.40 with 1 eq. of mCPBA, led to formation of mixture of 
sulfoxide and sulfone. Sulfoxide decomposed when heated to 110 °C in toluene.  
Sulfone can directly be converted to the deprotected sugar, by β elimination on reaction with 
lithium naphthalenide.
[17]
 But due to unavailability of the chemical in lab, this reaction was not 
tried out. 
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Sl. No. Reaction Conditions Outcome 
1. mCPBA (1 eq.) / THF, - 78 °C→rt Sulfoxide + sulfone 
2. (i) 50 % H2O2, rt (ii) AcOH /  DCM No Reaction 
 
Since suflides readily undergo methylation, methylation of a 2-(arylthio) ethyl ether can be 
followed by elimination by use of a non-nucleophilic base to give a vinyl ether, which can then 
be removed hydrolytically.
[18]
 Sulfide 3.40 was refluxed in DCM, in the presence of MeOTf, to 
yield a sulfonium ion 3.41. This sulfonium ion was initially isolated, using column 
chromatography and was then dissolved in THF, and a non-nucleophilic base potassium tert-
butoxide was added. Almost instantaneously a new product was observed on t.l.c... On analysis, 
it was realized that the deprotected sugar 3.42 had formed. 
Later the procedure was improved upon, and a one pot reaction was carried in DCM. After the 
methylation reaction had gone to completion, the reaction mixture was cooled and a non-
nucleophilic base potassium tert-butoxide was added. Pleasingly this one pot procedure directly 
yielded the deprotected sugar 3.37. Two other sugars 3.24 and 3.30 were deprotected in the same 
manner (Scheme 3.20). 
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Scheme 3.20 
Analysis of the mass spectrum of the reaction mixture indicated that the reaction proceeded via a 
β-elimination mechanism following to formation of a sulfur ylid intermediate (Scheme 3.21). A 
peak corresponding to the elimination product methyl(2,4,6-trimethoxyphenyl)(vinyl)sulfonium 
3.48 HRMS (ES
+
) calculated for C12H17O3S (M
+
) 241.0898, found 241.0892  was observed 
(Figure 3.5).
[18]
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Scheme 3.21 
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Figure 3.5 
However compound 3.48 could not be isolated; work-up actually led to the isolation of sulfoxide 
3.43 (Figure 3.6) was purified by column chromatography and was characterized by NMR and 
mass spectrometry.  
S
OMeMeO
OMe
O
3.43  
Figure 3.6 
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3.8 Attempted synthesis of tetrasaccharide Glc3Man N-glycan 
tetrasaccharide by NGP 
Post-translational modification of proteins by glycosylation
[19] 
is well known to have an 
important role in protein folding,
[20]
 is able to modulate protein stability and enzymatic 
activity,
[21]
 and in addition can also affect other important protein properties, such as circulatory 
lifetime.
[22]
 The most common form of protein glycosylation is N-linked glycosylation, in which 
the oligosaccharides (N-glycans) are attached to the side chains of asparagines residues. The 
interesting and diverse roles played by residues present in the glucose terminated arm have 
therefore initiated significant interest from the synthetic community. 
The tetrasaccharide Glcα(1→2) Glcα(1→3) Glcα(1→3)ManαOMe 3.49 (Figure 3.7) corresponds 
to the terminal tetrasaccharide portion of the glucose terminated arm of the N-glycan 
tetrasaccharide. Fairbanks’ group has reported a completely stereoselective approach to the 3.49 
tetrasaccharide in which two of the terminal α-gluco linkages are formed by successive 
Intramolecular glycosylation reactions using the allyl IAD approach.
[23]
 Synthesis of 3.49 was 
mulled upon employing novel six membered ring neighbouring group participation in the last 
two steps.  
O
O
HO
HO
OMe
OH
HO
O
HO
HO
O
HO
HO
HO
O
HO
HO
HO
O
O
HO
3.49
 
Figure 3.7 
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3.8.1 Retrosynthetic Analysis 
Thus a retrosynthesis based on modification of the group’s linear synthesis towards an iterative 
NGP approach is shown in Scheme 3.22. 
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Disconnection of an appropriately protected tetrasaccharide 3.50 gives trisaccharide alcohol 3.51 
and 2-O-arylthio ethyl ether protected glucosyl trichloroacetamidate 3.1. It is clear that the 
trisaccharide 3.52 could be the product of a NGP controlled  reaction between disaccharide 3.53 
and the same donor 3.1. 
Allyl protected disaccharide 3.54 could be derived from the intermolecular glycosylation of 
manno acceptor 2.44 with allyl protected thioglycoside 3.55, in diethyl ether to give α product  
exclusively.
[23]
 The gluco donor 3.55 could be made by standard transformations from the 3-O-
allyl protected tetraacetate 3.57.
[23]
 3.57  can in turn be synthesized from allyl protected 
glucodiacetonide 3.53.
[24] 
3.53 could be synthesized by allylation of glucodiacetonide 3.59, 
which in turn could be synthesized by acetonization of D-glucose 2.19.
[25]
 
3.8.2 Attempted Synthesis 
The known 3-O-allyl protected tetraacetate 3.57 was was synthesized using standard procedures 
from D-glucose pentaacetate 2.20 (Scheme 3.23). Treatment of 2.20 with acetone in the presence 
of iodine afforded the diacetone glucose 3.59 in 42% yield. The free hydroxyl group at position 3 
was allylated on reaction with allyl bromide in the presence of sodium hydride to give 3.58 in 
96% yield. Acid hydrolysis followed by acetylation in the presence of sodium acetate and acetic 
anhydride afforded the 3-O-allyl protected tetraacetate 3.57 in 76% yield. 
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Scheme 3.23 
Tetraacetate 3.57 was treated with thiocresol in the presence of a Lewis acid catalyst to obtain 
the β-thioglycoside 3.56 in albeit low yield.[26] Subsequent Zemplén deacetylation[27] and 
reprotection with benzyl ethers
[28]
 afforded the 3-O-allyl donor 3.55 in 89% yield over two steps 
(Scheme 3.24). 
O
AcO
AcO
AcO
3.57
O OAc
O
AcO
AcO
AcO
3.56
O STol
BF3.OEt2, p-Thiocresol
DCM, rt, 1.5 h
(47%)
O
BnO
BnO
BnO
3.55
O STol
1. NaOMe/MeOH, rt, 2 h
2. BnBr, NaH/DMF, rt, 18 h
(89%)
 
Scheme 3.24 
Unfortunately hydrolysis of STol by I2/AgOTf in presence of base in diethyl ether to yield α 
disaccharide continuously failed on repeated attempts (Scheme 3.25). Though it was a well 
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established procedure by Fairbanks’ group,[23] this reaction resulted in multiple products, 
including iodination of allyl group.  
O
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+
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OBn
OMe2.44
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O
Ph
O
OBn
OMe
Bn
O
BnO
O
BnO
BnO
3.54
3.55
DCM, -78 °C rt, 16 h
Scheme 3.25 
It was therefore felt that probably STol was not the best leaving group to be attached on 
anomeric position, which requires I2 as activating reagent.  
The synthesis route was changed accordingly, to synthesize SEthyl glycoside. Tetraacetate 3.57 
was treated with ethanthiol in the presence of a Lewis acid catalyst to obtain the β-thioglycoside 
3.60 in low yield of 47%.
[26]
 Subsequent Zemplén deacetylation
[27]
 and reprotection with benzyl 
ethers
[28]
 afforded the 3-O-allyl donor 3.61 in a 76% yield over two steps (Scheme 3.26). 
O
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O OAc
O
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AcO
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O SEt
BF3.OEt2, EtSH
DCM, rt, 6 h
(47%)
O
OBn
BnO
BnO
3.61
O SEt
1. NaOMe/MeOH, rt, 2 h
2. BnBr, NaH/DMF, rt, 18 h
(76%)
 
Scheme 3.26 
Methyl triflate-mediated intermolecular glycosylation of donor 3.61 and acceptor 2.44 was 
carried out in ether in order to ensure good α-selectivity,[29] and disappointingly again mixture of 
products were observed. The major product was separated and spectral analysis followed by 
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HRMS confirmed formation of ethyl glycoside of the donor 3.61. It was realized later that the 
anhydrous diethyl ether used in the reaction had very little amount of ethanol as stabilizer. The 
ethanol competed with the acceptor and led to formation of mixture of products.  
After this a new bottle of anhydrous diethyl ether without stabilizer was used and the methyl 
triflate-mediated glycosylation reaction indeed afforded the disaccharide 3.54 as the pure α 
anomer, with a 62% yield. Allyl isomerisation on reaction with Wilkinson’s catalyst, followed by 
the hydrolysis of vinyl ether in presence of NIS/H2O
[30]
 cleanly afforded the alcohol 3.53 in a 
74% yield over two steps (Scheme 3.27). 
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Scheme 3.27 
To afford the trisaccharide in complete α-stereoselectivity, the donor 3.1 was reacted with the 
disaccharide acceptor 3.53, using TMSOTf as activator, employing protocol B. However, the 
glycosylation reaction led to isomerization of trichloroacetamidate donor 3.1 to amide 3.62. 
When the reaction was tried out using TMSOTf as activator employing protocol A, again 
rearrangement of donor was observed. Later a different approach was adopted where in 1 equiv. 
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of BF3.Et2O and 1 equiv. of TMSOTf was added as activator to premixed solution of donor and 
acceptor at 0 °C and allowed to warm to rt in two different reaction vessels. But in both the cases 
again rearrangement of the donor was seen. So it was concluded that the donor 3.1 was not a 
suitable donor for carrying out glycosylation reactions for a sterically hindered secondary 
glycosyl acceptors. The series of failed glycosylation reactions are tabled down in Scheme 3.28. 
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Sl. No. Reaction Conditions Outcome 
1. 1 eq. TMSOTf, -78 °C→rt, Protocol B Rearrangement of donor to amide 
2. 0.1 eq. TMSOTf, -78 °C→rt, Protocol A Rearrangement of donor to amide 
3. 1 eq. TMSOTf, -78 °C→rt, Protocol A Rearrangement of donor to amide 
4. 1 eq. TMSOTf, 0 °C→rt, Protocol A Rearrangement of donor to amide 
5. 1 eq. BF3.Et2O, 0 °C→rt, Protocol A Rearrangement of donor to amide 
 
Scheme 3.28 
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 3.9 Conclusions 
Significant improvement in stereoselectivity of glycosylation reaction was observed when the 
achiral ethylthiophenyl ether group at position-2 which was initially used by Boons,
[1a]
 was 
replaced ethyltrimethoxythiophenyl ether group. It had been suggested that that increasing the 
stability of sulfonium ion favour an SN2 mechanism.
[31]
 It was shown by Turnbull
[32]
 that the 
compound 1.105 (Chapter 1) resuled in complete stereoselectivity, as an axial methoxy group on 
the oxathiane ring can stabilise a methyl sulfonium ion, when compared to the oxithane ring with 
absence of methoxy group. Trimethoxy phenyl group, owing to its electron donating methoxy 
groups thus stabilizes the sulfonium ion which inturn favoured SN2 attack of acceptor through 
axial position leading to α- selectivity of the glycosides formed. Boons reported variation of the 
stereoselectivity of glycosyl donors which undergo 6-ring NGP with the protecting group 
pattern. In this report
[14]
 he stated that a completely disarmed donor showed highest 
stereoselectivity, and postulated that the lower stereoselectivity observed during glycosylation 
with completely armed donors was due to non-selective reaction of the glycosyl cation, which 
could be accessed according to the Curtin-Hammet principle. However, in the studies reported 
here it was the completely armed donor that reacted complete α-selectivity, and the completely 
disarmed donor that showed lower stereoselectivity. In the case of the completely armed donor 
reported here low temperature NMR studies did strongly indicate the formation of a cyclic β-
sulfonium intermediate, thus leading to absolute stereoselectivity. However, in the partially 
disarmed donor, the low temperature NMR indicated towards absence of NGP. Though the 
formation of α- triflate intermediate was observed by the low temperature NMR spectra, but the 
higher stereoselectivity observed in glycosylation was attributed to the fact there existed a 
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dynamic equilibrium between α- and β- triflate. The α- triflate being stable is trapped in the low 
temperature NMR stectra, but the β- triflate being more reactive, reacts faster in a SN2 
mechanism leading to high stereoselectivity (α:β = 5:1) in both cases. 
In conclusion the trimethoxythiophenylethyl ether is a useful achiral protecting group, that when 
attached at position 2, which produces α-1,2 cis glucosides with complete stereoselectivity when 
completely armed donors are used. Good -selectivity is also observed when disarmed donors 
are used.  
The deprotection methodology for the trimethoxythiophenyl ethyl ether proved to be a facile, 
high yielding one pot reaction which further encourages the use of protecting group at position-2 
for effective NGP leading to stereoselective glycosylation. 
However, glycosylation reactions carried out with the donor 3.1 resulted in poor yields of the 
disaccharides, especially with secondary glycosyl acceptors. It suggests that the protecting group 
at position-2, being a bulky substituent, blocks the anomeric position thus affecting the 
efficiency of glycosylation. Therefore, when the bulky disaccharide acceptor 3.48 was used for 
glycosylation, rearrangement of the donor 3.1 was observed, as the acceptor was practically 
unavailable to the donor.    
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Chapter 4: A study into the potential use of organocatalysis 
for the stereochemical control of glycosylation reactions 
4.1 Introduction 
Organocatalysis, or the use of small organic molecules to catalyze organic transformations, is a 
relatively new and popular field within the domain of asymmetric synthesis.
[1]
 Organocatalytic 
asymmetric assembly reactions are powerful tools that can be used to rapidly construct 
stereochemically complex molecules from simple precursors.
[2]
 The regioselective and 
stereoselective synthesis of glycosidic bonds still remains as one of the most challenging areas 
within organic synthesis. Despite the broad use of organocatalysis within asymmetric synthesis, 
its application towards oligosaccharide synthesis by diastereoselective glycosylation is still in its 
infancy.
[3]
 Neighboring-group participation is a powerful method for control of the 
stereoselectivity of glycosylation reactions. However, this approach generally relies upon 
multiple protecting-group manipulations in order to synthesize the required oligosaccharides. An 
in-depth research into the potential applications of organocatalysis for the stereoselective 
synthesis of glycosides may provide efficient and high yielding synthetic procedures. 
Asymmetric synthesis has frequently been applied to control the diastereoselectivity of a variety 
of chemical processes.
[4]
 However there are only a very few reports in literature of previous 
efforts that have been made to control the stereochemical outcome of glycosylation reactions 
using chiral catalysts. This is perhaps not surprising, as much of the work in the field of 
asymmetric catalysis has focused on the use of transition metal complexes, for example, titanium 
complexes used in the Sharpless epoxidation,
[5]
 or palladium complexes used in asymmetric 
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allylic alkylation.
[6]
 It is difficult to see how the use of such transition metal complexes could be 
applied to glycosylation reactions. However recent developments in the growing field of 
organocatalysis
[1] 
have provided
 
a section of new asymmetric process that may be more 
applicable to the control of the diastereoslectivity of glycosyaltion reactions. In particular, the 
potential use of chiral Brønsted acids for the activation of glycosyl donors represents an 
attractive prospect for controlling the stereochemistry of the glycosylation product.
[7]
     
4.1.1 Recent developments in the application of organocatalysis to 
glycosylations 
4.1.1.1 Chiral organocatalysts  
Fairbanks et al. reported that β-selective glycosylations of glycosyl trichloroacetamidates can be 
achieved using a chiral BINOL-derived phosphoric acid catalyst 4.1 (Scheme 4.16).
[7]
 It was 
found that the use of (R)-4.1 generally gave low levels of β-selectivity, whereas (S)-4.1 generally 
afforded the β-anomer with high selectivity. The work was the first demonstration that the 
configuration of a chiral catalyst can have a strong influence on the stereoselectivity of a 
glycosylation reaction with complex acceptors – an important step towards achieving catalyst 
control. Further mechanistic investigations are required to understand whether this selectivity 
arises solely from non-bonded interactions, or whether the catalyst forms covalent bonds with 
either donor or acceptor (Scheme 4.1).  
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Scheme 4.1 
Chiral thioureas have been employed by Jacobsen et al. for the catalytic enantioselective addition 
of silyl ketene acetals to oxocarbenium ions and preliminary results of the application of this 
methodology towards glycosylation reactions were also reported (Scheme 4.2).
[8]
 Although the 
stereoselectivities were low, with methanol as the acceptor it was shown that changing the 
enantiomer of the thiourea catalyst changed the anomeric selectivity. Interpretation of these 
results is complicated by the fact that the starting material is a mixture of anomers each of which 
may react differently. A possible cooperative effect between the boron and the thiourea catalyst 
4.5 in this case cannot be ruled out, and therefore the mechanistic basis of these reactions needs 
further investigation. 
                   α:β 
(R) 4.1       1:5.7    
(S) 4.1        1:70  
                              
(R) 4.1        1:2  
(S) 4.1         1:7    
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O
OAc
AcO
AcO
OAc
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BCl3 (0.2 eq.)
MeOH, TBME
O
OAc
AcO
AcO
OMe
N
H
t -Bu
N
H
CF3
CF3
S
O
Ph
* *
catalyst
4.4 4.6
4.5
 
Scheme 4.2 
Following on from the work of Fairbanks, the Toshima group
[9]
 used the same chiral phosphoric 
acid (4.1) as an organocatalyst, and demonstrated that glycosylation using a racemic mixture of a 
chiral alcohol ( + ) 4.8 as the acceptor was selective for one enantiomer and in addition was β-
selective. Catalyst (S)-4.1 gave complete diastereoselectivity of β glycoside 4.9 exclusively with 
(R) 4.8 alcohol in the presence of a racemic mixture of alcohols ( + ) 4.8 as the acceptor. A 
schematic presentation and the mechanism proposed is depicted below in Scheme 4.3. 
Catalyst       Conv. (%)        α:β 
None               19              1:1.1 
R/S                   94              1:1.7   
S/R                   56              1.4:1   
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(R)
OO
BnO O
OBn
Bn
Bn O
CCl3
HN
R1
R2 O
H
R alcohol
Ar
O
Ar
O
P
O
O
(S)-4.1
H
4.7
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Scheme 4.3 
4.1.1.2 Achiral organocatalysts  
The catalytic use of phenylboron difluoride, diphenylboron fluoride, and phenylsilyl trifluoride 
as activators for glycosylation reactions of glycosyl trichloroacetimidates 4.10 was demonstrated 
by Schmidt et al.
[10]
 Good to excellent yields and useful β-selectivities were achieved in many of 
the reported examples (Scheme 4.4). It was proposed that the organoboron or organosilicon 
catalyst initially activates the acceptor to generate the intermediate (4.11); this in turn activates 
the donor (4.12) through hydrogen bonding and then proton transfer. As would be expected from 
the proposed SN2-like mechanism, α-trichloroacetimidates favor β-glycosides 4.13. However, the 
reactions do not proceed with complete inversion especially with more hindered alcohols, thus an 
alternative SN1 pathway can compete. 
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O
OR1
R1O
R1O
OO
CCl3
NH
R1
+ R
2OH
Ph2BF or PhBF2 or Ph SiF3 (0.1 eq.)
DCM
O
OR1
R1O
R1O
OR1
OR2
Y = BPh2, BPhF
or PhSiF2
R2 O
Y
F
H
O
OR1
R1O
R1O
OO
CCl3
NH
R1
R2 O
Y
F
H
4.11 4.12
4.10
4.13
Scheme 4.4 
Schreiner et al. had reported organocatalytic tetrahydropyranylation of alcohols, using thiourea 
4.16 as the organocatalyst leading to formation of 4.17 from 4.14 (Scheme 4.5).
[11]
  
O
+ ROH
4.14
CF3
F3C N
H
N
H
CF3
CF3
S
1 mol%
4.16
THF, rt or 40 °C
O OR
4.17
4.15
 
Scheme 4.5 
Later McGarrigle et al. adopted the same methodology and organocatalyst to develop a 
glycosylation method.
[12]
 Dihydropyran was replaced with glycols 4.19 to achieve glycosylation 
reactions affording 2-deoxyglycosides 4.20 (Scheme 4.6). However, by using 1 mol% of thiourea 
4.16 in refluxing DCM the desired transformation was achieved with a wide range of galactals 
4.18 and acceptors in high yield and exclusively gave the α-anomer. The nature of the acceptor 
(position/orientation of the free hydroxyl group) did not affect the yield or selectivity for the α-
anomer.  
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O
OPG
PGO
PGO
+
O
PGO
OH Thiourea 4.16 (1 mol %)
DCM, reflux
O
PGO
O
O
PGO
O
OPG
4.18
4.19
4.20
PG
 
Scheme 4.6 
When exploring the mechanism of this organocatalyzed reaction, it was shown that 
anomerization of the β-anomer to the more thermodynamically favorable α-anomer does not 
occur under the reaction conditions. When the deuterated galactal 4.21 was used, the newly 
formed C–O and C–H bonds were found to be cis to each other, thus the formation of both bonds 
is diastereoselective. This led to proposed mechanism (Scheme 4.7) in which the catalyst alcohol 
complex delivers the proton to the least hindered face of the galactal (4.22). The resulting ion-
pair intermediate (4.23) then rapidly collapses to form the new C–O bond, forming α galactoside 
4.24. 
O
BnO
BnO
+
Thiourea 4.16 (1 mol %)
DCM, ref lux
OR
O
BnO
O
OBn
4.21
4.24
D
ROH
Bn D
O
D
BnO
OBn
OBn
H
H
= cat.
H
H
O
R
H
O
D
BnO
H
H
O
R
OBn
H
OBn
4.22 4.23
OBn
 
Scheme 4.7 
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In conclusion, over recent years some progress has been made in catalyzing glycosylations with 
small organic molecules. These readily accessible catalysts provide new opportunities for regio- 
and stereoselective synthesis of glycosides, especially where it may be possible to develop 
catalysts capable of overcoming the inherent substrate bias for a given stereochemical outcome 
in these important reactions. Organocatalysis offers mild reaction conditions, tunable chiral 
scaffolds, and multiple activation modes, which may lead to general methods for catalyst control 
of the anomeric configuration of the product formed during glycosylation reactions being 
developed in the future. 
4.2 Cooperative catalysis in glycosylation reactions with O-glycosyl 
trichloroacetimidates as glycosyl donors 
4.2.1 Introduction 
The use of thioureas for the catalysis of glycosylation reactions using various kinds of donors has 
been reported by several research groups.
[3]
 As explained in the previous section, Jacobson used 
a thiourea derivative along with a Lewis acid catalyst to achieve stereoselective glycosylation 
reactions.
[9]
 Though interesting stereoselectivities were observed in a variety of glycosylation 
reactions, any co-operative effect of the Lewis acid and the thiourea needs to be investigated 
further . 
Along similar lines, Schmidt
[13]
 group reported a series of β stereoselective glycosylation 
reactions by activation of trichloroacetamidate donors with an achiral phosphoric acid and an 
achiral thiourea as organocatalysts.                                                                                                                           
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One specific example reported by this group is shown in Scheme 4.8. When isopropyl alcohol 
4.26 was glycosylated with the donor 4.25, the resulting glycoside 4.28 was produced with the 
highest stereoselectivity (β:α > 20:1), when bis(4-nitrophenyl) phosphoric acid 4.27 and 1,3-
bis(3,5-bis(trifluoromethyl)phenyl) thiourea 4.16 were used as the catalytic acid and co-catalyst 
respectively. However, when the reaction was carried out without the co-catalyst 4.16, the 
selectivity observed was extremely poor (β:α = 3:2). 
O
OBn
BnO
BnO
O O
CCl3
NH
Bn
+ OH
4.25
4.26
(p-NO2C6H4O)2PO2H 4.27 (5 mol%)
N
H
N
H
CF3
4.16 (5 mol%)
CF3
DCM, rt, 48 h
(90%)
O
OBn
BnO
BnO
OBn
4.28
O
S
CF3
F3C
Scheme 4.8 
Schmidt proposed that the observed stereoselectivity arose from a co-operative effect between 
the thiourea and the acid catalyst as shown in Scheme 4.9.  
O
BnO
BnO
BnO
O N
CCl3
H
OBn
R
O
H
CF3
CF3
N
H
N
S
H
CF3
F3C
P
O
O
NO2
NO2
O
OH
 
Scheme 4.9 
   β:α > 20:1 
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When the reaction was carried out with donor 4.12 under the same reaction conditions, including 
the co-catalyst 4.16, the stereoselectivity observed for the resulting glycoside 4.29 was produced 
with stereoselectivity (β:α = 7:1) (Scheme 4.10).  
O
OBn
BnO
O O
CCl3
NH
Bn
+ OH
4.12
4.26
4.27 (5 mol%)
4.16 (5 mol%)
DCM, rt, 48 h
(89%)
O
OBn
BnO
OBn
4.29
O
OBn OBn
                    
Scheme 4.10 
Interestingly, even when TMSOTf and 4.16 were used as the catalyst and co-catalyst 
respectively, much higher stereoselectivity (β:α = 25:1) was seen when compared to the reaction 
that was performed without the co-catalyst (β:α = 12:1) (Scheme 4.11).  
O
OBn
BnO
BnO
O O
CCl3
NH
Bn
+ OH
4.25
4.26
TMSOTf (5 mol%)
DCM, -78 °C, 0.5 h
(> 90%)
O
OBn
BnO
BnO
OBn
4.28
O
                           
Section 4.11 
As discussed earlier (Scheme 4.1), the Fairbanks
[7]
 group reported the β-selective glycosylation 
of 4.12 with diacetone galactose 2.42, while using the (S)-BINOL derived phosphoric acid 
catalyst (S)-4.1.  
 
   β:α = 7:1 
+ 4.16 β:α = 25:1                           
-  4.16 β:α = 12:1 
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4.2.2 The catalysts and co-catalyst 
Glycosylation reactions were carried out with donor 4.12, acceptor 2.42, and the BINOL derived 
phosphoric acid catalyst, “TRIP” (figure 4.1) as the acid catalyst, which is similar in structure to 
those used previously by the Fairbanks’ group,[7] and the co-catalyst 4.16, used by Schmidt[13]. 
The choice of TRIP was based on the fact that, it has been used as a powerful Brønsted acid 
catalyst for asymmetric synthesis.
[14]
 Both (R)-TRIP (4.30) and (S)-TRIP (4.31) were used as 
catalysts to observe any effect of catalyst stereochemistry on the stereoselectivivity of 
glycosylation. 
i-Pr
i-Pr
i-Pr
i-Pr
i-Pr
i-Pr
O
O
P
O
OH
(R)-TRIP
i-Pr
i-Pr
i-Pr
i-Pr
i-Pr
i-Pr
O
O
P
O
OH
(S)-TRIP
4.30 4.31
                                                    
Figure 4.1 
The (R) and (S) TRIP organocatalysts were purchased and the co-catalyst thiourea derivative 
(4.16) was synthesized starting from thiocarbonyldiimidazole (4.11) and bis-
trifluoromethylaniline (4.12) as in Scheme 4.12.
[15]
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N
H
N
H
S
CF3
4.16
CF3
F3C
CF3
DCM, rt, 24 h
(93%)
Scheme 4.12 
4.2.3 Synthesis of the donor 
The trichloroacetimidate donor 4.12, chosen for direct comparison with Schmidt’s[13] and 
Fairbanks’[7] work, was synthesized by reaction of tetrabenzyl galactopyranose 4.34 with 
trichloroacetonitrile in presence of catalytic amount of DBU (Scheme 4.11).
[16]
 
O
O
BnO
OBn
OH
OBnBn
O
O
BnO
O
OBn
Cl3CCN, DBU
DCM, rt, 1 h
Bn
Bn O
Cl3C
NH4.34
4.12
(89%)
                                 
Scheme 4.13 
4.2.4 Results and discussions 
4.2.4.1 Organocatalytic stereoselective synthesis of DAG glycoside 
The glycosylation reaction that was studied is shown in Scheme 4.14. 
O
O
BnO
O
OBnBn
Bn O
Cl3C
NH
4.12
+ O
OH
O
O
O O
2.42
4.16 (5 mol %)
Catalyst (5 mol %)
O
O
BnO
O
OBnBn
Bn
O
O
O
O O
O
a
b
4.35
DCM
                           
Scheme 4.14 
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When diacetone galactose 2.42 was glycosylated with the donor 4.12, using TMSOTf as the 
catalyst, in the absence of co-catalyst 4.16, the disaccharide 4.35 was obtained as a mixture of 
diastereomers in a ratio of β:α = 3.9:1 (Table 4.1, entry 2). However, in contrast to the report of 
Schmidt, the addition of co-catalyst 4.16 did not lead to any improvement in the stereoselectivity 
of the reaction (β:α = 3.7:1) (Table 4.1, entry 1). When the asymmetric organocatalysts, (R)-
TRIP 4.30 and (S)-TRIP 4.31 were used along with the co-catalyst 4.16, both gave very poor 
stereoselectivity (β:α = 1.5:1) (Table 4.1, entry 3 and 5 respectively). Furthermore in the absence 
of co-catalyst 4.16, no stereoselectivity was observed when (R)-TRIP 4.30 was used as the 
catalyst (Table 4.1, entry 4). However, interestingly, when (S)-TRIP 4.31 was used as catalyst in 
absence of the co-catalyst 4.16 an improvement was observed in β stereoselectivity (β:α = 1.5:1) 
(Table 4.1, entry 5). These results raise serious doubts about any co-operative effect between the 
catalyst and co-catalyst during the glycosylation reaction. Since only very modest 
stereoselectivity has been observed further investigations were required.   
Interestingly, in terms of product formation it was observed that reactions carried out in the 
presence of co-catalyst 4.16 proceeded to completion. In the absence of the co-catalyst, reactions 
did not reach completion even after stirring for 96 h. It was concluded that TRIP alone is not 
acidic enough to efficiently catalyze the reaction so that it goes to completion as and the co-
catalyst certainly improved the catalytic efficiency by some form of synergistic interaction.   
In order to investigate the effect of co-catalyst 4.16, the glycosylation reaction was carried out 
using only a catalytic amount of 4.16 without using any additional acid catalyst. However 4.16 
proved to be a very inefficient catalyst as the maximum yield of disaccharide obtained was only 
9% (Table 4.1, entry 7). However, the stereoselectivity of this reaction was found to be the same 
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(1.5:1, β:α) as when the reactions were carried out using both (R)-TRIP 4.30 and (S)-TRIP 4.31 
together with the co-catalyst 4.16 (Table 4.1, entry 3 and 5 respectively).  
Since the stereoselectivity of the glycosylation reactions investigated so far was poor, 
glycosylations were attempted with the catalyst bis(4-nitrophenyl)phosphoric acid 4.27, which 
had shown the best results in stereoselectivity in the experiments reported out by the Schmidt 
group.
[13]
 This acid [pKa 2.79 (H2O)] was found to be more effective as the reaction always went 
to completion either with or without any added co-catalyst. In contrast to the report by Schmidt 
the stereoselectivity was slightly higher (β:α = 2.3:1) when the reaction was carried out without 
using the co-catalyst 4.16 (Table 4.1, entry 11), as compared to the reaction performed with the 
co-catalyst (β:α = 2:1) (Table 4.1, entry 10). Similar observations were made when the reaction 
was carried out using diphenyl phosphoric acid 4.36 as catalyst. These results directly contradict 
the report by Schmidt and we can conclude that the transition state suggested by Schmidt it not 
applicable for reactions with diacetone galactose 2.42 as the acceptor.    
The outcomes of glycosylation
[a] 
reactions performed with donor 4.12 and acceptor 2.42 to yield 
the disaccharide 4.35 are summarized in Table 4.1.     
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Entry Catalyst 
Co-
Catalyst 
(4.16) 
Reaction 
Status 
Time 
(h) 
Temp. 
Yield 
(%) 
β:α 
ratio 
[b]
 
1. TMSOTf + Complete 6 -78 °C 
74 
 
3.7:1 
2. TMSOTf - Complete 6 -78 °C 
70 
 
3.9:1 
3. (R)-TRIP 4.30 + Complete 72 rt 
60 
 
1.5:1 
4. (R)-TRIP 4.30 - Incomplete 96 rt 
18 
 
2.5:1 
5. (S)-TRIP 4.31 + Complete 72 rt 
64 
 
1.5:1 
6. (S)-TRIP 4.31 - Incomplete 96 rt 
28 
 
1.1:1 
7. - + Incomplete 96 rt 
9 
 
1.5:1 
8. 
Diphenyl phosphoric acid 
4.36 
+ Complete 72 rt 
65 
 
1.1:1 
9. 
Diphenyl phosphoric acid 
4.36 
- Incomplete 96 rt 
19 
 
1.9:1 
10. 
Bis(4-nitrophenyl)    
phosphoric acid 4.27 
 
 
+ Complete 72 rt 
74 
 
2:1 
11. 
Bis(4-nitrophenyl)    
phosphoric acid 4.27 
 
 
- Complete 72 rt 
60 
 
2.3:1 
12. 
Bis(4-nitrophenyl)    
phosphoric acid 4.27 
 
 
+ Complete 3 rt 
11 
 
2:1 
[a] Reaction conditions: acceptor (1.2 equiv.), Catalyst (0.025 equiv.), Co-Catalyst (0.05 equiv.),  
DCM.  
[b] Anomeric ratios were determined by integration of appropriate peaks in the 
1
H NMR spectra. 
Glycosylation reactions were carried out in duplicate to confirm the reproducibility of results. 
 
Table 4.1 
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4.2.4.2 Organocatalytic stereoselective synthesis of isopropyl glycoside 
After obtaining unsatisfactory results using diacetone galactose 2.42 as acceptor, the focus was 
shifted to using isopropyl alcohol 4.26 as the acceptor to determine the stereochemical outcome 
of these glycosylation reactions. Again the catalysts were varied, in a search for more 
stereoselective processes catalysts. 
 The glycosylation reaction is shown below (Scheme 4.15). 
O
O
BnO
O
OBnBn
Bn O
Cl3C
NH
4.12
+
Catalyst (5 mol%)
4.16 (5 mol%)
O
O
BnO
O
OBnBn
Bn O
OH
4.26
4.29
DCM
           
Scheme 4.15 
The glycosylation reaction shown in Scheme 4.15 using donor 4.12, isopropyl alcohol 4.26 as 
acceptor, TMSOTf as the catalyst, and 4.16 as the co-catalyst, yielded the isopropyl galactoside 
4.29 in a 25:1 β:α ratio, exactly as reported by the Schmidt group (Table 4.2, entry 1). However 
when the reaction was carried out without the addition of the co-catalyst, the observed 
stereoselectivity was (β:α = 23:1), which was significantly higher than that reported by the 
Schmidt group (12:1) (Table 4.2, entry 2).             
When the glycosylation was carried out using bis(4-nitrophenyl)phosphoric acid 4.27 as catalyst 
and co-catalyst 4.16, the isopropyl galactoside 4.29 was formed in an anomeric ratio that was 
exactly as reported by Schmidt’s group (β:α = 7:1) (Table 4.2, entry 10). When the same reaction 
was carried out without using the co-catalyst 4.16, there was a slight reduction in the 
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stereoselectivity of the reaction (β:α = 5:1) (Table 4.2, entry 11). the use of diphenyl phosphoric 
acid 4.36 as the catalyst gave very similar results as compared to catalyst 4.27, viz a 
stereoselectivity of (β:α = 6:1) when the reaction was carried with the co-catalyst 4.16, and a 
stereoselectivity of  (β:α = 4:1) when reaction was carried on without the co-catalyst 4.16 (Table 
4.2, entry 8 and 9 respectively). 
To evaluate the efficiency of the asymmetric phosphoric acid catalyst, (R)-TRIP 4.30 and (S)-
TRIP 4.31 were used as catalysts for the glycosylation reaction. Both (R)-TRIP 4.30 and (S)-
TRIP 4.31, when used with the co-catalyst 4.16, gave very similar stereoselectivities to those 
observed by the use of other two organocatalysts viz 4.27 and 4.36 (Table 4.2, entry 3 and 5 
respectively). However, when (S)-TRIP 4.31 was used in absence of co-catalyst 4.16, an 
unprecedented improvement in stereoselectivity (β:α = 20:1) was observed, though the yield of 
the process was poor (25%) (Table 4.2, entry 6). When the reaction was carried out in the 
presence of only the co-catalyst 4.5, the lowest stereoselectivity was observed (3.1) (Table 4.2, 
entry 7).  
The glycosylation
[c] 
reactions performed with donor 4.7 and acceptor 4.15 to yield the isopropyl 
glycoside 4.16 are summarized in Table 4.2. 
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Entry Catalyst 
Co-
Catalyst 
(4.16) 
Reaction 
Status 
Time 
(h) 
Temp. 
Yield 
(%) 
β:α 
ratio 
[d]
 
1. TMSOTf + Complete 6 -78 °C 
67  
 
25:1 
2. TMSOTf - Complete 6 -78 °C 
67  
 
23:1 
3. (R)-TRIP 4.30 + Complete 72 rt 
61  
 
6:1 
4. (R)-TRIP 4.30 - Incomplete 96 rt 
28
e
 
 
7:1 
5. (S)-TRIP 4.31 + Complete 72 rt 
64  
 
6:1 
6. (S)-TRIP 4.31 - Incomplete 96 rt 
25
e
 
 
20:1 
7. - + Incomplete 96 rt 
16
e
 
 
3:1 
8. 
Diphenyl phosphoric acid 
4.36 
+ Complete 72 rt 
65  
 
6:1 
9. 
Diphenyl phosphoric acid 
4.36 
- Incomplete 96 rt 
22
e
 
 
4:1 
10. 
Bis(4-nitrophenyl)    
phosphoric acid 4.27 
 
 
+ Complete 72 rt 
72  
 
7:1 
11. 
Bis(4-nitrophenyl)    
phosphoric acid 4.27 
 
 
- Complete 72 rt 
71  
 
7:1 
12. 
Bis(4-nitrophenyl)    
phosphoric acid 4.27 
 
 
+ Complete 3 rt 
73  
 
5:1 
[c] Reaction conditions: acceptor (1.2 equiv.), Catalyst (0.025 equiv.), Co-Catalyst (0.05 equiv.), 
DCM.   
[d] Anomeric ratios were determined by integration of appropriate peaks in the 
1
H NMR spectra. 
Glycosylation reactions were carried out in duplicate to confirm the reproducibility of results.
 
 
 [e] Determined by 
1
H-NMR 
Table 4.2 
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4.2.4.4 Organocatalytic stereoselective synthesis of methyl glycoside 
Finally his organocatalytic glycosylation was carried out using methanol 4.37 as the acceptor and 
either TMSOTf or bis(4-nitrophenyl)phosphoric acid 4.27 as catalysts, both with and without co-
catalyst 4.16 as shown in Scheme 4.11. 
O
O
BnO
O
OBnBn
Bn O
Cl3C
NH
4.12
+
catalyst (5 mol%)
4.16 (5 mol%)
O
O
BnO
O
OBnBn
Bn OMe
MeOH
4.37
4.38
DCM
                    
Scheme 4.16 
Strangely, all the reaction conditions investigated led exclusively to the β-product. A summary of  
glycosylation
[f] 
reactions performed with donor 4.12 and methanol 4.37 as acceptor to yield the 
methyl glycoside 4.38 is shown in  Table 4.3. 
Entry Catalyst 
Co-
Catalyst 
4.16 
Reaction 
Status 
Time 
(h) 
Temp. 
Yield 
(%) 
β:α[g] 
1. TMSOTf + Complete 0.5 -78 °C 
71 
 
1:0 
2. TMSOTf - Complete 0.5 -78 °C 
71 
 
1:0 
3. 
Bis(4-nitrophenyl)    
phosphoric acid 4.27 
 
+ Complete 4 rt 
65 
 
1:0 
4. 
Bis(4-nitrophenyl)    
phosphoric acid 4.27 
 
+ Complete 72 rt 
64 
 
1:0 
5. 
Bis(4-nitrophenyl)    
phosphoric acid 4.27 
 
- Complete 48 h rt 
60 
 
1:0 
 
[f] Reaction conditions: acceptor (1.2 equiv.), Catalyst (0.025 equiv.), Co-Catalyst 4.16 (0.05 
equiv.), DCM.   
[g] Anomeric ratios were determined by integration of appropriate peaks in the 
1
H NMR spectra. 
Glycosylation reactions were carried out in duplicate to confirm the reproducibility of results.      
 
Table 4.3   
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4.2.4.5 Verification of anomerization under reaction conditions 
Since the reaction times for most of the glycosylation reactions were very long (up to 72 h), there 
was also a need to verify whether any anomerization of the product occurred in the acidic 
conditions provided by the catalyst. Therefore a pure α disaccharide 3.45 (Figure 4.2) (20 mg) 
was stirred in DCM along with (i) catalysts (5 mol %) 4.27, 4.36, 4.30 and 4.31 along with co-
catalyst (5 mol %) 4.16 in different reaction vessels, (ii) with co-catalyst 4.16 (5 mol %) alone. 
1
H-NMRs of the aliquots of all the reaction vessels were recorded at intervals of 1 h, 3 h, 6 h, 24 
h, 48 h and 72 h, however there was no isomerization of the α diastereomer to β diastereomer 
seen at any time, it was concluded that the observed anomeric stereochemistry is not a result of 
product equilibration. 
O
O
BnO
BnO
BnO
O
O
O
OO
3.45
OH
 
      Figure 4.2 
4.2.5 Conclusions 
It is well-established that the stereochemical outcome of glycosylation reactions can be highly 
dependent on the acceptor used in glycosylation step. In particular, a match or mis-match of 
donor and acceptor may occur.
[17]
 In these studies, it was found that the smaller the acceptor that 
was used, the higher the -stereoselectivity that was obtained. Undoubtedly, the thiourea 
derivative co-catalyst 4.16 assisted the catalyst in making the reaction faster, especially in the 
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cases where the catalyst was itself not a strong enough acidic, and thus reactions performed in 
the its presence was not effective in improving the stereochemical outcome of the reaction, and 
in many cases the reaction gave better selectivity when the co-catalyst was not used. The -
stereoselectivity observed when using TMSOTf, either with or without the co-catalyst 4.16, was 
always higher than when the organocatalysts were used, either with or without the co-catalyst. 
So, the existence and role of the transition state suggested by Schmidt’s group in their 
explanation of the high stereoselectivity they observed appears to be highly dubious. Indeed their 
stereoselectivtites were highly acceptor specific, casting significant doubt on the utility of their 
work. The co-operative effect between the catalyst and co-catalyst needs to be investigated 
further.    
4.3 Hydrogen-bond donor and Brønsted acid organocatalysis 
A guanidinium salt was selected as a potential catalyst for glycosylation reactions of 
trichloroacetimidate donors by a catalytic Brønsted acid activation mechanism. Glycosylation 
reactions of trichloroacetimidates are generally catalysed using Lewis acids as opposed to 
Brønsted acids, and examples of catalytic Brønsted acid activated glycosylation protocols are 
limited.
[18]
 However as mentioned above the Fairbanks group have previously reported that β-
selective glycosylations of glycosyl trichloroacetamidates can be achieved with a chiral BINOL-
derived phosphoric acid catalyst 4.1 (Scheme 4.1).   
 
Guanidinium salts have been used as organocatalysts for a variety of purposes including 
diastereo- and enantioselective Claisen rearrangement.
[19]
 One example is shown in Scheme 4.17. 
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O
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R2
O
O
R3
Catalyst 4.19
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O
R3R2
R1O
4.41
ee dr > 14:1  
Scheme 4.17 
Detailed theoretical investigations of this reaction revealed that catalyst 4.19 works by stabilizing 
the transition state with multiple non-covalent interactions like hydrogen bonding and 
electrostatic interactions, as shown below (Figure 4.3). 
O
OMeO
R''
R'
R
N
N H
H
H2N
R'''
+
 
Figure 4.3 
As the transition state involved the guanidiniun salt acting as both a H-bond donor and acceptor 
in co-operative acid-base catalysis the possible application of such catalysts for the cooperative 
glycosylation of alcohols using trichlroacetmidate donors was investigated. 
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4.3.1 Synthesis of the organocatalyst 
The guanidinium organocatalyst 1,5,7-triazabicyclo[4.4.0]dec-5-enium hexafluorophosphate 
4.44, was prepared in two steps starting from a guanidine derivative 4.42 (Scheme 4.18). 1,5,7-
Triazabicyclo[4.4.0]dec-5-ene TBD 4.42 was first treated with ammonium chloride to give 
TBD.HCl 4.43.
[20]
 This salt was then treated with NaPF6 to give the desired organocatalyst 
TBD.HPF6 4.44.
[21]
 We decided to investigate the potential application of  4.44 instead of the 
chloride 4.43 as we required a non-nucleophilic counter ion which would not compete during the 
glycosylation reaction. 
N
N
N
H
NH4Cl
MeOH, rt 60 °C, 24 h N
N
N
H
. HCl
NaPF6
CH3CN, rt, 0.5 h N
N
N
H
. HPF6
4.444.42 4.43
(95%) (95%)
 
Scheme 4.18 
4.3.2 Synthesis of the donors  
Tetrabenzyl-α-D-galactopyranosyl trichloroacetimidate 4.12 and tetrabenzyl-β-D-
galactopyranosyl trichloroacetimidate 4.45 were prepared as donors from 
tetrabenzylgalactopyranose 4.34 by treatment with trichloroacetonitrile and either DBU and 
K2CO3 as bases respectively (Scheme 4.19).              
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O
O
BnO
OBn
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Cl3CCN, K2CO3
DCM, rt, 36 h
Bn
O CCl3
NH
4.45
O
O
BnO
OBn
OH
OBnBn
O
O
BnO
O
OBn
Cl3CCN, DBU
DCM, rt, 1 h
Bn
Bn O
Cl3C
NH4.34
4.12
(89%)
(51%)
 
Scheme 4.19 
4.3.3 Results and discussions 
Glycosylation of both 4.12 and 4.45 was attempted using 4.44 as an organocatalytic activator. 
Initially, the glycosylations were attempted in DCM as the solvent and using diacetone galactose 
2.42 as the acceptor. At rt no glycosylation was seen. So, the reaction was repeated by refluxing 
the mixture in DCM overnight. Under these conditions disaccharide 4.46 was obtained but in a 
very poor yield of 20%. The reaction was then repeated by refluxing the reaction mixture in 
toluene for 16 h. Glycosylation was more effective under these conditions and disaccharide 4.46 
(α:β = 1:1) was prodcuced in yields of 30% and 40% of from 4.12 and 4.45 respectively (Scheme 
4.20).  
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H
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Scheme 4.20 
A control glycosylation reaction was also carried out without using the organocatalyst, and 4.12 
as donor. Formation of the disaccharide 4.46, with stereoselectivity (α:β = 5:1), and same yield 
of 30%, was observed. It was concluded that the glycosylation observed in those harsh 
conditions had occurred due to the thermal energy provided, unaided from organocatalyst.  
Finally, the Guanidine TBD 4.42 was itself used as possible organocatalyst. Very surprisingly, 
this led to the transfer of the trichloroacetimidate group from the donor to the acceptor molecule 
resulting in the formation of diacetone galactose-6-trichloroacetimidate 4.47 (Scheme 4.21).      
   
O
O
CCl3
NHO
O
BnO
OBn
Bn
+ O
OO
O
O
OH
O
O
BnO
OBn
Bn
+ O
OO
O
O
O
OH
CCl3
NH
4.12
4.42
4.34
4.47
2.42
N
N
N
H OBn Bn
DCM, rt, 16 h
(70%)
Scheme 4.21 
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Due to lack of any observable organocatalytic effect resulting from the addition of either 
guanidine 4.42 or guanidiunium salt 4.44 to these glycosylation reactions this avenue of 
investigation was abandoned. 
4.3.4 Conclusion 
The guanidine salt chosen for organocatalysis was not acidic enough [pKa ≈ 13 (H2O)],
[22]
 to 
activate the trichloroacetamidate donor. Organic acids with lower pKa needs to be investigated to 
utlize them as effective organocatalytic acid in glycosylation reactions.    
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Chapter 5: Experimental 
5.1 General chemical procedures  
Unless otherwise stated, reagents were obtained from commercial sources and used as received. 
HPLC–grade solvents were used for reactions and in case of moisture–sensitive reactions; 
solvents were dried by literature procedures and freshly distilled as required. Melting points were 
recorded on an Electrothermal melting point apparatus. Thin Layer Chromatography (t.l.c.) was 
carried out on Merck Kieselgel 60F254 pre-coated glass-backed plates. Visualisation of the plates 
was achieved using a UV lamp (λmax = 254 or 365 nm), and/or ammonium molybdate (5% in 2 
M sulfuric acid). Flash column chromatography was carried out using Sorbsil C60 40/60 silica.  
Nuclear Magnetic Resonance  
1
H and 
13
C NMR spectra were recorded on Agilent 400–MR and Varian 500 INOVA instruments 
operating for 
1
H NMR at 400 and 500 MHz, respectively and at 100 and 125 MHz, respectively, 
for 
13
C NMR. All the 
1
H NMR spectra recorded in deutrated solvents were referenced to the 
solvent peak and/or TMS: CDCl3, 7.26 ppm; CD3CN, 2.0 ppm; CD3OD, 3.3 ppm; DMSO, 2.6 
ppm. 
13
C NMR were all referenced to their solvent peaks: chloroform, 77.0 ppm; acetonitrile, 
36.8 ppm; methanol, 49.3 ppm; DMSO, 39.6 ppm. When required, gCOSY, 1–D TOCSY, 
HSQC, HSQC “non-decoupled”and HMBC experiments were performed using standard pulse 
sequences.  
Mass Spectrometry  
Mass spectra were recorded by Dr. Marie Squire and Dr. Alexander on either a DIONEX 
Ultimate 3000 or Bruker MaXis 4G spectrometer, operated in high resolution positive ion 
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electrospray mode. Samples were prepared by dissolving in an appropriate solvent at the required 
concentration.  
Infrared Spectroscopy  
Infrared spectra were recorded on a Perkin–Elmer Spectrum One FTIR instrument operating in 
diffuse reflectance mode with samples prepared as KBr pellets (KBr) or on a Bruker FTIR 
spectrometer with Alpha’s Platinum ATR single reflection diamond where the neat samples were 
recorded.  
Carbohydrates and derivatives have been named in accordance with IUPAC recommendations 
and numbered according to the carbohydrate convention. The two protons on C-6 are labelled H-
6 and H-6′. 
5.2 Experimental for chapter 2 
Penta-O-acetyl-β-D-glucopyranose[1] 2.20 
O
OH
HO O
OAc
AcO
NaOAc, Ac2O
OAc
2.19 2.20
OH
HO AcO
HO AcO
120 °C, 2h
(41%)
 
Sodium acetate (55.0 g, 676 mmol) was added to acetic anhydride (400 mL) and the mixture was 
heated to 120 °C for 30 min. Glucose (2.19) (60.0 g, 333 mmol) was then added slowly over 30 
min. After 90 min t.l.c. (petrol:ethyl acetate, 1:1) showed complete consumption of starting 
material (Rf 0) and the formation of single product (Rf 0.7). The mixture was then cooled to rt 
and of water and ice (400 mL) was added. The ensuing precipitate was filtered, and was then 
recrystallized (ethanol) to give  penta-O-acetyl-β-D-glucopyranose 2.20 (66.0 g, 51%) as white 
crystalline solid; m. p. 130 - 132 °C (ethanol) (lit.
[1]
 131 - 132 °C); [α]D
20
 + 4.2  (c, 1.0 in CHCl3) 
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(lit.
[1]
 [α]D
25
 +5 (c, 1.0 in CHCl3); δH (500 MHz, CDCl3)
[1]
: 2.01, 2.03, 2.03, 2.09, 2.12 (15H, 5 x 
s, 5 x CH3CO2), 3.84 (1H, ddd, J4,5 9.9 Hz, J5,6 2.2 Hz, J5,6’ 4.4 Hz, H-5), 4.11 (1H, dd, J6,6’ 12.5 
Hz, H-6), 4.29 (1H, dd, H-6’), 5.11-5.16 (2H, m, H-2, H-4), 5.25 (1H, at, J 9 Hz, H-3), 5.71 (1H, 
d, J1,2 8.3 Hz, H-1). 
Phenyl 2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranoside[2] 2.21 
O
OAcAcO
AcO
OAc
PhSH, BF3.Et2O O
SPhAcO
AcO
OAc
2.20 2.21
AcO AcO
DCM, rt, 12 h
(80%)
 
2.20 (20.0 g, 46.2 mmol) was dissolved in DCM (40 mL) under a nitrogen atmosphere. 
Thiophenol (7.40 mL, 71.8 mmol) was added and the solution was cooled to 0 °C. BF3.Et2O 
(18.4 mL, 148 mmol) was added and the mixture was left to stir at rt for 12 h, after which t.l.c. 
(petrol:ethyl acetate, 2:1) showed complete consumption of starting material (Rf 0.2), and 
formation of a major product (Rf 0.3). The mixture was diluted with DCM (200 mL), washed 
with saturated aq. sodium bicarbonate solution (3 x 150 mL), brine (100 mL), dried (MgSO4), 
filtered and concentrated in vacuo. The residue was recrystallized (petrol/ethyl acetate) to afford 
phenyl 2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranose 2.21 (18.0 g, 80%) as white crystalline 
solid; m. p. 112 - 115 °C (petrol/ethyl acetate) (lit.
[2]
 118 - 120 °C); [α]D
20
 – 15.3 (c, 1.0 in 
CHCl3) (lit.
[2] 
 [α]D
23
 - 22.7 (c, 1.0 in CHCl3); δH (500 MHz, CDCl3):
[2]
 1.99, 2.02, 2.08, 2.09 
(12H, 4 x s, 4 x CH3CO2), 3.71-3.75 (1H, ddd, J4,5 10.2 Hz, J5,6 2.2 Hz, J5,6’ 4.4 Hz, H-5), 4.16-
4.25 (2H, m, H-6, H-6’), 4.71 (1H, d, J1,2 10.1 Hz, H-1), 4.99 (1H, at, J 9.4 Hz, H-2), 5.04 (1H, 
at, J 9.4 Hz, H-4), 5.22 (1H, at, J  9.7 Hz, H-3), 7.30–7.34 (3H, m, Ar-CH), 7.48–7.51 (2H, m, 
Ar-CH). 
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Phenyl 4,6-O-benzylidene-1-thio-β-D-glucopyranoside[3] 2.23 
O
SPhAcO
AcO 1) NaOMe, MeOH, rt, 1.5 h
2) CSA, PhCH(OMe)2, DMF, 8h
O
SPh
AcO
OAc
HO
OH
O
O
Ph
(73% in two steps)2.21 2.23  
Sodium methoxide (0.220 g, 4.00 mmol) was dissolved in anhydrous Methanol (150 mL) and the 
solution was cooled to rt. 2.21 (15.7 g, 40.0 mmol) was added portion wise and the mixture was 
stirred at rt under a nitrogen atmosphere. After 90 min, t.l.c. (petrol:ethyl acetate, 1:1) indicated 
the formation of a single product (Rf 0) and the complete consumption of starting material (Rf 
0.45). The mixture was then concentrated in vacuo. DMF (100 mL), benzaldehyde 
dimethylacetal (7.20 mL, 48.0 mmol) and camphor sulfonic acid (1.86 g, 8.00 mmol) were 
added, and the mixture was rotated in a round bottom flask on a rotator evaporator at 60 °C, 
under a pressure of 240 mbar. After 4 h, t.l.c. (petrol:ethyl acetate, 1:1)  showed the formation of 
a major product (Rf 0.3). The reaction was quenched by the addition of triethylamine (0.840 mL, 
6.00 mmol) and concentrated in vacuo. The residue was dissolved in ethyl acetate (150 mL), then 
washed with water (2 x 100 mL), brine (100 mL), dried (MgSO4), filtered and concentrated in 
vacuo. The residue was recrystallized (Petrol/Ethyl acetate) to afford phenyl 4,6-O-benzylidene-
1-thio-β-D-glucopyranoside 2.23 (9.00 g, 73%) as white crystalline solid; m. p. 178 - 180 °C 
(petrol/ethyl acetate) (lit.
[3]
 172 – 174 °C); [α]D
20
 + 32.4  (c, 1.0 in CHCl3) (lit.
[3]
 [α]D
20
 + 27.8  
(c, 1.07 in CHCl3); δH (500 MHz, CDCl3)
[3]
: 2.82, 3.07 (2 x 1H, 2 x bs, 2 x OH), 3.46–3.55 (3H, 
m, H-2, H-3, H-4), 3.77-3.86 (2H, m, H-5, H-6), 4.38-4.40 (1H, m, H-6’), 4.63-4.65 (1H, d, J1,2 9 
Hz, H-1), 5.54 (1H, s, CHPh), 7.25-7.55 (10H, m, Ar-CH).      
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Phenyl-3-O-benzyl-4,6-O-benzylidene-1-thio-β-D-glucopyranoside[4] 2.25 
O
SPh
1) Bu2SnO, MeOH, reflux, 24 h
2) BnBr, CsF, DMF, 72 h
OH
HO
O
O
Ph
O
SPh
OH
BnO
O
O
Ph
(59%)2.23 2.25
 
2.23 (1.07 g, 2.98 mmol) was dissolved in methanol (25 mL). Dibutyl tin oxide (0.900 g, 3.57 
mmol) was added and the reaction was refluxed at 65 °C for 24 h. After cooling to rt the solvent 
was removed to yield a yellow oil. The residue was dissolved in DMF (25 mL) and the mixture 
was stirred at rt. Benzyl bromide (0.425 mL, 3.57 mmol) and cesium (I) fluoride (0.600 g, 3.87 
mmol) were added and the solution was stirred for 48 h. At this point t.l.c. (petrol:ethyl acetate, 
3:1) indicated complete consumption of starting material (Rf 0.1), and the formation of a major 
product (Rf 0.3). The mixture was then concentrated in vacuo and the residue extracted with 
DCM (50 mL). The organic layer was washed with  potassium fluoride (50 mL of 1M), dried 
(MgSO4), filtered, and concentrated in vacuo. Purification by flash chromatography (petrol:ethyl 
acetate, 3:1) yielded  phenyl-3-O-benzyl-4,6-O-benzylidene-1-thio-β-D-glucopyranoside 2.25 
(0.790 g, 59%)  as white crystalline solid; m. p. 131 - 134 °C (petrol/ethyl acetate) (lit.
[5]
 132 - 
134 °C); [α]D
20
 - 44.3  (c, 1.0 in CHCl3) (lit.
[6]
 [α]D
20
 - 41  (c, 1.0 in CHCl3); δH (500 MHz, 
CDCl3)
5
: 2.56 (1H, s, OH), 3.50 – 3.54 (2H, m, H-2 and H-5), 3.68 (2H, m, H-3 and H-4), 3.85 
(1H, at, J 10.27 Hz, H-6), 4.39 (1H, dd, J6’,6 10.45 Hz, J 6’,5 5.0 Hz, H-6’), 4.63 (1H, d, J1,2 9.7 
Hz, H-1), 4.79, 4.95 (2H, ABq, JAB 11.6 Hz, CH2Ph), 5.57 (1-H, s, CH-Ph), 7.55–7.25 (15-H, m, 
Ar-CH).    
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Phenyl-2-O-allyl-3-O-benzyl-4,6-O-benzylidene-1-thio-β-D-glucopyranoside[7] 2.28 
O
SPh
OH
Allyl Bromide, NaH
DMF, rt
2.25
2.28
BnO
O
SPh
O
BnO
O
O
Ph O
O
Ph
(87%)
 
2.25 (0.500 g, 1.10 mmol) was dissolved in anhydrous DMF (2 mL). To it was added a 
suspension of sodium hydride (0.104 g, 2.20 mmol) in anhydrous DMF (2 mL) at 0 °C slowly 
under a nitrogen atmosphere. Allyl bromide (0.200 mL, 2.40 mmol) was then added slowly in 
the mixture. The reaction was then allowed to warm till rt and was then stirred for 1h, at this time 
t.l.c. (petrol:ethyl acetate, 4:1) showed complete absence of starting material (Rf 0.3) and 
formation of a major product (Rf 0.5). The reaction was quenched by the addition of methanol (5 
mL) and concentrated in vacuo. The residue was dissolved in diethyl ether (50 mL) and washed 
with water (100 mL) and aqueous layer was extracted with diethyl ether (2 x 50 mL). The 
combined organic extracts were washed with brine (100 mL), dried (MgSO4), filtered and 
concentrated in vacuo. Purification by flash chromatography (petrol:ethyl acetate, 8:1) yielded  
phenyl-2-O-allyl-3-O-benzyl-4,6-O-benzylidene-1-thio-β-D-glucopyranoside 2.28 (0.472 g, 
87%) as white crystalline solid,  m. p. 117 – 119 °C (petrol/ethyl acetate); [α]D
 20
 (c, 1.0 in 
CHCl3); νmax (KBr) 1700 (s, C=C) cm
-1; δH (500 MHz, CDCl3): 3.35-3.45 (2H, m, H-2, H-5), 
3.65 (1H, at, J 9.5 Hz, H-6), 3.75 (2H, m, H-3, H-4), 4.33 (3H, m, H-6’, OCH2CH=CH2), 4.68 
(1H, d, J1,2 9.7 Hz, H-1), 4.78, 4.90 (2H, ABq, JAB 12 Hz, -OCH2Ph), 5.18 (1H, d, Jz 10.2 Hz, J 
1.5 Hz, CH=CHEHz), 5.28 (1H, m, JE 16 Hz, Jgem 1.5 Hz CH=CHEHz),  5.55 (s, 1H, CH-Ph), 
5.98 (1H, m, CH=CH2 ), 7.52-7.24 (15H, m, Ar-CH). δC (126 MHz, CDCl3): 69.0 (t, C-6), 70.5 
(d, C-5), 75.0 (d, C-2), 75.6 (t, CH2Ph), 80.5 (d, C-4), 81.6 (d, C-3), 88.5 (t, CH2CH=CH2), 101.4 
(d, CHPh), 117.6 (t, CH2CH=CH2), 126.3, 128.0, 128.1, 128.4, 128.5, 128.7, 129.3, 132.6, 133.5, 
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135.0, 137.6, 138.6 (12 types of aromatic-C, CH2CH=CH2); HRMS (ES
+
) calculated for 
C19H31O5S (MH
+
)  491.1886, found 491.1885. 
Phenyl-2-O-(2-hydroxyethyl)-3-O-benzyl-4,6-O-benzylidene-1-thio-β-D-glucopyranoside[8] 
2.31 
O
O
1) O3, CH2Cl2/MeOH, -78
oC
2) NaBH4
2.28 2.31
BnO SPh
O
O
BnO SPh
OH
O
O
Ph O
O
Ph
(69%)
 
A solution of 2.23 (0.100 g, 0.21 mmol) in DCM:methanol (3 mL, 1:1) was treated with ozone at 
– 78 °C until the solution turned blue. The reaction was quenched by the addition of NaBH4 
(0.036 g, 0.93 mmol) in small portions after which t.l.c. (petrol:ethyl acetate, 4:1) showed 
complete consumption of starting material (Rf 0.7) and  formation of a major product (Rf 0.1). 
The mixture was then allowed to warm to rt and concentrated in vacuo. Purification by  flash 
chromatography (petrol:ethyl acetate, 3:1) yielded phenyl-2-O-(2-hydroxyethyl)-3-O-benzyl-4,6-
O-benzylidene-1-thio-β-D-glucopyranoside 2.25 (0.07 g, 69%) as white crystalline solid; δH (500 
MHz, CDCl3): 2.95 (1H, bs, OH), 3.40 (1H, at, H-2), 3.45 (1H, m, H-5), 3.5 (3H, m, H-6, -
OCH2CH2OH, 3.63–3.82 (2H, m, -OCH2CH2OH), 3.90 (2H, m, H-3, H-4), 4.39 (1H, m, H-6’), 
4.65 (1H, d, J1,2 10.0 Hz, H-1), 4.78, 4.96 (2H, ABq, JAB 12 Hz, -OCH2Ph), 5.58 (s, 1H, -CHPh), 
7.26-7.52 (m, 15-H, Ar-CH); HRMS (ES
+
) calculated for C18H31O6S (MH
+
) 495.1836, found 
491.1842.  
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(p-Methoxyphenyl) 2,3,4,6-tetra-O-acetyl-β-D-glucopyranoside[9] 2.22 
O
OAc
AcO
AcO
OAc
O
OAc
AcO
AcO
OPMP
2.20 2.22
p-Methoxyphenol, BF3.OEt2
AcOAcO DCM, rt, 3h
(81%)
 
To a stirred solution of 2.20 (25.0 g, 64.1 mmol) in DCM (150 mL), p-methoxyphenol (12.0 g, 
124 mmol) was added and was stirred at rt for 5 min under a nitrogen atmosphere. BF3.Et2O 
(11.6 mL, 124 mmol) was added to the mixture and was stirred at rt for 3 h. The mixture was 
poured onto saturated aq. sodium bicarbonate solution (200 mL), extracted with DCM (3 x 50 
mL), washed with saturated aq. sodium bicarbonate solution (2 x 75 mL), dried (MgSO4), 
filtered and concentrated in vacuo. The residue was purified by flash chromatography 
(petrol:ethyl acetate, 4:1, Rf 0.3) to afford  (p-methoxyphenyl) 2,3,4,6-tetra-O-acetyl-β-D-
glucopyranoside 2.22 as white crystalline solid (23.5 g, 81%); m. p. 101 – 103 °C (petrol/ethyl 
acetate) (lit.
[9] 
102 – 104 °C); [α]D
20
 – 10.5  (c, 1.0 in CHCl3), lit.
[9]
 [α]D
20
 - 16  (c, 1.0 in CHCl3); 
δH (400 MHz, CDCl3)
[9]
: 2.02-2.08 (12H, m, -OCOCH3), 3.76 (3H, s, -OCH3), 3.77 (1H, m, H-
5), 4.10-4.28 (2H, m, H-6, H-6’), 4.95 (1H, d, J1,2 7.1 Hz, H-1), 5.10-5.30 (3H, m, H-2, H-3, H-
4), 6.79-6.95 (4H, m, Aromatic – H); HRMS (ES+) calculated for C21H26O11Na (MNa
+
) 
477.1367, found 477.1376.  
(p-Methoxyphenyl) 3-O-benzyl-4,6-O-benzylidene-β-D-glucopyranoside[3] 2.24 
O
OPMPAcO
AcO 1) NaOMe, MeOH, rt, 1.5 h
2) CSA, PhCH(OMe)2, DMF, 8h
O
OPMP
AcO
OAc
HO
OH
O
O
Ph
(56% in two steps)2.22 2.24  
Sodium methoxide (0.250 g, 4.63 mmol) was dissolved in anhydrous methanol (150 mL) and the 
solution was stirred at rt.  2.22 (21.0 g, 46.3 mmol) was added portionwise and the mixture was 
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stirred at rt under a nitrogen atmosphere. After 90 min, t.l.c. (petrol:ethyl acetate, 1:1), indicated 
the formation of a single product (Rf  0) and the complete consumption of starting material (Rf  
0.5). The mixture was then concentrated in vacuo. DMF (75 mL), benzaldehydedimethylacetal 
(8.30 mL, 55.0 mmol) and camphorsulfonic acid (2.20 g, 9.30 mmol) were added and the 
mixture was rotated on a round bottomed flask on a rotator evaporator at 60 °C under pressure of 
240 mbar for 8 h. After this time t.l.c. (petrol:ethyl acetate, 3:2) showed formation of a major 
product (Rf 0.1) and the complete consumption of starting material (Rf 0.5). The reaction was 
quenched by the addition of triethylamine (0.97 mL, 6.94 mmol) and then concentrated in vacuo. 
The residue was dissolved in ethyl acetate (1 L), then washed with water (2 x 300 mL), brine 
(100 mL), dried (MgSO4), filtered and concentrated in vacuo. Recrystallization 
(propanol/methanol) yielded (p-methoxyphenyl) 3-O-benzyl-4,6-O-benzylidene-β-D-
glucopyranoside 2.24 (10.0 g, 56%); m. p. 192 – 195 °C (propanol/methanol); [α]D
20
 – 51.3  (c, 
1.0 in MeOH); νmax (KBr) 3560 (br, OH) cm
−1
; δH (400 MHz, CD3OD): 3.52-3.56 (3H, m, H-2, 
H-3 and H-4), 3.72-3.84 (5H, m, H-5, H-6, -OCH3), 4.28-4.32 (dd, J6,6’ 10.4 Hz, J6’5 5.0 Hz 1H, 
H-6’), 5.60 (1H, s, -CHPh), 4.91 (d, 1H, J1,2 8Hz, H-1), 6.83-7.04 (9H, m, Aromatic – H);  δC 
(100 MHz, CD3OD): 155.8-114.7 (8 C, Ar-C), 102.2 (d, C-1), 101.8 (d, CHPh), 80.2 (d, C-4), 
74.2 (d, C-3), 72.5 (d, C-2), 68.0 (d, C-5), 66.0 (t, C-6), 54.2 (q, -OMe); HRMS (ES
+
) calculated 
for C20H22O7Na (MNa
+
) 397.1257, found 397.1263.  
(p-Methoxyphenyl) 3-O-benzyl-4,6-O-benzylidene-β-D-glucopyranoside[4] 2.26 
O
OPMP
1) Bu2SnO, MeOH, reflux, 24 h
2) BnBr, CsF, DMF, 72 h
2.24 2.26
OH
HO
O
O
Ph
O
OPMP
OH
BnO
O
O
Ph
(43%)
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2.24 (6.50 g, 17.4 mmol) was dissolved in methanol (200 mL). Dibutyltin oxide (5.20 g, 20.8 
mmol) was added and the reaction was stirred under reflux for 24 h. The solvent was removed 
and the residue was dissolved in DMF (200 mL) and the mixture was stirred at rt. Then benzyl 
bromide (2.47 mL, 20.8 mmol) and cesium fluoride (3.42g, 34.7 mmol), were added and the 
solution was stirred for 72 h at which t.l.c. (petrol:ethyl acetate, 2:1) showed formation of a 
major product (Rf 0.5), but t.l.c. (DCM:diethyl ether, 19:1) showed a major spot at Rf 0.8 and 
minor spots at Rf 0.9. The mixture was then concentrated in vacuo, and the residue extracted 
with DCM (400 mL), and the organic layer was with KF solution (400 mL, 1M conc.), dried 
(MgSO4), filtered and concentrated in in vacuo. Recrystallization (methanol) yielded  (p-
methoxyphenyl) 3-O-benzyl-4,6-O-benzylidene-β-D-glucopyranoside 2.26 (3.50 g, 43%) as 
white crystalline solid; m. p. 198 – 201 °C (methanol); [α]D
20
 - 22.1 (c, 1.0 in CHCl3); νmax (KBr) 
3560 (br, OH) cm
−1
; δH (400 MHz, CDCl3): 2.53 (1H, bs, OH), 3.50-3.59 (1H, m, H-5), 3.71-
3.86 (7H, m, H-2, H-3, H-4, H-6, -OCH3), 4.37 (1H, m, H-6’), 4.90 (1H, d, J1,2 8Hz, H-1), 4.83, 
5.00 (2H, ABq, JAB 12 Hz, -OCH2Ph), 5.60 (1H, s, CHPh), 6.82-7.51 (14H, 14H, Aromatic – H); 
δC (100 MHz, CD3OD): 55.6 (q, -OMe), 66.6 (t, C-6), 68.7 (d, C-5), 74.1 (d, C-2), 74.7 (t, 
CH2Ph), 80.2 (d, C-4),  81.2 (d, C-3), 101.3 (d, CHPh), 102.5 (d, C-1), 159.2-114.6 (14 C, Ar-C); 
HRMS (ES
+
) calculated for C27H28O7Na (MNa
+
) 487.1727, found 487.1732. 
(p-Methoxyphenyl) 2-O-acetyl-3-O-benzyl-4,6-O-benzylidene-β-D-glucopyranoside[10] 2.27 
O
OPMP
OH
2.26 2.27
Acetic anhydride/Pyridine
BnO
O
OPMP
OAc
BnO
O
O
O
OPh
Ph
rt
 
 It was cross verified that 2.26 was indeed 3- benzyl product and not the 2- benzyl by acetylating 
it (stirring in Ac2O/Pyridine 1:1 for 20 h) to give (p-methoxyphenyl) 2-O-acetyl-3-O-benzyl-4,6-
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O-benzylidene-β-D-glucopyranoside 2.27, m. p. 122 – 126 °C (petrol/ethyl acetate), [α]D
20
 + 1.6 
(c, 0.125 in CHCl3); νmax (KBr) 1747 (s, C=O) cm
−1
;
 
The free hydroxyl group at position 2 gets 
acetylated and H-2 shows bathochromic shift (3.57 to 5.27). δH (400 MHz, CDCl3): 2.03 (3H, s, -
COCH3), 3.58 (1H, m, H-5), 3.76-3.86 (6H, m, H-3, H-4, H-6, -OCH3), 4.41 (1H, m, H-6’),    
4.72 (1H, d, Jgem 12Hz, -OCHH’Ph), 4.94 (2H, m,  -OCHH’Ph, H-1), 5.27 (1H, at, J 8 Hz, H-2), 
5.601 (1H, s, CHPh), 6.80-7.58 (14H, m, Aromatic – H);  δC (100 MHz, CDCl3):  55.6 (q, 
OCH3), 66.4 (d, C-5), 68.6 (t, C-6), 72.8 (d, C-2), 74.2 (t, OCH2Ph), 78.4 (d, C-4), 81.3 (d, C-4), 
101.1 (d, CHPh), 101.3 (d, C-1), 155.7-114.6 (12 C, Ar-C), 169.3 (s, -OOCCH3); HRMS (ES
+
) 
calculated for C29H30O8Na (MNa
+
) 529.1832, found 529.1834.         
(p-Methoxyphenyl)-2-O-allyl-3-O-benzyl-4,6-O-benzylidene-β-D-glucopyranoside[7] 2.29 
O
OPMP
Allyl Bromide, NaH
2.26
2.29
BnO
OH
O
OPMPBnO
O
O
O
O
O
Ph Ph
(72%)
DMF, rt, 4 h
 
2.26 (3.00 g, 6.40 mmol) was dissolved in anhydrous DMF (20 mL) and to it was added a 
suspension of sodium hydride (0.330 g, 13.7 mmol), anhydrous DMF (20 mL) at 0 °C under a 
nitrogen atmosphere. Allyl bromide (1.17 mL, 13.7 mmol) was then added slowly to the mixture. 
Once the addition was complete the reaction was then allowed to warm to rt and stirred. After 4 
h t.l.c. (petrol:ethyl acetate, 4:1) showed complete consumption of starting material (Rf  0.1) and 
formation of a single product (Rf 0.3). The reaction was then quenched by the addition of 
methanol (20 mL) and then concentrated in vacuo. The residue was dissolved in DCM (30 mL), 
washed with water (2 x 15 mL), brine (15 mL) and dried (MgSO4), filtered and concentrated in 
vacuo. Purification by flash chromatography (petrol:ethyl acetate, 6:1) yielded  (p-
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methoxyphenyl)-2-O-allyl-3-O-benzyl-4,6-O-benzylidene-β-D-glucopyranoside 2.29 (2.33 g, 
72%) as white crystalline solid; m. p. 177 – 180 °C (petrol/ethyl acetate); [α]D
20
 – 34.6  (c, 1.0 in 
CHCl3); δH (400 MHz, CDCl3): 3.56 (m, 1H, H-5), 3.62 (1H, m, H-2), 3.71-3.86 (6H, m, H-3, H-
4, H-6, -OCH3), 4.49 (2H, m, -OCH2CH=CH2), 4.37 (1H, m, H-6’), 4.85 (1H, d, Jgem  11.2 Hz, -
OCHH’2Ph), 4.98 (2H, m, -OCHH’Ph, H-1), 5.21 (1H, d, JZ 10 Hz, -OCH2CH=CHzHE), 5.35 
(1H, d, JE 16 Hz, -OCH2CH=CHzHE), 5.59 (1H, s, CHPh), 6.00 (1H, m, -OCH2CH=CH2), 6.84-
7.52 (14H, m,  Aromatic – H);  δC (100 MHz, CDCl3): 55.6 (q, -OMe), 68.7 (d, C-5), 66.2 (t, C-
6), 74.282 (d, C-2), 75.1 (t, CH2Ph), 80.8 (d, C-4), 81.1 (d, C-3), 81.6 (t, -OCH2CH=CH2), 101.2 
(d, CHPh), 103.3 (d, C-1), 114.6-155.6 (14C, Ar-C, -OCH2CH=CH2, -OCH2CH=CH2); HRMS 
(ES
+
) calculated for C30H32O7Na (MNa
+
) 527.2040, found 527.2051.     
3-O-Benzyl-4,6-O-benzylidene-2-O-(2-hydroxyethyl)-α/β-D-glucopyranose 2.33 
O
BnO
O
OPMP
1) O3, CH2Cl2/MeOH, -78
oC
2) NaBH4, rt
O
BnO
O
OH
OH
2.29 2.33
O
O
O
O
Ph Ph
(73%)
 
A solution of 2.29 (0.200 g, 0.400 mmol) in DCM:MeOH (9 mL, 2:1) was treated with ozone at 
– 78 °C until the solution turned blue. The reaction was quenched by the addition of NaBH4 
(0.027 g, 0.720 mmol) in small portions over 90 min. On completion of the addition of NaBH4, 
t.l.c. (DCM:MeOH, 195:5) showed formation of a major product (Rf 0.4) and complete 
disappearance of starting material (Rf 0.95). The mixture was then allowed to warm to rt and 
then concentrated in vacuo. The residue was dissolved in ethyl acetate (20 mL), then washed 
with saturated aq. sodium bicarbonate solution (2 x 5 mL), brine (5 mL), dried (MgSO4), filtered 
and concentrated in vacuo. Purification by flash column chromatography (DCM:MeOH, 97:3) 
followed by recrystallization yielded  3-O-benzyl-4,6-O-benzylidene-2-O-(2-hydroxyethyl)-α/β-
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D-glucopyranose 2.33 (0.117 g, 73%) as white crystalline solid; m. p. 148 – 151 °C (petrol/ethyl 
acetate); νmax (KBr) 3,400 (br, O-H) cm
−1
; δH (400 MHz, CDCl3) [1:1.4 mixture of α:β anomers 
observed]: 3.34 (1H, at, J 8 Hz, H-2 β), 4.46 (1H, m, -OCHH’CH2OH α), 3.58 (1H, dd, J2,3 12 
Hz, J1,2 3.6 Hz, H-2 α), 3.78-3.83 (10H, m, -OCH2CH2OH α, -OCH2CH2OH β, -OCHH’CH2OH 
β, H-3 α, H-3 β, H-5 α, H-6 α, H-6 β), 3.84-3.93 (2H, m, -OCHH’CH2OH α, -OCHH’CH2OH β), 
4.00 (1H, at, J 8 Hz, H-4 α), 4.09 (1H, m, H-5 β), 4.29-4.36 (2H, m, H-6’ α, H-6’ β), 4.73 (1H, d, 
J1,2 8 Hz, H-1 β), 4.77, 4.97 (4H, ABq, JAB 12 Hz, CH2Ph α, CH2Ph β), 5.34 (1H, d, J1,2 3.6 Hz, 
H-1 α), 5.57 (1H, s, CHPh β), 5.58 (1H, s, CHPh α), 7.26-7.48 (20 H, m, 10 x Ar-CH α, 10 x Ar-
CH β); δC (100 MHz, CDCl3): 62.2 (d, C-5 β), 62.3, 62.5 (2 x t, -OCH2CH2OH α, -OCH2CH2OH 
β), 66.2 (t, -OCH2CH2OH α), 68.7 (d, C-6 β), 69.0 (d, C-6 α), 73.0 (d, C-5 α), 74.5 (d, -
OCH2CH2OH β), 75.0, 75.2 (2 x t, -CH2Ph α, -CH2Ph β), 77.8 (d, C-4 α), 80.5, 80.8 (2 x d, C-3 
α, C-3 β), 81.8 (d, C-4 β), 82.2, 83.4 (2 x d, C-2 α, C-2 β), 91.7 (d, C-1 β), 97.4 (d, C-1 α), 101.2, 
101.3 (2 x d, -CHPh α, -CHPh β), 126.0 – 134.5 (16 C, 8 x Ar-CH α, 8 x Ar-CH β); HRMS (ES+) 
calculated for C22H26O7Na (MNa
+
) 425.1570, found 425.1575. 
 3-O-Benzyl-4,6-O-benzylidene-2-O-(2-iodoethyl)-α/β-D-glucopyranose[11] 2.34 
O
O
OH
OHBnO
2.33 2.34
O
O
I
OHBnOI2, PPh3, imidazole,
O
O
O
O
Ph Ph
THF, ref lux, 16 h
(39%)
 
2.33 (0.214 g, 0.500 mmol) was dissolved in THF (10 mL) under a nitrogen atmosphere. Then  I2 
(0.191 g, 0.760 mmol), imidazole (0.051 g, 0.760 mmol) and PPh3 (0.200 g, 0.760 mmol) were 
added to the solution. The mixture was then heated to reflux. After 16 h, t.l.c. (petrol:ethyl 
acetate, 2:1) indicated the formation of a major product (Rf 0.3) and the complete consumption 
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of starting material (Rf 0.1). The reaction was cooled to rt and concentrated in vacuo. The residue 
was purified by flash chromatography (petrol:ethyl acetate, 5:1) to afford 3-O-benzyl-4,6-O-
benzylidene-2-O-(2-iodoethyl)ether-α/β-D-glucopyranose 2.34 (0.112 g, 39%) as white 
crystalline solid; m. p. 179 – 182 °C (petrol/ethyl acetate); δH (400 MHz, CDCl3) [1:1.6 mixture 
of α:β anomers observed]: 3.08 (1H, bs, -OH α), 3.27 (7H, m, -OH β, H-2 α, H-2 β, H-3 α, H-3 β, 
H-4 α, H-4 β), 3.50 (1H, m, H-5 α), 3.69 (6H, m, H-5 β, -OCH2CH2I α, -OCH2CH2I β, -
OCHH’CH2I α), 3.82-4.17 (5H, m, -OCHH’CH2I β, -OCHH’CH2I α, -OCHH’CH2I β, H-6’ α, H-
6’ β), 3.35 (2H, m, -OCHH’CH2I α, -OCHH’CH2I β), 4.48 (1H, d, J1,2 8Hz, H-1 β), 4.81, 4.96 
(4H, ABq, JAB 12 Hz, CH2Ph α, CH2Ph β), 5.36 (1H, d, J1,2 3.6 Hz, H-1 α), 5.58 (2H, s, CHPh α, 
CHPh β), 7.27-7.50 (20 H, m, 10 x Ar-CH α, 10 x  Ar-CH β); δC (100 MHz, CDCl3): 3.2, 3.6 (2 
x t, -OCH2CH2I α, -OCH2CH2I β), 62.5, 66.3 (2 x t, C-6 α, C-6 β), 68.6, 69.0 (2 x t, -OCH2CH2I 
α, -OCH2CH2I β), 72.5, 73.5 (2 x d, C-5 α, C-5 β), 75.1, 75.2 (2 x t, -CH2Ph α, -CH2Ph β), 78.1 
(d, C-4 α), 80.5, 80.6 (2 x d, C-3 α, C-3 β), 81.6 (d, C-4 β), 82.0, 83.6 (2 x d, C-2 α, C-2 β), 92.1 
(d, C-1 β), 97.4 (d, C-1 α), 101.2, 101.3 (2 x d, -CHPh α, -CHPh β), 126.0-138.5 (16 C, 8 x Ar-
CH α, 8 x Ar-CH β); HRMS (ES+) calculated for C22H25O6NaI (MNa
+
) 535.0584, found 
535.0594. 
3-(O-Benzyl-4,6-O-benzylidene-2-O-(2-iodoethyl) -α/β-D-glucopyranosyl) 
trichloroacetimidate
[12]
 2.15 
O
O
I
OHBnO
2.34
2.15
O
O
I
OBnO CCl3
NHO
O
O
O
Ph Ph
Cl3CCN, DBU
CH2Cl2, 0 °C, 8 h
(96%)
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2.28 (0.091 g, 0.178 mmol) was dissolved in distilled DCM (3 mL) under a nitrogen atmosphere.  
DBU (0.011 mL, 0.071 mmol), followed by trichloroacetonitrile (0.182 mL, 1.78 mmol), were 
added to the solution at 0° C. After 8 h, t.l.c. (petrol:ethyl acetate, 3:1, with 1% TEA) indicated 
the formation of a major product (Rf 0.4) and the complete consumption of starting material (Rf 
0.2). The reaction was cooled to rt and concentrated in vacuo. The residue was purified by flash 
chromatography (petrol:ethyl acetate, 7:1, with 1% TEA) to afford 3-(O-benzyl-4,6-O-
benzylidene-2-O-(2-iodoethyl)ether-α/β-D-glucopyranosyl) trichloroacetimidate 2.10 (0.112 g, 
96%) as colorless oil; νmax (KBr) 3451 (w, N-H), 1674 (s, C=N) cm
−1
; δH (400 MHz, CDCl3) 
[3.5:1 mixture of α:β anomers observed]: 3.15 (4H, m, -OCH2CH2I α, -OCH2CH2I β), 3.56 -3.87 
(6H, m, H-3 α, H-3 β, -OCH2CH2I α, - OCH2CH2I β), 3.89 -4.09 (8H, m, H-2 α, H-2 β, H-4 α, H-
4 β, H-5 α, H-5 β, H-6’ α, H-6’ β), 4.32 – 4.36 (1H, dd, J6,6’ 10.4 Hz, J6,5 4.8 Hz, H-6 α), 4.38-
4.42 (1H, dd, J6,6’ 10.4 Hz, J6,5 4.8 Hz, H-6 β), 4.85, 4.93 (4H, ABq, JAB 12 Hz, CH2Ph α, CH2Ph 
β), 5.57 (1H, s, CHPh β), 5.59 (1H, s, CHPh α), 5.84 (1H, d, J1,2 7.8 Hz, H-1 β), 6.51 (1H, d, J1,2 
3.6 Hz, H-1 α), 7.26-7.51 (20 H, m, 10 x Ar-CH α, 10 x Ar-CH β), 8.62 (1H, s, NH α), 8.73 (1H, 
s, NH β); 13C (100 MHz, CDCl3): 2.3, 2.4 (2 x t, -OCH2CH2I α, -OCH2CH2I β), 65.1, 66.6 (2 x t, 
C-6 α, C-6 β), 68.5, 68.7 (2 x t, -OCH2CH2I α, -OCH2CH2I β), 72.4, 74.0 (2 x d, C-5 α, C-5 β), 
75.1, 75.2 (2 x t, -CH2Ph α, -CH2Ph β), 77.3, 77.7, 79.6, 80.5, 81.1 (6 x d, C-2 α, C-2 β, C-3 α, 
C-3 β, C-4 α,  C-4 β), 81.2, 81.4 (2 x s, CCl3 α, CCl3 β), 94.6 (d, C-1 β), 97.9 (d, C-1 α), 101.3, 
101.3 (2 x d, -CHPh α, -CHPh β), 125.9–138.4 (16 C, 8 x Ar-CH α, 8 x Ar-CH β), 161.3 (s, 
C=NH); HRMS (ES
+
) calculated for C24H25NO6Cl3INa (MNa
+
) 677.9678, found 677.9694.    
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Methyl 3-O-benzyl-4,6-O-benzylidene-2-O-(2-iodoethyl)-α-D-glucopyranoside[13] 
 
O
BnO
O
I
O CCl3
NH
2.15
+
4 A° M S, TMSOTf
CH2Cl2, -78 °C, 5 h
O
BnO
O
I
2.48
OMe
CH3OH
O
OO
O
Ph
Ph
2.47
(58%)
 
A solution of 3-(O-benzyl-4,6-O-benzylidene-2-O-(2-iodoethyl)ether-α/β-D-glucopyranosyl) 
trichloroacetimidate 2.15 (0.100 g, 0.153 mmol) and methanol 2.47 (5.20 μL, 0.306 mmol) in 
freshly distilled DCM (2 mL) was added to a flame-dried round-bottom flask containing 
activated 4 Å molecular sieves (0.100 g). The mixture was cooled to -78 °C under a nitrogen 
atmosphere, then TMSOTf (3.00 μL, 0.015 mmol) was added. After 5 h, t.l.c. (petrol:ethyl 
acetate, 3:1) showed formation of a major product (Rf 0.7) and the complete consumption of the 
trichloroacetimidate starting material (Rf 0.8) was observed. The reaction was quenched with 
saturated aq. sodium bicarconate solution (2 mL) and filtered through Celite
®
. The mixture was 
diluted with DCM (20 mL), washed with saturated aq. sodium bicarbonate solution (2 x 10 mL), 
and the aqueous layer extracted with DCM (2 x 20 mL). The combined organic extracts were 
washed with brine (25 mL), dried (MgSO4), filtered and concentrated in vacuo. The residue was 
purified by flash column chromatography (petrol:ethyl acetate, 6:1) to afford methyl 2-O-(2-
iodoethyl)-3-O-benzyl-4,6-O-benzylidene-α-D-glucopyranoside 2.48 (0.048 g, 58%) as a white 
crystalline solid; m. p. 125 – 128 °C (petrol/ethyl acetate);   [δH (400 MHz, CDCl3) [1:50 mixture 
of α:β anomers observed, major β anomer quoted]: 3.21-3.29 (3H, m, -CH2CH2I, H-3), 3.42-3.47 
(1H, m, H-5), 3.58 (1H, bs, -OCH3), 3.61-3.74 (2H, m, H-2, H-4), 3.76-3.81 (1H, at, J 10Hz, H-
6), 3.92-4.09 (2H, m, -CH2CH2I), 4.34-4.41 (2H, m, H-1, H-6’), 4.83, 4.92 (4H, ABq, JAB 11.2 
Hz, CH2Ph), 5.57 (1H, s, CHPh), 7.27-7.50 (10H, m, Ar-CH); δH (400 MHz, DMSO-D6) [1:50 
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mixture of α:β anomers observed, major β anomer quoted]: 3.17-3.29 (2H, m, -CH2CH2I), 3.42-
3.48 (5H, m, H-3, H-5, -OCH3), 3.64-3.66 (2H, m, H-2, H-4), 3.70-3.75 (1H, at, J 10Hz, H-6), 
3.81-3.98 (2H, m, -CH2CH2I), 4.21-4.25 (1H, m, H-6’), 4.44 (1H, d, J1,2 8 Hz, H-1), 4.78 (2H, s, 
CH2Ph), 5.66 (1H, s, CHPh), 7.25-7.43 (10H, m, Ar-CH); δC (100 MHz, CDCl3): [major β 
anomer quoted] 3.3 (OCH2CH2I), 65.9 (d, C-5), 68.7 (t, C-6), 73.5 (t, OCH2CH2I), 75.1 (t, 
ArCH2), 80.5, 81.4, 82.4 (3 x d, C-2, C-3, C-4), 101.2 (d, CHPh), 104.5 (d, CHPh), 126.0, 127.7, 
127.9, 128.2, 128.7, 129.0 (6 x d, Ar-CH), 137.3, 138.4 (2 x s, Ar-C); HRMS (ES
+
) calculated 
for C23H27O6INa (MNa
+
) 549.0746, found 549.0747. 
3-O-Benzyl-4,6-O-benzylidene-2-O-(2-iodoethyl)-α/β-D-glucopyranosyl-(1→6)-1:2,3:4-di-O-
isopropylidene-D-galactopyranose
[14]
 2.49 
O
BnO
O
I
O CCl3
NH
2.15
+
O
OO
O
O
OH
2.42
O
BnO
O
I O
O
O
O
O
O
2.49
O
O
Ph
O
O
Ph
a
b
4 A° M S, TMSOTf
DCM, -78 °C, 7 h
(77%)
 
A solution of 3-(O-benzyl-4,6-O-benzylidene-2-O-(2-iodoethyl)-α/β-D-glucopyranosyl) 
trichloroacetimidate 2.15 (0.100 g, 0.153 mmol) and 1,2:3,4–di–O–isopropylidene–α–D–
galactopyranose 2.42 (0.080 g, 0.306 mmol) in freshly distilled DCM (2 mL) was added to a 
flame-dried round-bottom flask containing activated 4 Å molecular sieves (0.100 g). The mixture 
was cooled to -78 °C under a nitrogen atmosphere, then TMSOTf (3μL, 0.015 mmol) was added. 
After 7 h, t.l.c. (toluene:ethyl acetate, 4:1) showed formation of a major product (Rf 0.7) and the 
complete consumption of the trichloroacetimidate starting material (Rf 0.8). The reaction was 
quenched with saturated aq. sodium bicarbonate solution (2 mL) and filtered through Celite
®
. 
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The mixture was diluted with DCM (20 mL), washed with saturated aq. sodium bicarbonate 
solution (2 x 10 mL), and the aqueous layer extracted with DCM (20 mL). The combined organic 
extracts were washed with brine (25 mL), dried (MgSO4), filtered and concentrated in vacuo. 
The residue was purified by flash column chromatography (petrol:ethyl acetate, 6:1) to afford 3-
O-benzyl-4,6-O-benzylidene-2-O-(2-iodoethyl)-α/β-D-glucopyranosyl-(1→6)-1:2,3:4-di-O-
isopropylidene-D-galactopyranoside 2.49 (0.176 g, 77%) as a colourless oil; δH (400 MHz, 
CDCl3) [1:2 mixture of α:β anomers observed]: 1.35, 1.37, 1.47, 1.56, 1.58, 1.61, 1.63 (24H, 8 x 
s, 4 x CH3α, 4 x CH3β), 3.27-3.34 (5H, m, OCH2CH2I α, OCH2CH2I β, H-5b α), 3.40 (1H, m, H-
5bβ), 3.53 (1H, m, H-5a α), 3.60-3.87 (9H, m, H-2a α, H-2a β, H-5a β, H-2b α, H-4b α, H-4b β, H-
5b α, H-5b β, H-6’a α/β), 3.93-4.09 (9H, m, H-2a α, H-2a β, H-3a α, H-3a β, H-4a α, H-4b β, H-6b α, 
H-6b β, H-6’a α/β), 4.16-4.24 (2H, m, OCH2CH2I α/β,), 4.33-4.47 (4H, m, OCH2CH2I α/β, H-6a 
α, H-6a β), 4.50 (1H, d, J1,2 8 Hz, H-1a β),  4.61 (2H, m, H-6’b α, H-6’b β), 4.82-4.93 (4H, m, 
CH2Ph α, CH2Ph β), 5.05 (1H, d, J1,2 3.5 Hz, H-1a α), 5.56 (4H, s, CHPh α, CHPh β, H-1b α, H-
1b β), 7.27-7.50 (20H, m, 10 x Ar-CHα, 10 x Ar-CHβ); δC (100 MHz, CDCl3): 3.8, 3.9 (2 x t, 
OCH2CH2I α, OCH2CH2I β), 24.5, 24.8, 24.9, 25.0, 25.9, 26.0, 26.1, 26.2 (4 x q, CH3 α, 4 x q, 
CH3 β), 62.5, 65.7 (2 x t, C-6a α, C-6a β), 66.0, 66.8 (2 x t, C-6b α, C-6b β), 67.4, 68.7 (2 x t, 
OCH2CH2I α, OCH2CH2I β), 69.0, 70.4 (2 x t, ArCH2 α, ArCH2 β), 70.6, 70.7, 70.8, 70.9, 71.4, 
72.0, 73.6, 75.2, 76.7, 77.3, 78.2, 80.4, 80.6, 81.4, 82.1, 82.5 (16 x d, C-2a α, C-3a α, C-4a α, C-5a 
α, C-2a β, C-3a β, C-4a β, C-5a β, C-2b α, C-3b α, C-4b α, C-5b α, C-2b β, C-3b β, C-4b β, C-5b β), 
96.4 (d, C-1a β), 98.0 (d, C-1a α), 101.1 (d, C-1b β), 101.3 (d, C-1b α), 104.5, 104.5 (d, CHPh α, 
CHPh β), 108.7, 108.7, 109.4, 109.5 (4 x s, C(CH3)2 x 2 α, C(CH3)2 x 2 β), 126.0, 126.5, 126.6, 
127.2, 127.6, 127.7, 127.9, 128.1, 128.2, 128.3, 128.4, 129.0 (12 x d, Ar-CH), 137.3, 137.4, 
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138.3, 138.6 (4 x s, Ar-C); HRMS (ES+) Calculated for C34H43O11INa (MNa+) 777.1742, found 
777.1752).  
Methyl 3-O-Benzyl-4,6-O-benzylidene-2-O-(2-iodoethyl) -α/β-D-glucopyranosyl-(1→3)-2-O-
benzyl-4,6-O-benzylidene-α-D-mannopyranoside[15] 2.50 
O
BnO
O
I
O CCl3
NH
2.15
+ O
OMe
2.44
O
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O
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O
Ph
O
O
Ph
O
O
Ph
a
b
4 A° M S, TMSOTf
CH2Cl2, -78 °C, 8 h
(83%)
A solution of 3-(O-benzyl-4,6-O-benzylidene-2-O-(2-iodoethyl)ether-α/β-D-glucopyranosyl) 
trichloroacetimidate 2.15 (0.100 g, 0.153) and methyl-2-O-benzyl-4,6-di-O-benzylidene-α-D-
mannopyranoside 2.44 (0.114, 0.306 mmol) in freshly distilled DCM (2 mL) was added to a 
flame-dried round-bottom flask containing activated 4 Å molecular sieves (0.100 g). The mixture 
was cooled to -78 °C under a nitrogen atmosphere, then TMSOTf (3 μL, 0.015 mmol) was 
added. After 8 h, t.l.c. (toluene:ethyl acetate, 4:1) showed formation of a major product (Rf 0.6) 
and the complete consumption of trichloroacetimidate starting material (Rf 0.8). The reaction 
was quenched with saturated aq. sodium bicarbonate solution (2 mL) and filtered through 
Celite
®
. The mixture was diluted with DCM (20 mL), washed with saturated aq. sodium 
carbonate solution (2 x 10 mL), and the aqueous layer extracted with DCM (20 mL). The 
combined organic extracts were washed with brine (25 mL), dried (MgSO4), filtered and 
concentrated in vacuo. The residue was purified by The residue was purified by flash column 
chromatography (petrol:ethyl acetate, 7:1) to afford 3-O-benzyl-4,6-O-benzylidene-2-O-(2-
iodoethyl)ether-α/β-D-glucopyranosyl-(1→3)-methyl-2-O-benzyl-4,6-di-O-benzylidene-α-D-
mannopyranoside 2.50 (0.110, 83%) as a colourless oil; δH (400 MHz, CDCl3) [1:1 mixture of 
α:β anomers observed]: 2.86-3.09 (4H, m, -OCH2CH2I α, -OCH2CH2I β) 3.35, 3.37 (6H, 2 x  s, -
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OMe α, -OMe β), 3.42-3.99 (20H, m, H-2a α, H-2a α, H-2a β, H-3a α, H-3a β, H-4a α, H-4a β, H-6a 
α, H-6a β, H-2b α, H-2b β, H-3b α, H-3b β, H-4b α, H-4b β, H-5b α, H-5b β), 4.09-4.39 (8H, m, -
OCH2CH2I α, OCH2CH2I β, H-6b α, H-6b β, H-6’b α, H-6’b β), 4.59 (1H, d, J1,2 8 Hz, H-1a β),  
4.71-4.93 (10H, m, H-1b α, H-1b β, PhCH2a α, PhCH2a β, PhCH2b α, PhCH2b β), 5.38 (1H, d, J1,2 
3.5 Hz, H-1a α), 5.43, 5.47 (2H, 2 x s, CHPhb α, CHPhb β), 5.61, 5.63 (2H, 2 x s, CHPha α, 
CHPha β)  7.18-7.47 (40H, m, 20 x Ar-CH α, 20 x Ar-CH β); δC (100 MHz, CDCl3): 2.8, 3.1 
(OCH2CH2I α, OCH2CH2I β), 54.8, 54.9 (2 x  q, -OCH3 α, -OCH3 β), 68.7, 68.8, 68.9, 69.0 (4 x  
t, C-6a α, C-6a β, C-6b α, C-6b β), 70.8, 70.8 (2 x t, -OCH2CH2I α, -OCH2CH2I β), 73.2, 73.3, 
74.8, 75.0 (4 x t, CH2Pha α, CH2Pha β, CH2Phb α, CH2Phb β), 63.1, 63.9, 64.2, 66.1, 73.9, 76.6, 
77.7, 77.8, 79.4, 80.3, 80.8, 81.4, 81.7, 81.7, 82.4, 82.4 (16 x d, C-2a α, C-3a α, C-4a α, C-5a α, C-
2a β, C-3a β, C-4a β, C-5a β, C-2b α, C-3b α, C-4b α, C-5b α, C-2b β, C-3b β, C-4b β, C-5b β), 98.3 
(d, C-1a α), 102.3 (d, C-1b β), 99.8, 100.4, 101.0, 101.3, 101.7, 102.6 (6 x d, C-1b α, C-1b β, 
CHPha α, CHPha β, CHPhb α, CHPhb β), 126.0–129.3 (24 x d, Ar-CH α, Ar-CH β), 137.4–138.6 
(8 x s, Ar-C); HRMS (ES
+
) Calculated for C34H43O11INa (MNa
+
) 777.1742, found 777.1752.  
3-O-Benzyl-4,6-O-benzylidene-2-O-(2-(phenylselenyl)ethyl)-α/β-D-glucopyranose[16] 2.35 
O
O
I
OHBnO
2.34 2.35
O
O
SePh
OHBnOPhSeH, NaH
O
O
O
O
Ph Ph
THF, ref lux, 16 h
(66%)
 
Selenophenol (0.120 mL, 1.15 mmol) was added to a stirred suspension of sodium hydride 
(0.018 g, 0.750 mmol) in THF (5 mL). After 30 min, 3-O-benzyl-4,6-O-benzylidene-2-O-(2-
iodoethyl)-α/β-D-glucopyranose 2.34 (0.300 g, 0.590 mmol) was added as a solution in THF (5 
ml) and the reaction was then heated to reflux. After 16 h, t.l.c (toluene:ethyl acetate, 2:1) 
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indicated the formation of a single major product (Rf 0.65) and the complete consumption of 
starting material (Rf 0.60). The reaction was diluted with DCM (20 mL) and washed with water 
(20 mL). The aqueous layer was then extracted with DCM (2 x 20 mL) and the combined 
organic extracts were washed with saturated aq. sodium bicarbonate solution (20 mL) and brine 
(20 mL). The organic phase was dried (MgSO4), filtered, and concentrated in vacuo. The residue 
was purified by flash column chromatography (petrol:ethyl acetate, 4:1) to afford 3-O-benzyl-
4,6-O-benzylidene-2-O-(2-(phenylselenyl)ethyl)-α/β-D-glucopyranose 2.35 (0.210 g, 66%) as a 
white crystalline solid; m. p. 128 – 130 °C (petrol/ethyl acetate); δH (400 MHz, CDCl3) [1.4:1 
mixture of α:β anomers observed]: 3.05-3.08 (4H, m, OCH2CH2SePh α, OCH2CH2SePh β), 3.22 
(1H, at, J 5.0 Hz, H-2 β), 3.39-3.44 (3H, m, H-2 α, H-3 α, H-3 β), 3.49-3.97 (8H, m, H-4 α, H-4 
β, H-5 α, H-5 β, H-6’ α, H-6’ β), 4.02-4.20 (4H, m, OCH2CH2SePh α, OCH2CH2SePh β), 4.29-
4.36 (2H, m, H-6 α, H-6 β), 4.74-4.92 (5H, m, PhCH2 α, PhCH2 β, H-1 β), 4.26 (1H, d, J1,2 3.3 
Hz, H-1 α), 7.26-7.49 (30H, m, 15 x Ar-CH α, 15 x Ar-CH β); δC (100 MHz, CDCl3): 27.4, 27.9 
(2 x t, OCH2CH2SePh α, OCH2CH2SePh β), 62.5, 66.4 (2 x d, C-5 α, C-5 β), 68.7, 69.0 (2 x t, C-
6 α, C-6 β), 71.2, 72.4 (2 x t, OCH2CH2SePh α, OCH2CH2SePh β), 75.0, 75.1 (2 x t, CH2Ph α, 
CH2Ph β), 78.1, 80.5, 80.7, 81.5, 81.8, 83.8 (6 x d, C-2 α, C-2 β, C-3 α, C-3 β, C-4 α, C-4 β), 
91.9 (d, C-1 β), 97.5 (d, C-1 α), 101.2, 101.3 (2 x d, CHPh α, CHPh β), 126.0–132.8 (24 x Ar-C); 
HRMS (ES
+
) Calculated for C28H30O6SeNa (MNa
+
) 565.1099, found 565.1105.  
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3-(O-Benzyl-4,6-O-benzylidene-2-O-(2-(phenylselenyl)ethyl)-α/β-D-glucopyranosyl) 
trichloroacetimidate
[17]
 2.16 
O
O
SePh
OHBnO
2.35 2.16
O
O
SePh
OBnO CCl3
NHO
O
O
O
Ph Ph
Cl3CCN, DBU
CH2Cl2, 0 °C, 8 h
(92%)
 
3-O-benzyl-4,6-O-benzylidene-2-O-(2-(phenylselenyl)ethyl)-α/β-D-glucopyranose 2.35 (0.060 g, 
0.111 mmol) was dissolved in distilled DCM (2.5 mL) under a nitrogen atmosphere. The 
solution was cooled to 0 °C, and to it were added DBU (0.005 mL, 0.044 mmol) followed by 
trichloroacetonitrile (0.143 mL, 1.11 mmol). After 8 h, t.l.c. (petrol:ethyl acetate, 3:1, with 1% 
TEA) indicated the formation of a major product (Rf 0.5) and the complete consumption of 
starting material (Rf 0.2). The reaction was warmed to rt and concentrated in vacuo. The residue 
was purified by flash chromatography (petrol:ethyl acetate, 8:1, with 1% TEA) to afford 3-(O-
benzyl-4,6-O-benzylidene-2-O-(2-(phenylselenyl)ethyl)-α/β-D-glucopyranosyl) 
trichloroacetimidate 2.16 (0.072 g, 92%) as colorless oil; νmax (KBr) 3350 (w, N-H), 1673 (s, 
C=N) cm
−1
; δH (400 MHz, CDCl3) [1.6:1 mixture of α:β anomers observed]: 2.99-3.04 (5H, m, -
OCH2CH2SePh α, OCH2CH2SePh β, H-5 α/β), 3.49-3.79 (7H, m, H-2 α, H-2 β, H-3 α, H-3 β, H-
4 α, H-4 β, H-5 α/β), 3.84–3.92 (2H, m, OCH2CH2SePh α/β), 3.94–4.08 (4H, m, OCH2CH2SePh 
α/β, H6’ α, H-6’ β), 4.33 (1H, dd, J6,6’ 10.4 Hz, J6,5 5.4 Hz, H-6 α), 4.38 (1H, dd, J6,6’ 10.4 Hz, 
J6,5 5.4 Hz, H-6 β), 4.79-4.93 (4H, m, CH2Ph α, CH2Ph β), 5.56 (1H, s, CHPh β), 5.58 (1H, s, 
CHPh α), 5.80 (1H, d, J1,2 7.8 Hz, H-1 β), 6.48 (1H, d, J1,2 4.0 Hz, H-1 α), 7.26–7.51 (30 H, m, 
15 x Ar-CH α, 15 x Ar-CH β), 8.57 (1H, s, NH α), 8.69 (1H, s, NH β); δC (100 MHz, CDCl3): 
26.7, 26.9 (2 x t, -OCH2CH2SePh α, -OCH2CH2SePh β), 65.1, 66.6 (2 x d, C-6 α, C-6 β), 68.6, 
68.7 (2 x t, -OCH2CH2SePh α, -OCH2CH2SePh β), 71.2, 72.8 (2 x d, C-5 α, C-5 β), 75.0, 75.2 (2 
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x t, -CH2Ph α, -CH2Ph β), 77.3, 77.7, 79.7, 80.6, 80.8, 81.0 (6 x d, C-2 α, C-2 β, C-3 α, C-3 β, C-
4 α,  C-4 β), 81.1, 81.3 (2 x s, CCl3 α, CCl3 β), 94.5 (d, C-1 β), 98.0 (d, C-1 α), 101.3, 101.3 (2 x 
d, -CHPh α, -CHPh β), 125.9–138.4 (24 C, 12 x Ar-CH α, 12 x Ar-CH β), 161.0, 161.2  (2 x s, 
C=NH α, C=NH β); HRMS (ES+) calculated for C30H30O6NCl3SeNa (MNa
+
) 708.0186, found 
708.0198. 
 
3-O-Benzyl-4,6-O-benzylidene-2-O-(2-(phenylselenyl)ethyl)-α/β-D-glucopyranosyl-(1→6)-
1:2,3:4-di-O-isopropylidene-D-galactopyranose
[18]
 2.52 
O
BnO
O
SePh
O CCl3
NH
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+
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O
PhSe O
O
O
O
O
O
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O
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a
b
4 A° M S, TMSOTf
CH2Cl2, -78 °C, 7h
(93%)
 
A solution of 3-(O-benzyl-4,6-O-benzylidene-2-O-(2-(phenylselenyl)ethyl)-α/β-D-
glucopyranosyl) trichloroacetimidate 2.16 (0.060 g, 0.086 mmol) and 1,2:3,4–di–O–
isopropylidene–α–D–galactopyranose 2.42 (0.045, 0.172) in freshly distilled DCM (1 mL) was 
added to a flame-dried round-bottom flask containing activated 4 Å molecular sieves (0.100 g). 
The mixture was cooled to -78 °C under a nitrogen atmosphere, then TMSOTf (1.5 μL, 0.008 
mmol) was added. After 7 h, t.l.c. (petrol:ethyl acetate, 3:1) showed formation of a major product 
(Rf 0.45) and the complete consumption of trichloroacetimidate starting material (Rf 0.50). The 
reaction was quenched with saturated aq. sodium bicarbonate solution (2 mL) and filtered 
through Celite
®
. The mixture was diluted with DCM (20 mL), washed with saturated aq. sodium 
bicarbonate solution (2 x 10 mL), and the aqueous layer extracted with DCM (20 mL). The 
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combined organic extracts were washed with brine (25 mL), dried (MgSO4), filtered and 
concentrated in vacuo. The residue was purified by flash column chromatography (petrol:ethyl 
acetate, 5:1) to afford 3-O-benzyl-4,6-O-benzylidene-2-O-(2-(phenylselenyl)ethyl)-α/β-D-
glucopyranosyl-(1→6)-1:2,3:4-di-O-isopropylidene-D-galactopyranoside 2.52 (0.065 g, 93%) as 
a colorless oil; δH (400 MHz, CDCl3) [1:3 mixture of α:β anomers observed]: 1.34 (12H, m, 2 x 
CH3 α, 2 x CH3 β), 1.46, 1.47, 1.53, 1.55 (12H, 4 x s, 2 x CH3 α, 2 x CH3 β), 3.06-3.18 (5H, m, 
OCH2CH2SePh α, OCH2CH2SePh β, H-5b α), 3.40 (1H, m, H-5b β), 3.53 (1H, m, H-5a α), 3.49 
(1H, dd, J6,6’ 8.2 Hz, J5,6 3.2 Hz  H-6b α), 3.58-3.82 (8H, m, H-2a α, H-2a β, H-5a β, H-2b α, H-4b 
α, H-4b β, H-5b α, H-5b β), 3.84-4.13 (7H, m, H-2a α, H-2a β, H-3a α, H-3a β, H-4a α, H-4b β, H-6b 
β), 4.16-4.24 (4H, m, OCH2CH2SePh α/β, H-6a α/β H-6’a α, H-6’a β), 4.33-4.47 (3H, m, 
OCH2CH2SePh α/β, H-6a α/β), 4.48 (1H, d, J1,2 8 Hz, H-1a β),  4.61 (2H, m, H-6’b α, H-6’b), 
4.80-4.88 (4H, m, CH2Ph α, CH2Ph β), 5.02 (1H, d, J1,2 3.5 Hz, H-1a α), 5.53 (4H, s, CHPh α, 
CHPh β, H-1b α, H-1b β), 7.27-7.50 (30H, m, 15 x Ar-CH α, 15 x Ar-CH β); δC (100 MHz, 
CDCl3): 24.4, 24.6 (OCH2CH2SePh α, OCH2CH2SePh β), 24.9, 25.0, 25.9, 26.0, 26.1, 26.2, 27.0, 
27.1 (4 x q, CH3 α, 4 x q, CH3 β), 62.5, 62.5 (2 x t, C-6a α, C-6a β), 65.8, 66.0 (2 x t, C-6b α, C-6b 
β), 66.9, 67.3 (2 x t, OCH2CH2SePh α, OCH2CH2SePh β), 68.9, 69.0 (2 x t, ArCH2 α, ArCH2 β), 
70.2, 70.4, 70.6, 70.7, 70.8, 70.9, 71.3, 72.4, 75.0, 75.1, 78.2, 80.5, 80.6, 81.3, 82.0, 82.4 (16 x d, 
C-2a α, C-3a α, C-4a α, C-5a α, C-2a β, C-3a β, C-4a β, C-5a β, C-2b α, C-3b α, C-4b α, C-5b α, C-2b 
β, C-3b β, C-4b β, C-5b β), 96.3 (d, C-1a β), 98.0 (d, C-1a α), 101.1 (d, C-1b α), 101.2 (d, C-1b β), 
104.6, 104.6 (d, CHPh α, CHPh β), 108.6, 108.6, 109.2, 109.4 (4 x s, C(CH3)2 x 2 α, C(CH3)2 x 2 
β), 126.0, 126.5, 126.6,126.9, 127.2, 127.3 127.6, 127.7, 127.8, 127.9, 128.1, 128.2, 128.3, 
128.4, 129.0, 129.1, 129.2, 130.4 (18 x d, Ar-CH), 132.2, 132.6, 137.3, 137.4, 138.3, 138.6 (6 x 
s, Ar-C); HRMS (ES
+
) Calculated for C40H48O11SeNa (MNa
+
) 807.2254, found 807.2258).  
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(p-Methoxyphenyl)-2-O-allyl-3-O-benzyl-4,6-diacetyl-β-D-glucopyranoside[19] 2.37 
2.29
O
OPMPBnO
O
AcOH/H2O
O
OPMP
HO
HO
BnO
O
O
OPMP
AcO
AcO
BnO
O
Ac2O/Pyridine-DMAP
2.37
O
O
Ph
60 °C, 48 h rt, 16 h
2.36
(91 %in two steps)
 
Acetic acid (aq. 80%, 6 mL) was added to a solution of 2.29 (100 mg, 0.200 mmol) in DCM (1 
mL). The mixture was then stirred at 60 °C. After 48 h, t.l.c. (petrol:ethyl acetate, 3:1) indicated 
the formation of a major product (Rf 0.1) and the complete consumption of starting material (Rf 
0.8). The mixture was diluted with DCM (10 mL) and carecompletely washed with saturated aq. 
NaHCO3 (2 x 15 mL), dried (MgSO4), filtered and concentrated in vacuo. The residue (2.36) was 
dissolved in the mixture of Ac2O:pyridine (1:1, 5 mL) and DMAP (0.005 g, 0.040 mmol) was 
added. The mixture was then stirred at rt. After 16 h, t.l.c. (petrol:ethyl acetate, 3:1) indicated the 
formation of a major product (Rf 0.3) and the complete consumption of starting material (Rf 0.1). 
The mixture was then repeatedly co-evaporated with toluene (4 x 25 mL). The residue was 
purified by flash column chromatography (petrol:ethyl acetate, 4:1) to afford (p-
methoxyphenyl)-2-O-allyl-3-O-benzyl-4,6-diacetyl-β-D-glucopyranoside 2.37 (0.091 g, 91%) as 
a white crystalline solid; m. p. 63 – 65 °C (petrol/ethyl acetate); [α]D
20
 - 62.8  (c, 1.0 in CHCl3); 
δH (400 MHz, CDCl3): 1.93, 2.06 (2 x s, 6H, 2 x COCH3) 3.82 (m, 3H, H-2, H-4, H-5), 3.78 (3H, 
s, -OCH3), 4.07-4.11 (1H, dd, J6,6’ 9.2 Hz, J6,5 3.8 Hz, H-6), 4.21-4.25 (1H, dd, J6’,6 9.2 Hz, J6’,5 
3.8 Hz, H-6’), 4.29-4.33 (1H, dd, Jgem 9.2 Hz, Jvic 3.8 Hz, -OCHH’CH=CH2), 4.47 – 4.51 (1H, 
dd, Jgem 9.2 Hz, Jvic 3.8 Hz, -OCHH’CH=CH2), 4.67, 4.87 (2H, ABq, JAB 11.2 Hz, CH2Ph), 4.81 
(1H, d, J1,2  11.2 Hz, H-1), 5.05 (1H, at, J 8 Hz, H-3), 5.19 (1H, d, Jz 10 Hz, -OCH2CH=HEHZ), 
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5.86 (1H, d, JE 16 Hz, -OCH2CH=HEHZ) 6.01 (1H, m, -OCH2CH=CH2), 6.79-7.52 (9H, m,  
Aromatic – H);  δC (100 MHz, CDCl3): 20.7, 20.7 (2 x q, 2 x COCH3) 55.6 (q, -OMe), 62.5 (t, C-
6), 69.6 (d, C-3), 73.8 (t, -OCH2CH=CH2) 75.2 (t, CH2Ph) 72.0, 81.3, 81.4 (3 x d, C-2, C-4, C-
5), 102.8 (d, H-1), 114.5 (t, -OCH2CH=CH2), 117.3-128.4 (5 x d, ArC-H), 134.7 (-
OCH2CH=CH2), 138.2, 151.3, 155.5 (3 x s, Ar-C), 169.5, 170.7 (2 x s, 2 x COCH3); HRMS 
(ES
+
) calculated for C27H32O9Na (MNa
+
) 523.1938, found 523.1945.     
3-O-Benzyl-4,6-diacetyl-2-O-(2-iodoethyl)-α/β-D-glucopyranose[11] 2.39 
O
OPMPAcOBnO
O
2.37
AcO
OAcO
BnO
O
OH
AcO
OH
2.38
1) O3, CH2Cl2, -78
oC
2) NaBH3CN, CH2Cl2, AcOH
OAcO
BnO
O
I
AcO
OH
2.39
I2, PPh3, imidazole
THF, reflux, 16 h
(20% over 3 steps)
 
2.37 (5.00 g, 10.00 mmol) was dissolved in DCM (150 mL) under N2 and cooled to -78 °C. 
Ozone was then bubbled through the solution until it turned a deep blue. The excess ozone was 
then removed by bubbling N2 through the solution until the colour had dissipated. Dimethyl 
sulfide (3.7 mL, 50 mmol) was then added, and the solution was then allowed to warm to room 
temperature over an hour. The reaction was then concentrated under vacuum to remove the 
excess dimethyl sulfide before re-dissolving in DCM (150 mL) and acetic acid (4.0 mL, 66.0 
mmol). The solution was then cooled to 0 °C and sodium cyanoborohydride (1.51 g, 24 mmol) 
was added portionwise before the reaction was left to stir. After 16h, t.l.c. (petrol:ethyl acetate, 
1:4) showed formation of a major product (Rf 0.2), complete disappearance of starting material 
(Rf 0.95). The reaction was then quenched by the addition of H2O (25 mL). Brine (100 mL) was 
then added and the organic layer separated before the aqueous layer was extracted with DCM (2 
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x 100 mL). The combined organic layers were then dried (MgSO4), filtered and concentrated in 
vacuo and purified by flash column chromatography (petrol:ethyl acetate, 1:4) to afford 3-O-
benzyl-4,6-diacetyl-2-O-(2-hydroxyethyl)-α/β-D-glucopyranose 2.38 (2.00 g) as a colorless oil.  
The residue (2.38) was dissolved in THF (100 mL) under a nitrogen atmosphere. I2 (1.92 g, 7.55 
mmol), imidazole (0.514 g, 7.55 mmol) and PPh3 (1.98 g, 7.55 mmol) were added and the 
mixture was heated to reflux. After 16 h, t.l.c. (petrol:ethyl acetate, 2:1) indicated the formation 
of a major product (Rf 0.3) and the complete consumption of starting material (Rf 0.0). The 
reaction was cooled to rt and concentrated in vacuo. The residue was purified by flash 
chromatography (petrol:ethyl acetate, 5:2) to afford 3-O-benzyl-4,6-diacetyl-2-O-(2-
iodoethyl)ether-α/β-D-glucopyranose 2.39 (1.00 g, 20%) as colorless oil; νmax (KBr) 1744 (s, 
C=O); δH (400 MHz, CDCl3) [1:1 mixture of α:β anomers observed]: 1.92, 1.93, 2.06, 2.07 (12 
H, 4 x s, 2 x COCH3 α, 2 x COCH3 β), 3.03 (2H, bs, -OH α, -OH β), 3.22–3.30 (6H, m, -OH β, -
OCH2CH2I α, OCH2CH2I β, H-2 α/β), 3.52-3.62 (3H, m, H-2 α/β, H-3 α, H-3 β), 3.87-4.22 (10H, 
m, H-6 α, H-6 β, H-6’ α, H-6’ β, -OCH2CH2I α, -OCH2CH2I β, H-4 α, H-4 β), 3.82-4.17 (5H, m, 
-OCHH’CH2I β, -OCHH’CH2I α, -OCHH’CH2I β, H-6’ α, H-6’ β), 4.63-4.88 (5H, m, CH2Ph α, 
CH2Ph β, H-1 β), 4.98-5.03 (2H, m, H-5 α, H-5 β), 5.37 (1H, d, J1,2 2.8 Hz, H-1 α), 7.25-7.35 (10 
H, m, 5 x Ar-CH α, 5 x  Ar-CH β); δC (100 MHz, CDCl3): 2.9, 3.3 (2 x t, -OCH2CH2I α, -
OCH2CH2I β), 20.7, 20.7, 20.7, 20.7 (4 x q, 2 x COCH3 α, 2 x COCH3 β), 62.2, 62.4 (2 x t, C-6 
α, C-6 β), 68.0, 68.0 (2 x d, C-2 α, C-2 β), 69.5, 69.6 (2 x t, -OCH2CH2I α, -OCH2CH2I β), 75.4, 
75.7 (2 x t, -CH2Ph α, -CH2Ph β), 72.1, 73.1, 78.6, 80.7, 81.3, 83.4 (6 x d, C-3 α, C-3 β, C-4 α, 
C-4 β, C-5 α, C-5 β), 91.2 (d, C-1 β), 97.4 (d, C-1 α), 127.7-128.4 (6 x d, 3 x Ar-CH α, 3 x Ar-
CH β), 138.1, 138.1 (Ar-C α, Ar-C β), 169.6-171.4 (4C, 2 x CH3CO α, 2 x CH3CO β); HRMS 
(ES
+
) calculated for C19H25O8NaI (MNa
+
) 531.0486, found 531.0494. 
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3-(O-Benzyl-4,6-acetyl-2-O-(2-iodoethyl) -α/β-D-glucopyranosyl) trichloroacetimidate[12] 
2.17 
OAcO
BnO
O
I
AcO
OH
2.39
Cl3CCN, DBU
DCM, 0 °C, 8 h
OAcO
BnO
O
I
AcO
O
2.17
CCl3
NH
(89%)
 
2.39 (0.144 g, 0.283 mmol) was dissolved in distilled DCM (3 mL) under a nitrogen atmosphere 
and cooled to 0 °C.  DBU (0.017 mL, 0.112 mmol), and trichloroacetonitrile (0.284 mL, 2.83 
mmol), were added, and the mixture was then allowed to stir. After 8 h, t.l.c. (petrol:ethyl 
acetate, 2:1, with 1% TEA) indicated the formation of a major product (Rf 0.5), and the complete 
consumption of starting material (Rf 0.1). The reaction was cooled to rt and concentrated in 
vacuo. The residue was purified by flash chromatography (petrol:ethyl acetate, 3:1, with 1% 
TEA) to afford 3-(O-benzyl-4,6-acetyl-2-O-(2-iodoethyl)ether-α/β-D-glucopyranosyl) 
trichloroacetimidate 2.17 (0.164 g, 89%) as colorless oil; νmax (KBr) 1740 (s, C=O), 1672 (s, 
C=N) cm
−1
; δH (400 MHz, CDCl3) [2:1 mixture of α:β anomers observed]: 1.93, 1.95, 2.05 (12 
H, 2 x s, 2 x COCH3 α, 2 x COCH3 β), 3.18 (4H, m, -OCH2CH2I α, OCH2CH2I β), 3.62–4.25 
(14H, m, -OCH2CH2I α, OCH2CH2I β, H-5 α, H-5 β, H-3 α, H-3 β, H-6 α, H-6 β, H-6’ α, H-6’ β, 
H-4 α, H-4 β) 4.67, 4.90 (4H, ABq, JAB 11.6 Hz, CH2Ph α, CH2Ph β), 5.08 (2H, m, H-2 α, H-2 
β), 5.73 (1H, d, J1,2 8 Hz, H-1 β), 6.53 (1H, d, J1,2 3.2 Hz, H-1 α), 7.25-7.35 (10 H, m, 5 x Ar-CH 
α, 5 x  Ar-CH β), 8.62, 8.71 (N-H α, N-H β); δC (100 MHz, CDCl3): 2.1, 2.2 (2 x t, -OCH2CH2I 
α, -OCH2CH2I β), 20.6, 20.6, 20.7, 20.7 (4 x q, 2 x COCH3 α, 2 x COCH3 β), 61.8, 61.9 (2 x t, C-
6 α, C-6 β), 68.8, 69.3 (2 x d, C-2 α, C-2 β), 70.5, 71.8 (2 x t, -CH2Ph α, -CH2Ph β), 72.8, 73.3 (2 
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x t, -OCH2CH2I α, -OCH2CH2I β), 70.5, 71.8, 75.3, 77.3, 77.9, 79.9 (6 x d, C-3 α, C-3 β, C-4 α, 
C-4 β, C-5 α, C-5 β), 81.0, 81.3 (2 x s, CCl3 α, CCl3 β) 93.7 (d, C-1 β), 97.6 (d, C-1 α), 127.7, 
127.8, 127.9, 128.0, 128.3, 128.4 (6 C, 3 x Ar-CH α, 3 x Ar-CH β), 138.1, 138.1 (Ar-C α, Ar-C 
β), 160.8, 160.9 (2 x s, C=NH α, C=NH β), 169.5, 169.5, 170.6, 170.6 (4 x s, 4C, 2 x CH3CO α, 
2 x CH3CO β); HRMS (ES
+
) calculated for C21H25NO8Cl3INa (MNa
+
) 673.9582, found 
673.9589. 
3-O-benzyl-4,6-diacetyl-2-O-(2-iodoethyl)-α/β-D-glucopyranosyl-(1→6)-1:2,3:4-di-O-
isopropylidene-D-galactopyranoside
[14]
 2.51 
O
BnO
O
I
O CCl3
NH
2.17
+
O
OO
O
O
OH
2.42
O
BnO
O
I O
O
O
O
O
O
2.51
AcO
AcO
AcO
AcO a
b
4 A° M S, TMSOTf
DCM, -78 °C, 7 h
(81%)
 
A solution of 3-(O-benzyl-4,6-diacetyl-2-O-(2-iodoethyl)-α/β-D-glucopyranosyl) 
trichloroacetimidate 2.17 (0.140 g, 0.215 mmol) and 1,2:3,4–di–O–isopropylidene–α–D–
galactopyranose 2.42 (0.112 g, 0.430 mmol) in freshly distilled DCM (2 mL) was added to a 
flame-dried round-bottom flask containing activated 4Å molecular sieves (0.100 g). The mixture 
was cooled to -78 °C under a nitrogen atmosphere, then TMSOTf (4.5 μL, 0.022 mmol) was 
added. After 7 h, t.l.c. (toluene:ethyl acetate, 3:1) showed formation of a major product (Rf 0.6) 
and the complete consumption of the trichloroacetimidate starting material (Rf 0.7). The reaction 
was quenched with saturated aq. sodium bicarbonate solution (2 mL) and filtered through 
Celite
®
. The mixture was diluted with DCM (20 mL), washed with saturated aq. sodium 
bicarbonate solution (2 x 10 mL), and the aqueous layer extracted with DCM (20 mL). The 
     Chapter 5                                                                                                                       Experimental 
                                                                                                                                                                                                                                                     
187 
 
combined organic extracts were washed with brine (25 mL), dried (MgSO4), filtered and 
concentrated in vacuo. The residue was purified by flash column chromatography (toluene:ethyl 
acetate, 6:1) to afford 3-O-benzyl-4,6-diacetyl-2-O-(2-iodoethyl)-α/β-D-glucopyranosyl-(1→6)-
1:2,3:4-di-O-isopropylidene-D-galactopyranoside 2.51 (0.130 g, 81%) as a colourless oil; δH (400 
MHz, DMSO-D6) [1:2 mixture of α:β anomers observed]: 1.25-1.44 (24H, m, 4 x CH3α, 4 x 
CH3β), 1.91-1.96 (12H, m, 2 x COCH3 α, 2 x COCH3 β), 3.20-3.29 (5H, m, OCH2CH2I α, 
OCH2CH2I β, H-5b α/β), 3.49-3.94 (14H, m, H-2a α, H-2a β, H-3a α, H-3a β, H-4a α, H-4a β, H-3b 
α, H-3b β,  H-5b α/β, H-6b α, H-6b β, H-6’b α, H-6’b β, -OCHH’CH2I α/β), 4.03-4.09 (3H, m, -
OCHH’CH2I α, -OCHH’CH2I β, -OCHH’CH2I α/β), 4.20-4.33 (4H, m, H-5a α, H-5a β, H-4b α, 
H-4b β), 4.33-4.47 (4H, m, H-6a α, H-6a β, H-6’a α, H-6’a β), 4.51 (1H, d, J1,2 8 Hz, H-1a β),  
4.55-4.82 (6H, m, CH2Ph α, CH2Ph β, H-2b α, H-2b β), 5.01 (1H, d, J1,2 3.5 Hz, H-1a α), 5.43 
(2H, d, J1,2 4.8 Hz, H-1b α, H-1b β), 7.25-7.33 (10H, m, 5 x Ar-CH α, 5 x Ar-CH β); δC (100 
MHz, DMSO-D6): 5.7, 5.8 (2 x t, OCH2CH2I α, OCH2CH2I β), 20.9, 20.9, 21.0, 21.0 (4 x q, 2 x 
COCH3 α, 2 x COCH3 β), 24.6, 24.7, 24.8, 25.1, 25.2, 25.3, 26.3, 26.4 (4 x q, CH3 α, 4 x q, CH3 
β), 62.4, 62.5 (2 x t, C-6b α, C-6b β), 66.2, 66.5 (2 x t, C-6a α, C-6a β), 67.3, 67.4 (2 x t, 
OCH2CH2I α, OCH2CH2I β), 69.7, 69.8 (2 x t, ArCH2 α, ArCH2 β), 70.1, 70.2, 70.3, 70.4, 70.5, 
70.6, 70.8, 70.9, 71.0, 72.8, 74.6, 74.8, 78.5, 79.8, 80.9, 82.1 (16 x d, C-2a α, C-3a α, C-4a α, C-5a 
α, C-2a β, C-3a β, C-4a β, C-5a β, C-2b α, C-3b α, C-4b α, C-5b α, C-2b β, C-3b β, C-4b β, C-5b β), 
96.1, 96.1 (2 X d, C-1b α, C-1b β)  96.6 (d, C-1a β), 98.0 (d, C-1a α), 108.2, 108.3, 108.7, 108.8 (4 
x s, C(CH3)2 x 2 α, C(CH3)2 x 2 β), 127.8, 127.9, 128.1, 128.2, 128.5, 128.6 (6 x d, Ar-CH), 
138.9, 139.0 (2 x s, Ar-C), 169.8, 169.8, 170.5, 170.5 (4 x s, 4C, 2 x CH3CO α, 2 x CH3CO β); 
HRMS (ES+) Calculated for C34H43O11INa (MNa+) 777.1742, found 777.1752).   
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3-O-Benzyl-4,6-diacetyl-2-O-(2-(phenylselenyl)ethyl)-α/β-D-glucopyranose[16] 2.40 
O
O
I
OHBnO
2.39 2.40
O
O
SePh
OHBnOPhSeH, NaH
THF, reflux, 16 h
AcO
AcO
AcO
AcO
(75%)
 
Selenophenol (0.140 mL, 1.30 mmol) was added to a stirred suspension of sodium hydride 
(0.016 g, 0.650 mmol) in THF (5 mL). After 30 min, 3-O-benzyl-4,6-diacetyl-2-O-(2-iodoethyl)-
α/β-D-glucopyranose 2.39 (0.240 g, 0.470 mmol) was added as a solution in THF (5 ml) and the 
reaction was then heated to reflux. After 16 h, t.l.c (toluene:ethyl acetate, 2:1) indicated the 
formation of a single major product (Rf 0.55) and the complete consumption of starting material 
(Rf 0.50). The reaction was cooled and diluted with DCM (20 mL) and washed with water (20 
mL). The aqueous layer was then extracted with DCM (2 x 20 mL) and the combined organic 
extracts were washed with saturated aq. sodium bicarbonate solution (20 mL) and brine (20 mL). 
The organic phase was dried (MgSO4), filtered, and concentrated in vacuo. The residue was 
purified by flash column chromatography (petrol:ethyl acetate, 4:1) to afford 3-O-benzyl-4,6-
diacetyl-2-O-(2-(phenylselenyl)ethyl)-α/β-D-glucopyranose 2.40 (0.190 g, 75%) as colorless oil; 
(KBr) 1740 (s, C=O), 1672 (s, C=N) cm
−1
;
 δH (400 MHz, CDCl3) [1:1 mixture of α:β anomers 
observed]: 1.90-2.09 (12 H, m, 2 x COCH3 α, 2 x COCH3 β), 3.03-3.08 (4H, m, OCH2CH2SePh 
α, OCH2CH2SePh β), 3.14 (1H, bs, -OH α/-OH β) 3.26 (1H, at, J 5.0 Hz, H-2 β), 3.46-3.58 (3H, 
m, H-2 α, H-3 α, H-3 β), 3.48-3.58 (4H, m, H-4 α, H-4 β, H-5 α, H-5 β), 3.80-4.23 (12H, m, 
OCH2CH2SePh α, OCH2CH2SePh β, , H-6’ α, H-6’ β, H-6 α, H-6 β), 4.60-4.85 (4H, m, PhCH2 α, 
PhCH2 β), 4.97 (1H, at, J  9.2 Hz, H-1 β), 5.29 (1H, d, J1,2 3.3 Hz, H-1 α), 7.26-7.49 (20H, m, 10 
x Ar-CH α, 10 x Ar-CH β); δC (100 MHz, CDCl3): 20.7, 20.7, 20.7, 20.7 (4 x q, 2 x COCH3 α, 2 
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x COCH3 β), 27.3, 27.6 (2 x t, OCH2CH2SePh α, OCH2CH2SePh β), 62.2, 62.4 (2 x t, C-6 α, C-6 
β), 68.0, 69.4 (2 x t, C-5 α, C-5 β), 69.6, 70.7 (2 x t, OCH2CH2SePh α, OCH2CH2SePh β), 72.0, 
72.1 (2 x t, CH2Ph α, CH2Ph β), 75.2, 75.3, 78.6, 80.7, 81.4, 83.5 (6 x d, C-2 α, C-2 β, C-3 α, C-3 
β, C-4 α, C-4 β), 91.1 (d, C-1 β), 97.2 (d, C-1 α), 127.1, 127.2, 127.3, 127.5, 127.6, 127.7, 127.8, 
127.9, 128.4, 129.1, 129.2, 129.3, 132.6, 132.8, 138.2, 138.3 (16 x Ar-C), 169.5, 169.6, 170.8, 
170.8 (4C, 2 x CH3CO α, 2 x CH3CO β); HRMS (ES
+
) calculated for C25H30O8NaSe (MNa
+
) 
561.0994, found 561.0998. 
3-(O-Benzyl-4,6-diacetyl-2-O-(2-(phenylselenyl)ethyl)-α/β-D-glucopyranosyl) 
trichloroacetimidate
[17]
 2.18 
OAcO
BnO
O
SePh
AcO
OH
2.40
Cl3CCN, DBU
DCM, 0 °C, 8 h
OAcO
BnO
O
SePh
AcO
O
2.18
CCl3
NH
(74%)
 
3-O-Benzyl-4,6-diacetyl-2-O-(2-(phenylselenyl)ethyl)-α/β-D-glucopyranose 2.40 (0.190 g, 0.353 
mmol) was dissolved in distilled DCM (10 mL) under a nitrogen astmosphere. The solution was 
cooled to 0 °C, and DBU (0.018 mL, 0.118 mmol) and trichloroacetonitrile (0.354 mL, 3.53 
mmol) were added, and the kept for stirring. After 8 h, t.l.c. (petrol:ethyl acetate, 2:1, with 1% 
TEA) indicated the formation of a major product (Rf 0.7) and the complete consumption of 
starting material (Rf 0.2). The reaction was warmed to rt and concentrated in vacuo. The residue 
was purified by flash chromatography (petrol:ethyl acetate, 4:1, with 1% TEA) to afford 3-(O-
benzyl-4,6-diacetyl-2-O-(2-(phenylselenyl)ethyl)-α/β-D-glucopyranosyl) trichloroacetimidate 
2.18 (0.177 g, 74%) as colorless oil; νmax (KBr) 3319 (w, N-H), 1745 (s, C=O), 1673 (s, C=N) 
cm
−1
; δH (400 MHz, CDCl3) [50:1 mixture of α:β anomers observed, major α anomer quoted]: 
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1.95, 2.04 (6H, 2 x s, 2 x COCH3) 3.01 (2H, m, -OCH2CH2SePh), 3.67 (1H, dd, J2,3 9.6 Hz, J1,2 
3.2 Hz, H-2), 3.79-3.97 (3H, m, OCH2CH2SePh, H-3), 4.04–4.21 (3H, m, H-6, H-6’, H-4), 4.64, 
4.87 (2H, ABq, JAB 11.2 Hz, -OCH2Ph), 5.09 (1H, at, J 10 Hz, H-5), 6.51 (1H, d, J1,2 3.6 Hz, H-
1), 7.23–7.48 (10 H, m, Ar-CH), 8.60 (1H, s, NH); δC (100 MHz, CDCl3): 20.6, 20.7 (2 x q, 2 x 
COCH3), 26.9 (t, -OCH2CH2SePh), 61.8 (t, C-6), 68.7 (d, C-5), 70.4, 70.6 (2 x t, CH2Ph, -
OCH2CH2SePh), 75.2 (d, C-3), 77.9 (d, C-4), 93.07 (d, C-1), 127.1, 127.7, 127.9, 128.3, 129.1, 
129.7, 132.7, 138.2 (8 C, 12 x Ar-C), 161.0 (s, C=NH), 169.5, 170.6 (2 x s, 2 x COCH3); HRMS 
(ES
+
) calculated for C27H30O8NCl3SeNa (MNa
+
) 704.0094, found 704.0098. 
 
3-O-Benzyl-4,6-diacetyl-2-O-(2-(phenylselenyl)ethyl)-α/β-D-glucopyranosyl-(1→6)-1:2,3:4-
di-O-isopropylidene-D-galactopyranoside
[18]
 2.53 
 
O
BnO
O
SePh
O CCl3
NH
2.18
+
O
OO
O
O
OH
2.42
O
BnO
O
PhSe O
O
O
O
O
O
2.53
AcO
AcO
AcO
AcO a
b
DCM, -78 °C, 7 h
(94%)
4 A° M S, TMSOTf
 
A solution of 3-(O-benzyl-4,6-diacetyl-2-O-(2-(phenylselenyl)ethyl)-α/β-D-glucopyranosyl) 
trichloroacetimidate 2.18 (0.130 g, 0.191 mmol) and 1,2:3,4–di–O–isopropylidene–α–D–
galactopyranose 2.42 (0.100, 0.380) in freshly distilled DCM (1 mL) was added to a flame-dried 
round-bottom flask containing activated 4 Å molecular sieves (0.100 g). The mixture was cooled 
to -78 °C under a nitrogen atmosphere, then TMSOTf (1.5 μL, 0.008 mmol) was added. After 7 
h, t.l.c. (toluene:ethyl acetate, 6:1) showed formation of a major product (Rf 0.5) and the 
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complete consumption of trichloroacetimidate starting material (Rf 0.7). The reaction was 
quenched with saturated aq. sodium bicarbonate solution (2 mL) and filtered through celite
®
. The 
mixture was diluted with DCM (20 mL), washed with saturated aq. sodium bicarbonate solution 
(2 x 10 mL), and the aqueous layer extracted with DCM (20 mL). The combined organic extracts 
were washed with brine (25 mL), dried (MgSO4), filtered and concentrated in vacuo. The residue 
was purified by flash column chromatography (petrol:ethyl acetate, 5:1) to afford 3-O-benzyl-
4,6-diacetyl-2-O-(2-(phenylselenyl)ethyl)-α/β-D-glucopyranosyl-(1→6)-1:2,3:4-di-O-
isopropylidene-D-galactopyranoside 2.53 (0.140 g, 94%) as a colorless oil; δH (400 MHz, 
CD3CN) [1:4 mixture of α:β anomers observed]: 1.32-1.53 (24H, m, 4 x CH3 α, 4 x CH3 β), 1.96-
2.03 (12H, m, 2 x COCH3 α, 2 x COCH3 β), 3.10-3.14 (4H, m, OCH2CH2SePh α, 
OCH2CH2SePh β), 3.24 (2H, at, J 6.8 Hz, H-2a α, H-2a β), 3.93 (10H, m, H-5b α, H-5b β, H-6a α, 
H-6a β, H-6’a α, H-6’a β, H-6b α, H-6b β, H-6’b α, H-6’b β), 3.91-4.02 (7H, m, -OCH2CH2SePh 
α/β, H-3a α, H-3a β, H-4a α, H-4a β), 4.21-4.40 (5H, m, -OCH2CH2SePh α/β, H-5a β, H-5a β), 
4.41-4.62 (2H, m, H-2b α, H-2b β), 4.71-4.78 (2H, m, H-3b α, H-3b β), 4.45 (1H, d, J1,2 8 Hz, H-1a 
β),  4.58-4.89 (8H, m, CH2Ph α, CH2Ph β, H-4b α, H-4b β, H-5b α, H-5b β), 5.03 (1H, d, J1,2 3.5 
Hz, H-1a α), 5.49 (2H, d, J1,2 4 Hz, H-1b α, H-1b β), 7.27-7.53 (20H, m, 10 x Ar-CH α, 10 x Ar-
CH β); δC (100 MHz, CD3CN): 19.9, 19.9, 20.1, 21.1 (4 x q, 2 x COCH3 α, 2 x COCH3 β), 23.7, 
23.8 (2 x t, OCH2CH2SePh α, OCH2CH2SePh β), 24.2, 24.3, 24.4, 25.3, 25.3, 25.4, 25.4, 26.7 (8 
x q, 4 x CH3 α, 4 x CH3 β), 62.2, 62.2 (2 x t, OCH2CH2SePh α, OCH2CH2SePh β), 66.3, 66.8, 
67.3, 67.5 (4 x t, C-6a α, C-6a β, C-6b α, C-6b β), 69.4, 69.7 (2 x d, C-2b α, C-2b β), 70.3, 70.4, 
70.5, 70.6, 70.7, 70.9, 71.0, 71.3, 71.4, 71.8 (8 x d, C-3a α, C-4a α, C-5a α, C-3a β, C-4a β, C-5a β, 
C-3b α, C-4b α, C-3b β, C-4b β), 74.7, 74.9 (2 x t, ArCH2 α, ArCH2 β), 80.3, 81.2 (2 x d, C-2a α, 
C-2a β), 78.4, 82.2 (2 x d, C-5b α, C-5b β), 96.2 (d, C-1a β), 96.5 (d, C-1a α), 103.7, 103.7 (2 x d, 
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C-1b α, C-1b β), 108.4, 108.4, 108.9, 108.9 (4 x s, 2 x C(CH3)2 α, 2 x C(CH3)2 β), 126.6-131.7 
(12 x d, Ar-CH), 131.8, 131.9, 138.7, 138.9 (4 x s, Ar-C), 169.6, 169.6, 170.3, 170.3 (4C, 2 x 
CH3CO α, 2 x CH3CO β); HRMS (ES
+
) Calculated for C37H48O13SeNa (MNa
+
) 803.2150, found 
803.2168).  
2,4,6-Tri-tert-butylpyrimidine
[20] 2.46 
O
+
O
SF3C O
O
S CF3
O
O
+ CN
N
N
2.46
rt, 5 days
(68 %)
CH2Cl2
 
A solution of picoline (6.57 mL, 52 mmol) in DCM (10 mL) was slowly added to a solution 
containing Tf2O (10.1 mL, 60 mmol) and trimethylacetonitrile (12.5 mL, 110 mol) in DCM (35 
mL) at 20 °C under a nitrogen atmosphere. After stirring for 5 days, additional 
trimethylacetonitrile (2 mL, 18 mmol) was added. The mixture was stirred for a further 24 h, 
then quenched by the addition of saturated aq. sodium bicarbonate solution (10 mL), washed 
with brine (1 x 10 mL), dried (MgSO4) and concentrated in vacuum. The residue was 
recrystallized (MeOH) to give 2,4,6-tri-tert-butylpyrimidine 2.46 (9 g, 68%) as white solid; m. p. 
77 - 78 °C (MeOH) (lit. 77 - 78 °C);
[20]
 δH (400 MHz, CDCl3): δH (400 MHz, CDCl3): 1.31, 1.37 
(27H, 2 x s, 9 x CH3), 7.00 (1H, s, Ar-CH). 
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1,2:3,4–di–O–isopropylidene–α–D–galactopyranose[21] 2.42 
O
OH
HO
OH OH
Acetone, H+ O
O OH
OO
2.41
2.42
OH
Ort, 24 h
(64%)
 
2.41 (20.0 g, 112 mmol) was dissolved in acetone (500 mL), in a flame dried flask containing 4 
Å molecular sieves (c.a. 20g). Sulfuric acid (5.00 mL, 94 mmol) was added to the mixture and 
was stirred in under a nitrogen atmosphere. After 24 h, t.l.c. (petrol:ethyl acetate, 1:1) indicated 
the formation of a major product (Rf 0.4) and the complete consumption of starting material (Rf 
0). The mixture was quenched by the addition of triethylamine (10 mL) and filtered through 
Celite
®
. Mixture was diluted with ethyl acetate (5 L) and washed with saturated aq. sodium 
bicarbonate solution (5 L), followed by brine solution (5 L). The organic layer was dried 
(MgSO4), filtered and concentrated in vacuo. Purification by flash chromatography yielded  
1,2:3,4–di–O–isopropylidene–α–D–galactopyranose 2.42 (18.3 g, 64%) as colourless oil; [α]D
20
 - 
60.1 (c, 1.0 in CHCl3), (lit.
[22]
 [α]D
 20
 – 57.5 (c, 3.0 in CHCl3);  δH (500 MHz, CDCl3):
[22]
 1.32 
(6H, s, 2 x CH3), 1.46 (3H, s, CH3), 1.53 (3H, s, CH3), 3.75 (1H, t, J 7.5 Hz, H-4), 3.84–3.88 
(2H, m, H-2, H-5), 4.27 (1H, d, J 7.7 Hz, H-3), 4.33 (1H, dd, J6,6’ 4.9 Hz, J6,5 2.3 Hz, H-6), 4.61 
(1H, dd, J6’,5 7.9 Hz, J6’5 2.3 Hz, H-6’), 5.57 (1H, d, J1,2 5.1 Hz, H-1); HRMS (ES
+
) calculated 
for C12H20O6Na (MNa
+
) 261.1325, found 261.1338. 
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Methyl-2-O-benzyl-4,6-di-O-benzylidene-α-D-mannopyranoside[23] 2.44 
                                                and 
Methyl-3-O-benzyl-4,6-di-O-benzylidene-α-D-mannopyranoside[23] 2.45 
                                                 
O
OMe
2.43
DIBAL-H, Toluene
+O
OPh
H
O
O
Ph
2.44
O
OMe
HO
OBn
O
O
Ph
O
OMe
2.45
BnO
OH
O
O
Ph
-40 °C to rt, 2 h
(65 %)
(22 %)
 
Exo-dibenzylidene methylmannopyranoside 2.43 (14.8 g, 40.0 mmol) was dissolved in freshly 
distilled toluene (200 mL), and cooled at – 40 °C under a nitrogen atmosphere. Di-
isobutylaluminium hydride (100 mL, 100 mmoL of 1 M solution in toluene) was slowly added to 
the mixture and then the mixture was slowly allowed to warm to rt. After 2 h, t.l.c. (petrol:ethyl 
acetate, 3:1) indicated complete consumption of starting material (Rf 0.8) and formation of two 
products (Rf 0.4 and 0.3). Methanol was added drop wise to quench the reaction and then the 
reaction was diluted with DCM (350 mL). The organic layer was washed with Rochelle’s salt 
(300 mL of 10% solution), dried (MgSO4), filtered and concentrated in vacuo. Purification with 
flash chromatography (petrol:ethyl acetate, 4:1) yielded  methyl-2-O-benzyl-4,6-di-O-
benzylidene-α-D-mannopyranoside 2.44 (9.73 g 65%), first as white crystalline solid; m. p. 44 – 
46 °C (petrol/ethyl acetate) (lit.
[23]
 43 – 45 °C); [α]D
20
 + 3.4  (c, 1.0 in CHCl3) (lit.
[23]
 [α]D
25
 + 2.8  
(c, 0.5 in CHCl3); δH (500 MHz, CDCl3)
 [23]
: 3.31 (3H, s, OMe), 3.69 – 3.80 (3H, m, H-2, H-3, 
H-5), 3.86 (at, 1H, J  9.4 Hz, H-4), 4.05 (1H, dd, J  9.9 Hz, J 3.5 Hz, H-6), 4.23 (1H, dd, 1H, J 
9.4 Hz, J 4.0 Hz, H-6’), 4.60-4.75 (3H, m, H-1, CH2Ph), 5.57 (1H, s, CHPh), 7.26-7.50 (10H, m, 
Ar – H); HRMS (ES+) calculated for C21H25O6 (MH
+
) 373.1646, found 373.1654; 
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followed by methyl-3-O-benzyl-4,6-di-O-benzylidene-α-D-mannopyranoside 2.45 (3.25 g, 22%) 
as colorless oil; [α]D
20
 + 57.7 (c, 1.0 in CHCl3) (lit.
[23]
 [α]D
25
 + 54.0 (c, 0.5 in CHCl3); δH (500 
MHz, CDCl3):
[23]
 2.67 (1H, bs, OH), 3.39 (3H, s,  OMe), 3.79–3.93 (3H, m, H-3, H-5, H-6), 4.06 
(d, 1H, J 3 Hz, H-2), 4.10 (1H, at, J 9.2 Hz, H-4), 4.29 (dd, 1H, J6/6’ 9.5 Hz, J6’/5 4.1 Hz, H6’), 
4.78 (1H, s, H-1), 4.72, 4.86 (2H, ABq,  JAB  11.6 Hz, -OCH2Ph), 5.62 (s, 1H, PhCH), 7.27–7.53 
(m, 10H, Ar – H); HRMS (ES+) calculated for C21H25O6 (MH
+
) 373.1646, found 373.1652.    
 
5.3 Experimental for chapter 3 
3-O-Benzyl-4,6-O-benzylidene-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α/β-D-
glucopyranose
[24]
 3.15 
 
O
O
I
OHBnO
2.34
3.15
O
O
S
OHBnO
N,N-Diisopropylethylamine
DMF, rt, 16 h
O
O
O
O
Ph Ph
OMeMeO
OMe
+
SH
OMeMeO
OMe
(87%)
 
3-O-Benzyl-4,6-O-benzylidene-2-O-(2-iodoethyl)-α/β-D-glucopyranose 2.34 (300 mg, 0.59 
mmol) was dissolved in DMF (10 mL) under a nitrogen atmosphere. Hünig’s base (0.12 mL, 
0.70 mmol) and 2,4,6-trimethoxybenzenethiol (140 mg, 0.70 mmol) were added, and the mixture 
was stirred at rt. After 16 h, t.l.c. (petrol:ethyl acetate, 1:1) indicated the complete consumption 
of starting material (Rf 0.6) and the formation of product (Rf 0.4). The solution was then 
concentrated in vacuo and the residue was purified by flash chromatography (petrol:ethyl 
acetate, 3:2) to afford 3-O-benzyl-4,6-O-benzylidene-2-O-(2-(2,4,6-
     Chapter 5                                                                                                                       Experimental 
                                                                                                                                                                                                                                                     
196 
 
trimethoxybenzenethio)ethyl)-α/β-D-glucopyranose 3.15 (300 mg, 87%) as white amorphous 
solid; νmax (KBr) 3408 (br, OH) cm
−1
; δH (400 MHz, CDCl3) [1:1 mixture of α:β anomers 
observed]: 2.80-3.03 (4H, m, CH2CH2SAr α, CH2CH2SAr β), 3.25 (1H, at, J 7.90 Hz, H-5 α/β), 
3.40-3.51 (2H, m, H-2 α, H-2 β), 3.58-3.73 (9H, m, H-5 α/β, CH2CH2SAr α, CH2CH2SAr β, H-6 
α, H-6 β, H-6’ α, H-6’ β), 3.76-3.87 (18H, m, 3 x OCH3 α, 3 x OCH3 β), 3.98-4.11 (2H, m, H-4 
α, H-4 β), 4.30-4.41 (2H, m, H-3 α, H-3 β) 4.66-4.83 (4H, CH2Ph α, CH2Ph β), 4.89 (1H, d, J1,2 
11.3 Hz, H-1 β), 5.32 (1H, d, J1,2 3.5 Hz, H-1 α), 5.55 (2H, s, CHPh α, CHPh β), 6.15 (4H, s, 2 x 
SAr-CH α, 2 x SAr-CH) 7.24-7.54 (20H, m, 10 x Ar-CH α, 10 x Ar-CH β); δC (100 MHz, 
CDCl3): 34.6, 35.4 (2 x t, CH2CH2SAr α, CH2CH2SAr β) 55.4, 55.9, 56.1, 56.2 (4 x q, 2 x OMe 
α, 2 x OMe β), 62.4, 62.6 (2 x d, CHPh α, CHPh β), 69.0, 69.1 (2 x d, C-2 α, C-2 β), 69.8, 70.0 
(2 x t, C-6 α, C-6 β) 70.6, 71.2 (2 x t, CH2CH2SAr α, CH2CH2SAr β), 75.0, 75.1 (2 x d, C-4 α, C-
4 β), 76.7, 78.10 (2 x d, C-5 α, C-5 β), 80.8, 80.9 (2 x t, CH2Ph, α, CH2Ph β),  81.1, 81.6 (2 x d, 
SArC-H α, SArC-H β), 81.9, 90.6 (2 x d, C-3 α, C-3 β), 91.1 (d, C-1 α), 91.8 (d, C-1 β), 101.1, 
101.2 (2 x d, CHPh α, CHPh β), 125.0, 126.0, 127.5, 127.6, 127.8, 127.8, 127.9, 128.1, 128.2, 
128.3, 128.5, 128.6 (12 x d, 6 x ArC-H α, 6 x ArC-H β), 134.4, 135.6, 136.3, 138.7 (4 x s, 2 x 
ArC α, 2 x ArC β), 161.9 (s, SArC-OMe), 162.3 (s, SArC-OMe); HRMS (ES+) calculated for 
C48H52O11Na (MNa
+
) 607.1972, found 607.1972.  
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3-(O-Benzyl4,6-O-benzylidene-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α/β-D-
glucopyranosyl) trichloroacetimidate
[12]
 3.2 
O
O
S
OHBnO
O
O
Ph
OMeMeO
OMe
+ Cl3CCN
DBU
DCM, rt, 6h
(92%)
3.15
O
O
S
OBnO
O
O
Ph
OMeMeO
OMe
3.2
CCl3
NH
 
 
3-O-benzyl-4,6-O-benzylidene-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α/β-D-
glucopyranose 3.15 (0.15 g, 0.26 mmol) was dissolved in distilled DCM (2.5 mL) under a 
nitrogen atmosphere. The solution was cooled to 0 °C, DBU (0.012 mL, 0.104 mmol) and 
trichloroacetonitrile (0.34 mL, 2.60 mmol) were added sequentially. After 6 h, t.l.c. (petrol:ethyl 
acetate, 1:1, with 1% TEA) indicated the formation of a major product (Rf 0.6) and the complete 
consumption of starting material (Rf 0.5). The reaction was warmed to rt and concentrated in 
vacuo. The residue was purified by flash chromatography (petrol:ethyl acetate, 3:1, with 1% 
TEA) to afford 3-(O-benzyl4,6-O-benzylidene-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α/β-
D-glucopyranosyl) trichloroacetimidate 3.2 (0.20 g, 92%) as a white amorphous solid; νmax (KBr) 
3350 (w, N-H), 1679 (s, C=N) cm
−1
; δH (400 MHz, CDCl3) [4:1 mixture of α:β anomers 
observed]: 2.76-2.96 (10H, m, OCH2CH2SAr α, OCH2CH2SAr β), 3.60-3.79 (20H, m, 
OCH2CH2SAr α, OCH2CH2SAr β, H-2 α, H-2 β, H-3 α, H-3 β, H-5 α, H-5 β, H-6 α, H-6 β), 
3.79-3.92 (45H, m, 3 x OMe α, 3 x OMe β), 3.94-4.02 (5H, H-4 α, H-4 β), 4.28-4.40 (5H, m, H-
6’ α, H-6’ β), 4.76-4.91 (10H, m, CH2Ph α, CH2Ph β), 5.53-5.59 (5H, m, CHPh α, CHPh β), 5.75 
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(1H, d, J1,2 7.6 Hz, H-1 β), 6.09-6.16 (10H, m, SArC-H α, SArC-H β), 6.47 (1H, d, J1,2 3.8 Hz, 
H-1 α), 7.22-7.54 (50H, m, ArC-H α, ArC-H β), 8.53-8.63 (5H, m, N-H α, N-H β); δC (100 MHz, 
CDCl3): 33.6, 34.0 (2 x t, OCH2CH2SAr α, OCH2CH2SAr β), 55.3, 55.3, 56.1, 56.1 (4 x q, o-
OMe α, o-OMe β, p-OMe α, p-OMe β), 65.0, 66.6 (2 x d, C-2 α, C-2 β), 68.6, 68.7 (2 x t, C-6 α, 
C-6 β), 71.1, 72.0 (2 x t, CH2Ph α, CH2Ph β), 74.8, 75.1 (2 x t, OCH2CH2SAr α, OCH2CH2SAr 
β), 77.7, 79.8 (2 x d, C-4 α, C-4 β) 80.4, 80.8 (2 x d, C-5 α, C-5 β), 80.9, 81.0 (2 x s, CCl3 α, 
CCl3 β), 81.2, 81.3 (2 x d, C-3 α, C-3 β), 91.0, 91.2 (2 x d, SArC-H α, SArC-H β), 94.7 (d, C-1 
α), 98.0 (s, C-1 β), 101.0, 101.0 (2 x s, SCAr α, SCAr β), 101.2, 101.2 (2 x d, -CHPh α, -CHPh 
β), 126.0, 126.0, 127.5, 127.6, 127.7, 127.9, 128.0, 128.1, 128.2, 128.3, 128.4, 129.0 (12 x d, 6 x 
ArC-H α, 6 x ArC-H β), 137.1, 138.3, 138.6 (4 x s, 2 x ArC α, 2 x ArC β), 161.0, 161.3, 161.8, 
161.9, 162.0, 162.0 (6 x s, C=NH α, C=NH β, S-ArC-OMe o α, S-ArC-OMe o β, S-ArC-OMe p 
α, S-ArC-OMe p β); HRMS (ES+) calculated for C33H36O9NCl3SNa (MNa
+
) 750.1068, found 
750.1086. 
3-O-Benzyl4,6-O-benzylidene-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α/β-D-
glucopyranosyl-(1→6)-1:2,3:4-di-O-isopropylidene-D-galactopyranoside (Protocol B)[25] 
3.25 
O
O
S
OBnO
O
O
Ph
OMeMeO
OMe
3.2
CCl3
NH
O
O
S
OBnO
O
O
Ph
OMeMeO
OMe
O
O
O
O
O
3.25
a
b
i) TMSOTf (1 eq), (-78 °C 0 °C) / DCM
ii)
O
O
O
OH
O O
,TTBP 2.46, -78 °C / DCM
(66%)
2.42
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A mixture of donor 3-O-benzyl4,6-O-benzylidene-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-
α/β-D-glucopyranosyl trichloroacetimidate 3.2 (150 mg, 0.20 mmol) and activated molecular 
sieves (3 Å) (100 mg) was stirred in DCM (5 mL) for 10 min under a nitrogen atmosphere at rt. 
The mixture was then cooled to -78 °C, and TMSOTf (37 µL, 0.20 mmol) was added. The 
mixture was then allowed to warm to 0 °C over a period of 40 min. The mixture was again 
cooled to -78 °C, diacetone-D-galactose 2.42 (73 mg, 0.24 mmol) and TTBP 2.46 (100 mg, 0.40 
mmol) were added. The mixture was stirred and allowed to warm slowly to rt. After 16 h, t.l.c. 
(petrol:ethyl acetate, 3:2) indicated the formation of a major product (Rf 0.6) and the complete 
consumption of donor (Rf 0.8). The reaction was quenched by the addition of saturated aq. 
NaHCO3 (5 mL), the organic phase was separated, dried (MgSO4), filtered, and was then 
concentrated in vacuo. The residue was purified by flash chromatography (petrol:ethyl acetate, 
11:4) to afford 3-O-benzyl4,6-O-benzylidene-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α/β-D-
glucopyranosyl-(1→6)-1:2,3:4-di-O-isopropylidene-D-galactopyranoside 3.25 (0.110 g, 66%) as 
colorless oil; δH (400 MHz, CDCl3) [5:1 mixture of α:β anomers observed]: 1.33-1.60 (72H, m, 4 
x CH3 α, 4 x CH3 β), 2.80-3.02 (12 H, m, CH2CH2SAr α, CH2CH2SAr β), 3.43 (5H, dd, J4,5 9.2 
Hz, J5,6 3.6 Hz, H-5a α), 3.50-3.63 (8H, m, H-5a β, H-4a α, H-4a β, H-4b β), 3.63-3.86 (87H, m, 3 
x OMe α, 3 x OMe β, H-4b α, H-5b α, H-5b β, OCH2CH2SAr α, OCH2CH2SAr β, H-6a α, H-6b α) 
3.86-4.08 (22H, m, H-2a α, H-2a β, H-3a α, H-3a β, H-3b α, H-3b β, H-6a β, H-6b β) 4.20 - 4.37 
(12H, H-6’a α, H-6’a β, H-6’b α, H-6’b), 4.47 (1H, J1,2 9.20 Hz, H-1a β), 4.61 (6H, m, H-2b α, H-
2b β), 4.73 - 4.85 (12H, m, CH2Ph α, CH2Ph β) 5.04 (5H, d, J1,2 3.57 Hz, H-1a α), 5.46-5.58 
(12H, m, CHPh α, CHPh β, H-1b α, H-1b β) 6.13 (12H, SArC-H α, SArC-H β), 7.19-7.52 (60H, 
m, ArC-H α, ArC-H β); δC (100 MHz, CDCl3): 22.7, 24.3, 24.4, 24.5, 24.9, 25.0, 25.9, 26.0 (8 x 
q, 4 x CH3 α, 4 x CH3 β), 31.9, 34.2 (2 x t, CH2CH2SAr α, CH2CH2SAr β), 55.3, 55.3, 56.1, 56.1 
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(4 x q, o-OMe α, o-OMe β, p-OMe α, p-OMe β), 62.4, 62.5 (2 x t, C-6a α, C-6a β) 66.0, 66.2 (2 x 
t, C-6b α, C-6b β), 67.2, 67.3, 68.1, 68.8, 69.1, 69.7, 70.5, 70.6, 70.7, 70.8, 78.3, 80.5 (12 x d, C-
2a α, C-2a β, C-3a α, C-3a β, 2b α, C-2b β, C-3b α, C-3b β C-4b α, C-4b β, C-5b α, C-5b β), 71.2, 71.6 
(2 x t, OCH2CH2SAr α, OCH2CH2SAr β), 74.9, 75.0 (2 x t, CH2Ph α, CH2Ph β), 80.9, 81.1, 82.0, 
82.6 (4 x d, C-4a α, C-4a β, C-5a α, C-5a β), 91.0, 91.0 (2 x d, SArC-H α, SArC-H β), 96.3, 96.3 
(2 x d, CHPh α, CHPh β), 98.6, 98.6 (2 x d, C-1a α, C-1a β), 101.1, 101.2 (2 x d, C-1b α, C-1b β), 
104.6, 104.6 (2 x s, SCAr α, SCAr β), 108.6, 109.2, 109.3, 109.5 (4 x s, 2 x C(CH3)2 α, 2 x 
C(CH3)2 β), 126.0, 126.1, 127.4, 127.5, 127.8, 128.0, 128.1, 128.1, 128.2, 128.3, 128.8, 129.0 
(12 x d, 5 x ArC-H α, 5 x ArC-H β), 137.5, 138.6, 138.8, 138.9 (4 x s, 2 x ArC α, 2 x ArC β),s 
161.6, 161.8, 162.0, 163.5 (4 x s, S-ArC-OMe o α, S-ArC-OMe o β, S-ArC-OMe p α, S-ArC-
OMe p β); HRMS (ES+) calculated for C43H54O14SNa (MNa
+
) 849.3137, found 849.3132. 
3-O-Benzyl-4,6-O-benzylidene-2-O-(2-(phenylthionyl)ethyl)-α/β-D-glucopyranose[16] 3.21 
O
O
I
OHBnO
2.14 3.21
O
O
SPh
OHBnOPhSH, NaH
THF, reflux, 16 h
O
O
O
O
Ph Ph
(99%)
 
 
Thiophenol (0.117 mL, 1.15 mmol) was added to a stirred suspension of sodium hydride (0.018 
g, 0.750 mmol) in THF (5 mL). After 30 min, 3-O-benzyl-4,6-O-benzylidene-2-O-(2-iodoethyl)-
α/β-D-glucopyranose 2.14 (0.300 g, 0.590 mmol) was added as a solution in THF (5 ml) and the 
reaction was then heated to reflux. After 16 h, t.l.c (toluene:ethyl acetate, 2:1) indicated the 
formation of a single major product (Rf 0.75) and the complete consumption of starting material 
(Rf 0.70). The reaction was diluted with DCM (20 mL) and washed with water (20 mL). The 
aqueous layer was further extracted with DCM (2 x 20 mL) and the combined organic extracts 
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were then washed with saturated aq. sodium bicarbonate solution (20 mL) and brine (20 mL). 
The organic phase was dried (MgSO4), filtered, and concentrated in vacuo. The residue was 
purified by flash column chromatography (petrol:ethyl acetate, 2:1) to afford 3-O-benzyl-4,6-O-
benzylidene-2-O-(2-(phenylthionyl)ethyl)-α/β-D-glucopyranose 3.21 (0.290 g, 99%) as a white 
amorphous solid; νmax (KBr) 3400 (br, OH) cm
−1
; δH (400 MHz, CDCl3) [1:1 mixture of α:β 
anomers observed]: 3.02-3.18 (4H, m, OCH2CH2SPh α, OCH2CH2SPh β), 3.21 (1H, m, H-2 α/β), 
3.34-3.53 (2H, m, H-5 α, H-5 β), 3.61 (1H, m, H-2 α/β), 3.63-3.86 (6H, m, H-2 α, H-2 β, H-3 α, 
H-3 β, H-6 α, H-6 β), 3.86-4.08 (4H, m, OCH2CH2SPh α, OCH2CH2SPh β), 4.12 (2H, m, H-4 α, 
H-4 β), 4.19-4.42 (2H, m, H-6’ α, H-6’ β), 4.65-5.00 (5H, m, CH2Ph α, CH2Ph β, H-1 β), 5.26 
(1H, d, J1,2 3.72 Hz, H-1 α), 5.54-5.62 (2H, m, CHPh α, CHPh β), 7.13-7.69 (30H, m, ArC-H); 
δC (100 MHz, CDCl3): 33.9, 34.1 (2 x t, OCH2CH2SPh α, OCH2CH2SPh β), 62.5, 66.3, 68.7, 
69.0 (4 x d, C-4 α, C-4 β, C-5 α, C-5 β), 70.6, 71.6 (2 x t, C-6 α, C-6 β), 80.6, 80.7 (2 x t, 
OCH2CH2SPh α, OCH2CH2SPh β), 81.5, 81.8 (2 x t, CH2Ph α, CH2Ph β), 75.0, 75.1, 78.0, 83.9 
(4 x d, C-2 α, C-2 β, C-3 α, C-3 β), 91.9 (d, C-1 β), 97.5 (d, C-1 α), 101.2, 101.3 (2 x d, CHPh α, 
CHPh β), 126.0, 126.1, 126.4, 126.5, 127.6, 127.7, 127.9, 127.9, 128.0, 128.2, 128.3, 128.4, 
128.9, 128.9, 129.0, 129.5, 129.6 (18 x d, 9 x ArC-H α, 9 x ArC-H β), 135.6, 135.7, 137.2, 137.3, 
138.3, 138.5 (6 x s, 3 x Ar-C α, 3 x Ar-C β); HRMS (ES+) Calculated for C28H30O6SNa (MNa
+
) 
517.1655, found 517.1665.  
3-(O-Benzyl-4,6-O-benzylidene-2-O-(2-(phenylthionyl)ethyl)-α/β-D-glucopyranosyl) 
trichloroacetimidate
[17]
 3.22 
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O
O
SPh
OHBnO
CCl3CN, DBU
DCM, rt, 6 h
3.21 3.22
O
O
SPh
OBnO CCl3
NHO
O
O
O
Ph Ph
(93%)
 
3-O-Benzyl-4,6-O-benzylidene-2-O-(2-(phenylthionyl)ethyl)-α/β-D-glucopyranose 3.21 (0.26 g, 
0.53 mmol) was dissolved in distilled DCM (2.5 mL) under a nitrogen atmosphere. The solution 
was cooled to 0 °C, DBU (0.025 mL, 0.220 mmol), and trichloroacetonitrile (0.36 mL, 5.30 
mmol) were added sequentially. After 6 h, t.l.c. (petrol:ethyl acetate, 4:1, with 1% TEA) 
indicated the formation of a major product (Rf 0.5) and the complete consumption of starting 
material (Rf 0.2). The reaction was warmed to rt and concentrated in vacuo. The residue was 
purified by flash chromatography (petrol:ethyl acetate, 6:1, with 1% TEA) to afford 3-(O-benzyl-
4,6-O-benzylidene-2-O-(2-(phenylthionyl)ethyl)-α/β-D-glucopyranosyl) trichloroacetimidate 
3.22  (0.27 g, 93%) as colorless oil; νmax (KBr) 3350 (w, N-H), 1673 (s, C=N) cm
−1
; δH (400 
MHz, CDCl3) [3:1 mixture of α:β anomers observed]: 3.05-3.11 (8H, m, -OCH2CH2SPh α, 
OCH2CH2SPh β), 3.55-4.15 (28H, m, H-2 α, H-2 β, H-3 α, H-3 β, H-4 α, H-4 β, H-5 α, H-5 β, H-
6 α, H-6 β, OCH2CH2SPh α, OCH2CH2SPh β), 4.32-4.36 (3H, dd, J6,6’ 10 Hz, J5,6’ 5.6 Hz, H-6’ 
α), 4.37-4.43 (1H, dd, J6,6’ 10 Hz, J5,6’ 5.6 Hz, H-6’ β), 4.81-4.96 (8H, m, CH2Ph α, CH2Ph β), 
5.57, 5.59 (4H, 2 x s, CHPh α, CHPh β), 5.82 (1H, d, J1,2 8.0 Hz, H-1 β), 6.49 (3H, d, J1,2 4.0 Hz, 
H-1 α), 7.26–7.51 (60 H, m, 15 x Ar-CH α, 15 x Ar-CH β), 8.60, 8.71 (4H, 2 x s, NH α, NH β); 
δC (100 MHz, CDCl3): 33.3, 33.5 (2 x t, -OCH2CH2SPh α, -OCH2CH2SPh β), 65.1, 66.6 (2 x d, 
C-6 α, C-6 β), 68.6, 68.7 (2 x t, -OCH2CH2SPh α, -OCH2CH2SPh β), 75.0, 75.2 (2 x t, -CH2Ph α, 
-CH2Ph β), 70.3, 72.0, 71.2, 72.8, 76.7, 77.7, 79.9, 81.3 (8 x d, C-2 α, C-2 β, C-3 α, C-3 β, C-4 α, 
C-4 β, C-5 α, C-5 β), 80.6, 81.0 (2 x s, CCl3 α, CCl3 β), 94.5 (d, C-1 β), 98.0 (d, C-1 α), 101.3, 
101.3 (2 x d, -CHPh α, -CHPh β), 126.0, 126.1, 126.4, 126.5, 127.6, 127.7, 127.9, 127.9, 128.0, 
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128.2, 128.3, 128.4, 128.9, 128.9, 129.0, 129.5, 129.6 (18 x d, 9 x ArC-H α, 9 x ArC-H β), 135.6, 
135.7, 137.2, 137.3, 138.3, 138.5 (6 x s, 3 x Ar-C α, 3 x Ar-C β), 161.2, 161.3 (2 x s, C=NH α, 
C=NH β); HRMS (ES+) calculated for C30H30O6NCl3SNa (MNa
+
) 660.0751, found 660.0769. 
3-O-Benzyl-4,6-O-benzylidene-2-O-(2-(phenylselenyl)ethyl)-α/β-D-glucopyranosyl-(1→6)-
1:2,3:4-di-O-isopropylidene-D-galactopyranoside (Protocol B)
[25]
 3.23 
O
O
SPh
OBnO
O
O
Ph
3.22
CCl3
NH O
O
SPh
OBnO
O
O
Ph
O
O
O
O
O
3.23
a
b
i) TMSOTf (1 eq), (-78 °C 0 °C) / DCM
ii)
O
O
O
OH
O O
,TTBP 2.46, -78 °C / DCM
(72%)
2.42
 
A mixture of donor 3-O-Benzyl-4,6-O-benzylidene-2-O-(2-(thiophenyl)ethyl)-α/β-D-
glucopyranosyl trichloroacetimidate 3.22 (100 mg, 0.17 mmol) and activated molecular sieves (4 
Å) (100 mg) was stirred in DCM (5 mL) for 10 min under a nitrogen atmosphere at rt. The 
reaction was cooled to -78 °C, TMSOTf (32 µL, 0.17 mmol) was added, and the mixture was 
then allowed to warm to 0 °C over a period of 40 min. The mixture was then cooled to -78 °C, 
and glycosyl acceptor 1:2,3:4-di-O-isopropylidene-D-galactopyranoside 2.42 (49 mg, 0.19 
mmol) and TTBP (85 mg, 0.34 mmol) were added. The mixture was then  allowed to warm 
slowly to rt. After 16 h, t.l.c. (petrol:ethyl acetate, 4:1) indicated the formation of a major product 
(Rf 0.3) and the complete consumption of donor (Rf 0.4). The reaction was quenched by the 
addition of saturated aq. NaHCO3 (5 mL) and the organic phase was separated, dried (MgSO4), 
filtered and concentrated in vacuo. The residue was purified by flash chromatography 
(petrol:ethyl acetate, 11:4) to afford 3-O-Benzyl-4,6-O-benzylidene-2-O-(2-(thiophenyl)ethyl)-
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α/β-D-glucopyranosyl-(1→6)-1:2,3:4-di-O-isopropylidene-D-galactopyranoside 3.23 (0.090 g, 
72%) as colorless oil; δH (400 MHz, CD3CN) [3.5:1 mixture of α:β anomers observed]: 1.30-1.52 
(54H, m, 4 x CH3 α, 4 x CH3 β), 3.12-3.18 (9H, m, OCH2CH2SPh α, OCH2CH2SPh β), 3.50 
(3.5H, dd, J6,6’ 8.2 Hz, J5,6 3.2 Hz  H-6b α), 3.59-4.08 (41.5H, m, H-2b α, H-2b β, H-3b α, H-3b β, 
H-4b α, H-4b β, H-5b α, H-5b β, H-6b β, H-3a α, H-3a β, H-4a α, H-4a β, H-5a α, H-5a β, H-6b β, H-
6’b α, H-6’b β, H-6a α), 4.21-4.38 (14.5H, m, OCH2CH2SPh α, OCH2CH2SPh β, H-6a β, H-6’a α, 
H-6’a β), 4.50 (1H, d, J1,2 8.0 Hz, H-1a β),  4.65 (4.5H, m, H-2a α, H-2a β), 4.77-4.83 (9H, m, 
CH2Ph α, CH2Ph β), 5.03 (3.5H, d, J1,2 3.5 Hz, H-1a α), 5.49 (4.5H, m, H-1b α, H-1b β), 5.61 
(4.5H, s, CHPh α, CHPh β), 7.18-7.56 (67.5H, m, 15 x Ar-CH α, 15 x Ar-CH β); δC (100 MHz, 
CD3CN): 23.7, 23.8, 23.9, 24.2, 24.3, 25.4, 25.5, 25.6 (8 x q, 4 x CH3 α, 4 x CH3 β), 32.8, 33.0 (2 
x t, OCH2CH2SPh α, OCH2CH2SPh β),  62.5, 62.5 (2 x t, C-6a α, C-6a β), 65.8, 66.2 (2 x t, C-6b 
α, C-6b β), 66.8, 67.2 (2 x t, OCH2CH2SPh α, OCH2CH2SPh β), 68.3, 68.6 (2 x t, ArCH2 α, 
ArCH2 β), 69.3, 69.5, 70.4, 70.5, 70.6, 70.9, 71.0, 71.3, 74.2, 74.3, 77.7, 80.4, 80.5, 80.7, 80.9, 
81.5 (16 x d, C-2a α, C-3a α, C-4a α, C-5a α, C-2a β, C-3a β, C-4a β, C-5a β, C-2b α, C-3b α, C-4b α, 
C-5b α, C-2b β, C-3b β, C-4b β, C-5b β), , 82.6, 82.6 (2 x s, SCAr α, SCAr β), 96.3 (d, C-1a α), 
97.8 (d, C-1a β), 100.8 (d, C-1b β), 101.0 (d, C-1b α), 104.4, 104.4 (d, CHPh α, CHPh β), 108.4, 
108.4, 108.9, 108.9 (4 x s, 2 x C(CH3)2 α, 2 x C(CH3)2 β), 126.0, 126.5, 126.6,126.9, 127.2, 
127.3 127.6, 127.7, 127.8, 127.9, 128.1, 128.2, 128.3, 128.4, 129.0, 129.1, 129.2, 130.4 (18 x d, 
Ar-CH), 132.2, 132.6, 137.3, 137.4, 138.3, 138.6 (6 x s, Ar-C); HRMS (ES
+
) Calculated for 
C40H48O11SNa (MNa
+
) 759.2809, found 759.2804. 
3-O-Benzyl-4,6-O-benzylidene-2-O-(2-(phenylselenyl)ethyl)-α/β-D-glucopyranosyl-(1→6)-
1:2,3:4-di-O-isopropylidene-D-galactopyranoside (Protocol B):
[25]
 2.52 
     Chapter 5                                                                                                                       Experimental 
                                                                                                                                                                                                                                                     
205 
 
O
BnO
O
SePh
O CCl3
NH
2.16
O
BnO
O
PhSe O
O
O
O
O
O
2.52
O
O
O
OPh
Ph
a
b
i) TMSOTf (1 eq), (-78 °C 0 °C) / DCM
ii)
O
O
O
OH
O O
,TTBP, -78 °C / DCM
2.42
(66%)
 A mixture of donor 3-O-Benzyl-4,6-O-benzylidene-2-O-(2-(phenylselenyl)ethyl)-α/β-D-
glucopyranosyl trichloroacetimidate 3.22 (100 mg, 0.17 mmol) and activated molecular sieves (4 
Å) (100 mg) was stirred in DCM (5 mL) for 10 min under a nitrogen atmosphere at rt. The 
reaction was cooled to -78 °C, TMSOTf (32 µL, 0.17 mmol) was added, and the mixture was 
then allowed to warm to 0 °C over a period of 40 min. The mixture was then cooled to -78 °C, 
and glycosyl acceptor 1:2,3:4-di-O-isopropylidene-D-galactopyranoside 2.42 (49 mg, 0.19 
mmol) and TTBP (85 mg, 0.34 mmol) were added. The mixture was then  allowed to warm 
slowly to rt. After 16 h, t.l.c. (petrol:ethyl acetate, 4:1) indicated the formation of a major product 
(Rf 0.3) and the complete consumption of donor (Rf 0.4). The reaction was quenched by the 
addition of saturated aq. NaHCO3 (5 mL) and the organic phase was separated, dried (MgSO4), 
filtered and concentrated in vacuo. The residue was purified by flash chromatography 
(petrol:ethyl acetate, 11:4) to afford 3-O-Benzyl-4,6-O-benzylidene-2-O-(2-
(phenylselenyl)ethyl)-α/β-D-glucopyranosyl-(1→6)-1:2,3:4-di-O-isopropylidene-D-
galactopyranoside 2.52 (0.088 g, 66%) as colorless oil; δH (400 MHz, CDCl3) [3.5:1 mixture of 
α:β anomers observed]: 1.34 (12H, m, 2 x CH3 α, 2 x CH3 β), 1.46, 1.47, 1.53, 1.55 (12H, 4 x s, 2 
x CH3 α, 2 x CH3 β), 3.06-3.18 (5H, m, OCH2CH2SePh α, OCH2CH2SePh β, H-5b α), 3.40 (1H, 
m, H-5b β), 3.53 (1H, m, H-5a α), 3.49 (1H, dd, J6,6’ 8.2 Hz, J5,6 3.2 Hz  H-6b α), 3.58-3.82 (8H, 
m, H-2a α, H-2a β, H-5a β, H-2b α, H-4b α, H-4b β, H-5b α, H-5b β), 3.84-4.13 (7H, m, H-2a α, H-
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2a β, H-3a α, H-3a β, H-4a α, H-4b β, H-6b β), 4.16-4.24 (4H, m, OCH2CH2SePh α/β, H-6a α/β H-
6’a α, H-6’a β), 4.33-4.47 (3H, m, OCH2CH2SePh α/β, H-6a α/β), 4.48 (1H, d, J1,2 8 Hz, H-1a β),  
4.61 (2H, m, H-6’b α, H-6’b), 4.80-4.88 (4H, m, CH2Ph α, CH2Ph β), 5.02 (1H, d, J1,2 3.5 Hz, H-
1a α), 5.53 (4H, s, CHPh α, CHPh β, H-1b α, H-1b β), 7.27-7.50 (30H, m, 15 x Ar-CH α, 15 x Ar-
CH β). 
3,4,6-Triacetyl-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α/β-D-glucopyranose[24] 3.17 
O
O
I
OHAcO
3.16
3.17
O
O
S
OHAcON,N-Diisopropylethylamine
DMF, rt, 16 h
AcO
AcO
AcO
AcO
OMeMeO
OMe
+
SH
OMeMeO
OMe
(73%)
 
3,4,6-Tri-O-acetyl-2-O-(2-iodoethyl)-α/β-D-glucopyranose 3.16 (345 mg, 0.75 mmol) was 
dissolved in DMF (10 mL) ) under a nitrogen atmosphere. Hünig’s base (0.16 mL, 0.90 mmol) 
and 2,4,6-trimethoxybenzenethiol (180 mg, 0.90 mmol) were added, and the mixture was stirred 
at rt. After 16 h, t.l.c. (toluene:ethyl acetate, 1:1) indicated the complete consumption of starting 
material (Rf 0.6) and the formation of a major product (Rf 0.4). The solution was then 
concentrated in vacuo and the residue obtained was purified by flash chromatography 
(petrol:ethyl acetate, 3:2) to afford 3,4,6-triacetyl-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-
α/β-D-glucopyranose 3.17 (290 mg, 73.0%) as white amorphous solid; νmax (KBr) 1740 (s, C=O) 
cm
−1
; δH (400 MHz, CDCl3) [2:1 mixture of α:β anomers observed]: 2.00, 2.07 (27H, 2 x s, 3 x 
COCH3 α, 3 x COCH3 β), 2.73-3.00 (6H, m, CH2CH2SAr α, CH2CH2SAr β), 3.33 (1H, at, J 7.90 
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Hz, H-2 β), 3.43 - 3.52 (2H, m, H-2 α), 3.52 - 3.59 (3H, H-5 α, H-5 β), 3.64-3.93 (32H, m, 
CH2CH2SAr α, CH2CH2SAr β, 3 x OCH3 α, 3 x OCH3 β), 4.02-4.18 (3H, m, H-6 α, H-6 β), 4.19-
4.35 (3H, H-6’ α, H-6’ β), 4.73 (1H, d, J1,2 7.63 Hz, H-1 β), 4.88 - 5.02 (3H, m, H-4 α, H-4 β), 
5.05 - 5.16 (1H, H-3 β), 5.25 - 5.42 (4H, m, H-1 α, H-3 α), 6.07 - 6.21 (6H, m, ArC-H α, ArC-H 
β); δC (100 MHz, CDCl3): 20.6, 20.6, 20.7, 20.7, 20.8, 20.8  (6 x q, 3 x COCH3 α, 3 x COCH3 β), 
34.4, 35.3 (2 x t, OCH2CH2SAr α, OCH2CH2SAr β), 55.4, 55.4, 56.1, 56.1 (4 x q, 2 x OMe α, 2 x 
OMe β), 62.0, 62.2 (2 x t, C-6), 67.6 (d, C-5 α), 68.3, 68.3 (d, C-4 α, C-4 β), 68.7 (t, 
OCH2CH2SAr α/β), 70.3 (d, C-3 α), 71.8 (d, C-5 β), 71.9 (t, OCH2CH2SAr α/β), 74.8 (d, C-3 β), 
78.4 (d, C-2 α), 81.8 (d, C-2 β), 90.9 (d, C-1 α), 91.1, 91.2 (2 x d, SArC-H α, SArC-H β), 96.9 (d, 
C-1 β), 161.9, 161.9, 162.0, 162.0 (4 x s, S-ArC-OMe o α, S-ArC-OMe o β, S-ArC-OMe p α, S-
ArC-OMe p β), 169.8, 169.9, 170.0, 170.3, 170.3, 170.9, 170.9 (6 x s, 3 x C=O α, 3 x C=O β); 
HRMS (ES
+
) calculated for C23H32O12SNa (MNa
+
) 555.1506, found 555.1517.  
3,4,6-Triacetyl-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α/β-D-glucopyranosyl) 
trichloroacetimidate
[12]
 3.3 
3.17
O
O
S
OHAcO
AcO
AcO
OMeMeO
OMe
Cl3CCN, DBU
DCM, rt, 16 h
(89%)
3.3
O
O
S
OAcO
AcO
AcO
OMeMeO
OMe
CCl3
NH
 
3,4,6-Triacetyl-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α/β-D-glucopyranose 3.17 (125 mg, 
0.235 mmol) was dissolved in DCM (10 mL) under a nitrogen atmosphere. Trichloroacetonitrile 
(0.16 mL, 2.35 mmol) and DBU (0.011 mL, 0.094 mmol) were added, and the reaction was 
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stirred at 0 °C. After 6 h, t.l.c. (petrol:ethyl acetate, 4:1, with 1% TEA) indicated the formation of 
a major product (Rf 0.5) and the complete consumption of starting material (Rf 0.2). The reaction 
was warmed to rt and concentrated in vacuo and the residue was purified by flash 
chromatography (petrol:ethyl acetate, 6:1, with 1% TEA) to afford 3,4,6-triacetyl-2-O-(2-
(phenylthionyl)ethyl)-α/β-D-glucopyranosyl) trichloroacetimidate 3.3 (127 g, 89%) as colorless 
oil; νmax (KBr) 1748 (s, C=O), 1674 (s, C=NH) cm
-1; δH (400 MHz, CDCl3) [mixture of α:β 
anomers observed, major α anomer quoted] 2.00-2.07 (9H, m, 3 x C(O)CH3), 2.72-2.82 (2H, m, 
OCH2CH2SAr), 3.56-3.61 (2H, m, OCH2CH2SAr), 3.73 (1H, dd, J1,2 3.6 Hz, J2,3 10.0 Hz, H-2), 
3.83, 3.86 (9H, 2 x s, 3 x OCH3), 4.06-4.19 (2H, m, H-5, H-6), 4.25 (1H, dd, J6,6’ 12.4, J5,6’ 4.4 
Hz, H-6’), 5.09 (1H, m, H-4), 5.38 (1H, at, J 10.0 Hz, H-3), 6.14 (2H, d, SArC-H), 6.52 (1H, d, 
J1,2 3.2 Hz, H-1), 8.58 (1H, br s, NH); δC (100 MHz, CDCl3) 20.5, 20.6, 20.7 (3 x q, 3 x 
C(O)CH3), 33.8 (t, OCH2CH2SAr), 55.4, 56.1 (2 x q, 2 x OMe), 61.6 (t, C-6), 67.9 (d, C-4), 69.9 
(d, C-5), 70.8 (t, OCH2CH2SAr), 71.6 (d, C-3), 75.2 (s, OC(NH)CCl3), 76.6 (d, C-2), 91.0 (d, 
SArC-H), 93.6 (d, C-1), 161.0 (s, C=NH), 161.9, 162.0 (2 x s, S-ArC-OMe o, S-ArC-OMe p), 
162.0 (s, SArC-OMe), 170.0, 170.1, 170.5 (3 x s, 3 x C=O); HRMS (ES
+
) calculated for 
C25H32Cl3NO12SNa (MNa
+
) 698.0602, found 698.0619.  
3,4,6-Triacetyl-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α/β-D-glucopyranosyl-(1→6)-
1:2,3:4-di-O-isopropylidene-D-galactopyranoside (Protocol B)
[25]
 3.26 
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i) TMSOTf (1 eq), (-78 °C 0 °C) / DCM
ii)
O
O
O
OH
O O
,TTBP 2.46, -78 °C / DCM
(63%)
2.42
O
O
S
OAcO
AcO
AcO
OMeMeO
OMe
3.3
CCl3
NH
O
O
S
OAcO
AcO
AcO
OMeMeO
OMe
O
O
O
O
O
3.26
a
b
 
A mixture of donor afford 3,4,6-triacetyl-2-O-(2-(phenylthionyl)ethyl)-α/β-D-glucopyranosyl) 
trichloroacetimidate 3.3 (80 mg, 0.12 mmol) and activated molecular sieves (3 Å) (100 mg) was 
stirred in DCM (5 mL) for 10 min under a nitrogen atmosphere at rt. The reaction was then 
cooled to -78 °C, TMSOTf (22 µL, 0.12 mmol) was added, and the mixture was then allowed to 
warm to 0 °C over a period of 40 min. The mixture was then cooled to -78 °C, and glycosyl 
acceptor 1:2,3:4-di-O-isopropylidene-D-galactopyranoside 2.42 (44 mg, 0.14 mmol) and TTBP 
2.46 (60 mg, 0.24 mmol) were added. The mixture was then allowed to warm slowly to rt. After 
16 h, t.l.c. (petrol:diethyl ether, 1:2) indicated the formation of a major product (Rf 0.4) and the 
complete consumption of donor (Rf 0.8). The reaction was quenched by addition of saturated aq. 
NaHCO3 (5 mL), and the organic phase was separated, dried (MgSO4), filtered, and concentrated 
in vacuo. The residue was purified by flash chromatography (petrol:diethyl ether, 2:3) to afford 
3,4,6-triacetyl-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α/β-D-glucopyranosyl-(1→6)-1:2,3:4-
di-O-isopropylidene-D-galactopyranoside 3.26 (0.058 g, 63%) as colorless oil; δH (400 MHz, 
CDCl3) [3.5:1 mixture of α:β anomers observed]: 1.29, 1.30, 1.32, 1.33, 1.42, 1.44, 1.48, 1.54 
(60H, 8 x s, 4 x CH3 α, 4 x CH3 β), 1.98, 1.99, 2.00, 2.01, 2.06, 2.07 (54H, 6 x s, 3 x C(O)CH3 α, 
3 x C(O)CH3 β), 2.72-2.84 (9H, m, OCH2CH2SAr α, OCH2CH2SAr β), 3.28 (1H, at, J 8.0 Hz, H-
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2a β), 3.49 (3.5H, dd, J1,2 3.6 Hz, J2,3 10.0 Hz, H-2a α), 3.52-3.80 (14.5H, m, H-4b α, H-4b β, H-5b 
α, H-5b β, H-5a β, H-6b α, H-6b β), 3.81-3.85 (40.5H, m, 3 x OMe α, 3 x OMe β), 3.98-4.12 (17H, 
m, H-5b α, H-5b β, H-5a α, H-6’b α, H-6’b β, H-6a α, H-6a β), 4.18-4.32 (18H, m, OCH2CH2SAr α, 
OCH2CH2SAr β, H-2b α, H-2b β, H-6’a α, H-6’a β), 4.45 (1H, d, J1,2 8.0 Hz, H-1a β), 4.57-4.61 
(4.5H, m, H-3b α, H-3b β), 4.96-5.01 (4.5H, m, H-4a α, H-4a β), 5.05 (1H, d, J1,2 3.6 Hz, H-1a α), 
5.10 (1H, m, H-3a β), 5.36 (3.5H, at, J 9.6 Hz, H-3a α), 5.49-5.51 (4.5H, m, H-1b α, H-1b β), 6.18 
(9H, m, 2 x SArCH α, 2 x SArC-H β); δC (100 MHz, CDCl3) 20.6, 20.7, 20.7, 20.8, 20.8, 20.9 (6 
x q, 3 x C(O)CH3 α, 3 x C(O)CH3 β), 24.3, 24.4, 24.5, 24.5, 25.0, 25.9, 26.0, 26.1 (8 x q, 4 x 
(C)CH3 α, 4 x (C)CH3 β),  33.9 (t, OCH2CH2SAr α), 34.0 (t, OCH2CH2SAr β), 55.3, 55.4, 56.0, 
56.1 (4 x q, 2 x OMe α, 2 x OMe β), 62.1 (t, C-6a α), 62.2 (t, C-6a β), 66.5 (d, C-5a α), 67.2 (d, C-
5b α), 67.4 (d, C-5b β), 67.8 (t, OCH2CH2SAr), 68.6 (d, C-4a α), 68.6 (d, C-4a β), 69.6 (t, C-6b α), 
70.4 (t, C-6b β), 70.5 (d, C-2b α), 70.6 (d, C-2b β), 70.7 (d, C-3b β), 70.8 (d, C-3b α), 71.2, 71.2 (2 x 
d, C-4b α, C-4b β), 71.5 (d, C-5a β), 72.0 (d, C-3a α), 73.9 (t, OCH2CH2SAr), 76.7 (d, C-3a β), 78.2 
(d, C-2a α), 79.5 (d, C-2a β), 91.0, 91.1 (2 x d, SArC-H α, SArC-H β), 96.2 (d, C-1b α), 96.4 (d, C-
1b β), 97.6 (d, C-1a α), 100.8, 100.8 (2 x s, SCAr α, SCAr β), 104.0 (d, C-1a β), 108.8, 108.9, 
109.4, 109.6 (4 x s, 2 x (C)CH3 α, 2 x (C)CH3 β), 126.9, 127.3, 129.2, 129.3, 129.7, 130.4, 132.5, 
132.9 (8 x ArC), 161.6, 161.8, 161.9, 162.0 (4 x s, S-ArC-OMe o α, S-ArC-OMe o β, S-ArC-
OMe p α, S-ArC-OMe p β), 169.9 (s, C=O), 170.0 (s, C=O), 170.3 (s, C=O), 170.3 (s, C=O), 
170.8 (s, C=O), 170.9 (s, C=O); HRMS (ES
+
) calculated for C35H50O17SNa (MNa
+
) 797.2660, 
found 797.2669. 
2,3,4,6-Tetra-O-acetyl-1-α-D-glucopyranosyl bromide[26] 3.4 
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O
OAcAcO
AcO
OAc
HBr, AcOH
OAcO
AcO
AcO
2.20 3.4
AcO AcO
DCM, 0 °C
Br
rt, 2 h
(93%)
 
2.20 (10.0 g, 25.6 mmol) was dissolved in DCM (20 mL) and cooled to 0 °C under a nitrogen 
atmosphere. HBr (33% in AcOH, 20 mL) was added dropwise and the reaction was then allowed 
to warm to rt and then stirred for 2 h, after which t.l.c. (petrol:ethyl acetate, 2:1) showed 
complete consumption of starting material (Rf 0.2), and formation of a major product (Rf 0.3). 
The mixture was poured into ice-water (50 mL) and the flask was washed with DCM (200 mL). 
The organic layer was separated and washed with saturated aq. sodium bicarbonate solution (6 x 
50 mL) until no effervescence occurs. The organic layer was washed with water, dried (MgSO4), 
filtered and concentrated in vacuo. The residue was recrystallized (petrol/diethyl ther) to give 
2,3,4,6-tetra-O-acetyl-1-α-D-glucopyranosyl bromide 3.4 (9.75 g, 93%) as white crystalline 
solid; m. p. 85 - 86 °C (petrol/diethyl ether) (lit.
[26]
 88 – 89 °C); δH (400 MHz, CDCl3):
[3]
 2.01-
2.09 (12H, m, 4 x CH3CO2),  4.11 (1H, m, H-6), 4.27-4.235 (2H, m, H-4, H-6’), 4.81-4.85 (1H, 
m, H-5), 5.18 (1H, m, H-2), 5.55 (1H, at, J 10.0 Hz, H-3), 5.20 (1H, d, J1,2  3.6 Hz, H-1). 
 
 
3,4,6-Tri-O-acetyl-1,2-O-(exo-ethoxyethylidine)-α-D-glucopyranoside[27] 3.5 
OAcO
AcO
AcO
3.4
AcO
Br
TBAB, 2,4,6-collidine
DCM, reflux, 16 h
OAcO
AcO
3.5
AcO
O O
OEtMe
+ EtOH
(92%)
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2,3,4,6-Tetra-O-acetyl-α-D-glucopyranosyl bromide 3.4 (52.5 g, 127.7 mmol) and tetra-N-
butylammonium bromide (4.1 g, 12.8 mmol) were dissolved in freshly distilled DCM (300 ml). 
Ethanol (14.9 ml, 166.0 mmol) and 2,4,6-collidine (21.9 ml, 255 mmol) were added and the 
reaction mixture refluxed at 50 °C. After 16 h, t.l.c. (petrol:ethyl acetate, 3:1) indicated the 
formation of a single product (Rf 0.4) and complete consumption of starting material (Rf 0.6). 
The reaction was diluted with water (125 ml) and the aqueous layer extracted with DCM (2 x 
150 ml). The combined organic extracts were washed with saturated aq. sodium bicarbonate 
solution (2 x 100 ml) then brine (100 ml). The organic phase was dried (MgSO4), filtered and 
concentrated in vacuo. The residue was purified by recrystallisation (ethanol) to afford 3,4,6-tri-
O-acetyl-1,2-O-(exo-ethoxyethylidine)-α-D-glucopyranoside 3.5 (44.1 g, 92%) as a white 
crystalline solid; m. p. 95 – 96 °C (petrol/ethyl acetate) (lit.[27] 95 – 96 °C); [α]D
20
 + 38.4  (c, 1.0 
in CHCl3), lit.
[27]
 [α]D
20
 + 34.0  (c, 1.0 in CHCl3); δH (400 MHz, CDCl3):
[27]
  1.18 (3H, t, J 7.1 
Hz, CH3CH2) 1.72 (3H, s, CH3), 2.09, 2.10, 2.11 (9H, 3 x s, 3 x COCH3), 3.54 (2H, q, J 7.1 Hz, 
CH3CH2), 3.92-3.97 (1H, m, H-5), 4.19-4.20 (2H, m, H-6, H-6’), 4.32 (1H, dd, J1,2 5.0 Hz, J2,3 
2.8 Hz, H-2), 4.90 (1H, dd, J3,4 3.0 Hz, J4,5 9.4 Hz, H-4), 5.19 (1H,at, J 2.9 Hz, H-3), 5.71 (1H, d, 
J1,2 5.0 Hz, H-1). 
3,4,6-Tri-O-benzyl-1,2-O-(exo-ethoxyethylidine)-α-D-glucopyranoside[28] 3.6 
OAcO
AcO
3.5
AcO
O O
OEtMe
1) Na / MeOH, r t, 1 h
2) BnBr / DMF, rt, 16 h
OBnO
BnO
3.6
BnO
O O
OEtMe(95%)
 
A solution of sodium (0.32 g) in methanol (20 ml) was added to a stirred solution of 3,4,6-tri-O-
acetyl-1,2-O-(exo-ethoxyethylidine)-α-D-glucopyranoside 3.5 (10.5 g, 27.9 mmol) in methanol 
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(80 ml). After 1 h, t.l.c. (petrol:ethyl acetate, 1:1) indicated the formation of a single product (Rf 
0) and complete consumption of starting material (Rf 0.7). The reaction mixture was 
concentrated in vacuo, and left under high vacuum for 2 h. The residue was then dissolved in 
anhydrous DMF (100 ml) and slowly added to a suspension of sodium hydride (6.66 g, 166.6 
mmol) in anhydrous DMF (100 ml) at 0 °C under a nitrogen atmosphere. Benzyl bromide (14.9 
ml, 125.0 mmol) was then added slowly and the reaction mixture was then allowed to warm to rt. 
After 16 h, t.l.c (petrol:ethyl acetate, 1:1) indicated the formation of a single product (Rf 0.9) and 
complete consumption of starting material (Rf 0). Methanol (50 ml) was added portion-wise and 
the reaction mixture was then concentrated in vacuo. The residue was dissolved in ether (200 
ml), washed with water (500 ml), and the aqueous layer was re-extracted with ether (2 x 200 ml). 
The combined organic extracts were washed with brine (200 ml), dried (MgSO4), filtered, and 
concentrated in vacuo. The residue was purified by flash column chromatography (petrol:ethyl 
acetate, 5:1) to afford 3,4,6-tri-O-benzyl-1,2-O-(exo-ethoxyethylidine)-α-D-glucopyranoside 3.6 
(13.9 g, 95%) as a pale yellow oil; [α]D
20
 + 34.8  (c, 1.0 in CHCl3), lit.
[28]
 [α]D
20
 + 35.8  (c, 1.0 in 
CHCl3); δH (400 MHz, CDCl3):
[28]
 1.26 (3H, t, J 7.1 Hz, CH3CH2) 1.73 (3H, s, CH3), 3.57-3.64 
(2H, m, CH3CH2), 3.69-3.76 (2H, m, H-6, H-6’), 3.79 (1H, dd, J3,4 4.55 Hz, J4,5 9.6 Hz, H-4), 
3.85-3.89 (1H, m, H-5), 3.94 (1H, dd, J2,3 3.5 Hz, J3,4 4.3 Hz, H-3), 4.45 (1H, d, J 11.4, 
PhCHH’), 4.49 (1H, dd, J1,2 5.3 Hz, J2,3 3.5 Hz, H-2), 4.56 (1H, d, J 12.1, PhCHH’), 4.62-4.68 
(3H, m, 3 x PhCHH’), 4.77 (1H, d, J 11.9, PhCHH’), 5.84 (1H, d, J1,2 5.3 Hz, H-1), 7.21-7.48 
(15H, m, 15 x ArC-H). 
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1,2-O-Acetyl-3,4,6-tri-O-benzyl-α,β-D-glucopyranoside[29] 3.7 
OBnO
BnO
3.6
BnO
O O
OEtMe
1) AcOH 60% (aq.), rt, 2 h
2) Ac2O, DMAP /
Pyridine, rt, 16 h
OBnO
BnO
3.7
BnO
OAcOAc
(81%)
 
3,4,6-Tri-O-benzyl-1,2-O-(exo-ethoxyethylidine)-α-D-glucopyranoside 3.6 (14.5 g, 27.8 mmol) 
was dissolved in glacial acetic acid (60% in water, 250 ml) and stirred at room temperature. 
After 16 h, t.l.c. (petrol:ethyl acetate, 1:1) indicated the formation of a single product (Rf 0.6) and 
complete consumption of starting material (Rf 0.9). The reaction mixture was co-evaporated with 
750 mL toluene and left under high vacuum for 2 h. The residue and DMAP (0.34 g, 2.79 mmol) 
were dissolved in anhydrous pyridine (100 ml) and the mixture was then cooled to 0 °C under a 
nitrogen atmosphere. Acetic anhydride (5.27 ml, 55.8 mmol) was then added slowly and the 
reaction was then allowed to warm to room temperature. After 16 h, t.l.c. (petrol:ethyl acetate, 
1:1) indicated the formation of a single product (Rf 0.9) and complete consumption of starting 
material (Rf 0.6). The reaction mixture was cooled to 0 °C, quenched by the addition of ethanol 
(75 ml) and concentrated in vacuo. The residue was dissolved in ether (100 ml) and washed with 
1M HCl (100 ml), saturated aq. sodium bicarbonate (100 ml), brine (100 ml). The organic 
extracts were dried (MgSO4), filtered, and concentrated in vacuo. The residue was purified by 
flash column chromatography (toluene:ethyl acetate, 8:1) to afford 1,2-O-acetyl-3,4,6-tri-O-
benzyl-α,β-D-glucopyranoside 3.7 (12.0 g, 81%) as a pale yellow oil; δH (400 MHz, CDCl3)
[29]
 
[13:1 mixture of α:β anomers observed, major α anomer quoted] 2.00, 2.14 (6H, 2 x s, 2 x CH3), 
3.70 (1H, dd, J5,6 1.8 Hz, J6,6’ 10.9 Hz, H-6), 3.77-3.87 (2H, m, H-4, H-6’), 3.94 (1H, ddd, J4,5 
10.1 Hz, J5,6 1.8 Hz, J5,6’ 3.3 Hz, H-5), 4.03 (1H, at, J 9.5 Hz, H-3), 4.45 (1H, d, J 11.37, 
PhCHH’), 4.52-4.67 (3H, m, 1 x PhCHH’, 2 x PhCHH’), 4.79, 4.88 (2H, ABq, JAB 11.4, 
     Chapter 5                                                                                                                       Experimental 
                                                                                                                                                                                                                                                     
215 
 
PhCH2), 4.85 (1H, d, J 10.6, PhCHH’), 5.09 (1H, dd, J1,2 3.6 Hz, J2,3 10.0 Hz, H-2), 6.34 (1H, d, 
J1,2 3.6 Hz, H-1), 7.17-7.39 (15H, m, 15 x ArC-H). 
Ethyl 2-O-acetyl-3-4-6-tri-O-benzyl-1-thio-α/β-D-glucopyranoside[30] 3.8 
OBnO
BnO
3.8
BnO
OAc SEt
OBnO
BnO
3.7
BnO
OAcOAc
EtSH, BF3.Et2O
(88%)
DCM, rt, 6 h
 
1,2-O-Acetyl-3,4,6-tri-O-benzyl-α,β-D-glucopyranoside 3.7 (4.00 g, 7.50 mmol) was dissolved 
in freshly distilled DCM (80 ml) under a nitrogen atmosphere. Ethanethiol (0.810 ml, 11.2 
mmol) was added and the mixture then cooled to 0 °C. BF3.Et2O (1.30 ml, 9.75 mmol) was 
added dropwise and the mixture was then allowed to warm to room temperature. After 6 h, t.l.c. 
(petrol:ethyl acetate, 2:1) indicated the formation of a single product (Rf 0.8) and complete 
consumption of starting material (Rf 0.7). Once addition of the boron trifluoride diethyl etherate 
was complete, the mixture was allowed to warm to room temperature. After 6 h, t.l.c. 
(petrol:ethyl acetate, 2:1) indicated the formation of a single product (Rf 0.8) and complete 
consumption of starting material (Rf 0.7). The reaction was diluted with DCM (250 ml) and 
washed with saturated aq. sodium bicarbonate (100 ml), water (100 ml), and brine (100 ml). The 
organic phase extracts were dried (MgSO4), filtered, and concentrated in vacuo. The residue was 
purified by flash column chromatography (petrol:ethyl acetate, 9:1) to afford ethyl 2-O-acetyl-3-
4-6-tri-O-benzyl-1-thio-α/β-D-glucopyranoside 3.8 (3.54 g, 88%) as pale yellow oil. δH (400 
MHz, CDCl3)
[30]
 [1:5 mixture of α:β anomers observed, major β anomer quoted] 1.33 (3H, t, J 
7.4 Hz, SCH2CH3), 2.05 (3H, s, CH3), 2.78 (2H, m, SCH2CH3), 3.57 (1H, m, H-5), 3.74 (1H, at, 
J 9.0 Hz, H-3), 3.77 (1H, at, J 8.8 Hz, H- 4), 3.78 (1H, dd, J5,6 4.5 Hz, J6,6’ 11.3 Hz, H-6), 3.83 
(1H, dd, J6,6’ 11.1 Hz, J5,6’ 1.9 Hz, H-6’), 4.43 (1H, d, J1,2 10.0 Hz, H-1), 4.62-4.68 (3H, m, 3 x 
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ArCHH’), 4.76 (1H, d, J 11.4 Hz, ArCHH’), 4.86 (1H, d, J 10.6 Hz, ArCHH’), 4.88 (1H, d, J 
11.3 Hz, ArCHH’), 5.10 (1H, at, J 9.2 Hz, H-2), 7.26–7.41(15H, m, ArH). 
Ethyl 3-4-6-tri-O-benzyl-1-thio-β-D-glucopyranoside[31] 3.9 
OBnO
BnO
3.9
BnO
OH SEt
OBnO
BnO
3.8
BnO
OAc SEt MeOH/THF, rt, 16 h
Na
(92%)
 
A solution of sodium (0.23 g) in methanol (10 ml) was added to a stirred solution of ethyl 2-O-
acetyl-3-4-6-tri-O-benzyl-1-thio-α/β-D-glucopyranoside 3.8 (1.38 g, 2.57 mmol) in methanol-
THF (20 ml, 1:1). After 16 h, t.l.c. (petrol:ethyl acetate, 2:1) indicated the formation of a single 
product (Rf 0.6) and complete consumption of starting material (Rf 0.8). Amberlite 120 (H+) 
resin (3 g) was added and the mixture stirred for 15 min until pH 7. The reaction was filtered and 
concentrated in vacuo. The residue was purified by flash column chromatography (petrol:ethyl 
acetate, 5:1) to afford ethyl 3,4,6-tri-O-benzyl-1-thio- α/β-D-glucopyranoside 3.9 (1.17 g, 92%) 
as a pale yellow oil. δH (400 MHz, CDCl3) [1:5 mixture of α:β anomers observed, major β 
anomer quoted] 1.26 (3H, t, J 7.4 Hz, SCH2CH3), 2.45 (1H, d, JOH,2 2.0 Hz, OH), 2.78 (2H, m, 
SCH2CH3), 3.49-3.58 (2H, m, H-2, H-5), 3.60-3.66 (2H, m, H-3, H-4), 3.76 (1H, dd, J5,6 4.4 Hz, 
J6,6’ 11.0 Hz, H-6), 3.82 (1H, dd, J5,6’ 1.8 Hz, J6,6’ 11.0 Hz, H-6’), 4.53 (1H, d, J1,2 9.6 Hz, H-1), 
4.56-4.66 (3H, m, 3 x PhCHH’), 4.84-4.95 (3H, m, 3 x PhCHH’), 7.21-7.39 (15H, m, 15 x Ar-
H). 
Ethyl 2-O-allyl-3-4-6-tri-O-benzyl-1-thio-β-D-glucopyranoside[32] 3.10 
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OBnO
BnO
3.10
BnO
O SEt
OBnO
BnO
3.9
BnO
OH SEt
NaH, Allyl bromide
DMF, rt, 1 h
(94%)
 
Ethyl 3-4-6-tri-O-benzyl-1-thio-β-D-glucopyranoside 3.9 (1.09 g, 2.21 mmol) was dissolved in 
anhydrous DMF (4 ml) and then slowly added to a suspension of sodium hydride (0.177 g, 4.42 
mmol) in anhydrous DMF (4 mL) at 0 °C under an argon atmosphere. Allyl bromide (0.38 mL, 
4.42 mmol) was then added slowly and the reaction was then allowed to warm to rt. After 1 h, 
t.l.c. (petrol:ethyl acetate, 4:1) indicated the formation of a single product (Rf 0.6) and complete 
consumption of starting material (Rf 0.4). The reaction was quenched with methanol (5 ml), and 
concentrated in vacuo. The residue was dissolved in ether (50 ml), washed with water (100 ml), 
and the aqueous layer extracted with ether (2 x 50 ml). The combined organic extracts were 
washed with brine (100 ml), dried (MgSO4), filtered, and concentrated in vacuo. The residue was 
purified by flash column chromatography (petrol:ethyl acetate, 6:1) to afford ethyl 2-O-allyl-3-4-
6-tri-O-benzyl-1-thio-β-D-glucopyranoside 3.10 (1.11 g, 94%) as pale yellow oil. δH (400 MHz, 
CDCl3) [1:5 mixture of α:β anomers observed, major β anomer quoted] 1.30 (3H, t, J 7.2 Hz, 
SCH2CH3), 2.75 (2H, m, SCH2CH3), 3.13 (1H, dd, J1,2 9.8 Hz, J2,3 8.5 Hz, H-2), 3.41 (1H, at, J 
9.0 Hz, H-4), 3.48-3.51 (1H, m, H-5), 3.64 (1H, at, J 9.0 Hz, H-3), 3.72 (1H, dd, J6,6’ 10.3 Hz, 
J5,6 3.9 Hz, H-6), 3.73 (1H, dd, J6,6’ 10.3 Hz, J5,6’ 2.0 Hz, H-6’), 4.22 (1H, ddat, Jgem 11.3 Hz, Jvic 
6.0 Hz, J 1.4 Hz, OCHH’CH=CH2), 4.39 (1H, ddat, Jgem 11.2 Hz, Jvic 5.5 Hz, J 1.8 Hz, 
OCHH’CH=CH2), 4.54, 4.63 (2H, ABq, JAB 12.0 Hz, PhCH2), 4.59, 4.84 (2H, ABq, JAB 10.9 
Hz, PhCH2), 4.61 (1H, d, J1,2 9.8 Hz, H-1), 4.85, 4.92 (2H, ABq, JAB 10.9 Hz, PhCH2), 5.20 (1H, 
daq, JZ 10.4 Hz, J 1.8 Hz, CH=CHEHZ), 5.30 (1H, daq, JE 17.0 Hz, J 1.8 Hz, CH=CHEHZ), 5.99 
(1H, ddat, JE 17.0 Hz, JZ 10.4 Hz, J 5.9 Hz, CH=CH2), 7.19-7.33 (15H, m, 15 x Ar-H). 
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2-O-Allyl-3,4,6-tri-O-benzyl-α/β-D-glucopyranose[33] 3.11 
OBnO
BnO
3.10
BnO
O OH
Dioxane / H2O, rt, 3 h
OBnO
BnO
BnO
O SEt
3.11
MeOTf, TTBP
(80%)
 
Ethyl 2-O-allyl-3-4-6-tri-O-benzyl-1-thio-β-D-glucopyranoside 3.10 (0.267 g, 0.500 mmol) and 
TTBP (0.372 g, 1.50 mmol) were dissolved in a mixture of 1,4-dioxane and water (10.5 ml, 
20:1). MeOTf (1.50 mmol) was added and reaction stirred at rt. After 3 h, t.l.c (petrol:ethyl 
acetate, 4:1) indicated the formation of a single product (Rf 0.3) and complete consumption of 
starting material (Rf 0.6). The reaction was diluted with DCM (20 ml) and washed with water (20 
ml). The aqueous layer was then extracted with DCM (2 x 20 ml), and the combined organic 
extracts were washed with saturated aq. sodium bicarbonate (20 ml) and brine (20 ml). The 
organic phase was dried (MgSO4), filtered, and concentrated in vacuo. The residue was purified 
by flash column chromatography (petrol:ethyl acetate, 4:1) to afford 2-O-allyl-3,4,6-tri-O-
benzyl-α/β-D-glucopyranose 3.11 (0.196 g, 80%) as white crystalline solid. δH (400 MHz, 
CDCl3) [5:1 mixture of α:β anomers observed, major α anomer quoted] 3.34 (1H, m, H-2), 3.52-
3.64 (4H, m, H-3, H-4, H- 6, H-6’), 3.90 (1H, m, H-5), 4.26 (1H, ddat, Jgem 11.7 Hz, Jvic 6.1 Hz, 
J 1.4 Hz, OCHH’CH=CH2), 4.39 (1H, ddat, Jgem 11.7 Hz, Jvic 5.7 Hz, J 1.4 Hz, 
OCHH’CH=CH2) 4.53, 4.63 (2H, ABq, JAB 12.1 Hz, PhCH2), 4.56, 4.82 (2H, ABq, JAB 10.9 Hz, 
PhCH2), 4.85 (2H, br s, PhCH2), 5.15 (1H, daq, JZ 10.4 Hz, J 1.5 Hz, CH=CHEHZ), 5.27 (1H, 
daq, JE 17.2 Hz, J 1.6 Hz, CH=CHEHZ), , 5.35 (1H, dd, J1,2 3.3 Hz, H-1), 5.96 (1H, ddat, JE 17.2 
Hz, JZ 10.4 Hz, J 5.9 Hz, CH=CH2), 7.14-7.35 (15H, m, 15 x Ar-H). 
3,4,6-Tri-O-benzyl-2-O-(2-hydroxyethyl)ether-α/β-D-glucopyranose[34] 3.12  
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O
BnO
O
1) O3, DCM/MeOH, -78
oC
2) NaBH4, rt
O
BnO
O
OH
OH
3.11 3.12
BnO
BnO
BnO
BnO
(76%)
OH
 
A solution of 2-O-allyl-3,4,6-tri-O-benzyl-α/β-D-glucopyranose 3.11 (121 mg, 0.246 mmol) in 
DCM-Methanol (3 mL, 1:1) was treated with ozone at -78 °C until the solution turned blue. The 
reaction was then quenched by the addition of NaBH4 (19 mg, 0.492 mmol) in small portions 
over 50 min. The reaction mixture was allowed to warm to rt and then concentrated in vacuo. 
The residue was purified by flash column chromatography (petrol:ethyl acetate, 4:1) to afford 
3,4,6-tri-O-benzyl-2-O-(2-hydroxyethyl)ether-α/β-D-glucopyranose 3.12 (101 mg, 76%) as a 
colourless oil; δH (400 MHz, CDCl3) [5:1 mixture of α:β anomers observed, major α anomer 
quoted] 3.31 (1H, m, H-2), 3.50-3.75 (8H, m, H-3, H-4, H-6, H-6’, OCH2CH2OH, 
OCH2CH2OH), 3.90 (1H, m, H-5) 4.57, 4.66 (2H, ABq, JAB 12.1 Hz, PhCH2), 4.59, 4.84 (2H, 
ABq, JAB 10.9 Hz, PhCH2), 4.91 (2H, br s, PhCH2), 5.38 (1H, dd, J1,2 3.3 Hz, H-1), 7.14-7.35 
(15H, m, 15 x Ar-H). 
3,4,6-Tri-O-benzyl-2-O-(2-iodoethyl)-α/β-D-glucopyranose[11] 3.13 
O
O
OH
OHBnO
3.12 3.13
O
O
I
OHBnOI2, PPh3, imidazole,
BnO
BnO
BnO
BnO
THF, ref lux, 16 h
(76%)
 
3,4,6-Tri-O-benzyl-2-O-(2-hydroxyethyl)ether-α/β-D-glucopyranose 3.12 (0.249 g, 0.504 mmol) 
was dissolved in freshly distilled THF (5 ml) under an atmosphere of argon. Iodine (0.191 g, 
0.756 mmol), imidazole (0.051 g, 0.756 mmol) and PPh3 (0.147 g, 0.756 mmol) were added as a 
solution in THF (5 ml), and the reaction was then heated to reflux. After 16 h, t.l.c. (petrol:ethyl 
acetate, 4:1) indicated formation of a single major product (Rf 0.4) and complete consumption of 
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starting material (Rf 0.1). The reaction was cooled to rt and concentrated in vacuo. The resulting 
residue was purified by flash column chromatography (petrol:ethyl acetate, 6:1) to afford 3,4,6-
tri-O-benzyl-2-O-(2-iodoethyl)-α/β-D-glucopyranose 3.13 (0.231 g, 76%) as a colourless oil; δH 
(400 MHz, CDCl3) [5:1 mixture of α:β anomers observed, major α anomer quoted] 3.12-3.16 
(2H, m, OCH2CH2I), 3.35 (1H, dd, J1,2 3.3 Hz, J2,3 8.2 Hz, H-2), 3.46-3.55 (2H, m, H-4, H-5), 
3.59-3.65 (3H, m, H-4, H-6, H-6’), 3.79-3.85 (1H, m, OCHH’CH2I), 3.93-3.99 (1H, m, 
OCHH’CH2I), 4.46, 4.54 (2H, ABq, JAB 11.8 Hz, PhCH2), 4.46, 4.72 (2H, ABq, JAB 11.2 Hz, 
PhCH2), 4.74, 4.88 (2H, ABq, JAB 11.1 Hz, PhCH2), 5.35 (1H, d, J1,2 3.3 Hz, H-1), 7.06-7.29 
(15H, m, 15 x Ar-H). 
3,4,6-Tribenzyl-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α/β-D-glucopyranose[24] 3.14 
 
O
O
I
OHBnO
3.13
3.14
O
O
S
OHBnO
N,N -Diisopropylethylamine
DMF, rt, 16 h
BnO
BnO
BnO
BnO
OMeMeO
OMe
+
SH
OMeMeO
OMe (71%)
 
3,4,6-Tri-O-benzyl-2-O-(2-iodoethyl)-α/β-D-glucopyranose 3.13 (140 mg, 0.28 mmol) was 
dissolved in DMF (10 mL) under a atmosphere of nitrogen. Hünig’s base (0.06 mL, 0.34 mmol) 
and 2,4,6-trimethoxybenzenethiol (68 mg, 0.34 mmol) were added, and the mixture was stirred at 
rt. After 16 h, t.l.c. (petrol:ethyl acetate, 3:2) indicated the complete consumption of starting 
material (Rf 0.7) and the formation of a major product (Rf 0.4). The solution was then 
concentrated in vacuo, and the residue was purified by flash chromatography (petrol:ethyl acetate, 
3:1) to afford 3,4,6-triacetyl-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α/β-D-glucopyranose 
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3.14 (135 mg, 71%) as white amorphous solid; δH (400 MHz, CDCl3) [2:1 mixture of α:β anomers 
observed]: 3.02-3.07 (6H, m, OCH2CH2SAr α, OCH2CH2SAr β), 3.20 (1H, at J 10.0 Hz, H-2 β), 
3.40 (2H, dd, J1,2 3.3 Hz, J2,3 8.2 Hz, H-2 α), 3.56-3.94 (46H, m, 3 x OCH3 α, 3 x OCH3 β, H-3 α, 
H-3 β, H-4 α, H-4 β, H-5 α, H-5 β, H-6 α, H-6 β, H-6’ α, H-6’ β, OCHH’CH2SAr α, 
OCHH’CH2SAr β, OCHH’CH2SAr β), 4.02-4.09 (2H, m, OCHH’CH2SAr α), 4.48-4.91 (19H, m, 
H-1 β, 3 x PhCH2 α, 3 x PhCH2 β), 5.34 (2H, d, J1,2 3.3 Hz, H-1 α), 6.14 (6H, s, 2 x SArCH α, 2 x 
SArCH β), 7.09-7.32 (45H, m, 15 x Ar-CH α, 15 x Ar-CH β); δC (100 MHz, CDCl3): 34.5 (t, 
OCH2CH2SAr α), 35.1 (t, OCH2CH2SAr β), 55.3, 55.4, 56.1, 56.2 (4 x q, 2 x OMe α, 2 x OMe β), 
68.6 (t, C-6a α), 62.2 (t, C-6a β), 70.2 (t, OCH2CH2SAr β), 70.5 (t, OCH2CH2SAr α), 73.5, 73.8, 
74.9, 75.0, 75.5, 76.7 (6 x t, 3 x PhCH2 α, 3 x PhCH2 β), 72.0, 76.9, 77.8, 77.9, 81.4, 81.6, 84.2, 
85.0 (8 x d, C-2 α, C-2 β, C-3 α, C-3 β, C-4 α, C-4 β, C-5 α, C-5 β), 91.0, 91.1, 91.2 (3 x d, SArC-
H α, SArC-H β, C-1 β), 91.5 (d, C-1 α), 127.0, 127.2, 127.3, 127.4, 127.5, 127.6, 127.7,127.7, 
127.8, 127.9, 127.9, 128.0, 128.1, 128.2, 128.3, 128.3, 128.4, 128.4 (18 x d, 9 x ArCH α, 9 x 
ArCH β), 137.8, 137.9, 138.2, 138.3, 138.8, 138.9 (6 x s, 3 x ArC α, 3 x ArC β), 161.6, 161.8, 
161.9, 162.0 (4 x s, S-ArC-OMe o α, S-ArC-OMe o β, S-ArC-OMe p α, S-ArC-OMe p β); HRMS 
(ES
+
) calculated for C35H50O17SNa (MNa
+
) 797.2660, found 797.2669.  
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3,4,6-Tribenzyl-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α-D-glucopyranosyl) 
trichloroacetimidate
[12]
 3.1 
3.14
O
O
S
OHBnO
BnO
BnO
OMeMeO
OMe
Cl3CCN, DBU
DCM, rt, 7 h
3.1
O
O
S
OBnO
BnO
BnO
OMeMeO
OMe
(93%)
CCl3
NH
 
3,4,6-triacetyl-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α/β-D-glucopyranose 3.14 (160 mg, 
0.235 mmol) was dissolved in DCM (10 mL) under a nitrogen atmosphere. Trichloroacetonitrile 
(0.16 mL, 2.35 mmol) and DBU (0.011 mL, 0.094 mmol) were added, and the reaction was 
stirred at 0 °C. After 7 h, t.l.c. (petrol:ethyl acetate, 3:2, with 1% TEA) indicated the formation of 
a major product (Rf 0.8) and the complete consumption of starting material (Rf 0.2). The reaction 
was warmed to rt and concentrated in vacuo. The residue was purified by flash chromatography 
(petrol:ethyl acetate, 4:1, with 1% TEA) to afford 3,4,6-tribenzyl-2-O-(2-(phenylthionyl)ethyl)-
α-D-glucopyranosyl) trichloroacetimidate 3.1 (190 mg, 93%) as colorless oil; νmax (KBr) 3345(w, 
NH), 1664 (s, C=NH) cm
-1; δH (400 MHz, CDCl3) 2.76-2.90 (2H, m, OCH2CH2SAr), 3.58-3.78 
(6H, m, OCH2CH2SAr, H-2, H-3, H-6, H-6’), 3.83 (9H, s, 3 x OCH3), 3.89-3.95 (2H, m, H-4, 
H5), 4.45, 4.58 (2H, ABq, JAB 11.9 Hz, PhCH2), 4.50, 4.83 (2H, ABq, JAB 10.8 Hz, PhCH2), 
4.77, 4.94 (2H, ABq, JAB 10.9 Hz, PhCH2), 6.13 (2H, s, 2 x SArCH), 6.49 (1H, d, J1,2 3.4 Hz, H-
1), 7.10-7.34 (15H, m, Ar-H), 8.46 (1H, br s, NH); δC (100 MHz, CDCl3) 33.9 (t, 
OCH2CH2SAr), 55.4 (t, C-6), 56.0, 56.1 (2 x q, 2 x OMe), 68.1 (t, OCH2CH2SAr), 73.0, 73.4, 
75.3 (3 x t, 3 x ArCH2), 70.4, 75.5, 80.3, 81.1 (4 x d, C-2, C-3, C-4, C-5), 90.9 (d, SArC-H), 91.3 
     Chapter 5                                                                                                                       Experimental 
                                                                                                                                                                                                                                                     
223 
 
(s, CCl3), 94.0 (d, C-1), 100.9 (s, SCAr), 127.5, 127.7, 127.9, 128.0, 128.1, 128.2, 128.3, 128.4, 
128.5 (9 x d, Ar-CH), 137.8, 138.2, 138.8, (3 x s, 3 x ArC), 161.6, 161.9,  162.2 (3 x s, S-ArC-
OMe o, S-ArC-OMe p, C=NH); HRMS (ES
+
) calculated for C40H44O9Cl3SNa (MNa
+
) 842.1694, 
found 842.1711. 
3,4,6-Tribenzyl-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α-D-glucopyranosyl-(1→6)-
1:2,3:4-di-O-isopropylidene-D-galactopyranoside (Protocol B)
[25]
 3.24 
i) TMSOTf (1 eq), (-78 °C 0 °C) / DCM
ii)
O
O
O
OH
O O
,TTBP 2.46, -78 °C / DCM
(69%)
2.42
O
O
S
OBnO
BnO
BnO
OMeMeO
OMe
3.1
CCl3
NH
O
S
O
BnO
BnO
BnO
O
O
O
O
O
3.24
a
b
O
MeO
OMe
MeO
 
A mixture of donor 3,4,6-tribenzyl-2-O-(2-(phenylthionyl)ethyl)-α-D-glucopyranosyl) 
trichloroacetimidate 3.1 (120 mg, 0.15 mmol) and activated molecular sieves (3 Å) (100 mg) in 
DCM (5 mL) was stirred for 10 min under a nitrogen atmosphere at rt. The mixture was cooled 
to -78 °C, TMSOTf (26 µL, 0.15 mmol) was added, and the mixture was then allowed to warm 
to 0 °C over a period of 40 min. After cooling of the mixture to -78 °C, glycosyl acceptor 
1:2,3:4-di-O-isopropylidene-D-galactopyranoside 2.42 (48 mg, 0.18 mmol) and TTBP 2.46 (80 
mg, 0.30 mmol) were added. The mixture was then allowed to warm slowly to rt. After 16 h, 
t.l.c. (toluene:ethyl acetate, 4:1) indicated the formation of a major product (Rf 0.4) and the 
complete consumption of donor (Rf 0.7). The reaction was quenched by the addition of saturated 
aq. sodium bicarbonate solution (5 mL), the organic phase was separated, dried (MgSO4), filtered 
and concentrated in vacuo. The residue was purified by flash chromatography (toluene:ethyl 
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acetate, 8:1) to afford 3,4,6-tribenzyl-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α-D-
glucopyranosyl-(1→6)-1:2,3:4-di-O-isopropylidene-D-galactopyranoside 3.24 (0.095 g, 69%) as 
colorless oil; [α]D
20
 - 0.5  (c, 1.0 in CHCl3); δH (400 MHz, CDCl3): 1.32-1.54 (12H, m, 4 x CH3), 
2.85-2.98 (2H, m, OCH2CH2SAr), 3.41 (1H, dd, J2,3 9.24, J1,2 3.37 Hz, H-2a), 3.59-3.69 (4H, m, 
H-6a, H-6’a, H-6b, H-6’b), 3.72-3.91 (14H, m, 3 x OCH3, OCH2CH2SAr, H-4a, H-4b, H-5b), 4.01 
(1H, at, J 9.4 Hz, H-3a), 4.31 (2H, m, H-2b, H-3b), 4.44-4.91 (7H, m, 3 x PhCH2, H-5a), 5.03 (1H, 
d, J1,2 4.1 Hz, H-1a), 5.49 (1H, d, J1,2 5.1 Hz, H-1b), 6.12 (2H, s, 2 x SArC-H), 7.12-7.32 (15H, 
m, Ar-CH); δC (100 MHz, CDCl3) 24.5, 24.9, 26.0, 26.1 (4 x q, 4 x CH3), 34.0 (OCH2CH2SAr), 
55.3, 56.0 (2 x q, 2 x OCH3), 65.8, 66.5 (2 x t, C-6a, C-6b), 68.4 (OCH2CH2SAr), 70.2, 70.5, 
70.6, 70.7, 70.8, 77.5 (6 x d, C-4a, C-5a, C-2b, C-3b, C-4b, C-5b),  73.4, 74.9, 75.5 (3 x t, 3 x 
CH2Ph),  81.2 (d, C-2a), 81.7 (d, C-3a) 91.0 (d, SArC-H), 96.2 (d, C-1b), 97.3 (d, C-1a), 108.5 (s, 
C(CH3)2), 109.1 (s, C(CH3)2), 127.4, 127.5, 127.6, 127.8, 127.9, 128.0, 128.2, 128.3, 128.4 (9 x 
d, 9 x Ar-CH), 138.0, 138.4, 139.0 (3 x Ar-C), 161.8, 162.0 (2 x s, S-ArC-OMe o, S-ArC-OMe 
p); HRMS (ES
+
) calculated for C50H62O14SNa (MNa
+
) 941.3752, found 941.3769. 
O-(2,3,4,6-tetra-O-benzyl)-α-D-glucopyranosyl trichloroacetimidate[35] 4.24 
4.23
O
O
OHBnO
BnO
BnO Cl3CCN / DBU
DCM
4.24
O
O
BnO
BnO
BnO
Bn Bn
O CCl3
NH
 
2,3,4,6-Tetra-O-benzyl-D-α/β-glucopyranose 4.23 (165 mg, 0.305 mmol) was dissolved in DCM (5 
mL) under N2. Trichloroacetonitrile (0.21 mL, 3.05 mmol) and DBU (0.014 mL, 0.122 mmol) 
were added, and the reaction was stirred at 0 °C. After 5 h, t.l.c. (petrol:ethyl acetate, 3:1, with 
1% TEA) indicated the formation of a major product (Rf 0.5) and the complete consumption of 
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starting material (Rf 0.1). The reaction was warmed to rt and concentrated in vacuo. The 
resulting residue was purified by flash chromatography (petrol:ethyl acetate, 5:1, with 1% TEA) 
to afford O-(2,3,4,6-tetra-O-benzyl)-α-D-glucopyranosyl trichloroacetimidate 4.24 (205 mg, 
100%) as colorless oil; δH (400 MHz, CDCl3):
[36]
 3.63-3.83 (4H, m, H-2, H-5, H-6, H-6’), 3.96-
4.10 (2H, m, H-3, H-4), 4.45-4.91 (8H, m, 4 x CH2Ph), 6.53 (1H, d, J1,2 3.4 Hz, H-1), 7.10-7.34 
(20H, m, Ar-H), 8.58 (1H, br s, NH). 
N-Trichloroacetyl-2,3,4,6-tetra-O-benzyl-α/β-D-glucopyranosylamine 3.19 
O
O
BnO
BnO
BnO
O
O O
O
O
Bn
O
O
O
BnO
BnO
BnO
N
H
3.18
O
O
BnO
BnO
BnO
Bn
O CCl3
NH
Bn CCl3
O
3.19
i) TMSOTf (1 eq), (-78 °C 0 °C) / DCM
ii)
O
O
O
OH
O O
,TTBP 2.46, -78 °C / DCM
(75%)
2.42
X
 
A mixture of donor O-(2,3,4,6-tetra-O-benzyl)-α-D-glucopyranosyl trichloroacetimidate 3.18 
(200 mg, 0.29 mmol) and activated molecular sieves (3 Å) (100 mg) was stirred in DCM (5 mL) 
for 10 min under a nitrogen atmosphere at rt. The mixture was cooled to -78 °C, TMSOTf (53 
µL, 0.29 mmol) was added, and the reaction mixture was allowed to warm to 0 °C over a period 
of 40 min. The mixture was then cooled to -78 °C, glycosyl acceptor 1:2,3:4-di-O-
isopropylidene-D-galactopyranoside 2.42 (103 mg, 0.37 mmol) and TTBP 2.46 (147 mg, 0.59 
mmol) were added. The reaction mixture was allowed to warm slowly to rt. After 16 h, t.l.c. 
(petrol:ethyl acetate, 3:2) indicated the formation of a major product (Rf 0.7) and the complete 
consumption of the donor (Rf 0.8). The reaction was quenched by the addition of saturated aq. 
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sodium bicarbonate solution (5 mL), the organic phase was separated, dried (MgSO4), filtered 
and concentrated in vacuo.  The residue was purified by flash chromatography (petrol:ethyl 
acetate, 9:1) to afford N-trichloroacetyl-2,3,4,6-tetra-O-benzyl-α/β-D-glucopyranosylamine 3.19 
(0.150 g, 75%) as colorless oil; δH (400 MHz, CDCl3) [6:1 mixture of α:β anomers observed, 
major α anomer quoted]:[37] 3.63-3.70 (3H, m, H-2, H-4, H-5), 3.73-3.81 (2H, m, H-2, H-6), 3.88 
(1H, dd, J6,6’ 9.0 Hz, J5,6’ 5.2 Hz H-6’), 3.47-3.92 (8H, m, 4 x CH2Ph), 5.60 (1H, at, J 8.0 Hz, H-
1), 7.12-7.37 (21H, m, 20 x Ar-CH, NH); δC (100 MHz, CDCl3):
9 
68.0 (t, C-6), 71.8 (d, C-4), 
72.9, 73.6, 75.1, 75.5 (4 x t, 4 x CH2Ph), 76.5 (d, C-5), 76.9 (d, C-1), 77.2 (d, C-2), 81.6 (d, C-3), 
92.3 (s, CCl3), 127.2-138.1 (12 x d, 12 x ArC-H), 136.9, 137.8, 138.2, 138.2 (4 x s, 4 x ArC), 
162.1 (s, C=O). 
2,3,4,6-Tribenzyl-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α/β-D-glucopyranosyl-(1→6)-
1:2,3:4-di-O-isopropylidene-D-galactopyranoside (Protocol B-modified) 3.20 
1) TTBP 2.46 (2 eq.)
2) TMSOTf (1eq.)
O
O
BnO
BnO
BnO
O
O O
O
O
Bn
O
3.18
O
O
BnO
BnO
BnO
Bn
O CCl3
NH
O
O O
O
O OH
+
2.42
3.20
a
b
DCM, -78 °C rt, 5 h
(64 %)
 
A mixture of donor O-(2,3,4,6-tetra-O-benzyl)-α-D-glucopyranosyl trichloroacetimidate 3.18 
(200 mg, 0.29 mmol), acceptor 1:2,3:4-di-O-isopropylidene-D-galactopyranoside 2.42 (103 mg, 
0.37 mmol), TTBP 2.46 (147 mg, 0.59 mmol) and activated molecular sieves (3 Å) (100 mg) in 
DCM (5 mL) was stirred for 10 min under a nitrogen atmosphere at rt. After the mixture was 
cooled to -78 °C, TMSOTf (53 µL, 0.29 mmol) was added, and the reaction mixture was stirred 
for 5 h -78 °C. The reaction mixture was then allowed to warm slowly to rt. After a further 16 h, 
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t.l.c. (petrol:ethyl acetate, 3:2) indicated the formation of a major product (Rf 0.6) and the 
complete consumption of the donor (Rf 0.8). The reaction was quenched by the addition of 
saturated aq. sodium bicarbonate solution (5 mL), the organic phase was separated, dried 
(MgSO4), filtered and concentrated in vacuo.  The residue was purified by flash chromatography 
(petrol:diethyl ether, 7:1) to afford 2,3,4,6-Tribenzyl-2-O-(2-(2,4,6-
trimethoxybenzenethio)ethyl)-α/β-D-glucopyranosyl-(1→6)-1:2,3:4-di-O-isopropylidene-D-
galactopyranoside 3.20 (0.145 g, 64%) as colorless oil; δH (400 MHz, CDCl3) [1:2.5 mixture of 
α:β anomers observed]:[38] 1.32, 1.46, 1.51, 1.54 (42H, 4 x br s, 4 x CH3 α, 4 x CH3 β), 3.42-3.49 
(7H, m, H-2a α, H-5a α, H-2a β, H-5a β), 3.57-3.85 (21H, m, H-2b α, H-4b α, H-5b α, H-4a α, H-
6a α, H-6’a α, H-2b β, H-4b β, H-5b β, H-4a β, H-6a β, H-6’a β), 3.99 (1H, at, J 9.2 Hz, H-3a α), 
4.02-4.11 (4.5H, m, H-3a β, H-6b α, H-6’b α), 4.17 (2.5H, dd, J5,6 3.5 Hz, J6,6’ 10.8 Hz, H-6b β), 
4.25 (2.5H, m, H-6’b β), 4.31-4.37 (3.5H, m, H-3b α, H-3b β), 4.46 (2.5H, d, J1,2 7.9 Hz, H-1a 
β), 4.49-5.07 (28H, 4 x PhCH2 α, 4 x PhCH2 β), 4.58 (1H, d, J1,2 2.4 Hz, H-1a α), 5.53 (1H, d, 
J1,2 5.1 Hz, H-1b α), 5.57 (2.5H, d, J1,2 5.1 Hz, H-1b β), 7.12-7.45 (70H, m, 20 x Ar-CH  α, 20 x 
Ar-CH β). 
3,4,6-Tribenzyl-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α-D-glucopyranosyl-(1→3)-
methyl-2-O-benzyl-4,6-O-benzylidene-α-D-mannopyranoside (Protocol B)[25] 3.27 
i) TMSOTf (1 eq), (-78 °C 0 °C) / DCM
ii)
,TTBP 2.46, -78 °C / DCM
(63%)
O
O
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A mixture of 3,4,6-tribenzyl-2-O-(2-(phenylthionyl)ethyl)-α-D-glucopyranosyl) 
trichloroacetimidate 3.1 (120 mg, 0.15 mmol) and activated molecular sieves (3 Å, 100 mg) in 
DCM (5 mL) was stirred for 10 min under a nitrogen atmosphere at rt. The mixture was cooled 
to -78 °C, TMSOTf (26 µL, 0.15 mmol) was added, and the mixture was then allowed to warm 
to 0 °C over a period of 40 min. After re-cooling of the mixture to -78 °C, methyl-2-O-benzyl-
4,6-O-benzylidene-α-D-mannopyranoside 2.44 (76 mg, 0.18 mmol) and TTBP 2.46 (80 mg, 0.30 
mmol) were added. The mixture was then allowed to warm slowly to rt. After 16 h, t.l.c. 
(toluene:ethyl acetate, 4:1) indicated the formation of a major product (Rf 0.3) and the complete 
consumption of 3.1 (Rf 0.7). The reaction was quenched by the addition of saturated aq. sodium 
bicarbonate (5 mL), the organic phase was separated, dried (MgSO4), filtered, and concentrated 
in vacuo. The residue was purified by flash chromatography (toluene:ethyl acetate, 10:1) to 
afford 3,4,6-tribenzyl-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α-D-glucopyranosyl-(1→3)- 
methyl-2-O-benzyl-4,6-O-benzylidene-α-D-mannopyranoside 3.27 (0.092 g, 63%) as colorless 
oil; [α]D
20
 + 10.3  (c, 1.0 in CHCl3); δH (400 MHz, CD3CN): 2.81-2.90 (2H, m, OCH2CH2SAr), 
3.25 (3H, s, OCH3b), 3.35-3.57 (3H, m, H-2a, H-6a, H-6’a), 3.65-3.93 (17H, m, 3 x OCH3, 
OCH2CH2SAr, H-4a, H-3a, H-3b, H-4b, H-5b, H-6b), 4.08 (1H, m, H-2b), 4.19-4.29 (2H, m, H-6’b, 
H-5a), 4.48-5.07, 4.69 (9H, m, 4 x PhCH2, H-1b), 5.36 (1H, d, J1,2 3.2 Hz, H-1a), 5.70 (1H, s, 
PhCH), 6.21 (2H, s, 2 x SArC-H), 7.12-7.32 (25H, m, Ar-CH); δC (100 MHz, CD3CN): 34.3 
(OCH2CH2SAr), 54.3 (q, OCH3b), 55.1, 55.7 (2 x q, 2 x OCH3a), 64.0, 69.4 (2 x t, C-6a, C-6b), 
70.6 (OCH2CH2SAr), 71.9, 72.8, 74.6, 74.7, 74.8 (5 x d, C-4a, C-5a, C-3b, C-4b, C-5b), 75.6, 75.7, 
77.8, 77.9 (4 x t, 3 x CH2Ph),  78.6 (d, C-2b), 80.9, 81.1 (2 x d, C-2a, C-3a) 91.2 (d, SArC-H), 
98.0 (d, C-1a), 100.7 (d, C-1b), 101.3 (CHPh), 101.4 (s, SCAr), 127.3, 127.4, 127.5, 127.6, 127.7, 
127.8, 127.9, 128.0, 128.1, 128.2, 128.3, 128.4, 128.5, 128.8 (15 x d, 15 x Ar-CH), 138.1, 138.6, 
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138.7, 138.8, 139.4 (4 x Ar-C), 161.8, 161.9 (2 x s, S-ArC-OMe o, S-ArC-OMe p); HRMS (ES
+
) 
calculated for C59H66O14SNa (MNa
+
) 1053.4065, found 1053.4079. 
3,4,6-Tribenzyl-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α-D-glucopyranosyl-(1→2)-
methyl-3-O-benzyl-4,6-O-benzylidene-α-D-mannopyranoside (Protocol B)[25] 3.28 
i) TMSOTf (1 eq), (-78 °C 0 °C) / DCM
ii)
,TTBP 2.46, -78 °C / DCM
(65%)
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A mixture of 3,4,6-tribenzyl-2-O-(2-(phenylthionyl)ethyl)-α-D-glucopyranosyl) 
trichloroacetimidate 3.1 (120 mg, 0.15 mmol) and activated molecular sieves (3 Å, 100 mg) in 
DCM (5 mL) was stirred for 10 min under a nitrogen atmosphere at rt. The mixture was cooled 
to -78 °C, TMSOTf (26 µL, 0.15 mmol) was added, and the mixture was then allowed to warm 
to 0 °C over a period of 40 min. After re-cooling of the mixture to -78 °C, methyl-3-O-benzyl-
4,6-O-benzylidene-α-D-mannopyranoside 2.45 (76 mg, 0.18 mmol) and TTBP 2.46 (80 mg, 0.30 
mmol) were added. The mixture was then allowed to warm slowly to rt. After 16 h, t.l.c. 
(toluene:ethyl acetate, 4:1) indicated the formation of a major product (Rf 0.3) and the complete 
consumption of 3.1  (Rf 0.7). The reaction was quenched by the addition of saturated aq. sodium 
bicarbonate (5 mL), the organic phase was separated, dried (MgSO4), filtered, and concentrated 
in vacuo. The residue was purified by flash chromatography (toluene:ethyl acetate, 10:1) to 
afford 3,4,6-tribenzyl-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α-D-glucopyranosyl-(1→2)- 
methyl-3-O-benzyl-4,6-O-benzylidene-α-D-mannopyranoside 3.28 (0.095 g, 65%) as colorless 
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oil; [α]D
20
 + 25.1  (c, 1.0 in CHCl3); δH (400 MHz, CDCl3): 2.77-2.94 (2H, m, OCH2CH2SAr), 
3.26 (3H, s, OCH3b), 3.42 (1H, dd, J2,3 9.24, J1,2 3.37 Hz, H-2a), 3.52-3.61 (2H, m, H-6a, H-6’a), 
3.62-3.95 (12H, m, 3 x OCH3, OCH2CH2SAr, H-4a), 3.87-3.97 (5H, m, H-3a, H-3b, H-4b, H-5b, 
H-6b), 4.06 (1H, m, H-2b), 4.24 (1H, dd, J5,6 3.2 Hz, J6,6’ 12.2Hz, H-6’b), 4.30 (1H, m, H-5a), 
4.43-5.05, 4.71 (9H, m, 4 x PhCH2, H-1b), 5.37 (1H, d, J1,2 3.2 Hz, H-1a), 5.68 (1H, s, PhCH), 
6.06 (2H, s, 2 x SArC-H), 7.12-7.32 (25H, m, Ar-CH); δC (100 MHz, CDCl3): 34.5 
(OCH2CH2SAr), 54.7 (q, OCH3b), 55.3, 56.0 (2 x q, 2 x OCH3a), 64.1, 68.7 (2 x t, C-6a, C-6b), 
68.8 (OCH2CH2SAr), 69.9, 70.6, 72.6, 73.4, 75.2 (5 x d, C-4a, C-5a, C-3b, C-4b, C-5b), 75.4, 75.5, 
75.9, 77.5 (4 x t, 3 x CH2Ph),  79.0 (d, C-2b), 81.1, 81.2 (2 x d, C-2a, C-3a) 91.0 (d, SArC-H), 
98.3 (d, C-1a), 100.9 (d, C-1b), 101.3 (CHPh), 101.7 (s, SCAr), 126.1, 127.4, 127.5, 127.6, 127.7, 
127.8, 127.9, 128.0, 128.1, 128.2, 128.3, 128.4, 128.5, 128.7 (15 x d, 15 x Ar-CH), 137.8, 138.0, 
138.2, 138.6, 139.1 (4 x Ar-C), 161.6, 162.0 (2 x s, S-ArC-OMe o, S-ArC-OMe p); HRMS (ES
+
) 
calculated for C59H66O14SNa (MNa
+
) 1053.4065, found 1053.4056. 
3,4,6-Tribenzyl-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α-D-glucopyranosyl-(1→6)-
methyl-2,3,4-O-tribenzyl-α-D-glucopyranoside (Protocol B)[25] 3.30 
i) TMSOTf (1 eq), (-78 °C 0 °C) / DCM
ii)
,TTBP 2.46, -78 °C / DCM
(68%)
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A mixture of 3,4,6-tribenzyl-2-O-(2-(phenylthionyl)ethyl)-α-D-glucopyranosyl) 
trichloroacetimidate 3.1 (120 mg, 0.15 mmol) and activated molecular sieves (3 Å, 100 mg) in 
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DCM (5 mL) was stirred for 10 min under a nitrogen atmosphere at rt. The mixture was cooled 
to -78 °C, TMSOTf (26 µL, 0.15 mmol) was added, and the mixture was then allowed to warm 
to 0 °C over a period of 40 min. After re-cooling of the mixture to -78 °C, methyl-2,3,4-O-
tribenzyl-α-D-glucopyranoside 3.29 (84 mg, 0.18 mmol) and TTBP 2.46 (80 mg, 0.30 mmol) 
were added. The mixture was then allowed to warm slowly to rt. After 16 h, t.l.c. (toluene:ethyl 
acetate, 4:1) indicated the formation of a major product (Rf 0.3) and the complete consumption 
of 3.1 (Rf 0.7). The reaction was quenched by the addition of saturated aq. sodium bicarbonate (5 
mL), the organic phase was separated, dried (MgSO4), filtered and concentrated in vacuo. The 
residue was purified by flash chromatography (toluene:ethyl acetate, 10:1) to afford 3,4,6-
tribenzyl-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α-D-glucopyranosyl-(1→6)-methyl-2,3,4-
O-tribenzyl-α-D-glucopyranoside 3.30 (0.114 g, 68%) as white amorphous solid; [α]D
20
 + 48.2 (c, 
1.0 in CHCl3); δH (400 MHz, CDCl3): 2.82-3.02 (2H, m, OCH2CH2SAr), 3.26 (4H, m, OCH3b, 
H-2a), 3.51-3.66 (5H, m, H-3a, H-2b, H-5b, H-6a, H-6’a), 3.71-3.92 (16H, m, OCH2CH2SAr, 3 x 
OCH3a, H-4b, H-6b, H-6’b, H-4a, H-5a), 3.99 (1H, at, J 8.8 Hz, H-3b), 4.67 (1H, d, J1,2 3.2 Hz, H-
1b), 4.51-5.04, (12H, m, 6 x PhCH2), 5.04 (1H, d, J1,2 3.2 Hz, H-1a), 6.13 (2H, s, 2 x SArC-H), 
7.12-7.43 (30H, m, Ar-CH); δC (100 MHz, CDCl3): 34.2 (t, OCH2CH2SAr), 55.0 (q, OCH3b), 
55.3, 56.0 (2 x q, OCH3a), 66.4 (d, C-6b), 68.9 (d, C-6a), 70.2 (t, OCH2CH2SAr), 70.3, 70.4 (2 x 
d, C-5a, C-4b), 73.2, 73.4, 74.7, 74.8, 75.6, 76.6 (6 x t, 6 x CH2Ph), 75.2 (d, C-5b), 78.1, 81.2, 
81.4 (4 x d, C-2a, C-3a, C-4a), 80.6 (d, C-3b), 82.1 (d, C-2b), 91.4 (d, SArC-H), 97.4 (d, C-1b), 
97.9 (d, C-1a), 101.9 (s, SCAr), 127.2, 127.3, 127.3, 127.4, 127.4, 127.5, 127.6, 127.7, 127.7, 
127.8, 127.9, 127.9, 128.1, 128.1, 128.2, 128.2, 128.3, 128.3 (18 x d, 18 x Ar-CH), 138.2, 138.4, 
138.6, 138.7, 139.0, 139.1 (6 x Ar-C), 161.8, 162.1 (2 x s, S-ArC-OMe o, S-ArC-OMe p); 
HRMS (ES
+
) calculated for C66H74O14SNa (MNa
+
) 1145.4691, found 1145.4713. 
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3,4,6-Tribenzyl-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α-D-glucopyranosyl-(1→4)-
methyl-2,3,6-O-tribenzyl-α-D-glucopyranoside (Protocol B)[25] 3.32 
i) TMSOTf (1 eq), (-78 °C 0 °C) / DCM
ii)
,TTBP 2.46, -78 °C / DCM
(61%)
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A mixture of 3,4,6-tribenzyl-2-O-(2-(phenylthionyl)ethyl)-α-D-glucopyranosyl) 
trichloroacetimidate 3.1 (120 mg, 0.15 mmol) and activated molecular sieves (3 Å,100 mg) in 
DCM (5 mL) was stirred for 10 min under a nitrogen atmosphere at rt. The mixture was cooled 
to -78 °C, TMSOTf (26 µL, 0.15 mmol) was added, and the mixture was then allowed to warm 
to 0 °C over a period of 40 min. After re-cooling of the mixture to -78 °C, methyl-2,3,6-O-
tribenzyl-α-D-glucopyranoside 3.31 (84 mg, 0.18 mmol) and TTBP (80 mg, 0.30 mmol) were 
added. The mixture was then allowed to warm slowly to rt. After 16 h, t.l.c. (toluene:ethyl 
acetate, 4:1) indicated the formation of a major product (Rf 0.3) and the complete consumption 
of 3.1  (Rf 0.7). The reaction was quenched by the addition of saturated aq. sodium bicarbonate 
(5 mL), the organic phase was separated, dried (MgSO4), filtered, and concentrated in vacuo. 
The residue was purified by flash chromatography (toluene:ethyl acetate, 10:1) to afford 3,4,6-
tribenzyl-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α-D-glucopyranosyl-(1→4)-methyl-2,3,6-
O-tribenzyl-α-D-glucopyranoside 3.32 (0.102 g, 61%) as colorless oil; [α]D
20
 + 30.6 (c, 1.0 in 
CHCl3); δH (400 MHz, CD3CN): 2.76-2.93 (2H, m, OCH2CH2SAr), 3.36 (3H, s, OCH3b), 2.80 
     Chapter 5                                                                                                                       Experimental 
                                                                                                                                                                                                                                                     
233 
 
(1H, m, H-2a), 3.43-3.61 (6H, m, OCH2CH2SAr, H-2b, H-5b, H-6a, H-6’a), 3.67-3.88 (17H, m, 3 x 
OCH3a, H-3a, H-2a, H-4b, H-6b, H-6’b, H-4a, H-5a, H-3b), 4.78 (1H, d, J1,2 3.2 Hz, H-1b), 4.41-
4.94, (12H, m, 6 x PhCH2), 5.04 (1H, d, J1,2 3.2 Hz, H-1a), 6.22 (2H, s, 2 x SArC-H), 7.20-7.36 
(30H, m, Ar-CH); δC (100 MHz, CD3CN): 34.3 (t, OCH2CH2SAr), 54.5 (q, OCH3b), 55.2, 55.8 (2 
x q, OCH3a), 66.1 (d, C-6b), 69.3 (d, C-6a), 69.9 (t, OCH2CH2SAr), 70.3, 70.5 (2 x d, C-5a, C-4b), 
72.3, 72.8, 74.3, 74.5, 74.8, 77.9 (6 x t, 6 x CH2Ph), 78.0, 80.5, 81.0, 81.1 (4 x d, C-2a, C-3a, C-
4a, C-5b), 81.2, 81.6 (2 x d, C-3b, C-2b), 91.6 (d, SArC-H), 97.0 (d, C-1b), 97.7 (d, C-1a), 101.7 (s, 
SCAr), 127.2, 127.3, 127.3, 127.4, 127.4, 127.5, 127.6, 127.7, 127.7, 127.8, 127.9, 127.9, 128.1, 
128.1, 128.2, 128.2, 128.3, 128.3 (18 x d, 18 x Ar-CH), 138.7, 138.8, 138.9, 138.9, 139.0, 139.3 
(6 x Ar-C), 162.0, 162.1 (2 x s, S-ArC-OMe o, S-ArC-OMe p); HRMS (ES
+
) calculated for 
C66H74O14SNa (MNa
+
) 1145.4691, found 1145.4707. 
3,4,6-Tribenzyl-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α-D-glucopyranosyl-(1→6)-
methyl-2,3,4-O-tribenzyl-α-D-glucopyranoside (Protocol B)[25] 3.34 
i) TMSOTf (1 eq), (-78 °C 0 °C) / DCM
ii)
,TTBP 2.46, -78 °C / DCM
(76%)
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A mixture of 3,4,6-tribenzyl-2-O-(2-(phenylthionyl)ethyl)-α-D-glucopyranosyl) 
trichloroacetimidate 3.1 (120 mg, 0.15 mmol) and activated molecular sieves (3 Å, 100 mg) in 
DCM (5 mL) was stirred for 10 min under a nitrogen atmosphere at rt. The mixture was cooled 
to -78 °C, TMSOTf (26 µL, 0.15 mmol) was added, and the mixture was then allowed to warm 
to 0 °C over a period of 40 min. After re-cooling of the mixture to -78 °C, methyl-2,3,4-O-
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tribenzoyl-α-D-glucopyranoside 3.33 (91 mg, 0.18 mmol) and TTBP 2.46 (80 mg, 0.30 mmol) 
were added. The mixture was then allowed to warm slowly to rt. After 16 h, t.l.c. (toluene:ethyl 
acetate, 4:1) indicated the formation of a major product (Rf 0.5) and the complete consumption 
of 3.1  (Rf 0.7). The reaction was quenched by the addition of saturated aq. sodium bicarbonate 
(5 mL), the organic phase was separated, dried (MgSO4), filtered, and concentrated in vacuo. 
The residue was purified by flash chromatography (toluene:ethyl acetate, 10:1) to afford 3,4,6-
tribenzyl-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α-D-glucopyranosyl-(1→6)-methyl-2,3,4-
O-tribenzoyl-α-D-glucopyranoside 3.34 (0.132 g, 76%) as colorless oil; [α]D
20
 + 102.3 (c, 1.0 in 
CHCl3); δH (400 MHz, CDCl3): 2.79-2.98 (2H, m, OCH2CH2SAr), 3.26 (4H, m, OCH3b, H-2a), 
3.50-3.72 (8H, m, OCH2CH2SAr, H-3a, H-4a, H-5a, H-6a, H-6’a, H-6b), 3.79-3.85 (9H, 2 x s, 3 x 
OCH3a), 3.85-3.91(2H, m, H-4b, H-6’b), 4.32-4.88 (6H, m, 3 x PhCH2), 4.95 (1H, d, J1,2 3.2 Hz, 
H-1a), 5.18 (1H, d, J1,2 3.2 Hz, H-1b), 5.25 (1H, dd, J4,5 9.6Hz, J5,6 3.6 Hz, H-5b), 6.04-6.16 (3H, 
m, 2 x SArC-H, H-2b), 7.12-8.00 (30H, m, Ar-CH); δC (100 MHz, CDCl3): 33.9 (t, 
OCH2CH2SAr), 55.3 (d, C-5a), 55.6 (q, OCH3b), 55.9, 56.0 (2 x q, OCH3a), 66.8 (d, C-6b), 68.3 
(d, C-4a), 68.4 (d, C-6a), 69.7 (t, OCH2CH2SAr), 70.3, 70.6 (2 x d, C-2a, C-3a),  72.2 (d, C-5b), 
73.4, 74.7, 75.4 (3 x t, 3 x CH2Ph), 76.7 (d, C-3b), 81.1 ,81.5 (2 x d, C-2b, C-4b), 91.0 (d, SArC-
H), 96.7 (d, C-1b), 97.1 (d, C-1a), 100.9 (s, SCAr), 127.4, 127.5, 127.6, 127.8, 127.9, 128.0, 
128.1, 128.2, 128.3, 128.3, 128.3, 128.4, 128.4, 128.9, 129.0, 129.1, 129.3, 129.6 (18 x d, 18 x 
Ar-CH), 129.9, 133.0, 133.3, 138.0, 138.7, 138.9 (6 x s, 6 x Ar-C), 161.8, 162.1 (2 x s, S-ArC-
OMe o, S-ArC-OMe p), 165.3, 165.7, 165.8 (3 x s, 3 x OCOArC); HRMS (ES
+
) calculated for 
C66H68O17SNa (MNa
+
) 1187.4069, found 1187.4066. 
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Methyl 2-O-(2-(phenylthionyl)ethyl)-3,4,6- benzyl-β-D-glucopyranoside 3.35 
 
O
O
S
OBnO
BnO
BnO
OMeMeO
OMe
3.1
CCl3
NH
+
O
S
BnO
BnO
BnO
3.35
O
MeO
OMe
MeO
MeOH
OMeTMSOTf
CH3CN
 
 
A solution of 3,4,6-tribenzyl-2-O-(2-(phenylthionyl)ethyl)-α-D-glucopyranosyl) 
trichloroacetimidate 3.1 (200 mg, 0.25 mmol) and methanol (7.0 μL, 0.50 mmol) in freshly 
distilled CH3CN (2 mL) was added to a flame-dried round-bottom flask containing activated 4 Å 
molecular sieves (0.100 g). The mixture was cooled to 0 °C under a nitrogen atmosphere, then 
TMSOTf (5.00 μL, 0.025 mmol) was added. After 5 h, t.l.c. (petrol:ethyl acetate, 3:2) showed 
formation of a major product (Rf 0.6) and the complete consumption of the trichloroacetimidate 
starting material (Rf 0.7) was observed. The reaction was quenched with saturated aq. sodium 
bicarconate solution (2 mL) and filtered through Celite
®
. The mixture was diluted with DCM (20 
mL), washed with saturated aq. sodium bicarbonate solution (2 x 10 mL), and the aqueous layer 
extracted with DCM (2 x 20 mL). The combined organic extracts were washed with brine (25 
mL), dried (MgSO4), filtered and concentrated in vacuo. The residue was purified by The residue 
was purified by flash column chromatography (petrol:ethyl acetate, 4:1) to afford methyl 2-O-(2-
(phenylthionyl)ethyl)-3,4,6- benzyl-β-D-glucopyranoside 3.35 (0.135 g, 78%) as a white 
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crystalline solid; m. p. 75 – 77 °C (petrol/ethyl acetate);   [δH (400 MHz, CDCl3): 2.88-2.92 (2H, 
m, OCH2CH2SAr), 3.19 (1H, at, J 6.6 Hz, H-2), 3.42 (1H, m, H-4), 3.49-3.53 (5H, m, OCH3, H-
3, H-5), 3.62-3.76 (3H, m, H-6, OCH2CH2SAr), 3.82 (9H, s, 3 x OCH3), 3.89-3.97 (1H, m, H-6’), 
4.16 (1H, d, J1,2 7.6 Hz, H-1), 4.72-4.91 (6H, m, 3 x CH2Ph), 6.13 (2H, s, 2 x SArC-H), 7.11-
7.32 (15H, m, Ar-CH); δC (100 MHz, CDCl3): 34.1 (t, OCH2CH2SAr), 55.3, 56.1, 57.0 (3 x q, 3 
x OCH3), 69.0 (t, OCH2CH2SAr), 72.2 (t, C-6), 73.5, 74.8, 75.0 (3 x t, 3 x CH2Ph), 75.6 (d, C-4), 
77.7 (d, C-5), 82.9 (d, C-2), 84.5 (d, C-3), 91.0 (d, SArC-H), 101.3 (s, SCAr), 104.4 (d, C-1), 
127.5, 127.6, 127.7, 127.7, 127.9, 128.0, 128.1, 128.3, 128.3) (9 x d, 9 x Ar-CH), 138.1, 138.2, 
138.6 (3 x s, 3 x Ar-C), 161.7, 162.0 (2 x s, S-ArC-OMe o α, S-ArC-OMe p); HRMS (ES+) 
calculated for C39H46O9SNa (MNa
+
) 713.2754, found 713.2762. 
Methyl 3,4,6-tri-O-benzyl-β-D-glucopyranoside 3.42 
O
O
S
BnO
BnO
BnO
OMeMeO
OMe
O
BnO
BnO
BnO
3.42
OH
OCH3
OCH3
O
O
S
BnO
BnO
BnO
OMeMeO
OMe
OCH3
MeOTf, TTBP
DCM, reflux, 3 h
3.40
OK
(88%)
DCM, 10 min
S
OMeMeO
OMe
O
3.43
+
3.41
 
MeOTf (51 µL, 0.45 mmol), and TTBP 2.46 (144 mg, 0.58 mmol) were added to the solution of 
methyl 2-O-(2-(phenylthionyl)ethyl)-3,4,6- benzyl-β-D-glucopyranoside 3.40 (200 mg, 0.29 
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mmol) in DCM (10 mL), and refluxed at 40 °C under a nitrogen atmosphere. After 3 h, t.l.c 
(petrol:ethyl acetate, 2:1) indicated the formation of a single product (Rf 0) and complete 
consumption of starting material (Rf 0.5). The solution was cooled to rt over 1 h, after which 
potassium tert-butoxide (67 mg, 0.58 mmol) was added portion wise. After 10 min, t.l.c. 
(petrol:ethyl acetate, 2:1) indicated fornation of a mojor product (Rf 0.3), apart from a minor spot 
(Rf 0.6) 3.43, and complete consumption of starting material (Rf 0). The reaction mixture was 
diluted with DCM (50 mL), and the mixture was washed with water (20 mL), saturated aq. 
sodium bicarbonate (20 ml) and brine (20 ml). The organic phase was dried (MgSO4), filtered, 
and concentrated in vacuo. The residue was purified by flash column chromatography 
(petrol:ethyl acetate, 6:1) to afford methyl 3,4,6-tri-O-benzyl-β-D-glucopyranoside 3.42 (0.118 g, 
88%) as white crystalline solid. m. p. 71 - 72 °C (petrol/ethyl acetate) (lit.
[39]
 71 - 72 °C); [α]D
20
 - 
4.2  (c, 1.0 in CHCl3) (lit.
[39] 
[α]D
25
 -4.7  (c, 1.0 in CHCl3); δH (400 MHz, CDCl3)
[39]
:  3.53 (1H, 
ddd, J4,5 9.9 Hz, H-5), 3.61 (3H, s, CH3O), 3.57–3.70 (3H, m, H-2, H-3, H-4), 3.75 (1H, dd, J5,6’ 
4.3 Hz, H-6), 3.81 (1H, dd J5,6’ 2.1, J6,6’ 10.8 Hz, H-6’), 4.23 (1H, d, J1,2 7.3 Hz, H-1), 4.60, 4.68 
(2H, ABq, J 12.2 Hz, CH2Ph), 4.59, 4.88 (2H, ABq, J 10.8 Hz, CH2Ph), 4.90, 4.97 (2H, ABq, J 
11.3 Hz, CH2Ph), 7.20–7.44 (15H, m, ArC-H). 
3.43: δH (400 MHz, CDCl3): 2.28 (3H, s, SOCH3), 3.82, 3.88 (9H, 2 x s, 3 x OCH3), 6.15 (2H, s, 
ArC-H); δC (100 MHz, CDCl3): 18.3 (q, SOCH3), 55.4, 56.2 (2 x q, o OCH3, p OCH3), 91.0 (d, 
Ar C-H), 103.6 (s, Ar-CSO), 161.5, 161.6 (2 x s, o, p Ar-COCH3); HRMS (ES
+
) calculated for 
C10H14O4SNa (MNa
+
) 253.0504, found 253.0511.         
 
 
     Chapter 5                                                                                                                       Experimental 
                                                                                                                                                                                                                                                     
238 
 
Methyl 3,4,6-tri-O-benzyl-α-D-glucopyranosyl-(1→6)-2,3,4-tri-O-benzyl-α-D-
glucopyranoside 3.45 
O
S
O
BnO
BnO
BnO
a
O
MeO
OMe
MeO
O
OMe
BnO
BnO
OBn
b
OK
O
O
BnO
BnO
BnO
a
O
O
OMe
BnO
BnO
OBn
b
H
3.45
O
S
O
BnO
BnO
BnO
a
O
MeO
OMe
MeO
O
OMe
BnO
BnO
OBn
b
MeOTf, TTBP
DCM, 40 °C, 3 h
3.30
(86%)
DCM, 10 min
3.44
 
MeOTf (26 µL, 0.22 mmol), and TTBP (72 mg, 0.30 mmol) were added to the solution of 3,4,6-
tribenzyl-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α-D-glucopyranosyl-(1→6)-methyl-2,3,4-
O-tribenzyl-α-D-glucopyranoside 3.30 (165 mg, 0.15 mmol) in DCM (10 mL), and refluxed at 40 
°C under a nitrogen atmosphere. After 3 h, t.l.c (petrol:ethyl acetate, 2:1) indicated the formation 
of a single product (Rf 0) and complete consumption of starting material (Rf 0.3). The solution 
was cooled to rt over 1 h, after which potassium tert-butoxide (33 mg, 0.29 mmol) was added 
portion wise. After 10 min, t.l.c. (petrol:ethyl acetate, 2:1) indicated fornation of a mojor product 
(Rf 0.2), and complete consumption of starting material (Rf 0). The reaction mixture was diluted 
with DCM (50 mL), and the mixture was washed with water (20 mL), saturated aq. sodium 
bicarbonate (20 ml) and brine (20 ml). The organic phase was dried (MgSO4), filtered, and 
concentrated in vacuo. The residue was purified by flash column chromatography (petrol:ethyl 
acetate, 4:1) to afford methyl 3,4,6-tri-O-benzyl-α-D-glucopyranosyl-(1→6)-2,3,4-tri-O-benzyl-
α-D-glucopyranoside 3.45 (0.116 g, 86%) as colorless oil; [α]D
20
 + 81.2 (c, 1.0 in CHCl3) (lit.
[40] 
[α]D
22
 + 73.6  (c, 1.0 in CHCl3); δH (400 MHz, CDCl3):
 [40]
  3.28 (3H, s, OCH3), 3.38-3.46 (3H, 
m, H-2b, 4b, 4a), 3.54-3.72 (7H, m, H-5b, 6b, 2a, 3a, 5a, 6a, 6’a), 3.85 (1H, dd, J5,6 4.3, 9.7 Hz, H-
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6b), 3.92 (1H, at, J2,3 9 Hz, H-3b), 4.36, 4.39 (2H, ABq, J 12Hz, CH2Ph), 4.49 (2H, d, J 11.9 Hz, 
CH2Ph), 4.53 (1H, d, J1,2 3.6 Hz, H-1b), 4.59 (1H, d, J 12 Hz, CHH’Ph), 4.69-4.76 (4H, m, 2 x 
CH2Ph), 4.83-4.86 (3H, m, H-1a, CH2Ph), 4.92 (1H, d, J 11 Hz, CHH’Ph), 7.05-7.31 (30H, m, 
ArC-H). 
3,4,6-tri-O-benzyl-α-D-glucopyranosyl-(1→6)-1,2:3,4-di-O-isopropylidene-α-D-
galactopyranose 3.47 
a
b
OK
O
S
O
BnO
BnO
BnO
a
O
MeO
OMe
MeO
b
MeOTf, TTBP
DCM, 40 °C, 3 h
3.24
(88%)
OO
O OO
O
S
O
BnO
BnO
BnO
O
MeO
OMe
MeO
OO
O OO
O
O
BnO
BnO
BnO
a
O
b
3.47
OO
O OO
H
DCM, 10 min
3.46
 
MeOTf (28 µL, 0.24 mmol), and TTBP (76 mg, 0.32 mmol) were added to the solution of 3,4,6-
tribenzyl-2-O-(2-(2,4,6-trimethoxybenzenethio)ethyl)-α-D-glucopyranosyl-(1→6)- 1,2:3,4-di-O-
isopropylidene-α-D-galactopyranose 3.24 (150 mg, 0.16 mmol) in DCM (10 mL), and refluxed at 
40 °C under a nitrogen atmosphere. After 3 h, t.l.c. (petrol:ethyl acetate, 2:1) indicated the 
formation of a single product (Rf 0) and complete consumption of starting material (Rf 0.4). The 
solution was cooled to rt over 1 h, after which potassium tert-butoxide (35 mg, 0.32 mmol) was 
added portion wise. After 10 min, t.l.c. (petrol:ethyl acetate, 2:1) indicated fornation of a mojor 
product (Rf 0.3), and complete consumption of starting material (Rf 0). The reaction mixture was 
diluted with DCM (50 mL), and the mixture was washed with water (20 mL), saturated aq. 
sodium bicarbonate (20 ml) and brine (20 ml). The organic phase was dried (MgSO4), filtered, 
and concentrated in vacuo. The residue was purified by flash column chromatography 
(petrol:ethyl acetate, 4:1) to afford 3,4,6-tri-O-benzyl-α-D-glucopyranosyl-(1→6)-1,2:3,4-di-O-
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isopropylidene-α-D-galactopyranose 3.47 (97 mg, 88%) as colourless oil, [α]D
22 
+ 28.6 (c, 0.3 in 
CHCl3) [lit.
[40]
 [α]D
22 
+ 27 (c, 0.3 in CHCl3), [δH (400 MHz, CDCl3):
[40]
 1.34, 1.36, 1.46, 1.54 
(12H, s, 3 x CH3), 3.64-3.79 (7H, m, H-2a, 3a, 4a, 5a, 6a, 6’a, 6b), 3.92 (1H, m, H-6’b), 4.00 (1H, 
at, J 4 Hz, H-5b), 4.27-4.34 (2H, m, H-2b, H-4b), 4.47, 4.44 (2H, ABq, J 7 Hz, CH2Ph), 4.59-4.63 
(2H, m, H-3b, CHH’Ph), 4.79, 4.81 (2H, ABq, J 7 Hz, CH2Ph), 4.90 (1H, d, J1,2 3.3 Hz, H-1a), 
4.95 (1H, d, J=11 Hz, CHH’Ph), 5.50 (1H, d, J1,2 5 Hz, H-1b), 7.13-7.41 (15H, m, ArC-H). 
1,2:5,6-Di-O-isopropylidene-α-D-glucofuranose[41] 3.59 
OHO
HO Acetone/I2 O
HO
O
O
O
O
2.19
3.59
OH
HO
OH
rt, 12 h
(42%)
 
Iodine (7.50 g, 39.4 mmol) was dissolved in acetone (1.5 L) and D–Glucose 2.19 (25.0 g, 139 
mmol) was added and stirred at rt. After 12 h, t.l.c. (CHCl3:MeOH, 9:1) showed formation major 
spot (Rf 0.75) with respect to the starting material (Rf 0.05). Iodine was consumed by adding 
dilute sodiumthiosulfate to make solution colorless. After that it was extracted thrice with DCM 
(2 L), which was washed with water (2 x 500 mL), brine (500 mL), dried (MgSO4) and 
concentrated in vacuo. Purification by column chromatography (petrol:ethyl acetate, 4:1) yielded 
1,2:5,6-di-O-isopropylidene-α-D-glucofuranose 3.59 (15.0 g, 42%) as white crystalline solid; m. 
p. 106 – 108 °C (petrol/ethyl acetate) (lit.[42] 105 – 107 °C);  [α]D
20
 - 11.0  (c, 1.0 in CHCl3), 
lit.
[42]
 [α]D
20
 – 13.5  (c, 1.0 in CHCl3); δH (400 MHz, CDCl3):
[42]
 1.32 (3H, s, -CH3), 1.36 (s, 3H, -
CH3), 1.44 (s, 3H, -CH3), 1.49 (s, 3H, -CH3), 2.21 (bs, OH), 3.97 – 3.99 (m, 1H, H-4), 4.04 – 
4.08 (dd, J6,6’ 8.0 Hz, J6,5 2.3 Hz 1H, H-6), 4.14–4.18 (1H, at, J 8.8 Hz  H-6’), 4.33 (m, 2H, H-3, 
H-5), 4.52–4.53 (1H, d, J 4.5, H-2), 5.94–5.95 (d, 1H, H-1).         
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3-Allyl-1,2:5,6-diacetonegluco-D-furanose
[7]
 3.58 
O
O
O
HO
O
O
Br
DMF, rt, 3 h
O
O
O
O
O
O
3.59
3.58
, NaH
(96%)
 
3.59 (13.0 g, 50.0 mmol) was dissolved in anhydrous DMF (100 mL) and then to it was added 
suspension of sodium hydride (3.10 g, 107 mmol) in DMF (100 mL) at 0 °C under a nitrogen 
atmosphere. Allyl Bromide (11.2 mL, 124 mmol) was tfhen added slowly to the mixture. After 3 
h, t.l.c. (petrol:ethyl acetate, 2:1) showed complete disappearance of starting material (Rf 0.1) 
and formation of a major product (Rf 0.7). The reaction was quenched by the addition of 
methanol and concentrated in vacuo. The residue was dissolved in diethyl ether (1 L), washed 
with water (2 x 100 mL), brine (100 mL), dried (MgSO4), filtered and concentrated in vacuo. 
Purification by flash chromatography (petrol:ethyl acetate, 7:1) yielded  3-allyl-1,2:5,6-
diacetonegluco-D-furanose 3.58 (14.5 g, 96%) as colorless oil;  [α]D
20
 - 37.5  (c, 1.0 in CHCl3), 
(lit.
[43]
 [α]D
20
 - 23.5 (c, 1.0 in CHCl3); δH (400 MHz, CDCl3):
[44]
 1.29 (3H, s, -CH3), 1.32 (3H, s, -
CH3), 1.40 (3H, s, -CH3), 1.47 (3H, s, -CH3), 3.86–4.12 (6H, m, -OCH2CH=CH2, H-3, H-5, H-6, 
H-6’), 4.29 (dd, 1H, J4,3 7.5 Hz, J4,5 6.0 Hz, H-4), 4.52 (d, 1H, J 3.7 Hz, H-2), 5.18 (dd, 1H, Jz 
10.8 Hz, Jgem 1.5 Hz, -OCH2CH=CHEHz), 5.30 (dd, 1H, JE 15.8 Hz, Jgem 1.5 Hz, -
OCH2CH=CHEHz), 5.82 – 5.94 (2H, m, H-1, -OCH2CH=CH2).      
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3-allyl-1,2,4,6-tetraacetyl-β-gluco-D-pyranose[7] 3.57 
O
O
O
O
O
O
3.58
1) MeOH-H2SO4/H2O O
OAc
AcO
AcO
2) Ac2O/NaOAc, 120 °C, 2 h
3.57
O OAc
(76%)
 
 
A mixture of 3.58 (0.900 g, 3.00 mmol) and 4% aq. H2SO4 (20 mL) was stirred at rt for 18 h. 
The resulting solution was then stirred with CaCO3 (2 g) for 2h. The mixture was filtered and the 
residue was repeatedly washed with methanol. The combined filtrate and the washings were 
evaporated under reduced pressure. The residual syrupy material was treated with minimal 
volume of water and filtered to remove some insoluble material. The residual was then 
concentrated in vacuo to give a syrup. This syrup was added slowly (over 15 minutes) to pre 
heated (heated over half an hour) solution of sodium acetate (0.656 g, 8.00 mmol) at 120 °C in 
10 mL of   acetic ahydride. After 2 h, t.l.c. ( petrol:ethyl acetate, 3:1) showed complete absence 
of starting material (Rf 0) and formation of a major product (Rf 0.3). The reaction was cooled to 
rt and then 10 mL of water and ice was added. The precipitate was filtered out. Purification by 
flash chromatography (petrol:ethyl acetate, 4:1) yielded  3-allyl-1,2,4,6-tetraacetyl-β-gluco-D-
pyranose 3.57 (0.850 g, 76%) as white crystalline solid; m. p. 89 – 91 °C (petrol/ethyl acetate),   
[α]D
20
 + 0.3 (c, 1.0 in CHCl3); δH (400 MHz, CDCl3): 2.05–2.08 (12H, 4 x s, 4 x CH3COO), 3.62 
(1H, ddd, J4,5 9.5 Hz, J5,6  3.1 Hz, J5,6’ 2.4 Hz, 1H, H-5), 3.71  (2H, m, H-3), 4.07 (3H, m, H-6’, 
OCH2CH=CH2), 4.19 (1H, m, H-6), 5.15 (4H, m, H-2, H-4, CH=CHEHz, CH=CHEHz), 5.62 (1H, 
d, J1,2 8.4Hz, H-1), 5.78 (1H, m, CH=CH2); δC (100 MHz, CDCl3): 20.7, 20.7, 20.8, 20.8 (4 x q, 
4 x COCH3), 61.8, 73.1 (2 x  t, C-6, CH2CH=CH2), 69.0, 71.5, 73.0, 79.6 (4 x d, C-2, C-3, C-4, 
     Chapter 5                                                                                                                       Experimental 
                                                                                                                                                                                                                                                     
243 
 
C-5), 92.0 (d, C-1), 117.2 (t, CH=CH2), 134.0 (d, CH=CH2), 169.0, 169.2, 170.7 (3 x s, 3 x 
C=O); HRMS (ES
+
) calculated for C17H24O10Na (MNa
+
) 411.1267, found 411.1272. 
p-Tolyl 2,4,6-tri-O-acetyl-3-O-allyl-1-thio-β-D-glucopyranoside[45] 3.56 
 
O
OAc
AcO
AcO
3.57
O OAc
O
OAc
AcO
AcO
3.56
O S
BF3.OEt2, p-Thiocresol
DCM, rt, 1.5 h
(47%)
 
Tetraacetate 3.57 (2.00 g, 5.15 mmol) was suspended in freshly distilled DCM (10 mL). p-
Thiocresol (766 mg, 6.18 mmol) was added and the mixture cooled to 0° C. BF3.OEt2 (0.95 mL, 
0.73 mmol) was added and the mixture was stirred under a nitrogen atmosphere. After 1.5 h, 
t.l.c. (petrol:ethyl acetate, 3:2) indicated the formation of a major product (Rf 0.3) and the 
complete consumption of starting material (Rf 0.25). Triethylamine (2 mL) was then added, and 
the mixture was then diluted with ether (100 mL) and washed with water (100 mL). The aqueous 
layer was re-extracted with ether (50 mL), and the combined organic extracts were washed with 
brine (50 mL), dried (MgSO4), filtered and concentrated in vacuo. The residue was purified by 
flash column chromatography (3:2, petrol:ethyl acetate) to afford the desired β thioglycoside 
3.56 (1.10 g, 47%) as a white solid; m. p. 118-120 °C (petrol/ethyl acetate), lit.
 [45]
 127–128 °C; 
[α]D
20
 – 16.2  (c, 1.0 in CHCl3), (lit.
[45]
 [α]D
20 
- 14.4 (c, 0.9 in CHCl3); νmax (KBr) 1740 (s, C=O) 
cm
−1
; δH (400 MHz, CDCl3):
[45]
 2.08, 2.08, 2.15 (9H, 3 x s, 3 x COCH3), 2.34 (3H, s, ArCH3), 
3.57–3.63 (1H, m, H-5), 3.59 (1H, at, J 9.2 Hz, H-3), 4.02–4.11 (2H, m, OCH2CH=CH2), 4.13–
4.20 (2H, m, H-6, H-6’), 4.56 (1H, d, J1,2 10.1 Hz, H-1), 4.96 (1H, at, J 9.5 Hz, H-2), 5.00 (1H, 
at, J 9.8 Hz, H-4), 5.13 (1H, d, JZ 10.4 Hz, CH=CHEHZ), 5.19 (1H, dd, Jgem 1.6 Hz, JE 17.2 Hz, 
CH=CHEHZ), 5.75 (1H, m, CH=CH2), 7.11, 7.40 (4H, 2 x d, J 8.1 Hz, Ar–H); δC (100 MHz, 
CDCl3):
[45]
 21.2, 21.3, 21.5, 21.6 (4 x  q, 3 x COCH3, ArCH3), 63.0, 73.5 (2 x t, C-6, 
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CH2CH=CH2), 69.9, 71.7, 76.4, 81.7 (4 x d, C-2, C-3, C-4, C-5), 86.8 (d, C-1), 117.5 (t, 
CH=CH2), 129.0, 138.8 (2 x s, Ar–C) 130.0, 133.7 (2 x d, Ar–CH), 134.6 (d, CH=CH2), 169.6, 
169.7, 171.2 (3 x s, 3 x C=O); HRMS (ES
+
) calculated for C22H28O8SNa (MNa
+
) 475.1403, 
found 475.1401. 
p-Tolyl 3-O-allyl-2,4,6-tri-O-benzyl-1-thio-β-D-glucopyranoside[45] 3.55 
 
O
OBn
BnO
BnO
3.55
O S
1. NaOMe/MeOH, rt, 2 hO
OAc
AcO
AcO
3.56
O S
2. BnBr, NaH/DMF, rt, 18 h
(89%)
 
 
Acetylated thioglycoside 3.56 (1.77 g, 3.92 mmol) was suspended in methanol (10 mL). Sodium 
(5.00 mg, 0.200 mmol) was dissolved in methanol (5 mL), and the solution then added to the 
mixture, which was then stirred under a nitrogen atmosphere. After 2 h, t.l.c. (ethyl acetate) 
indicated the formation of a single product (Rf 0.6) and the complete consumption of the starting 
material (Rf 0.7). The mixture was then concentrated in vacuo, and The residue was then 
dissolved in DMF (30 mL) and the solution cooled to 0 °C. Benzyl bromide (2.44 mL, 20.6 
mmol) and sodium hydride (1.10 g, 27.5 mmol) were added and the mixture was stirred under 
N2. After 18 h, t.l.c. (petrol:ethyl acetate, 5:1) indicated the formation of a major product (Rf 0.7) 
and the complete consumption of starting material (Rf 0.0). Methanol (10 mL) was added slowly, 
and the mixture was then diluted with ether (200 mL), and washed with water (200 mL). The 
organic extracts were dried (MgSO4), filtered, concentrated in vacuo and the residue was purified 
by flash column chromatography (petrol:ethyl acetate, 8:1) to afford benzylated thioglycoside 
3.55 (2.08 g, 89%) as a white, crystalline solid, m. p. 71 - 73 °C (EtOH), (lit.
[45]
 75 °C (EtOH)); 
[α]D
20
 – 6.3 (c, 1.0 in CHCl3), (lit.
[45]
 [α]D
20
 - 6.5 (c, 1.0 in CHCl3); νmax (KBr) 3025 (s, Ar-C-H) 
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cm
−1; δH (400 MHz, CDCl3):
[45]
 2.32 (3H, s, ArCH3), 3.41–3.51 (2H, m, H-2, H-5), 3.53–3.61 
(2H, m, H-3, H-4), 3.73 (1H, dd, J5,6 4.8 Hz, J6,6’ 10.9 Hz, H-6), 3.79 (1H, dd, J5,6’ 2.1 Hz, H-60), 
4.27–4.40 (2H, m, -OCH2CH=CH2), 4.55, 4.62 (2H, ABq, JAB 12.1 Hz, PhCH2), 4.58 (1H, d, J1,2 
9.7 Hz, H-1), 4.59, 4.83 (2H, ABq, JAB 11.1 Hz, PhCH2), 4.74, 4.88 (2H, ABq, JAB 10.1 Hz, 
PhCH2), 5.18 (1H, daq, JZ 10.4 Hz, J 1.4 Hz, CH=CHEHZ), 5.30 (1H, daq, J 1.7 Hz, JE 17.1 Hz, 
CH=CHEHZ), 5.98 (1H, ddat, CH=CH2), 7.04–7.52 (19H, m, Ar–H); δC (100 MHz, CDCl3):
[45]
 
21.1 (q, ArCH3), 69.0, 73.4, 74.5, 75.1, 75.5 (5 x t, C-6, CH2CH=CH2, 3 x PhCH2), 77.7, 79.0, 
80.7, 86.4, 87.6 (5 x d, C-1, C-2, C-3, C-4, C-5), 116.9 (t, CH=CH2), 127.5, 127.7, 127.8, 127.9, 
128.1, 128.3, 128.4, 129.6, 132.7, 134.9 (11 x d, Ar–CH, CH=CH2), 137.7, 138.1, 138.1, 138.4 
(4 x s, Ar–C); HRMS (ES+) calculated for C37H40O5SNa (MNa
+
) 619.2494, found 619.2499. 
Ethyl 2,4,6-tri-O-acetyl-3-O-allyl-1-thio-β-D-glucopyranoside[45] 3.60 
 
O
OAc
AcO
AcO
3.57
O OAc
O
OAc
AcO
AcO
3.60
O SEt
BF3.OEt2, EtSH
DCM, rt, 6 h
(47%)
 
Tetraacetate 3.57 (5.00 g, 13.00 mmol) was suspended in freshly distilled DCM (50 mL). 
Ethanethiol (1.5 mL, 20.00 mmol) was added and the mixture cooled to 0° C. BF3.OEt2 (2.50 
mL, 18.00 mmol) was added and the mixture was stirred under a nitrogen atmosphere. After 6 h, 
t.l.c. (petrol:ethyl acetate, 3:2) indicated the formation of a major product (Rf 0.3) and the 
complete consumption of starting material (Rf 0.2). Triethylamine (2 mL) was then added, and 
the mixture was then diluted with ether (500 mL) and washed with water (200 mL). The aqueous 
layer was re-extracted with ether (100 mL), and the combined organic extracts were washed with 
brine (100 mL), dried (MgSO4), filtered and concentrated in vacuo. The residue was purified by 
flash column chromatography (petrol:ethyl acetate, 2:1) to afford the desired β thioglycoside 
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3.60 (2.30 g, 47%) as a white solid; m. p. 118-120 °C (petrol/ethyl acetate), [α]D
20
 – 28.3  (c, 1.0 
in CHCl3), νmax (KBr) 1745 (s, C=O) cm
−1
; δH (500 MHz, CDCl3): 1.25 (3H, t, Jvic 7.5 Hz, 
SCH2CH3), 2.07, 2.08, 2.09 (9H, 3 x s, 3 x COCH3), 2.70 (2H, m, SCH2CH3), 3.57–3.61 (2H, m, 
H-2, H-4), 4.02–4.13 (3H, m, H-6, OCH2CH=CH2), 4.19 (1H, dd, J6,6’ 12.5 Hz, J6’,5 5.5 Hz H-
6’), 4.38 (1H, d, J1,2 10.0 Hz, H-1), 5.00–5.04  (2H, m, H-3, H-5), 5.13 (1H, d, JZ 10.0 Hz, 
CH=CHEHZ), 5.19 (1H, d, JE 17.0 Hz, CH=CHEHZ), 5.77 (1H, m, CH=CH2); δC (125 MHz, 
CDCl3): 14.8 (q, SCH2CH3) 20.8, 20.9, 21.0 (3 x  q, 3 x COCH3), 23.9 (t, SCH2CH3) 62.5 (t, C-
6), 69.5 (t, CH2CH=CH2), 71.2 (d, C-5), 73.1, 76.2 (2 x d, C-3, C-4), 81.2 (d, C-2), 83.6 (d, C-1), 
117.0 (t, CH=CH2), 134.6 (d, CH=CH2), 169.2, 169.3, 171.2 (3 x s, 3 x C=O); HRMS (ES
+
) 
calculated for C17H26O8SNa (MNa
+
) 413.1246, found 413.1243. 
Ethyl 3-O-allyl-2,4,6-tri-O-benzyl-1-thio-β-D-glucopyranoside[45] 3.61 
O
OBn
BnO
BnO
3.61
O SEt
1. NaOMe/MeOH, rt, 2 hO
OAc
AcO
AcO
3.60
O SEt
2. BnBr, NaH/DMF, rt, 18 h
(76%)
 
Acetylated thioglycoside 3.60 (2.30 g, 3.92 mmol) was suspended in methanol (20 mL). Sodium 
(14.0 mg, 0.60 mmol) was dissolved in methanol (5 mL), and this solution was then added to the 
mixture, which was then stirred under a nitrogen atmosphere. After 2 h, t.l.c. (petrol:ethyl 
acetate, 3:2) indicated the formation of a single product (Rf 0.0) and the complete consumption 
of the starting material (Rf 0.5). The mixture was then concentrated in vacuo, and The residue 
was then dissolved in DMF (50 mL) and the solution cooled to 0 °C. Benzyl bromide (6.00 mL, 
50.0 mmol) and sodium hydride (0.87 g, 36.0 mmol) were added, and the mixture was stirred 
under N2. After 18 h, t.l.c. (petrol:ethyl acetate, 2:1) indicated the formation of a major product 
(Rf 0.7) and the complete consumption of starting material (Rf 0.0). Methanol (50 mL) was 
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added slowly, and the mixture was then diluted with ether (200 mL), and washed with water (200 
mL). The organic extracts were dried (MgSO4), filtered, concentrated in vacuo and the residue 
was purified by flash column chromatography (petrol:ethyl acetate, 10:1) to afford benzylated 
thioglycoside 3.61 (2.10 g, 76%) as a white, crystalline solid, m. p. 32 - 34 °C (petrol/ethyl 
acetate); [α]D
20
 + 3.4  (c, 1.0 in CHCl3); νmax (KBr) 1647 (w, C=C) cm
−1; δH (500 MHz, CDCl3): 
1.32 (3H, t, Jvic 7.5 Hz, SCH2CH3), 2.79 (2H, m, SCH2CH3), 3.38 (1H, at, J 8.5 Hz H-2), 3.42 
(1H, m, H-5),  3.51–3.57 (2H, m, H-3, H-4), 3.65–3.75 (2H, m, H-6, H-6’), 4.33–4.39 (2H, m, -
OCH2CH=CH2), 4.42 (1H, d, J1,2 10.0 Hz, H-1), 4.54, 4.62 (2H, ABq, JAB 12.1 Hz, PhCH2), 
4.59, 4.83 (2H, ABq, JAB 11.1 Hz, PhCH2), 4.74, 4.88 (2H, ABq, JAB 10.1 Hz, PhCH2), 5.17 (1H, 
d, JZ 10.5 Hz, CH=CHEHZ), 5.30 (1H, d,  JE 17.5 Hz, CH=CHEHZ), 5.98 (1H, m, CH=CH2), 
7.04-7.52 (15H, m, Ar-CH); δC (125 MHz, CDCl3): 15.1 (q, SCH2CH3), 25.0 (t, SCH2CH3) 69.2 
(t, C-6), 74.5 (t, CH2CH=CH2) 73.4, 75.1, 75.6 (3 x t, 3 x PhCH2), 77.9 (d, C-3/C-4), 79.1 (d, C-
5), 81.7 (d, C-2), 85.0 (d, C-3/C-4), 86.4 (d, C-1), 116.8 (t, CH=CH2), 127.6, 127.7, 127.8, 127.9, 
128.1, 128.3, 128.4, 128.5, 128.6 (9 x d, Ar–CH), 135.0 (d, CH=CH2), 138.0, 138.1, 138.2 (3 x s, 
Ar–C); HRMS (ES+) calculated for C32H38O5SNa (MNa
+
) 557.2241, found 557.2336. 
Methyl 3-O-allyl-2,4,6-tri-O-benzyl-α-D-glucopyranosyl-(1→3)-2-O-benzyl-(R)-4,6-O-
benzylidene-α-D-mannopyranoside[4] 3.54 
 
O
O
BnO
BnO
O SEt
MeOTf, TTBP
DCM,
+
O
O
O
Ph
HO
OBn
OMe
2.44
O
O
O
Ph
O
OBn
OMeBn
O
BnO
O
BnO
BnO
3.54
a
b
0° C rt, 16 h
3.61
(62%)
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Alcohol 2.44 (1.00 g, 2.68 mmol), benzylated thioglycosyde 3.61 (1.30 g, 2.43 mmol), and 
TTBP 2.46 (2.00 g, 12.15 mmol) were dissolved in dry diethyl ether (10 mL) in a flame dried 
flask containing 4 Å molecular sieves (c.a. 500 mg). The mixture was cooled to 0° C, MeOTf 
(0.82 mL, 7.30 mmol) was added and the solution stirred. After 16 h, t.l.c. (petrol:ethyl acetate, 
3:1) indicated the formation of a single product (Rf 0.7) and the complete consumption of the 
thioglycoside (Rf 0.9). TEA (1 mL) was added, the solution was stirred for 10 min, and then 
filtered through Celite
®
. The filtrate was then concentrated in vacuo, and the residue 
purified by flash column chromatography (petrol:ethyl acetate, 7:1) to afford the disaccharide 
3.54 (1.35 g, 62%) as colorless oil; [α]D
20
 + 93.6 (c, 1.0 in CHCl3), (lit.
[45]
 [α]D
20
 + 93.0  (c, 1.0 in 
CHCl3); νmax (KBr) 3025 (s, Ar-C-H) cm
−1; δH (400 MHz, CDCl3):
[45]
3.33 (3H, s, OCH3), 3.46 
(1H, dd, J1,2 3.6 Hz, J2,3 9.6 Hz, H-2b), 3.54 (1H, at, J 9.4 Hz, H-4b), 3.64–3.71 (2H, m, H-6b, H-
6’b), 3.78–4.15 (5H, m, H-2a, H-5a, H-6a, H-3b, H-5b), 4.18–4.26 (2H, m, H-6’a, 
OCHH’CH=CH2), 4.31, 4.54 (2H, ABq, JAB  12.5 Hz, PhCH2), 4.31–4.35 (1H, m, H-4a), 4.39 
(1H, dd, J2,3 2.9 Hz, J3,4 10.0 Hz, H-3a), 4.42–4.49 (1H, m, OCHH’CH=CH2), 4.45, 4.58 (2H, 
ABq, JAB 12.2 Hz, PhCH2), 4.47, 4.88 (2H, ABq, JAB 1.0 Hz, PhCH2), 4.71 (1H, d, J1,2 1.3 Hz, 
H-1a), 4.78, 4.93 (2H, ABq, JAB 11.9 Hz, PhCH2), 5.09 (1H, dd, JZ 10.4 Hz, Jgem 1.0 Hz, 
CH=CHEHZ), 5.22 (1H, dd, Jgem 1.6 Hz, JE 17.2 Hz, CH=CHEHZ), 5.47 (1H, s, PhCH), 5.50 
(1H, d, H-1b), 5.96 (1H, m, CH=CH2), 7.00–7.47 (25H, m, Ar–CH); δC (100 MHz, CDCl3):
[45]
 
54.8 (q, OCH3), 63.9 (d, C-5a), 68.6 (t, C-6b), 68.9 (t, C-6a), 70.5 (t, PhCH2), 70.8 (d, C-5b), 72.7 
(d, C-3a), 73.4, 73.8, 74.3, 75.0 (4 x t, OCH2CH=CH2, 3 x PhCH2), 77.2, 77.3 (2 x d, C-2a, C-4b), 
78.6 (d, C-2b), 79.6 (d, C-4a), 81.0 (d, C-3b), 96.9 (d, C-1b), 100.6 (d, C-1a), 102.3 (d, PhCH), 
116.6 (t, CH=CH2), 126.4, 127.0, 127.1, 127.6, 127.6, 127.8, 127.8, 127.9, 128.1, 128.2, 128.2, 
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128.3, 128.4, 129.2 (14 x d, Ar–CH), 135.4 (d, CH=CH2), 137.4, 138.0, 138.0, 138.3, 138.5 (5 x 
s, Ar–C); HRMS (ES+) calculated for C55H58O11Na (MNa
+
) 917.3871, found 917.3879. 
Methyl -2,4,6-tri-O-benzyl-α-D-glucopyranosyl-(1→3)-2-O-benzyl-(R)-4,6-O-benzylidene-α-
D-mannopyranoside
[46] 
3.53 
3.54
O
O
O
Ph
O
OBn
OMe
O
BnO
O
BnO
BnO
O
O
O
Ph
O
OBn
OMe
O
BnO
O
BnO
BnO
O
O
O
Ph
O
OBn
OMe
O
BnO
HO
BnO
BnO
3.53
(PPh3)3RhCl,
n BuLi
THF, 70 °C, 2.5 h
NIS/H2O
THF, rt, 16 h
(74 %)
 
Wilkinson’s catalyst (86 mg, 0.093 mmol) was dissolved in distilled THF (4 mL) and degassed. 
n-Butyl lithium (0.09 mL, 0.14 mmol, 1.6 M solution in hexanes) was added and the mixture 
stirred for 10 min under a nitrogen atmosphere. Allyl protected disaccharide 3.54 (786 mg, 0.93 
mmol) was dissolved in distilled THF (4 mL) and the mixture heated to 70 °C. The catalyst 
solution prepared above was then added via cannula under a nitrogen atmosphere. After 2 h, 30 
min, t.l.c. (petrol:ethyl acetate, 4:1) indicated the presence of a single compound, the vinyl ether 
(Rf 0.3). The mixture was then allowed to cool to rt, and to the mixture was added H2O (5 mL), 
and NIS (1.05 g, 4.65 mmol). The mixture was stirred for 16 h at rt, after which t.l.c. 
(petrol:ethyl acetate, 2:1) indicated the formation of a single product (Rf 0.7), and the complete 
consumption of starting material (Rf 0.6). The solution was then concentrated in vacuo and the 
residue obtained was purified by flash chromatography (petrol:ethyl acetate, 7:2) to afford 
methyl -2,4,6-tri-O-benzyl-α-D-glucopyranosyl-(1→3)-2-O-benzyl-(R)-4,6-O-benzylidene-α-D-
mannopyranoside 3.53 (0.55 g, 74.0%) as white solid; m. p. 43 – 45 °C (petrol/ethyl acetate); 
[α]D
20
 + 104 (c, 1.0 in CHCl3); νmax (KBr) 3758 (br, OH) cm
−1
; δH (400 MHz, CDCl3): 3.30–3.34 
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(4H, m, OCH3, H-2b), 3.53 (1H, at, J 9.4 Hz, H-4b), 3.64–3.71 (2H, m, H-6b, H-6’b), 3.78–3.84 
(4H, m, H-2a, H-5a, H-3b, H-5b), 4.11 (1H, at, J 8.8 Hz, H-6a), 4.31, 4.54 (2H, ABq, JAB  12.5 Hz, 
PhCH2), 4.31–4.35 (1H, m, H-4a), 4.23 (1H, m, H-6’a), 4.36 (1H, dd, J2,3 2.9 Hz, J3,4 10.0 Hz, H-
3a), 4.45, 4.58 (2H, ABq, JAB 12.2 Hz, PhCH2), 4.47, 4.88 (2H, ABq, JAB 1.0 Hz, PhCH2), 4.68 
(1H, d, J1,2 1.3 Hz, H-1a), 4.78, 4.90 (2H, ABq, JAB 11.9 Hz, PhCH2), 5.40 (1H, s, PhCH), 5.50 
(1H, d, H-1b), 7.00–7.47 (25H, m, Ar–H); δC (100 MHz, CDCl3): 54.8 (q, OCH3), 63.9 (d, C-5a), 
68.7 (t, C-6b), 68.9 (t, C-6a), 70.3 (t, PhCH2), 70.4 (d, C-5b), 72.9 (d, C-3a), 73.4, 73.5, 73.8 (3 x 
t, 3 x PhCH2), 74.5, 77.2 (2 x d, C-2a, C-4b), 77.3 (d, C-2b), 77.9 (d, C-4a), 79.6 (d, C-3b), 96.4 (d, 
C-1b), 100.6 (d, C-1a), 102.4 (d, PhCH), 126.4, 127.0, 127.1, 127.6, 127.6, 127.8, 127.8, 127.9, 
128.1, 128.2, 128.2, 128.3, 128.4, 129.2 (14 x d, Ar–CH), 137.4, 138.0, 138.0, 138.3, 138.5 (5 x 
s, Ar–C); HRMS (ES+) calculated for C48H52O11Na (MNa
+
) 827.3401, found 827.3411.   
5.4 Experimental for chapter 4 
2,3,4,6-Tetrabenzyl-β-D-glucopyranosyl trichloroacetimidate[49] 4.45 
O
O
BnO
OBn
OBn
Cl3CCN, K2CO3
DCM, rt, 36 h
(51%)
Bn
O CCl3
NH
4.45
O
O
BnO
OBn
OH
OBnBn
4.34
 
 
Trichloroacetonitrile (1.8 mL, 13.0 mmol) and K2CO3 (flame dried) (5.80 g, 40.0 mmol) were 
added to a solution of 4.34 (500 mg, 0.93 mmol) in anhydrous DCM (50 mL) and the mixture 
was stirred at rt. After 36 h, t.l.c. (petrol:ethyl acetate, 4:1, with 1% TEA) indicated the 
formation of a major product (Rf 0.4) and a minor product (Rf 0.6), and complete disappearance 
of starting material (Rf 0.1). The mixture was then concentrated in vacuo and the residue was 
purified by flash column chromatography (petrol:ethyl acetate, 8:1, with 1% TEA)  and the 
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major product was isolated to afford 2,3,4,5-terabenzyl-β-D-glucopyranosyl trichloroacetimidate 
4.45 as a white crystalline solid (300 mg, 51%); m. p. 90 – 92 °C (petrol/ethyl acetate); νmax 
(KBr) 3336 (w, N-H), 1673 (s, C=N) cm
-1; δH (400 MHz, CDCl3): 3.39-3.49 (2H, m, H-6, H-6’), 
3.50-3.60 (1H, m, H-3), 3.99 (1H, m, H-2), 4.06-4.18 (2H, m, H-4, H-5), 4.44-4.97 (8H, m, 4 x 
OCH2Ph), 5.75 (1H, d, J1,2 7.6 Hz, H-1), 7.26-7.33 (20H, m, Ar-CH), 8.51 (1H, s, N-H); δC (100 
MHz, CDCl3):  68.1 (t, C-6), 73.1, 73.4, 73.5, 74.4 (4 x t, 4 x OCH2Ph), 74.8, 75.2, 78.1 (3 x d, 
C-2, C-4, C-5), 82.2 (d, C-3), 98.7 (d, C-1), 127.5, 127.6, 127.7, 127.8, 127.9, 128.0, 128.2, 
128.3, 128.4 (9 x d, ArCH), 138.3, 138.3, 138.5, 138.5 (4 x s, 4 x ArC), 161.5 (s, C=NH).    
2,3,4,6-Tetrabenzyl-α-D-glucopyranosyl trichloroacetimidate[50] 4.12 
O
O
BnO
OBn
OH
OBnBn
O
O
BnO
O
OBn
Cl3CCN, DBU
CH2Cl2, rt, 1 h
Bn
Bn O
Cl3C
NH4.34
4.12
(89%)
 
To a solution of 4.34 (800 mg, 1.48 mmol) in anhydrous DCM (10 mL) were added 
trichloroacetonitrile (1.7 mL, 12.3 mmol) and DBU (0.090 mL, 0.59 mmol) and the mixture was 
stirred at rt. After 1 h, t.l.c. (petrol:ethyl acetalte, 4:1, with 1% TEA) indicated the formation of a 
major product (Rf 0.6) and a minor product (Rf 0.4), and complete disappearance of starting 
material (Rf 0.1). The solvent was then concentrated in vacuo and the residue was purified by 
flash column chromatography (petrol:ethyl acetate, 10:1, with 1% TEA)  and the major product 
was isolated to afford 2,3,4,5-terabenzyl-α-D-glucopyranosyl trichloroacetimidate 4.12 as a 
colorless oil (900 mg, 89%); νmax (KBr) 3336 (w, N-H), 1673 (s, C=N) cm
-1; δH (400 MHz, 
CDCl3):
[50]
 3.48-3.63 (2H, m, H-6, H-6’), 3.96-4.08 (2H, m, H-3, H-2), 4.10-4.19 (1H, m, H-5), 
4.19-4.24 (1H, m, H-4), 4.38-4.50 (8H, m, 4 x OCH2Ph), 6.53 (1H, d, J1,2 3.2 Hz, H-1), 7.24-
7.34 (20H, m, Ar-CH), 8.51 (1H, s, N-H); δC (100 MHz, CDCl3):  68.3 (t, C-6), 72.2, 72.9, 72.9, 
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73.4 (4 x t, 4 x OCH2Ph), 74.6, 74.9, 75.9 (3 x d, C-2, C-4, C-5), 78.0 (d, C-3), 95.2 (d, C-1), 
127.4, 127.5, 127.6, 127.7, 127.8, 127.9, 128.0, 128.2, 128.3 (9 x d, ArCH), 137.8, 138.4, 138.5, 
138.6 (4 x s, 4 x ArC), 161.2 (s, C=NH).     
2,3,4,6-tetraacetyl-α/β-D-galactopyranosyl-(1→6)-1:2,3:4-di-O-isopropylidene-D-
galactopyranoside 4.46 
O
O
BnO
O
OBnBn
Bn O
Cl3C
NH
4.12
+
O
O
O
OO
OH
2.42
Toluene, reflux, 16 h
O
O
BnO
O
OBnBn
Bn OO
O OO
O
4.46
(30%)
4 A° MS,
N
N
N
H
. HPF6
4.44
 
A solution of 2,3,4,6-tetracetyl-α-D-galactopyranosyl trichloroacetimidate 4.12 (0.050 g, 0.073 
mmol), 1,2:3,4–di–O–isopropylidene–α–D–galactopyranose 2.42 (0.021, 0.079) and 1,5,7-
triazabicyclo[4.4.0]dec-5-enium hexafluorophosphate 4.44 (3.8 mg, 0.015 mmol) in freshly 
distilled toluene (5 mL) was added to a flame-dried round-bottom flask containing activated 4 Å 
molecular sieves (0.100 g). The mixture was refluxed under a nitrogen atmosphere. After 16 h, 
t.l.c. (petrol:ethyl acetate, 2:1) showed formation of a minor product 4.46 (Rf 0.7) together with 
some starting material 4.12 (Rf 0.9) and 2.42 (Rf 0.3). The reaction was quenched with saturated 
aq. sodium bicarbonate solution (5 mL) and filtered through Celite
®
. The mixture was diluted 
with DCM (20 mL), washed with saturated aq. sodium bicarbonate solution (2 x 10 mL), and the 
aqueous layer was extracted with DCM (20 mL). The combined organic extracts were washed 
with brine (25 mL), dried (MgSO4), filtered and concentrated in vacuo. The residue was purified 
by flash column chromatography (petrol:ethyl acetate, 6:1) to afford 2,3,4,6-tetraacetyl-α/β-D-
galactopyranosyl-(1→6)-1:2,3:4-di-O-isopropylidene-D-galactopyranoside 4.46 (0.020 g, 30%) 
     Chapter 5                                                                                                                       Experimental 
                                                                                                                                                                                                                                                     
253 
 
as a colorless oil; δH (400 MHz, CDCl3) [1:1 mixture of α:β anomers observed]: 1.32-1.53 (24H, 
m, 4 x CH3 α, 4 x CH3 β), 1.96-2.03 (12H, m, 2 x COCH3 α, 2 x COCH3 β), 3.44-3.82 (12H, m, 
H-6a α, H-6’a α, H-6a β, H-6’a β, H-6b α, H-6’b α, H-6b β, H-6’b β, H-5a α, H-5a β, H-4b α, H-4b β), 
3.90-4.36 (12H, m, H-2a α, H-2a β, H-2b α, H-2b β, H-3a α, H-3a β, H-3b α, H-3b β, H-4a α, H-4a β, 
H-5b α, H-5b β), 4.39-5.07 (8H, m, 4 x CH2Ph α, 4 x CH2Ph β), 4.41 (1H, m, H-1a β), 5.00 (1H, d, 
J1,2 3.2 Hz, H-1a α), 5.10 (1H, d, J1,2 3.5 Hz, H-1b β), 5.18 (1H, d, J1,2 3.5 Hz, H-1b α), 7.25-7.43 
(40H, m, 20 x Ar-CH α, 20 x Ar-CH β); δC (100 MHz, CDCl3): 24.4, 24.6, 24.9, 25.0, 25.3, 25.9, 
26.0, 26.1 (8 x q, 4 x CH3 α, 4 x CH3 β), 65.8, 66.3, 67.4, 68.6 (4 x t, C-6a α, C-6a β, C-6b α, C-6b 
β), 68.7, 69.2 (2 x d, C-2b α, C-2b β), 69.6, 70.5, 70.6, 70.7, 70.8, 70.9, 71.4, 72.7, 73.0, 73.1 (8 x 
d, C-3a α, C-4a α, C-5a α, C-3a β, C-4a β, C-5a β, C-3b α, C-4b α, C-3b β, C-4b β), 73.3, 73.4, 73.5, 
73.6, 74.5, 74.8, 75.0, 76.4 (8 x t, 4 x CH2Ph α, 4 x CH2Ph β), 77.3, 78.9 (2 x d, C-2a α, C-2a β), 
79.1, 81.9 (2 x d, C-5b α, C-5b β), 96.3 (d, C-1a α), 96.4, 97.5 (C-1b α, C-1b β), 104.6 (d, C-1a β), 
108.5, 108.6, 109.2, 109.3 (4 x s, C(CH3)2 x 2 α, C(CH3)2 x 2 β), 127.4-128.76 (24 x d, 12 x Ar-
CH α, 12 x Ar-CH β), 137.9, 138.0, 138.5, 138.6, 138.7, 138.8, 138.9, 140.0 (8 x s, 4 x Ar-C α, 4 
x Ar-C β); HRMS (ES+) Calculated for C46H54O11Na (MNa
+
) 801.4068, found 801.4072.  
N,N’-bis[3,5-bis(trifluoromethyl)phenyl]thiourea[51] 4.16 
 
S
N
N
N
N
4.32
+
NH2
CF3F3C
4.33
N
H
N
H
S
CF3
4.16
CF3
F3C
CF3
DCM, rt, 24 h
(93%)
 
 
To a mixture of 1,1’ – thiocarbonyldiimidazole 4.32 (500 mg, 2.81 mmol) in DCM (3 mL) was 
added 3,5 – bis(trifluoromethyl)aniline 4.33 (0.91 mL, 5.90 mmol) under a nitrogen atmosphere. 
The resulting solution was stirred for 24 h at rt. The solvent was evaporated and diethyl ether (25 
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mL) was then added. The organic phase was washed with aq. HCl (1 M, 3 x 10 mL), saturated 
aq. sodium bicarbonate solution (3 x 10 mL), and brine (3 x 10 mL). The organic phase was 
dried (MgSO4), filtered and concentrated in vacuo. The residue was recrystallized (CHCl3) to 
afford N,N’-bis[3,5-bis(trifluoromethyl)phenyl]thiourea 4.16 as white crystalline solid (1.13 g, 
93%); m. p. 167 – 168 °C (CHCl3) (lit.
[51] 
172 – 173 °C); δH (400 MHz, CDCl3):
 [51]
 1.55 (2H, s, 
2 x N-H), 7.78 (2H, s, C-Hpara), 7.87 (4H, s, C-Hortho); δC (100 MHz, [d4] methanol): 120.47 (d, 
CH), 123.17 (s, Cq), 125.87 (d, CH), 132.67 (s, Cq), 142.51 (s, Cq), 182.20 (s, C=S); δF (380 
MHz, CDCl3): -63.06; HRMS (ES
+
) calculated for C17H9F12N2S (MH
+
) 501.0297, found 
501.0300.  
2,3,4,6-Tetra-O-benzyl-α/β-D-glucopyranosyl-(1→6)-1:2,3:4-Di-O-isopropylidene-D-
glucopyranoside
[52]
 4.35 
O
O
BnO
O
OBnBn
Bn O
Cl3C
NH
4.12
+ O
OH
O
O
O O
2.42
4.16 (5 mol %)
Catalyst (5 mol %)
O
O
BnO
O
OBnBn
Bn
O
O
O
O O
O
a
b
4.35
DCM
 
 
O-(2,3,4,6-Tetra-O-benzyl-α-D-galactopyranosyl) trichloroacetimidate 4.12 (100 mg, 0.14 
mmol), 1,2:3,4-di-O-isopropylidene-α-D-galactopyranoside 2.42 (50 mg, 0.18 mmol) and the 
cocatalyst 4.16 (3.5 mg, 0.007 mmol) were dissolved in freshly distilled DCM (2 mL) and stirred 
at rt for 5 min under a nitrogen atmosphere. The phosphoric acid derived catalyst (0.0035 mmol) 
was then added. aftert.l.c. (petrol:ethyl acetate, 5:1) indicated the complete consumption of the 
trichloroacetimidate starting material (Rf 0.7) and the formation of product (Rf 0.5), the reaction 
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was quenched by the addition of triethylamine and filtered through Celite
®
. The mixture was 
then concentrated in vacuo and The residue was purified by flash column chromatography 
(petrol:ethyl acetate, 6:1) to afford 2,3,4,6-tetra-O-benzyl-α/β-D-galactopyranosyl-(1→6)-
1:2,3:4-Di-O-isopropylidene-D-galactopyranoside 4.35 as a pale yellow oil; δH (400 MHz, 
CDCl3)
[53]
 [Data provided for 1:1 mixture of α:β anomers] 1.26, 1.30, 1.32, 1.40, 1.43, 1.49, 
1.51, 1.63 (24H, 8 x s, 4 x CH3 α, 4 x CH3 β), 3.50-3.59 (6H, m, H-6a α, H-6a β, H-6’a α, H-6’a β, 
H-3b α, H-3b β), 3.68-3.84 (4H, m, H-4b α, H-4b β, H-5b α, H-5b β), 3.88 (1H, br d, J 2.7 Hz, H-2a 
α), 3.98-4.16 (7H, m, H-4a α, H-4a β, H-5a α, H-5a β, H-2a β, H-3a α, H-2b α/β), 4.22 (1H, dd, J 
7.9 Hz, J 2.1 Hz, H-3a β), 4.30-4.34 (3H, m, H-6b α, H-6b β, H-2b α/β), 4.39-4.52 (5H, m, H-1a β, 
CH2Ph α, CH2Ph β), 4.60 (2H, m, H-6’b α, H-6’b β), 4.59-5.06 (12H, m, 3 x CH2Ph α, 3 x CH2Ph 
β), 5.01 (1H, d, J1,2 3.4 Hz, H-1aα), 5.50 (1H, d, J1,2 5.1 Hz, H-1aα), 5.55 (1H, d, J1,2 4.8 Hz, H-
1aβ), 7.23-7.45 (40H, m, 20 x ArC-H α, 20 x ArC-H β); δC (100 MHz, CDCl3) 24.4, 24.5, 24.9, 
25.0, 25.1, 25.9, 26.0, 26.1 (8 x q, 4 x CH3 α, 4 x CH3 β), 65.8 (d, C-5b α/β), 66.3 (t, C-6a α), 67.4 
(t, C-6a β), 68.6 (d, C-5b α/β), 68.7, 69.1 (2 x d, C-2a α, C-2a β), 69.6, 70.5 (C-2b α, C-2b β), 70.6, 
70.7, 70.8, 70.9 (4 x d, C-3b α, C-3b β, C-4b α, C-4b β), 71.4, 72.7, 72.8, 73.0, 73.1, 73.2, 73.3, 
73.4, 73.5, 73.6 (10 x t, C-6b α, C-6b β, 4 x CH2Ph α, 4 x CH2Ph β), 74.5, 74.8 (2 x d, C-4b α, C-
4b β), 74.9 (d, C-3a α/β), 78.9, 79.1 (2 x d, C-5a α, C-5a β),  81.9 (d, C-3a α/β), 96.3, 96.4 (2 x d, 
C-1b α, C-1b β), 97.5 (d, C-1a α), 104.6 (d, C-1a β), 108.5, 108.6, 109.2, 109.3 (4 x s, 2 x C(CH3)2 
α, 2 x C(CH3)2 β), 127.3, 127.4, 127.4, 127.5, 127.6, 127.6, 127.7, 127.8, 127.8, 127.9, 127.9, 
128.0, 128.0, 128.1, 128.1, 128.2, 128.2, 128.3, 128.4, 128.4, 128.5, 128.5, 128.6, 128.7 (24 x d, 
12 x ArC-H α, 12 x ArC-H β) 137.9, 138.0, 138.5, 138.6, 138.8, 138.9, 139.0, 139.1 (8 x s, 4 x 
Ar-C α, 4 x Ar-C β); HRMS (ES+) calculated for C46H54O11Na (MNa
+
) 805.3558, found 
805.3568. 
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Isopropyl 2,3,4,6-Tetra-O-benzyl-α/β-D-galactopyranoside[52] 4.29 
O
O
BnO
O
OBnBn
Bn O
Cl3C
NH
4.12
+
Catalyst (5 mol%)
4.5 (5 mol%)
O
O
BnO
O
OBnBn
Bn O
OH
4.26
4.29
DCM
 
O-(2,3,4,6-Tetra-O-benzyl-α-D-galactopyranosyl) trichloroacetimidate 4.12 (100 mg, 0.14 
mmol), propan-2-ol 4.26 (14 μL, 0.18 mmol) and the cocatalyst 4.16 (3.5 mg, 0.007 mmol) were 
dissolved in freshly distilled DCM (2 mL) and stirred at rt for 5 min in a nitrogen atmosphere. 
The phosphoric acid catalyst (0.0035 mmol) was then added. Aftert.l.c. (toluene:ethyl acetate, 
9:1) indicated the complete consumption of starting material (Rf 0.7) and the formation of 
product (Rf 0.68) the reaction was quenched by the addition of triethylamine and filtered through 
Celite
®
. Then the reaction was then allowed to run for 72 h. The mixture was then concentrated 
in vacuo and The residue was purified by flash column chromatography (petrol:ethyl acetate, 
6:1) to afford isopropyl 2,3,4,6-tetra-O-benzyl-α/β-D-galactopyranoside 4.29 as a pale yellow oil; 
δH (400 MHz, CD3CN) [Data provided for 1:3 mixture of α:β anomers] 1.15-1.23 (24H, m, 
CH(CH3)2 α, 3 x CH(CH3)2 β), 3.49-3.64 (16H, m, H-2 α, 3 x H-2 β, H-5 α, 3 x H-5 β, H-6 α, 3 x 
H-6 β, H-6’ α, 3 x H-6 β), 3.88-4.04 (12H, m, H-3 α, 3 x H-3 β, H-4 α, 3 x H-4 β, CH(CH3)2 α, 3 
x CH(CH3)2 β), 4.45 (3H, d, J1,2 8.0 Hz, 3 x H-1 β), 4.48-4.89 (32H, m, 4 x CH2Ph α, 12 x 
CH2Ph β), 5.07 (1H, d, J1,2 3.2 Hz, H-1 α), 7.26-7.50 (80H, m, 20 x ArC-H α, 60 x ArC-H β); δC 
(100 MHz, CD3CN) 20.8, 21.4, 22.8, 23.0 (4 x q, CH(CH3)2 α, CH(CH3)2 β), 68.9 (t, C-6 β), 69.1 
(t, C-6 α), 69.3 (d, C-3 α), 71.4 (d, C-3 β), 72.0, 72.2 (2 x d, C-4 α, C-4 β), 72.3, 72.8, 72.9, 74.3, 
74.4, 74.5, 74.6, 75.6 (8 x t, 4 x CH2Ph α, 4 x CH2Ph β), 74.3,74.3 (2 x d, CH(CH3)2 α, 
CH(CH3)2 β), 76.1 (d, C-5 α), 78.5 (d, C-2 α), 79.3 (d, C-5 β), 79.3 (d, C-2 β), 95.3 (d, C-1 α), 
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101.9 (d, C-1 β), 127.3, 127.3, 127.4, 127.4, 127.5, 127.5, 127.6, 127.6, 127.7, 127.7, 127.8, 
127.8, 127.9, 127.9, 128.0, 128.0, 128.1, 128.1, 128.2, 128.2, 128.2, 128.3, 128.3, 128.4 (24 x d, 
12 x ArC-H α, 12 x ArC-H β) 138.6, 138.8, 138.9, 139.0, 139.1, 139.1, 139.2, 139.3 (8 x s, 4 x 
Ar-C α, 4 x Ar-C β); HRMS (ES+) calculated for C37H42O6Na (MNa
+
) 605.2861, found 
605.2867. 
Methyl 2,3,4,6-Tetra-O-benzyl-α/β-D-galactopyranoside[52] 4.38 
O
O
BnO
O
OBnBn
Bn O
Cl3C
NH
4.12
+
catalyst (5 mol%)
4.16 (5 mol%)
O
O
BnO
O
OBnBn
Bn OMe
MeOH
4.37
4.38
DCM
 
O-(2,3,4,6-Tetra-O-benzyl-α-D-galactopyranosyl) trichloroacetimidate 4.12 (100 mg, 0.14 
mmol), methanol 4.37 (6 μL, 0.18 mmol) and the cocatalyst 4.16 (3.5 mg, 0.007 mmol) were 
dissolved in freshly distilled DCM (2 mL) and stirred at rt for 5 min in a nitrogen atmosphere. 
The phosphoric acid derived catalyst (0.0035 mmol) was then added. When t.l.c. (petrol:ethyl 
acetate, 5:2) indicated the complete consumption of starting material (Rf 0.7) and the formation 
of product (Rf 0.65) the reaction was quenched by the addition of triethylamine and filtered 
through Celite
®
. The mixture was then concentrated in vacuo and The residue was purified by 
flash column chromatography (petrol:ethyl acetate, 6:1) to afford methyl 2,3,4,6-tetra-O-benzyl-
β-D-galactopyranoside 4.38 as a pale yellow oil, [α]D
20
 – 1.4 (c, 1.0 in CHCl3), lit.
[54]
 [α]D
20
 – 0.9 
(c, 1.0 in CHCl3); δH (400 MHz, CDCl3): 3.52-3.63 (5H, m, CH3, H-3, H-5), 3.82 (1H, at, J 8.4 
Hz, H-2), 3.91 (1H, m, H-4), 4.29 (1H, d, J1,2 7.2 Hz), 4.41-4.46 (2H, m, H-6, H-6’), 4.61-4.97 
(8H, m, 4 x CH2Ph), 7.25-7.39 (20H, m, ArC-H); δC (100 MHz, CDCl3) 57.0 (q, OCH3), 68.9 (d, 
C-3), 73.2 (d, C-4), 73.4 (t, C-6), 73.5, 73.6, 74.5, 75.1 (4 x t, 4 x CH2Ph), 79.6 (d, C-2), 82.1 (d, 
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C-5), 105.0 (d, C-1), 127.5, 127.6, 127.7, 127.8, 127.9, 128.0, 128.1, 128.2, 128.3, 128.3, 128.4, 
128.5 (12 x d, 12 x ArC-H) 137.9, 138.5, 138.6, 138.8 (4 x s, 4 x Ar-C); HRMS (ES
+
) calculated 
for C35H38O6Na (MNa
+
) 577.2560, found 577.2569. 
1,5,7-Triazabicyclo[4.4.0]dec-5-enium chloride
[47]
 4.20 
N
N
N
H
NH4Cl
MeOH, rt 60 °C, 24 h N
N
N
H
. HCl
4.20
(95%)
4.19  
Ammonium chloride (0.1605 g, 3.00 mmol) was suspended in methanol (2 mL) and stirred under 
a nitrogen atmosphere at rt. 1,5,7-triazabicyclo[4.4.0]dec-5-ene 4.19 (417 mg, 3.00 mmol) was 
added to the solution over a period of 30 min. The mixture was stirred for a further 3 h and the 
solvent was then evaporated. The residue was heated at 60 °C under vacuum for 24 h to afford 
1,5,7-triazabicyclo[4.4.0]dec-5-enium chloride 4.20 (500 mg, 95%), as a white solid; δH (400 
MHz, CDCl3):
 [47]
 1.79 (1H, bs, N-H), 1.97-2.03 (4H, m, H-2, H-2’, H-5, H-5’), 3.27-3.35 (8H, 
m, H-1, H-1’, H-3, H-3’, H-4, H-4’, H-6, H-6’), 8.70 (1H, bs, N-H(+)); δC (100 MHz, CDCl3): 
20.6 (t, C-2, C-5), 37.9 (C-3, C-4), 46.84 (t, C-1, C-6), 151.8 (s, C-7); HRMS (ES
+
) calculated 
for C7H14N3 (M
+ 
- Cl) 140.1182, found 140.1188. 
1,5,7-Triazabicyclo[4.4.0]dec-5-enium hexafluorophosphate
[48]
 4.21 
N
N
N
H
. HCl
NaPF6
CH3CN, rt, 0.5 h N
N
N
H
. HPF6
4.214.20
(95%)
 
NaPF6 (0.447 g, 2.66 mmol) was added to a stirred solution of 1,5,7-triazabicylo[4.4.0]dec-5-
enium chloride 4.20 (0.465g, 2.66 mmol) in anhydrous acetonitrile (5 mL), and was stirred at rt 
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for 30 min under a nitrogen atmosphere. The mixture was then filtered through Celite
®
 which 
was washed with acetonitrile (5 mL). The filtrate was then concentrated in vacuo to afford 1,5,7-
triazabicylo[4.4.0]dec-5-enium hexafluorophosphate 4.21 (0.720 g, 95%) as a white crystalline 
solid; νmax (KBr) 1637 (s, C=N), 3260 (s, sharp, N-H) cm
-1
;
 δH (400 MHz, CDCl3): 2.02-2.08 
(4H, m, H-2, H-2’, H-5, H-5’), 3.34-3.37 (8H, m, H-1, H-1’, H-3, H-3’, H-4, H-4’, H-6, H-6’), 
8.70 (1H, bs, N-H
(+)); δC (100 MHz, CDCl3): 20.6 (t, C-2, C-5), 37.9 (t, C-3, C-4), 46.9 (t, C-1, 
C-6); δF (380 MHz, CDCl3): -73.15, -71.25; δP (162 MHz, CDCl3): -157.4, -153.0, -148.6, -
144.2, -135.4, -131.0; HRMS (ES
+
) calculated for C7H14N3 (M
+ 
- PF6) 140.1182, found 
140.1183. 
1,2:3,4–di–O–isopropylidene-6-trichloroacetimidate–α–D–galactopyranose 4.47 
O
O
CCl3
NHO
O
BnO
OBn
Bn
+ O
OO
O
O
OH
O
O
BnO
OBn
Bn
+ O
OO
O
O
O
OH
CCl3
NH
4.12
4.42
4.34
4.47
2.42
N
N
N
H OBn Bn
DCM, rt, 16 h
(70 %)
 
 
A solution of 2,3,4,6-tetracetyl-α-D-galactopyranosyl trichloroacetimidate 4.12 (0.100 g, 0.146 
mmol), 1,2:3,4–di–O–isopropylidene–α–D–galactopyranose 2.42 (0.078, 0.300) and 1,5,7-
triazabicyclo[4.4.0]dec-5-enium 4.42 (3.2 mg, 0.030 mmol) in freshly distilled DCM (5 mL) was 
added to a flame-dried round-bottom flask containing activated 4 Å molecular sieves (0.100 g). 
The mixture was refluxed under a nitrogen atmosphere. After 16 h, t.l.c. (petrol:ethyl acetate, 
2:1) showed formation of two products 4.34 (Rf 0.2), 4.47 (Rf 0.7), and complete disappearance 
of starting material 4.12 (Rf 0.3). The reaction was quenched with saturated aq. sodium 
bicarbonate solution (5 mL) and filtered through Celite
®
. The mixture was diluted with DCM (20 
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mL), washed with saturated aq. sodium bicarbonate solution (2 x 10 mL), and the aqueous layer 
was extracted with DCM (20 mL). The combined organic extracts were washed with brine (25 
mL), dried (MgSO4), filtered and concentrated in vacuo. The residue was purified by flash 
column chromatography (petrol:ethyl acetate, 6:1) to afford 1,2:3,4–di–O–isopropylidene-6-
trichloroacetimidate–α–D–galactopyranose 4.47 (0.045 g, 70%) as a white solid; m.p. 63-65 °C; 
[α]D
20
 - 35.0  (c, 1.0 in CHCl3); νmax (KBr) 1,667 (s, C=NH) cm
−1
; δH (400 MHz, CDCl3): 1.31, 
1.32, 1.45, 1.48 (12H, 4 x s, 4 x CH3), 4.20 (1H, t, J 7.5 Hz, H-4), 4.28–4.32 (2H, m, H-2, H-5), 
4.39 (1H, d, J 7.7 Hz, H-3), 4.54 (1H, dd, J6,6’ 4.9 Hz, J6,5 2.3 Hz, H-6), 4.61 (1H, dd, J6’,5 7.9 
Hz, J6’5 2.3 Hz, H-6’), 5.53 (1H, d, J1,2 5.1 Hz, H-1), 8.31 (1H, s, NH); δC (100 MHz, CDCl3): 
24.4, 24.9, 25.9, 26.0 (4 x q, 4 x CH3), 65.4 (t, C-6), 67.8, 70.5, 70.6, 71.0 (4 x d, C-2, C-3, C-4, 
C-5), 96.3 (d, C-1), 108.8, 109.6 (2 x s, C(CH3)2), 162.6 (s, C=NH); HRMS (ES
+
) Calculated for 
C13H17O6NCl3 (MH
+
) 404.0429, found 412.0438. 
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